As filed with the Securities and Exchange Commission on August 14, 2020

Registration No. 333-[             ]

AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JANUARY 17, 2012

REGISTRATION NO. 333-177248

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington,

WASHINGTON, D.C. 20549

AMENDMENT NO. 4 TO

FORM S-1

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

MPHASEmPHASE TECHNOLOGIES, INC.


(Exact name of registrant as specified in its charter)

New Jersey738522-228-750322-2287503
(State or other jurisdiction of(Primary Standard Industrial(I.R.S. Employer
incorporation or organization)Classification CodeIdentification Number)Identification No.)

587 Connecticut Avenue
Norwalk, Ct. 06854
203-831-2242

9841 Washingtonian Blvd., Suite 390

Gaithersburg, MD 20878

(301) 329-2700

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

Martin Smiley
587 Connecticut Avenue
Norwalk, Ct. 06854
203-831-2242

Anshu Bhatnagar

Chief Executive Officer

mPhase Technologies, Inc.

9841 Washingtonian Blvd., Suite 390

Gaithersburg, MD 20878

(301) 329-2700

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to:

Martin Smiley
587 Connecticut Avenue
Norwalk, Ct. 06854
203-831-2242

Tad Mailander, Esq.

Mailander Law Office, Inc.

4811 49th Street

San Diego, CA 92115

Phone: (619) 239-9034

Approximate date of commencement of proposed sale to the public:From time to time As soon as practicable after the effective date of this registration statement.Registration Statement becomes effective.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box.box: [X]

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act of 1933, please check the following box and list the Securities Act of 1933 registration statement number of the earlier effective registration statement for the same offering. [  ]

(COVER CONTINUES ON FOLLOWING PAGE)

1


If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act of 1933, check the following box and list the Securities Act of 1933 registration statement number of the earlier effective registration statement for the same offering. [  ]

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act of 1933, check the following box and list the Securities Act of 1933 registration statement number of the earlier effective registration statement for the same offering. [  ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”filer,” “smaller reporting company” and “smaller reporting“emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

[   ] Large accelerated filer        [   ] Accelerated filer        [   ] Non-accelerated filer        [X]

Large accelerated filer[  ]Accelerated filer[  ]
Non-accelerated filer[X]Smaller reporting company[X]
Emerging growth company[  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. [  ]

CALCULATION OF REGISTRATION FEE


Title of each class of securities
to be registered
 
Amount
registered
 
 Proposed
maximum
offering
price
per share
(1)(2)
  Proposed
maximum
aggregate
offering price
(2)
  
Amount of
registration
fee
(3)
 
              
Common Stock issuable upon conversion of Convertible Note, $0.001 par value per share 185,400,000 (1)$ 0.005 $ 927,000.00 $ 106.23 
              
Common Stock issuable upon Conversion of Warrant 3,676,471  $ 0.005 $ 18,382.36 $ 2.11 
              
Common Stock issued to cover Commitment and Transaction Fees of Equity Line of Credit 26,000,000  $ 0.005 $ 130,000.00 $ 14.9 
              
Common Stock issuable upon Put feature of Equity Line Of Credit, $0.001 par value per share 250,000,000 (4)$ 0.005 $ 1,250,000 $ 143.25 
              
Total 465,076,471  $ 0.005 $2,325,382 $266.49 

     Proposed  Proposed    
     Maximum  Maximum    
  Amount  Offering  Aggregate  Amount of 

Title of Each Class of Securities to be

Registered (1)

 to be
Registered
  Price Per
Share (2)
  Offering
Price (2)
  Registration
Fee
 
Common Stock, par value $0.01 per share  10,406,591  $0.0340  $

353,824

  $46.00 

(1)

The Registrant is registering,shares of our common stock being registered hereunder are being registered for sale by the selling security holders named in the prospectus. Under Rule 416 of the Securities Act of 1933, as required pursuant to that certain registration rights agreement dated asamended, the shares being registered include such indeterminate number of September 13, 2011, with John Fife 185,400,000 shares of common stock “Convertible Shares”..

as may be issuable with respect to the shares being registered in this registration statement as a result of any stock splits, stock dividends or other similar event. The 10,406,591 shares being registered represent approximately 33% of the shares in the public float as of August 13, 2020. Assuming all of these shares are sold, the registrant’s total number of issued and outstanding shares of common stock will be 83,647,488, calculated on the total number of shares issued and outstanding at August 13, 2020, of 73,240,897. The total number of registered shares represents 14.21% of the issued and outstanding shares.
  
(2)

EstimatedThe proposed maximum offering price per share and the proposed maximum aggregate offering price have been estimated solely for the purpose of calculating the amount of the registration fee pursuant toin accordance with Rule 457(c) under the Securities Act of 1933, based uponas amended using the average of the high and low sales prices as reported on The OTCQB tier of the registrant’s common stockOTC Markets on October 2, 2011, as traded on the over the counter bulletin board.

(3)

Calculated pursuant to Rule 457(o) under the Securities Act of 1933, as amended, based on the proposed maximum aggregate offering price of all securities listed.

(4)

The Registrant is also registering, as required pursuant to that certain investment agreement registration rights agreement each dated as of November 30, 2011 with Dutchess Opportunity Fund II, L.P a total of 250,000,000 shares of its common stock that the Company, may from time to time, Put to Dutchess in exchange for cash based upon a 6% discount from the lowest Variable Weight Average Price of the Company’s Common stock during a ten consecutive day trading period following the Company’s exercise of the Put.

August 13, 2020.

In the event of stock splits, stock dividends, or similar transactions involving the Common Stock, the number of Common Shares registered shall, unless otherwise expressly provided, automatically be deemed to cover the additional securities to be offered or issued pursuant to Rule 416 promulgated under the Securities Act of 1933, as amended (the “Securities Act”).

2


The registrant hereby amends this Registration Statementregistration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statementregistration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this Registration Statementthe registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

January 17, 2012

PROSPECTUS

You should read

The information in this Prospectus Summary togetherpreliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the more detailed information containedSecurities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in this prospectus, includingany jurisdiction where the risk factors and financial statements. This prospectus contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those discussed in the forward-looking statements. Factors that may cause such a difference include those discussed in the Risk Factors section and elsewhere in this prospectus.offer or sale is not permitted.

mPhase Technologies, Inc.
465,076,471

PRELIMINARY PROSPECTUS - SUBJECT TO COMPLETION

Dated August 14, 2020

10,406,591 Shares of Common Stock

This prospectus relates to the resale of up to 465,076,47110,406,591 shares (the “Commonof our common stock, par value $0.01 per share (“Common Stock”), issuable to White Lion Capital, LLC (“White Lion”), a selling stockholder pursuant to a common stock purchase agreement (“Purchase Agreement”), dated July 13, 2020. The Purchase Agreement permits us to issue purchase notices to White Lion for up to three million dollars ($3,000,000) in shares of our Common Stock par value $.01 per share,over a period of mPhase Technologies, Inc. (“Company”), a New Jersey Corporation, by the selling stockholders including up to (a)185,400,000thirty (30) months or until $3,000,000 of such shares by John Fife, upon conversion from time to timehave been subject of a convertible note described below, (b) 3,676,471 of shares to be sold by Jay Wright, upon exercise from time to time of a warrant (c) 250,000,000 shares of common stock that may be PUT by the Company to Dutchess Opportunity Fund II, LP (“Dutchess”) and resold from time to time under an arrangement known as an “ Equity Line.” pursuant to the terms of an investment agreement and (d) 26,000,000 of a commitment fee payable to Duchess by the Company for the Equity Line.purchase notice.

The selling stockholdersstockholder may sell all or a portion of the shares being offered pursuant to this prospectus at fixed prices, at prevailing market prices at the time of sale, at varying prices or at negotiated prices. For additional information regarding the methods of sale you should refer to the section entitled “Plan of Distribution” in this Prospectus.

White Lion is an underwriter within the meaning of the Securities Act of 1933, and any broker-dealers or agents that are involved in selling the shares may be deemed to be “underwriters” within the meaning of the Securities Act of 1933 in connection with such sales. In such event, any commissions received by such broker-dealers or agents, and any profit on the resale of the shares purchased by them, may be deemed to be underwriting commissions or discounts under the Securities Act of 1933.

Our Common Stock from time to time inis presently quoted on the principal market on whichOTCQB under the stock is traded at the prevailing marketsymbol “XDSL.” The closing price or in negotiated transactions.

We will not receive any of the proceeds from the sale of Convertible Shares ofour Common Stock on August 13, 2020, as reported by the holder of the Convertible Note . We will receive up to $25,000 in proceeds if the Warrant is exercised in full. OTCQB, was $0.0321 per share.

We will not receive any proceeds from the offer for sale of shares of our Common Stock by Dutchess under the Equity Line. Weselling stockholder. However, we will however, receive proceeds from the sale to Dutchessof shares of our Common Stock pursuant to our exercise of the Equity Line.purchase notice offered by White Lion. We will paybear all costs relating to this offering, except that the selling stockholder will bear all broker discounts or commissions or equivalent expenses of registering allits legal counsel applicable to the sale of the foregoingits shares.

Investment

Investing in theour Common Stock involves a high degree of risk. You should consider carefullySee the risk factorssection entitled “Risk Factors” beginning on page 86 of this prospectus before purchasing anyand elsewhere in this prospectus for a discussion of the shares offered by this prospectus.

Our Common Stock is quoted on the Over-the-Counter Bulletin Board and trades under the symbol "XDSL". The last reported sale price ofinformation that should be considered in connection with an investment in our Common Stock on the Over-the-Counter Bulletin Board on December 22, 2011, was approximately $.0033 per share.Stock.

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read the entire prospectus and any amendments or supplements carefully before you make your investment decision.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined ifpassed upon the adequacy or accuracy of this prospectus is truthful or complete.prospectus. Any representation to the contrary is a criminal offense.

The date of this Prospectusprospectus is January 17, 2012.August 14, 2020.

3


mPhase Technologies, Inc.

TABLE OF CONTENTS

 Page
PART I - INFORMATION REQUIRED IN PROSPECTUS
Prospectus Summary54
Risk Factors86
Cautionary Note Regarding Forward-Looking Statements1718
Use of Proceeds1718
Determination of Offering Price1718
Dilution1718
Selling Security HoldersDividend Policy1819
Selling Stockholders19
Plan of Distribution1920
Description of Securities to be Registered2021
Shares Eligible for Future Sale22
Interests of Named Experts and Named Counsel2122
Description of BusinessInformation With Respect to the Registrant2122
Description of PropertyMarket for Common Equity and Related Stockholder Matters2531
Legal Proceedings25
Management’s Discussion and Analysis of Financial Condition and Results of Operations2631
Market Price of and Dividends on Registrant's Common Equity and Related Stockholder Matters35
Changes in and Disagreements with Accountants37
Quantitative and Qualitative Disclosures about Market Risk37
Directors, Executive Officers, Promoters and Control Persons3736
Executive Compensation3937
Security Ownership ofOf Certain Beneficial Owners andAnd Management4139
Certain Relationships andAnd Related Party Transactions and Corporate Governance4239
Additional Information46
Disclosure of Commission Position on Indemnification for Securities Act Liabilities47
Legal Matters4740
Experts4740
Audited Where You Can Find More Information41
Financial Statements4843
PART II - INFORMATION NOT REQUIRED IN PROSPECTUS
Other Expenses of Issuance and Distribution9944
Indemnification of Directors and Officers9944
Recent Sales of Unregistered Securities9944
Exhibits and Financial Statement Schedules46
105Undertakings46
Signatures48

 

You mayshould rely only rely on the information contained in this prospectus or in any free writing prospectus that we have referred you to.may specifically authorize to be delivered or made available to you. We have not authorized anyone to provide you with information that is different information.from that contained in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus does not constitute anmay only be used where it is legal to offer toand sell or a solicitation of an offer to buy any securities other than the Common Stock offered by this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any Common Stockour securities. The information in any circumstances in which such offer or solicitation is unlawful. Neither the delivery of this prospectus nor any sale made in connection with this prospectus shall, under any circumstances, create any implication that there has been no change in our affairs sinceis accurate only as of the date of this prospectus, or thatregardless of the information contained by reference totime of delivery of this prospectus or any sale of our securities. Our business, financial condition, results of operations and prospects may have changed since that date. We are not making an offer to sell these securities and are not soliciting an offer to buy these securities in any state where the offer or sale is correct as of any time after its date.

4


Prospectus Summarynot permitted.

 This

-3-

PROSPECTUS SUMMARY

The following summary highlightsis qualified in its entirety by, and should be read together with, the more detailed information containedand financial statements and related notes thereto appearing elsewhere in this prospectus. YouBefore you decide to invest in our securities, you should read the entire prospectus carefully;carefully, including the section entitled "Risk Factors" before decidingRisk Factors and the financial statements and related notes included in this prospectus.

Unless the context indicates or otherwise requires, the “Company,” “we,” “us,”, “our” “mPhase” or the “Registrant” refer to invest in our Common Stock.

About Us

mPhase Technologies, Inc., a New Jersey corporation, (the “Company”and its subsidiaries.

Overview

The Company was incorporated in the state of New Jersey in 1979 under the name Tecma Laboratory, Inc. and has subsequently operated under Tecma Laboratories, Inc., “mPhase”and Lightpaths TP Technologies, Inc., “we”until June 2, 1997 when the Company changed its name to mPhase Technologies, Inc.

Through fiscal year ended June 30, 2018, the Company solely focused on the management of intellectual property associated with the development of innovative power cells and related products through the science of microfluidics, microelectromechanical systems (MEMS) and nano-technology.

On January 11, 2019, the Company underwent a major change in management and control. The new management of the Company is positioning the Company to be a technology leader in artificial intelligence and machine learning while enabling a more rapid commercial development of its patent portfolio and other intellectual property. The Company’s goal is to generate significant revenue from its artificial intelligence and machine learning technologies.

On February 15, 2019, the Company acquired Travel Buddhi, a software platform to enhance travel via ultra-customization tools that tailor a planned trip experience in ways not previously available.

On June 30, 2019, the Company acquired 99% of the outstanding common shares of Alpha Predictions LLP (“Alpha Predictions”). Alpha Predictions is an India-based technology company that has developed a suite of commercial data analysis products for use across multiple industries. The current product offering includes software covering eight categories: inventory, stock management, marketing optimization, sentiment analysis, customer segmentation and behavior, agro-tech image detection, electrocardiogram automation, and a recommendation engine with multiple uses.

On May 11, 2020, the Company acquired all of the assets owned, used, or held by CloseComms Limited (“CloseComms”), “us”, or “our”a United Kingdom based company with offices in Wales (U.K.) and California (U.S.). One of the CloseComms acquired assets is a publicly-held New Jersey company foundedpatented software application platform that can be integrated into a retail customer’s existing Wi-Fi infrastructure, giving the retailer important customer data and enabling AI-enhanced, targeted promotions to drive store traffic and sales.

Competition

The industry of artificial intelligence and machine learning software is highly competitive. Well capitalized companies such as Amazon, Google, IBM and Microsoft are devoting significant resources and capital in 1996developing customer products and solutions using this type of technology. Such companies have far greater resources than the Company. The Company believes, however, that it has assembled a team of highly qualified software and technology experts on a very cost-effective basis. The Company is also acquiring entities that have already established customer relationships, revenues and market niches that will enable the Company to leverage off such capabilities, and where appropriate, enhance its existing technologies.

Recent Developments

Financings

On July 31, 2020, we issued a convertible note in the principal amount of $68,000, which note accrues interest at a rate of 8% per annum, matures on July 31, 2021 and is convertible into shares of our common stock at a conversion price as defined in the convertible note, subject to adjustment.

On July 24, 2020, we issued a convertible note in the principal amount of $105,000, which note accrues interest at a rate of 8% per annum, matures on July 24, 2021 and is convertible into shares of our common stock at a conversion price as defined in the convertible note, subject to adjustment.

On June 12, 2020, we issued a convertible note in the principal amount of $103,000, which note accrues interest at a rate of 8% per annum, matures on June 12, 2021 and is convertible into shares of our common stock at a conversion price as defined in the convertible note, subject to adjustment.

On June 2, 2020, we issued a convertible note in the principal amount of $78,000, which note accrues interest at a rate of 8% per annum, matures on June 2, 2021 and is convertible into shares of our common stock at a conversion price as defined in the convertible note, subject to adjustment.

-4-

THE OFFERING

On July 13, 2020, we entered into a Purchase Agreement with approximately 23,000 shareholdersWhite Lion Capital, LLC, a Nevada limited liability company. Pursuant to the Purchase Agreement, White Lion is committed to purchase up to $3,000,000 of our Common Stock over a period of up to 30 months. From time to time during the 30 month period commencing from the effectiveness of the registration statement, we may deliver a purchase notice to White Lion which states the dollar amount of our Common Stock that we intend to sell to White Lion on a date specified in the purchase notice. The maximum investment amount per notice must be no more than 250% of the average daily trading dollar volume of our Common Stock for the five (5) consecutive trading days immediately prior to date of the applicable purchase notice. The purchase price per share to be paid by White Lion will be 95% of the lowest traded price of the Common Stock the five business days prior to the closing date.

In connection with the Purchase Agreement with White Lion, we also entered into a registration rights agreement (“Registration Agreement”) with White Lion, pursuant to which we agreed to use our best efforts to, within 45 business days of July 13, 2020, file with the Securities and approximately 2,892,510,073Exchange Commission a registration statement, covering the resale of an aggregate 93,457,944 shares of our Common Stock underlying the Purchase Agreement with White Lion. Of the total number of shares underlying the Purchase Agreement, we are registering 10,406,591 shares of Common Stock, representing 33% of the shares in the public float as of August 13, 2020.

At an assumed purchase price under the Purchase Agreement of $0.03050 (equal to 95% of the closing price of our Common Stock of $0.03210 on August 13, 2020, we will be able to receive up to $317,349 in gross proceeds, assuming the sale of the entire 10,406,591 purchase notice shares being registered hereunder pursuant to the Purchase Agreement. At an assumed purchase price of $0.03050 under the Purchase Agreement, we would be required to register 87,970,192 additional shares of our Common Stock to obtain the balance of $2,682,651 under the Purchase Agreement. Due to the floating offering price, we are not able to determine the exact number of shares that we will issue under the Purchase Agreement.

There are substantial risks to investors as a result of the issuance of shares of our Common Stock under the Purchase Agreement with White Lion. These risks include dilution of stockholders’ percentage ownership, significant decline in our stock price and our inability to draw sufficient funds when needed.

We intend to sell White Lion periodically our Common Stock under the Purchase Agreement and White Lion will, in turn, sell such shares to investors in the market at the market price. This may cause our stock price to decline, which will require us to issue increasing numbers of common shares to White Lion to raise the same amount of funds, as our stock price declines.

The aggregate investment amount of $3,000,000 was determined based on numerous factors, including the following: the proceeds received from any purchase notices tendered to White Lion under the Purchase Agreement will be used for general corporate and working capital purposes and acquisitions of assets, businesses or operations or for other purposes that our board of directors, in its good faith deem to be in the best interest of the Company.

This prospectus relates to the resale from time to time by the selling stockholder identified herein of 10,406,591 shares of our Common Stock.

Common stock offered by selling stockholder:10,406,591 shares.
Offering price:Market price or privately negotiated prices.
Common stock outstanding after the offering:83,647,488 shares.
Use of proceeds:We will not receive any proceeds from the sale of shares of our Common Stock by the selling stockholder; however, we will receive the proceeds from the sale of shares of our Common Stock pursuant to our exercise of the purchase notice offered by White Lion.
Risk factors:An investment in our securities involves a high degree of risk and could result in a loss of your entire investment. Prior to making an investment decision, you should carefully consider all of the information in this prospectus and, in particular, you should evaluate the risk factors set forth under the caption “Risk Factors” beginning on page 6.
Symbol on OTCQB:XDSL

The number of shares of Common Stock to be outstanding immediately after this offering is based on 73,240,897 shares of Common Stock outstanding as of November 30, 2011. The Company'sAugust 13, 2020 and excludes 1,000 shares of Common Stock is tradedissuable upon conversion of 1,000 shares of Series A Convertible Preferred Stock.

-5-

RISK FACTORS

An investment in our securities involves a high degree of risk. This prospectus contains the risks applicable to an investment in our securities. Prior to making a decision about investing in our securities, you should carefully consider the specific factors discussed under the heading “Risk Factors” in this prospectus. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. The occurrence of any of these known or unknown risks might cause you to lose all or part of your investment in the offered securities.

Risks Related to Our Business

Revenue Concentration

Through March 31, 2020, the Company was party to agreements which potentially subject it to concentrations of revenue risk through one customer agreement for its artificial intelligence product platform. For the nine months ended March 31, 2020, this one customer accounted for 100% of our total revenue. At March 31, 2020, this one customer accounted for 100% of our total accounts receivable. Should this customer discontinue its use of the mPhase product platform, the Company could lose its only source of revenue.

International Operational Risk

The Company relies on a cost-competitive advantage for its artificial intelligence software through the exclusive use of software engineers in the countries of India and the United Kingdom. Any political, economic, or other disruptions in the use of key personnel located in these countries would have a significant impact on the OverCompany’s ability to grow revenue.

Funding of Operations

The Company expects to need to raise up to $10 million  in the Counter Bulletin Board undercapital markets to continue to fund the ticker symbol XDSL.Company’s primary operations over the next 12 months. The Company has offices in Little Falls, New Jersey as well as Norwalk, Connecticut and isrelied almost exclusively on the variable rate convertible debenture market to raise funds which entails a development-stage company.

Historically we have had net operating losses each year since our inception

Asvery high cost of September 30, 2011, we have an accumulated deficit of ($200,823,117) and a stockholder’s deficit of ($5,049,816) and a net loss of $6,179,222 for the three months then ended. As of June 30, 2011, we have an accumulated deficit of ($194,643,955) and a stockholder’s deficit of ($5,591,774). We incurred net losses of $486,391 and $7,365,745 for the years ended June 30, 2011 and June 30, 2010 respectively.The auditors’ report for the fiscal year ended June 30, 2011 includes the statementcapital. No assurances can be given that "there is substantial doubt of the Company's ability to continue as a going concern".

Business of the Company

Prior to February of 2004, the Company had been in the telecommunications industry focusing on hardware/software solutions for telephone service providers for the delivery of voice, digital television and high-speed internet,will continue to have access to this market which businesses the Company discontinued in December of 2007.

In February of 2004 the Company engaged the Bell Labs division of Lucent Technologies, Inc. to develop a new type of power cell energy storage device. Taking advantage of a superhydrophobic effect or suspension of a liquid electrolyte on silicon, Bell Labs created for the Company a reserve battery product with a virtually unlimited shelf-life prior to initial activation. This result was achieved by causing the suspension, in droplet form, of liquid electrolyte on a “smart surface” or repellant such as silicon. The phenomenon is baseddepends upon the superhydrophobic effect similar to beads of raindrops forming on a leaf in nature. An electronic impulse is used to trigger the process of “electrowetting” or collapse of the droplet and the mixing of the electrolyte, thereby providing a low level source of energy.

The Company’s first product is its Smart NanoBattery, a reserve battery having significant potential military applications for providing low energy power-sources needed to power guidance systems on small munitions as well as reserve sources of power needed to back up computer-memory systems. The Smart Battery is only activated upon command by either a g force or magnetic pulse and therefore has a virtually unlimited shelf-life prior to initial activation as a reserve source of energy. The Company believes there is a significant need for energy storage products that can be activated on command and that are guaranteed to generate reserve sources of power for mission-critical activities.

The Company has also developed a second product line designed by and co-branded with Porsche Design Studio, a premiere world-class company specializing in high-end products for the luxury automotive manufacturer. The Company’s double barrel illuminator is an emergency flashlight designed primarily as an accessory product for automobiles. The designer flashlight utilizes the Company’s new mechanically-activated battery with a shelf life of up to 20 years serving as a backup source of power to its primary batteries. The Company has completed a pilot program of distribution of such flashlight over the internet and has received an initial order for 140 such flashlights to be sold through Porsche Design’s Studio’s stores located in approximately 100 cities globally. mPhase’s research and product development now focuses on developing “smart surfaces” using materials science engineering, nanotechnology science and the principles of microfluidics and microelectromechanical systems (MEMS). The Company develops products for both commercial and military applications. As noted above, the Company's first flagship product is its Smart NanoBattery providing Power On Command™. The new patent pending and patented battery technology, based on the phenomenon of electrowetting, offers a unique way to store energy and manage power. Features of the Smart NanoBattery include potentially infinite shelf life, environmentally friendly design, fast ramp to power, programmable control, and direct integration with microelectronic devices. The platform technology behind the Smart NanoBattery is a porous nanostructured material used to repel and precisely control the flow of liquids. The innovative material is aSmart Surfacethat can potentially be designed for other innovative products such as self-cleaning applications, water purification/desalination, liquid filtration/separation, and environmental cleanup.

5


We have developed and maintain a portfolio of patents and patent applications that form the proprietary base for our research and development efforts in the area of “smart surfaces.” We believe that our intellectual property portfolio, which currently includes seven issued patents either directly owned or licensed by the Company and eight filed patent applications in various stages of review, is very strong. Our research and development over the years includes some of the world's leading institutions including Alcatel/Lucent Bell Labs. We believe our technology base, combined with our know-how, provides us with a strong competitive advantage and will facilitate future successful development and commercialization of additional products for use in a variety of potential military and commercial products. mPhase has recently completed work under a Phase II Small Business Technology Transfer Program (STTR) grant of approximately $750,000, as part of the Small Business Innovation Research (SBIR) program, from the U.S. Army. Under the grant the Company has continued development of its Smart NanoBattery as a reserve battery for critical mission computer memory. Such reserve battery can be activated by an electronic pulse.

Consistent with its strategy of developing cutting-edge energy products, the Company announced on July 28, 2011 that it has signed a letter of intent to acquired Energy Innovative Products, Inc. (EIP), a privately-held Nevada corporation. EIP is a developer of proprietary technology for reducing energy usage in refrigeration and cooling systems. The Company plans to acquire 81% of the outstanding shares of common stock of EIP in exchange for shares of common stock and warrants to purchase common stock in the Company.

About This Offering

Convertible Note

On September 13, 2011 the Company sold John Fife a convertible promissory note (the “Convertible Note”) in the initial principal amount of $357,500 and received proceeds of $300,000 in a first tranche of financing under the Convertible Note (representing an initial 29.50 % original issue discount). The Convertible Note provides for a second tranche of funding to the Company of $200,000 (thereby increasing the principal amount of such Convertible Note to $557,500) upon the filing of this Registration Statement with the Securities and Exchange Commission.

The Convertible Note bears interest at the rate of 8% per cent per annum and matures on August 31, 2012. . The Convertible Note is convertible into shares of common stock at a price of $.01 per share. Commencing on November 30, 2011the Company is required to repay the note in ten (10) monthly installments of $57,500 per month plus accrued interest. The Company may pay the monthly installments either in cash or in shares of Common Stock. If the Company chooses to pay in shares of common stock, it must make an irrevocable payment of shares 23 trading days prior to the installment payment date, and the value of the shares given shall equal 80% of the average of the three-lowest closing sales prices of our common stock during the 20 day trading period prior to payment of the installment amount. On the installment payment date an adjustment either upward or downward in shares of common stock shall be made. To the extent the Company owes additional shares on the installment payment date such shares shall be issued to the holder and to the extent the Company has issued the holder excess shares such shares shall be applied to the next installment payment. In order for the Company to be eligible to pay any installment in shares, the Company must have either an effective Registration Statement with respect to such shares effective or such shares must be eligible for sale pursuant to Rule 144 of the Securities Act of 1933 by the holder of the Convertible Note. If an event of default occurs under the Convertible Note, the Company is required to redeem the convertible note in cash at 135% of the unconverted principal amount of the note plus accrued interest. The conversion price of the Convertible Note is subject to adjustment in the case of stock splits, stock dividends, combination of shares and similar recapitalization transactions. The holder may not convert the Convertible Note if as a result of such conversion the holder or any of its affiliates would own more than 4.9% of the Company’s common stock.

Warrant

On August 10, 2011 the Company sold as part of a $25,000 private placement of a convertible note, a Warrant to purchase 3,676,471 shares of common stock to Jay Wright. The Warrant is exercisable at a fixed price of $.0068 per share (subject to an adjustment downward for dilution by any warrants issued at a lower price by the Company) and may be exercised at any time during a 5 year period following the date of issuance.

Equity Line

This Prospectus also includes to the offer and resale of up to 276,000,000 shares of our common stock by Dutchess Opportunity Fund II LP or “ Dutchess” Dutchess has agreed to purchase up to 250,000,000 described in this offering of our common stock pursuant to an investment agreement between Dutchess and the Company dated as of November 30, 2011 (the “Investment Agreement”). Subject to the terms and conditions of the Investment Agreement, the Company has the right to PUT up to $10,000,000 of our common stock to Dutchess. This arrangement is sometimes referred to as an Equity Line. For more information on the selling stockholder, please see the section of this prospectus entitled “Selling Shareholders” We will not receive any proceeds from the resale of these shares of common stock offered by Dutchess. We will, however, receive proceeds from the sale of shares to Dutchess pursuant to the Equity Line. When the Company puts an amount of shares to Dutchess, the per share purchase price that Dutchess will pay to us in respect of such put will be determined in accordance with a formula set forth in the Investment Agreement. Generally, in respect of each put, Dutchess will pay us a per share purchase price of ninety-four per cent (94%) of the lowest daily volume weighted average price of our common stock during the ten (10) consecutive trading day period beginning on the trading day of the day of the put notice.

Dutchess may sell the shares of common stock from time to time at the prevailing market price on the Over-the Counter (OTC) Bulletin Board. Dutchess is deemed an “underwriter: within the meaning of the Securities Act of 1933, as amended in connection with the resale of our common stock under the Equity Line.

The Company currently has reduced its cash needs to approximately $125,000 per month. The Company is only permitted under the Equity Line to “Put” 20,000,000 shares during any period. At a current price of $.0031 per share the Company could raise $62,000 for a current Put. The Company believes that it will be able to exercise, based upon current market conditions, at least one Put per month to Dutchess and intends to supplement its other cash needs currently through its traditional sources of financing including private placements of its common stock and the issuance of additional convertible securities. The $10,000,000 equity line commitment is binding for three years from the effective date of this Registration Statement. Given the current price and volatility of the Company’s common stock, itstock. Such financing is not possible to predict how much of the equity line will, in fact, be needed and accessed by the Company over the next three year period to supplement the Company’s other methods of raising capital.

Based upon our stock price of December 21, 2011 of $.0034 per share and the 6% discount Dutchess would have a conversion price of approximately $.0032 per share that would require the issuance of 3,125,000,000 additional shares of common stock by the Company. As of December 21, 2011 the Company has a total of 2,888,663,918 shares of common stock, 110,060,000 options and 19,323,974 warrants outstanding. In addition 525,412,408 and 228,255,988 shares are reserved for Convertible Securities currently outstanding, based upon the Company’s stock price of $.0034 on that date as well as for the convertible feature of Officers’ loans. This results in a fully diluted amount of 3,771,716,487 shares. Since the Company has 2,228,283,513 unissued shares out of 6 billion authorized shares, the Company, as of December 21, 2011, has only enough shares to draw approximately 71.2% or $7,121,594 of the Equity Line.

The likely hood of receiving the full $10,000,000 is based upon the Company’s stock price being at .004773 per share or greater during significant periods of time during the next three year period based upon the current capital structure of the Company. The Company has, in the past several years, had significant trading volume as comparedhighly dilutive to other stocks of comparable price. In addition the PUT option is within the controlshareholders of the Company so that it can chose the most advantageous price and volume history for any given PUT option exercise to mitigate the risk of not being able to draw the full $10,000,000.

The full discounted price when adding the commitment fee number of 26,000,000 shares to 3,205,128,105 shares (representing the 6% discount) is 3,231,128,205 shares which equates to approximately $0031 per share. 

Estimated use of proceeds

This prospectus relates to shares of our Common Stock that may be offered and sold from time to time by the selling stockholders. We will not receive anysince holders of the proceeds resulting from the sale of Common Stock John. Fife as one of the Selling Stockholders. We will receive proceeds from the exercise of the Warrant by Jay Wright in the amount of $25,000 l. As noted above we will receive proceeds in connection with the sale of shares to Dutchess under the Equity Line. All proceeds received will be used by the Company as additional working capital.

6


Summary of Shares offered by the Selling Shareholders.

The following is a summary of the Shares being offered by each of the Selling Shareholders:

Common Stock offered by the Convertible Noteholder: 185,400,000 shares that may be issued either upon (1) conversion of the Convertible Note at $.01 per share, (2) payment by the Company in shares ofconvertible debentures require substantial discounts for conversions into common stock of 10 monthly installments of $57,500 plus accrued interest at 8% on the principal balance then outstanding commencing on November 30, 2011 and each month thereafter through August 31, 2012 or (3) some combination of (1) and (2). The amount of shares calculated is equal to approximately 159,677,702 based upon the amount of shares necessary to amortize the full $557,500 principal amount of the Convertible Note plus accrued interest monthly assuming payment in shares by the Company at a 20% discount from the three lowest trading prices of the common stock for a twenty day period of time from the price of $.0046 per share on November 30, 2011. In addition a reasonable estimate of additional shares necessary are being registered to allow for expected future periodic downward market fluctuationsor prepayment premiums in the price of the common stock. It should be noted that the Company as of the date hereof has no made payment of the $57,500 payment owed on November 30, 2011 under the Convertible Note either in cash or in shares of common stock. No event of default has been declared by the Noteholder and it is anticipated that the Company will make such payment is shares upon the effectiveness of this Registration Statement.cash.

Common Stock offered by the Warrant Holder: 3,676,471 shares that may be issued upon exercise by the Warrant Holder of a Warrant given as part of a $25,000 financing to the Company that provides for exercise at $.0068 per share.

Common Stock to be offered by Equity Line Provider is up to 26,000,0000 shares issued by the Company as a Commitment Fee and 250,000,000 shares sold to Dutchess. Under the terms of the Investment Agreement dated as of November 30, 2011 with Dutchess the Company may put on a given PUT date up to 20 million shares of its common stock at a price equal to 94% of the lowest Variable Weighted Average Price (“VWAP”), of our common stock in the 10 consecutive trading days following exercise of the Put. Under the terms of the Investment Agreement the Company may not exercise another PUT until up to 15 days following the exercise of the Company exercising the immediately preceding Put.

Common Stock outstanding prior to the offering: 2,892,510,073 based upon the total amount of shares issued as of December 5, 2011.

Common Stock outstanding after the offering: 3,357,586,544 assuming the full conversion and or amortization of the Convertible Note in shares of common stock, exercise of the Warrant , payment of Commitment Shares and Exercise of the full Equity Line .

Use of Proceeds We will not receive any proceeds from conversion or payment in shares of amortization of the Convertible Note. The Company will receive $25,000 upon exercise, in full of the Warrant plus proceeds from the Put, from time to time of our common stock to Dutchess under the Equity Line. All proceeds will be used to provide additional working capital to the Company.

7


RISK FACTORS

          An investment in the Company’s Common Stock involves a high degree of risk. You should carefully consider the risks described below as well as other information provided to you in this prospectus, including information in the section of this document entitled “Forward Looking Statements.” If any of the following risks actually occur, our business, financial condition or results of operations could be materially adversely affected, the value of our Common Stock could decline, and you may lose all or part of your investment.

Risks Relating to the Company’s Early Stage of Development

Our businesscurrent “smart surface technology” is at an early stage of development and we may not develop products that can be commercialized.

 

We have derived very limited revenues from a Phase I Army Grant of approximately $100,000 and a Phase II Army Grant of approximately $750,000 with respect to our Smart NanoBattery product from inception of development in February 2004 through March 30, 2011. We have derived revenues of only $ 38,819 from our Emergency Flashlight product from inception of sales in April of 2010 through September 30, 2011 and we have been forced to discontinue product development and marketing of our magnetometer product owing to limited financial resources.the date hereof.

 

We have limited manufacturing, marketing, distribution and sales capabilities which may limit our ability to generate revenues.

          Due to the relatively early stage of our products, we have not yet invested significantly in manufacturing, marketing, distribution or product sales resources. We cannot assure you that we will be able to invest or develop any of these resources successfully or as expediently as necessary. The inability to do so may inhibit or harm our ability to generate revenues or operate profitably.

We have a history of operating losses and we may not achieve future revenues orhave only one quarter of generating an operating profits.profit in our history.

 We have generated modest revenue to date from our operations. Historically we have had net operating losses each year since our inception. As of September 30, 2011, we have an accumulated deficit of $(200,823,117) and a stockholders’ deficit of $(5,049,816) and incurred a net loss of $6,179,122. We incurred net losses of $486,391 and $7,365,745 for the years ended June 30, 2011 and June 30, 2010, respectively. The Company does not generate significant revenue outside of STTR grants and minor sales of its emergency illuminator product. Additionally, even if

If we are ableunable to commercialize our technologies or any products or services related to our technologies it is not certain that they will result in revenue or profitability.

We have a limitedcontinue generating operating history on which investors may evaluate our operationsprofits and prospects for profitable operations.

          If we continue to sufferresume suffering losses as we have in the past, investors may not receive any return on their investment and may lose their entire investment. Our prospects must be considered speculative in light of the risks, expenses and difficulties frequently encountered by companies with new products in their early stages of development, particularly in light of the uncertainties relating to the new, competitive and rapidly evolving markets in which we anticipate we willcurrently and expect to operate. To attempt to address these risks, we must, among other things, further develop our technologies, products and services, successfully implement our research, development, marketing and commercialization strategies, respond to competitive developments and attract, retain and motivate qualified personnel. A substantial risk is involved

We have limited resources to manage development activities.

Our limited resources in investingconducting and managing development activities might prevent us from successfully designing or implementing new products. If we do not succeed in us because, as an early stage companyconducting and managing our development activities, we have fewer resources than an established company,might not be able to commercialize our management mayproduct candidates, or might be more likelysignificantly delayed in doing so, which will materially harm our business.

Our ability to make mistakes at such an early stage,generate continued revenues from our entry into the fields of artificial intelligence and we may be more vulnerable operationally and financially to any mistakes that may be made,machine learning as well as from our Smart Nano Battery will depend on a number of factors, including our ability to external factors beyondsuccessfully complete and implement our control.commercialization strategy. In addition, even if we are successful in bringing our Smart Nano Battery to market, we will be subject to the risk that the marketplace will not accept such product. We are currently transitioning from a company with a research and development focus to a company capable of supporting commercial activities.

-6-

Because of the numerous risks and uncertainties associated with our product development and commercialization efforts, we are unable to predict the extent of our future losses or when or if we will become profitable.

Our failure to continue commercializing our new products in the fields of machine learning and artificial intelligence as well as successfully commercializing our Smart Nano Battery or to become and remain profitable could depress the market price of our Common Stock and impair our ability to raise capital, expand our business, diversify our product offerings and continue our operations.

Risks Relating to Technology

 

We are dependent on new and unproven technologies.

 

Our risks as an early stage company are compounded by our heavy dependence on emerging and sometimes unproven technologies.technologies such as artificial intelligence and machine learning as well as our Smart Nanobattery. If these technologies do not produce satisfactory results, our business may be harmed.

 

We may not be able to commercially developsuccessfully expand commercial development of our technologies and proposed product lines, which, in turn, would significantly harm our ability to earnexpand revenues and result in a lossan appreciation of investment.an investment in our common stock.

 

Our ability to commercially develop our technologies will be dictated in, large part, by forces outside our control which cannot be predicted, including, but not limited to, general economic conditions,conditions. Other such forces include the success of our research and field testing, the availability of collaborative partners to finance our work in pursuing applications of artificial intelligence, machine learning and “smart surfaces” using materials science engineering, nanotechnology science and the principles of microfluidics and MEMS and technological or other developments in the field which, due to efficiencies or technological breakthroughs may render one or more areas of commercialization more attractive, obsolete or competitively unattractive. It is possible that one or more areas of commercialization will not be pursued at all if a collaborative partner or entity willing to fund research and development cannot be located. Our decisions regarding the ultimate products and/or services we pursue could have a significant adverse affecteffect on our ability to earn revenue if we misinterpret trends, underestimate development costs and/or pursue wrong products or services. Any of these factors either alone or in concert could materially harm our ability to earn revenues or could result in a loss of any investment in us.

8


If we are unable to keep up with rapid technological changes in our field or compete effectively, we will be unable to operate profitably.profitably in the future.

 

We are engaged in activities in the artificial intelligence, machine learning, nanotechnology and microfluidics field, which is characterized by extensive research efforts and rapid technological progress. If we fail to anticipate or respond adequately to technological developments, our ability to operate profitably could suffer. We cannot assure you that research and discoveries by other companies will not render our technologies or potential products or services uneconomical or result in products superior to those we develop or that any technologies, products or services we develop will be preferred to any existing or newly-developed technologies, products or services.

-7-

Risks Related to Intellectual Property

 

Certain aspects of our technology are not protectable by patent.patent or copyright.

 

Certain parts of our know-how and technology are not patentable. To protect our proprietary position in such know-how and technology, we require all employees, consultants, advisors and collaborators with access to our technology to enter into confidentiality and invention ownership agreements with us. We cannot assure you; however, that these agreements will provide meaningful protection for our trade secrets, know-how or other proprietary information in the event of any unauthorized use or disclosure. Further, in the absence of patent protection, competitors who independently develop substantially equivalent technology may harm our business.

 

Patent litigation presents an ongoing threat to our business with respect to both outcomes and costs.

 

It is possible that litigation over patent matters with one or more competitors could arise. We could incur substantial litigation or interference costs in defending ourselves against suits brought against us or in suits in which we may assert our patents against others. If the outcome of any such litigation is unfavorable, our business could be materially adversely affected. To determine the priority of inventions, we may also have to participate in interference proceedings declared by the United States Patent and Trademark Office, which could result in substantial cost to us. Without additional capital, we may not have the resources to adequately defend or pursue this litigation.

 

We may not be able to protect our proprietary technology, which could harm our ability to operate profitably.

 

Patent and trade secret protection is critical for the new technologies we utilize, artificial intelligence, machine learning and nanotechnology and microfluidics, as well as the products and processes derived through them. Our success will depend, to a substantial degree, on our ability to obtain and enforce patent protection for our products, preserve any trade secrets and operate without infringing the proprietary rights of others. We cannot assure you that:

 -

we will succeed in obtaining any patents in a timely manner or at all, or that the breadth or degree of protection of any such patents will protect our interests,

   
 -

the use of our technology will not infringe on the proprietary rights of others,

   
 -

patent applications relating to our potential products or technologies will result in the issuance of any patents or that, if issued, such patents will afford adequate protection to us or not be challenged, invalidated or infringed, and

   
 -

patents will not issue to other parties, which may be infringed by our potential products or technologies.

technologies, and
   
 -

we will continue to have the financial resources necessary to prosecute our existing patent applications, pay maintenance fees on patents and patent applications, or file patent applications on new inventions.

9


The fields in which we operate have been characterized by significant efforts by competitors to establish dominant or blocking patent rights to gain a competitive advantage, and by considerable differences of opinion as to the value and legal legitimacy of competitors'competitors’ purported patent rights and the technologies they actually utilize in their businesses.

 

Patents obtained by other persons may result in infringement claims against us that are costly to defend and which may limit our ability to use the disputed technologies and prevent us from pursuing research and development or commercialization of potential products.

 

If third party patents or patent applications contain claims infringed by either our technology or other technology required to make and use our potential products and such claims are ultimately determined to be valid, there can be no assurance that we would be able to obtain licenses to these patents at a reasonable cost, if at all, or be able to develop or obtain alternative technology. If we are unable to obtain such licenses at a reasonable cost, we may not be able to develop some products commercially. We may be required to defend ourselves in court against allegations of infringement of third partythird-party patents. Patent litigation is very expensive and could consume substantial resources and create significant uncertainties. Any adverse outcome in such a suit could subject us to significant liabilities to third parties, require disputed rights to be licensed from third parties, or require us to cease using such technology.

 

-8-

We may not be able to adequately defend against piracy of intellectual property in foreign jurisdictions.

 

Considerable products research in the areasand development of micro fluid dynamicssoftware is being performed in countries outside of the United States, and a number of potential competitors are located in these countries. The laws protecting intellectual property in some of those countries may not provide adequate protection to prevent our competitors from misappropriating our intellectual property. Several of these potential competitors may be further along in the process of product development and also operate large, company-funded research and development programs. As a result, our competitors may develop more competitive or affordable products, or achieve earlier patent protection or product commercialization than we are able to achieve. Competitive products may render any products or product candidates that we develop obsolete.

 

We may incur substantial expenditures in the future in order to protect our intellectual property.

We believe that our intellectual property with respect to (i) our artificial intelligence software platforms and (ii) our Smart NanoBattery and our proprietary rights with respect to the Company’s permeable membrane design consisting of both micro and nano scale silicon features that are coated with a monolayer chemistry used to repel liquids are critical to our future success. The Company’s current battery related patent portfolio consists of seven issued patents, of which one is jointly owned with Rutgers University, two are jointly owned with Nokia (formerly Lucent Technologies) and four are licensed from Nokia. We also have four patent applications related to the Smart Surfaces technology that have been filed with the United States Patent Office and other foreign patent offices that are in various stages of examiner review, as well as four additional patent applications related to other Smart Surfaces technologies under review. Our pending patent applications may never be granted for various reasons, including the existence of conflicting patents or defects in our applications. Even if additional U.S. patents are ultimately granted, there are significant risks regarding enforcement of patents in international markets. There are many patents being filed as the science of nanotechnology develops and the Company has limited financial resources compared to large, well established companies to bring patent litigation based upon claims of patent infringement.

Our products may not be accepted on a significant scale in the marketplace.

 

The degree of market acceptance of those products will depend on many factors, including:

 -

Our ability to manufacture or obtain from third party manufacturers sufficient quantities of our product candidates with acceptable quality and at an acceptable cost to meet demand, and

  

 -

Marketing and distribution support for our products.

 

We cannot predict or guarantee that either military or commercial entities, in general, will accept or utilize any of our product candidates.nanotechnology products. Failure to achieve market acceptance would limit our ability to generate revenue and would have a material adverse effect on our business. In addition, if any of our product candidates achieve market acceptance, we may not be able to maintain that market acceptance over time if competing products or technologies are introduced that are received more favorably or are more cost-effective.

Financial Risks

We may not be able to raise the required capital to conduct our operations and develop and commercialize our products. We require substantial additional capital resources in order to conduct our operations and develop and commercialize our products and run our facilities. We will need significant additional funds or collaborative partners, or both, to finance the research and development activities of our potential products. Accordingly, we are continuing to pursue additional sources of financing. Our future capital requirements will depend upon many factors, including:

-The continued progress and cost of our research and development programs,
-The costs in preparing, filing, prosecuting, maintaining and enforcing patent claims,
-The costs of developing sales, marketing and distribution channels and our ability to sell the products if developed,
-The costs involved in establishing manufacturing capabilities for commercial quantities of our proposed products,
-Competing technological and market developments,
-Market acceptance of our proposed products,
-The costs for recruiting and retaining employees and consultants.

10


          Additional financing through strategic collaborations, public or private equity financings or other financing sources may not be available on acceptable terms, or at all. Additional equity financing could result in significant dilution to our shareholders. Further, if additional funds are obtained through arrangements with collaborative partners, these arrangements may require us to relinquish rights to some of our technologies, product candidates or products that we would otherwise seek to develop and commercialize on our own. If sufficient capital is not available, we may be required to delay, reduce the scope of or eliminate one or more of our programs or potential products, any of which could have a material adverse effect on our financial condition or business prospects.

Risks Relating to Our Debt Financings

If we are required for any reason to repay our outstanding convertible debt we would be required to deplete our working capital, if available, or raise additional funds. Our failure to repay the convertible debentures, if required, could result in legal action against us, which could require the sale of substantial assets.

          We had outstanding, as of September 30, 2011, $ 1,733,637 aggregate principal amount plus accrued interest of convertible debt.

There are a large number of shares underlying our convertible debt in full. The sale of these shares may depress the market price of our Common Stock.

          As of September 30, 2011, on an aggregated basis our convertible debt financings may result in conversions into 438,813,632 shares of our Common Stock, and warrants and options that may be converted into approximately 129,418,974 shares of our Common Stock.

          Sales of a substantial number of shares of our Common Stock in the public market could adversely affect the market price for our Common Stock and make it more difficult for you to sell shares of our Common Stock at times and prices that you feel are appropriate.

The issuance of shares upon conversion of the convertible debt will cause immediate and substantial dilution to our existing stockholders.

          The issuance of shares upon conversion of the convertible debt will result in substantial dilution to the interests of other stockholders since the selling security holders may ultimately convert and sell the full amount issuable on conversion. Although no single selling security holder may convert its convertible debentures and/or exercise its warrants if such conversion or exercise would cause it to own more than 4.99% of our outstanding Common Stock, this restriction does not prevent each selling security holder from converting some of its holdings and then converting the rest of its holdings. In this way, each selling security holder could sell more than this limit while never holding more than this limit. There is no upper limit on the number of shares that may be issued, which will have the effect of further diluting the proportionate equity interest and voting power of holders of our Common Stock.

The Company could face certain regulatory challenges with respect to its reliance on Rule 144 of the Securities Act of 1933, as amended, with respect to certain of its convertible debenture financings entered into with JMJ Financial (“JMJ”) that could result in a significant negative economic impact on the Company.

          The Company believes that any sales of Common Stock by JMJ are in full compliance with Rule 144 of the Securities Act of 1933, as amended, and has obtained an opinion of outside counsel regarding such compliance. Nevertheless, it is possible such compliance could be challenged in the future by either regulatory agencies or shareholders. In particular, questions regarding the economic risk of JMJ with respect to the collateral required under the secured note delivered by JMJ in payment of the purchase price for the Company's convertible notes could be raised since the secured notes each contain a prepayment provision allowing JMJ to prepay such note, in full, by returning the convertible note. If a court of law determines that any offer or sale of Common Stock of the Company received in a conversion by JMJ was not in compliance with Rule 144 then JMJ could be deemed to be an underwriter. The result would be that the Company would have been engaged in a primary offering of Common Stock through an underwriter in violation of the registration requirements of the Securities Act of 1933, as amended. The Securities Act of 1933, as amended, requires that any claim for rescission be brought within one year of the violation. The time periods within which claims for rescission must be brought under state securities laws vary and may be two years or more from the date of the violation. At September 30, 2011, approximately 395 million shares of our outstanding Common Stock issued in respect of our convertible note transactions with JMJ could be subject to rescission with a potential liability approximating $4.18 million, including a liability of approximately $550,000_ for interest at 10% per annum.

11


Risks Related to Third Party Reliance

 

We depend on third parties to assist us in the development of new products extensively, and any failure of those parties to fulfill their obligations could result in costs and delays and prevent us from successfully commercializing our product candidates on a timely basis, if at all.

 

We engage consultants and contract research organizations in India to help design, develop and to developmanufacture our products. The consultants and contract research organizations we engage provide us critical skills, resources and resourcesfinished products for sale that we do not have within our own company. As a result, we depend on these consultants and contract research and product supply organizations to deliver our existing automotive products and to perform the necessary research and development to create new products. We may face delays in developing and bringing new products to market if these parties do not perform their obligations in a timely or competent fashion or if we are forced to change service providers.

 

-9-

We depend on our collaborators to help us develop and test our proposed products, and our ability to develop and commercialize products may be impaired or delayed if collaborations are unsuccessful.

 

Our strategy for the development, testing and commercialization of our proposed products requires that we enter into collaborations with corporate partners, licensors, licensees and others. Some of these collaborators will be located in India and other countries outside of the United States which pose additional legal and economic risks. We are dependent upon the subsequent success of these other parties in performing their respective responsibilities and the continued cooperation of our partners. Under agreements with collaborators, we may rely significantly on such collaborators to, among other things:

 -Fund research and development activities with us;
   
 -Pay us fees upon the achievement of milestones under STIR and SBIR programs; and
   
 -Market with us any commercial products that result from our collaborations.

 

Our collaborators may not cooperate with us or perform their obligations under our agreements with them. We cannot control the amount and timing of our collaborators’ resources that will be devoted to our research and development activities related to our collaborative agreements with them. Our collaborators may choose to pursue existing or alternative technologies in preference to those being developed in collaboration with us.

 

The development and commercialization of potential products will be delayed if collaborators fail to conduct these activities in a timely manner, or at all.

 

If various outside vendors and collaborators do not achieve milestones set forth in our agreements, or if our collaborators breach or terminate their collaborative agreements with us, our business may be materially harmed.

 

Our reliance on the activities of our non-employee consultants, research institutions, and scientific contractors, whose activities are not wholly within our control, may lead to delays in development of our proposed products.

 

We rely extensively upon and have relationships with outside consultants and companies having specialized skills to conduct research. These consultants are not our employees and may have commitments to, or consulting or advisory contracts with, other entities that may limit their availability to us. We have limited control over the activities of these consultants and, except as otherwise required by our collaboration and consulting agreements to the extent they exist, can expect only limited amounts of their time to be dedicated to our activities. These research facilities may have commitments to other commercial and non-commercial entities. We have limited control over the operations of these collaborators and can expect only limited amounts of time to be dedicated to our research and product development goals.

Product Development Risks

We havelimited resources to manage development activities.

          Our limited resources in conducting and managing development activities might prevent us from successfully designing or implementing new products. If we do not succeed in conducting and managing our development activities, we might not be able to commercialize our product candidates, or might be significantly delayed in doing so, which will materially harm our business.

          Our ability to generate revenues from any of our product candidates will depend on a number of factors, including our ability to successfully complete and implement our commercialization strategy. In addition, even if we are successful in bringing one or more product candidates to market, we will be subject to the risk that the marketplace will not accept those products. We may, and anticipate that we will need to, transition from a company with a research and development focus to a company capable of supporting commercial activities and we may not succeed in such a transition.

12


Because of the numerous risks and uncertainties associated with our product development and commercialization efforts, we are unable to predict the extent of our future losses or when or if we will become profitable.

          Our failure to successfully commercialize our product candidates or to become and remain profitable could depress the market price of our Common Stock and impair our ability to raise capital, expand our business, diversify our product offerings and continue our operations.

Risks Related to Competition

 

The market for energy storage products, artificial intelligence and machine learning is highly competitive.

 

We expect that our most significant competitors will be large more established companies. These companies are developing products that compete with ours and they have significantly greater capital resources in research and development, manufacturing, testing, obtaining regulatory approvals, and marketing capabilities. Many of these potential competitors are further along in the process of product development and also operate large, company-funded research and development programs. As a result, our competitors may develop more competitive or affordable products, or achieve earlier patent recognition and filings.

 

-10-

Our industry is characterized by rapidly evolving technology and intense competition. Our competitors include major multinational energy-storage device and battery companies as well as nanotechnology companies that specialize in micro fluid dynamics and smart surfaces.

 

Many of these companies are well-established and possess technical, research and development, financial and sales and marketing resources significantly greater than ours. In addition, certain smaller nanotechnology companies have formed strategic collaborations, partnerships and other types of joint ventures with larger, well established industry competitors that afford these companies'companies’ potential research and development and commercialization advantages. Academic institutions, governmental agencies and other public and private research organizations are also conducting and financing research activities which may produce products directly competitive to those we are developing. Moreover, many of these competitors may be able to obtain patent protection, obtain regulatory approvals and begin commercial sales of their products before we do.

 In the general area of energy storage and micro fluid dynamics, we compete with a variety of companies, including Duracell, Eveready and Ultralife.

          Each of these companies is well-established and has substantial technical and financial resources compared to us. Many smaller companies may also be developing products in the rapidly changing area of energy storage and advanced micro fluid dynamics. These smaller companies may become significant competitors through rapid evolution of new technologies. Any of these companies could substantially strengthen their competitive position through strategic alliances or collaborative arrangements with larger companies.

Our competition includes both public and private organizations and collaborations among academic institutions and large companies, most of which have significantly greater experience and financial resources than we do.

 

Private and public academic and research institutions also compete with us in the research and development of nanotechnology products based on micro-fluid dynamics. In the past several years, the nanotechnology industry has selectively entered into collaborations with both public and private organizations to explore the development of new products evolving out of research in micro-fluid dynamics.

 

Risks Related to Financial Aspects of Our Business

We may not be able to raise the required capital to conduct our operations and develop and commercialize our products.

We require substantial additional capital resources in order to conduct our operations and develop and commercialize our products and run our facilities. We will need significant additional funds or collaborative partners, or both, to finance the research and development activities of our potential products. Accordingly, we are continuing to pursue additional sources of financing. Our future capital requirements will depend upon many factors, including:

The continued progress and cost of our research and development programs,
The costs in preparing, filing, prosecuting, maintaining and enforcing patent claims,
The costs of developing sales, marketing and distribution channels and our ability to sell the products if developed,
The costs involved in establishing manufacturing capabilities for commercial quantities of our proposed products,
Competing technological and market developments,
Market acceptance of our proposed products, and
The costs for recruiting and retaining employees and consultants.

Additional financing through strategic collaborations, public or private equity financings or other financing sources may not be available on acceptable terms, or at all. Additional equity financing could result in significant dilution to our shareholders. Further, if additional funds are obtained through arrangements with collaborative partners, these arrangements may require us to relinquish rights to some of our technologies, product candidates or products that we would otherwise seek to develop and commercialize on our own. If sufficient capital is not available, we may be required to delay, reduce the scope of or eliminate one or more of our programs or potential products, any of which could have a material adverse effect on our financial condition or business prospects.

-11-

Risks Relating to Our Debt Financings

If we are required for any reason to repay our outstanding debt, we would be required to deplete our working capital, if available, or raise additional funds. Our failure to repay the debt, if required, could result in future legal action against us, which could require depletion of our working capital.

At June 1, 2020, an aggregate principal amount of $902,000, plus accrued interest of $126,695, related to our convertible promissory notes was outstanding. Such outstanding principal and accrued interest, if not paid with cash, could be converted into 4,321,587 shares of the Company’s common stock. Sales of a substantial number of our shares of common stock in the public market could adversely affect the market price of our common stock and make it significantly more difficult for a purchaser of our common stock to sell shares of our common stock at times and at prices that a potential shareholder deems appropriate.

As of December 15, 2014, a Convertible Debenture Holder has a Judgment in the amount of approximately $1.6 million entered into by the United States District Court of the Northern District of Illinois.

The Company has entered into a Forbearance Agreement, as amended, with John Fife currently its largest debt holder arising out of a lawsuit and judgment in connection with the default on a Convertible Note in the original principal amount of $550,000 issued on September 13, 2011. The Company did not make the final payment of $195,000, which was due and payable in March of 2020, placing the Company in default of the Forbearance Agreement. The Company and Fife are negotiating a structure whereby the Company will be able to make the final payment of $195,000, which may include additional consideration depending on the timing of when the final payment is made. The Company expects to repay Fife the agreed upon balance due as quickly as possible based upon its available capital. The ultimate final payment amount is expected to be less than the liability balance of $762,921 at March 31, 2020, presented as liabilities in arrears – judgement settlement agreement on the consolidated balance sheets.

The energy storage deviceissuance of shares of our common stock upon conversion of convertible promissory notes will cause immediate and battery business aresubstantial dilution to our existing shareholders.

The issuance of shares of our common stock upon conversion of convertible promissory notes will result in substantial dilution to the interests of other stockholders since the selling security holders may ultimately convert and sell the full amount issuable on conversion at significant discounts ranging up to 40% from the then current market price of our stock. Although no single selling security holder may convert its convertible debentures and/or exercise its warrants if such conversion or exercise would cause it to own more than 4.99% of our outstanding common stock, this restriction does not prevent each characterizedselling security holder from converting some of its holdings and then converting the rest of its holdings. In this way, each selling security holder could sell more than this limit while never holding more than this limit. There is no upper limit on the number of shares that may be issued, which will have the effect of further diluting the proportionate equity interest and voting power of holders of our common stock.

mPhase’s stock price has suffered significant declines during the past year following our reverse stock split effective May 22, 2019, and remains volatile.

The market price of our common stock closed at $1.44 per share on May 22, 2019 and at $0.18 per share on June 8, 2020. During such period, the number of common shares outstanding increased by intense competition. We compete against numerous companies, both domestic and foreign, many of which have substantially greater experience and financialapproximately 2.5 million shares due to periodic private placements and other financing arrangements involving convertible promissory notes issued by the Company in order to finance company operations. Stocks in microcap companies having stock values below $1.00 per share have been very volatile during such period. Our common stock is a highly speculative investment and is suitable only for such investors with financial resources that enable them to sustain the loss of their entire investment in such stock. Because the price of our common stock is less than we have.

          Companies such as Duracell, Eveready$5.00 per share and Ultralife, as well as others, manyis not traded on the NASDAQ National or NASDAQ Small Cap exchanges, it is considered to be a “penny stock,” limiting the type of which have substantially greater resourcescustomers that broker/dealers can sell to. Such customers consist only of “established customers” and experience in our fields than we do, are well situated to effectively compete with us. Any“Accredited Investors” (within the meaning of Rule 501 of Regulation D of the world's largest battery companies representsSecurities Act of 1933, as amended), generally individuals and entities of substantial net worth, thereby limiting the liquidity of our common stock.

-12-

Other General Risks

We may not be able to raise sufficient capital to market our new products in the areas of artificial intelligence and machine learning and our Smart NanoBattery product applications of our technology on any meaningful scale.

We may not be able to obtain the amount of additional capital needed until the Company has established significant and predictable sales and revenues from our technology. We have been successful in the past as a micro-cap development stage company in raising capital; however, recent trends in the capital markets are likely to pose significant actualchallenges for the Company. Factors affecting the availability of capital include:

the price, volatility and trading volume of our common stock;
future financial results including sales and revenues generated from operations;
the market’s view of the business sector of nanotechnology reserve batteries and emergency flashlights; and
the perception in the capital markets of our ability to execute our business plan

We have reported net operating losses for each of our fiscal years from our inception.

We have reported net operating losses for each of our fiscal years from our inception in 1996 through the present and may not be able to operate profitability in the future.

We have had net losses of approximately $228,500,000 since our inception in 1996 and cannot be certain when or if we will ever be profitable. We expect to continue to have net losses for the foreseeable future. We need to raise at least $5 million in additional cash during the next 12 months through further equity private placements or debt financings to continue operations and implement the acquisition plans of the Company’s new management including the completion of the acquisitions of CloseComms, Alpha Predictions and Travel Buddhi. At March 31, 2020, we had a working capital surplus of $450,622 and stockholders’ equity of $2,597,121.

Our independent auditor’s report expresses doubt about our ability to continue as a going concern.

The reports of the Company’s outside auditor Assurance Dimensions, and its prior auditors D’Arelli Pruzansky, P.A., Demetrius Berkower, LLC., Rosenberg, Rich, Baker, Berman & Company, and Arthur Andersen & Co., with respect to its latest audited reports on Form10-K for each of the fiscal years commencing in the fiscal year ended June 30, 2001 through the fiscal year ended June 30, 2019, stated that “there is substantial doubt of the Company’s ability to continue as a going concern.” Such opinion from our outside auditors makes it significantly more difficult and expensive for the Company to raise additional capital necessary to continue our operations.

Risk Factors Related to Our Operations

We have not to date had completed final military or commercial development of our flagship product, the Smart NanoBattery.

We have derived no material revenues from our Smart NanoBattery from inception of development in February 2004 through March 31, 2020.

-13-

The loss of future potential competitorinvestments by prior officer and directors could adversely affect our business.

Management and employment contracts with vastly greater resources than ours. Theseall of our officers prior to January 11, 2019 have expired and other competitive enterprises have devoted, andno assurances can be given that such executives will continue to devote, substantial resourcesinvest in the Company or that the Company will be able to successfully enter into agreements with such key executives. All of our prior officers have made significant investments in the developmentCompany in the form of technologiesperiodic equity purchases of common stock and productsbridge loans and have been granted stock and stock options that are intended to represent a key component of their compensation. Such grants may not provide the intended incentives to such officers to continue investing in competition with us.

13


RISKS RELATED TO OUR TARGETED MARKETSour common stock if our stock price declines or experiences significant volatility. In addition, our three prior corporate officers accumulated past accrued and unpaid salaries in the aggregate amount of approximately $539,000 and certain notes and accrued interest that were settled for common stock and an amended conversion feature during the fiscal year ended June 30, 2017 and portions of the fiscal years ended June 30, 2018 and 2019, have agreed to convert such amounts into common stock of the Company.

 

Risks Related to Our Targeted Markets

The sale of new high technology products often has a long lead-time and a multiplicity of risks.

Commercialization of new technology products often has a very long lead time since it is not possible to predict when major companies will license such technology for sale to their customers. The sciencescientific disciplines of artificial intelligence, machine learning, nanotechnology and microfluidics used to develop our Smart NanoBattery isare each in itstheir very early stages and acceptance and demand for such products can often be a long evolutionary process.

The sciencesciences of artificial intelligence, machine learning and nanotechnology is at a very early stage as a disciplinedisciplines and each is subject to great uncertainty and swift changes in technologytechnology..

Microfluid

Artificial intelligence and microfluid dynamics, andincluding the manipulation of materials of nano size and dimensions, is a very new science and the creation of new products is dependent upon new and different properties of such materials created that will result in many uncertain applications and rapid change. The evolution of nanotechnology as a new science adds greater uncertainty to new applications and new and improvedproductimproved product introductions is unpredictable. Artificial intelligence and machine learning are even newer sciences and are subject to many uncertain future developments.

We may not be able to createface significant competition for our new products from our intellectual property using microfluidics that will be acceptable in water purification, oil separation from water and other environment markets.products.

The market for "green"“green” products, such as our smart nanobots , and solutions is characterized by changing regulatory standards, new and improved product introductions, and changing customer demands.

Large companies such as General Electric withAmazon, Google, Microsoft, and Facebook have great resources and are currently focusing significant moniescapital for new solutions.solutions using artificial intelligence and machine learning. Such companies have made significant inroads to date in the areas of artificial intelligence and machine learning owing to their substantial capital resources and focused and committed research and development.

Our future success will depend upon our ability to achieve compelling technology innovations that are economic and practical to produce in large deployments. Success in new technology, products and services is a complex and uncertain process requiring high levels of innovation, highly skilled engineering and development personnel, and the accurate anticipation of technological and market trends. We may not be able to identify, develop, market or support new or enhanced technology, products, or services on a timely basis, if at all, owing to our size and limited financial resources.

-14-

The commercialization of many applications of our technologies will depend on our ability to establish strategic relationships with commercial partners.

We are seeking commercial partners with established lines of business and greater financial resources than our own. Such partners may not place the priority that we do on joint projects because the success or failure of such projects is not as material to other existing well- developed lines of business.

Applications of our technology are components of end products and therefore our products are tied to the success of such end products.

The compelling need for critical mission batteries and other applications of our nanotechnology, as well as our artificial intelligence products, will depend upon both military and commercial needs going forward and the demand for our products as components. Thus, the success of our technology will depend upon the continuing need for the end user products and market demand.

The sale of new high technology products often has a long lead-time and a multiplicity of risks.

Commercialization of new technology products often has very long lead time since it is not possible to predict when major companies will license such technology for sale to their customers. The science of artificial intelligence and machine learning as well as nanotechnology and microfluidics used to develop our Smart NanoBattery are each in their very early stages and acceptance and demand for such products can often be a long evolutionary process.

The sciences of artificial intelligence and nanotechnology are each at a very early stage as a discipline and are subject to great uncertainty and swift changes in technology.

Artificial intelligence and microfluid dynamics (which includes the manipulation of materials of nano size and dimensions) are each very new sciences and the creation of new products is dependent upon new and different properties of such materials created that will result in many uncertain applications and rapid change. The evolution of nanotechnology as a new science adds greater uncertainty to new applications and new and improved product introductions is unpredictable.

Our future success will depend upon our ability to achieve compelling technology innovations that are economic and practical to produce in large quantities. Success in new technology, products and services is a complex and uncertain process requiring high levels of innovation, highly-skilled engineering and development personnel, and the accurate anticipation of technological and market trends. We may not be able to identify, develop, market or support new or enhanced technology, products, or services on a timely basis, if at all, owing to our size and limited financial resources.

The commercialization of many applications of our technologies will depend on our ability to establish strategic relationships with commercial partners.

We are seeking commercial partners with established lines of business and greater financial resources than our own. Such partners may not place the priority that we do on joint projects because the success or failure of such projects is not as material to other existing well developed lines of business.

Our Smart Battery and our potential applications of our technology are components of end products and therefore our products are tied to the success of such end products.

The compelling need for critical mission batteries and other applications of our nanotechnology will depend upon both military and commercial needs going forward and the demand for our products as components. Thus the success of our Smart Battery and other applications of our technology will depend upon the continuing need for the end user products and market demand.

General Risks Relating to Our Business

 

Our products are likely to be expensive to manufacture,Global or regional health pandemics or epidemics, including COVID-19, could negatively impact our business operations, financial performance and they may not be profitable if we are unable to control the costs to manufacture them.results of operations.

 

Our products are likely tobusiness and financial results could be significantly more expensive to manufacture than most other more developed currently onnegatively impacted by the market today. Our present manufacturing processes produce modest quantitiesrecent outbreak of product intended for use in our ongoing research activities, and we have not developed processes, procedures and capability to produce commercial volumes of product. We hope to substantially reduce manufacturing costs through process improvements, development of new science, increases in manufacturing scale and outsourcing to experienced manufacturers. If we are not able to make theseCOVID-19 or other improvements,pandemics or epidemics. The severity, magnitude and depending on the pricingduration of the product,current COVID-19 pandemic is uncertain, rapidly changing and hard to predict. During 2020, COVID-19 has significantly impacted economic activity and markets around the world, and it could negatively impact our profit margins may be significantly less than thatbusiness in numerous ways, including but not limited to those outlined below:

Purchasing power of consumers may be reduced thereby affecting demand for our products and services.
Decreased demand for our products and services due to significant capital constraints as a result of COVID-19 and the macro-economic environment.
Disruptions or uncertainties related to the COVID-19 outbreak for a sustained period of time could result in delays or modifications to our strategic plans and initiatives and hinder our ability to achieve our business objectives.
Illness, travel restrictions or workforce disruptions could negatively affect our business processes.
Government or regulatory responses to pandemics could negatively impact our business. Mandatory lockdowns or other restrictions could materially adversely impact our operations and results.
The COVID-19 outbreak has increased volatility and pricing in the capital markets and volatility is likely to continue which could have a material adverse effect on our ability to obtain debt or equity financing to fund operations.

-15-

These and other impacts of our competitors. In addition, we maythe COVID-19 or other global or regional health pandemics or epidemics could have the effect of heightening many of the other risks described in this “Risk Factors” section. We might not be able to chargepredict or respond to all impacts on a high enough price fortimely basis to prevent near- or long-term adverse impacts to our results. The ultimate impact of these disruptions also depends on events beyond our knowledge or control, including the duration and severity of any products we developoutbreak and actions taken by parties other than us to makerespond to them. Any of these disruptions could have a profit. If we are unable to realize significant profits from our potential product candidates,negative impact on our business wouldoperations, financial performance and results of operations, which impact could be materially harmed.material.

14


Our current very limited revenue depends on our ability to continue to obtain SBIR, STTR and other Government Grants for Research and Development.

          We have completed a Phase II STTR Army Research grant in the amount of $750,000. Although we are actively applying for new SBIR, STTR and other government grants and funding we are unable to predict whether we will be successful in obtaining such grants.

We depend on key personnel for our continued operations and future success, and a loss of certain key personnel could significantly hinder our ability to move forward with our business plan.

 

Because of the specialized nature of our business, we are highly dependent on our ability to identify, hire, train and retain highly qualified scientific and technical personnel for the research and development activities we conduct or sponsor. The loss of one or more certain key executive officers, or scientists, would be significantly detrimental to us. In addition, recruiting and retaining qualified scientific personnel to perform research and development work is critical to our success. Our anticipated growth and expansion into areas and activities requiring additional expertise, such as new applications for “smart surfaces”, manufacturing and marketing, will require the addition of new management personnel and the development of additional expertise by existing management personnel. Despite the current economic conditions and job market there is significant competition for qualified personnel in the areas of our present and planned activities, and there can be no assurance that we will be able to continue to attract and retain the qualified personnel necessary for the development of our business. The failure to attract and retain such personnel or to develop such expertise would adversely affect our business.

 

Our insurance policies are limited in scope and coverage and may be inadequate and potentially expose us to unrecoverable risks.

 

We do not carry director and officer insurance and have limited commercial insurance policies. Any significant insurance claims would have a material adverse effect on our business, financial condition and results of operations. Insurance availability, coverage terms and pricing continue to vary with market conditions. We endeavor to obtain appropriate insurance coverage for insurable risks that we identify, however, we may, faildue to limited financial resources, be unable to correctly cover those risks that we can anticipate or quantify as insurable risks, werisks. We may not be able to obtain appropriate insurance coverage, and insurers may not respond as we intend to cover insurable events that may occur. We have observed rapidly changing conditions in the insurance markets relating to nearly all areas of traditional corporate insurance. Such conditions have resulted in higher premium costs, higher policy deductibles, and lower coverage limits. For some risks, we may not have or maintain insurance coverage because of cost or availability.

 

We have no product liability insurance, which may leave us vulnerable to future claims we will be unable to satisfy.

 

The testing, manufacturing, marketing and sale of consumer products entail an inherent risk of product liability claims, and we cannot assure you that substantial product liability claims will not be asserted against us. We have no product liability insurance. In the event we are forced to expend significant funds on defending product liability actions, and in the event those funds come from operating capital, we will be required to reduce our business activities, which could lead to significant losses.

 

We cannot assure you that adequate insurance coverage will be available in the future on acceptable terms, if at all, or that, if available, we will be able to maintain any such insurance at sufficient levels of coverage or that any such insurance will provide adequate protection against potential liabilities. Whether or not a product liability insurance policy is obtained or maintained in the future, any product liability claim could harm our business or financial condition.

 We presently have members of management and other key employees located in various locations throughout the country which adds complexities to the operation of the business.

-16-

 Presently, we have members of management and other key employees located in both Connecticut and New Jersey, which adds complexities to the operation of our business.

We face risks related to compliance with corporate governance laws and financial reporting standards.

 

The Sarbanes-Oxley Act of 2002, as well as related new rules and regulations implemented by the Securities and Exchange Commission and the Public Company Accounting Oversight Board, require changes in the corporate governance practices and financial reporting standards for public companies. These new laws, rules and regulations, including compliance with Section 404 of the Sarbanes-Oxley Act of 2002 relating to internal control over financial reporting, referred to as Section 404, have materially increased our legal and financial compliance costs and made some activities more time-consuming and more burdensome.

15


Risks RelatingWe may not be able to Our Common Stock

Stock prices for development-stage technology companies have historically tended to be very volatile.adequately defend against piracy of intellectual property in foreign jurisdictions.

 Stock prices

Considerable research in the area of artificial intelligence is being performed in countries outside of the United States, and trading volumes for many small development-stage technology companies fluctuate widely for a number of potential competitors are located in these countries. The laws protecting intellectual property in some of those countries may not provide adequate protection to prevent our competitors from misappropriating our intellectual property. Several of these potential competitors may be further along in the process of product development and also operate large, company-funded research and development programs. As a result, our competitors may develop more competitive or affordable products, or achieve earlier patent protection or product commercialization than we are able to achieve. Competitive products may render any products or product candidates that we develop obsolete.

We may incur substantial expenditures in the future in order to protect our intellectual property.

We believe that our intellectual property with respect to our Smart NanoBattery, our proprietary rights with respect to the Company’s permeable membrane design consisting of both micro and nano scale silicon features that are coated with a monolayer chemistry used to repel liquids, and our recent entry into the area of artificial intelligence and machine learning are critical to our future success. The Company’s current battery related patent portfolio consists of Smart Surfaces technologies. Our pending patent applications may never be granted for various reasons, including the existence of conflicting patents or defects in our applications. Even if additional U.S. patents are ultimately granted, there are significant risks regarding enforcement of patents in international markets. There are many patents being filed as the science of nanotechnology develops and the Company has limited financial resources compared to large, well established companies to bring patent litigation based upon claims of patent infringement.

-17-

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Any statements in this prospectus about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not limitedalways, made through the use of words or phrases such as “believe,” “will,” “expect,” “anticipate,” “estimate,” “intend,” “plan” and “would.” For example, statements concerning financial condition, possible or assumed future results of operations, growth opportunities, industry ranking, plans and objectives of management, markets for our Common Stock and future management and organizational structure are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement.

Any forward-looking statements are qualified in their entirety by reference to the followingrisk factors somediscussed throughout this prospectus. You should read this prospectus and the documents that we reference herein and have filed as exhibits to the registration statement, of which this prospectus is part, completely and with the understanding that our actual future results may be unrelatedmaterially different from what we expect. You should assume that the information appearing in this prospectus is accurate as of the date on the front cover of this prospectus only. Because the risk factors referred to their businesseson page 6 of this prospectus could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of operations:the information presented in this prospectus and any accompanying prospectus supplement, and particularly our forward-looking statements, by these cautionary statements.

-

The amount of cash resources and ability to obtain additional funding,

-

Announcements of research activities, business developments, technological innovations or new products by companies or their competitors,

-

Entering into or terminating strategic relationships,

-

Disputes concerning patents or proprietary rights,

-

Changes in revenues or expense levels,

-

Reports by securities analysts,

-

Activities of various interest groups or organizations,

-

Media coverage, and

-

Status of the investment markets.

 This market volatility, as well as general domestic or international economic, market and political conditions, could materially and adversely affect

USE OF PROCEEDS

The selling stockholder will receive all of the market priceproceeds from the sale of our Common Stock andoffered by them pursuant to this prospectus. We will not receive any proceeds from the return on your investment.

A significant numbersale of shares of our Common Stock have become available forby the selling stockholder covered by this prospectus. However, we will receive proceeds from the sale and their sale could depress the price of our Common Stock.

          In addition to the shares underlying our convertible debt as described above, we may sell a substantial number of additional shares of our Common Stock in connection with a private placement or public offering of shares of our Common Stock (or other series or classpursuant to our exercise of capitalthe purchase notice offered by White Lion. We will use proceeds from the sale of our common stock to White Lion for general corporate and working capital purposes, including possibly acquiring assets, businesses and developing other operations, or for other purposes that our board of directors, using prudent business judgment, deems to be designated in the future)best interest of the Company.

We will pay for expenses of this offering, except that the selling stockholder will pay any broker discounts or commissions or equivalent expenses and expenses of its legal counsel applicable to the sale of its shares.

DETERMINATION OF OFFERING PRICE

Our shares of Common Stock are currently listed on the OTCQB tier of the OTC Markets under the symbol “XDSL”. The termsOTC Markets is not a national securities exchange registered with the SEC. The price of any such private placement would likely require us to register the resale of any shares of capital stock issued or issuable in the transaction. We have also issuedour Common Stock is thinly traded and subject to certain parties, such as vendorssignificant volatility on OTC Markets. The proposed offering price of the Shares has been estimated solely for the purpose of computing the amount of the registration fee in accordance with Rule 457(c) of the Securities Act of 1933, on the basis of the average of the high and service providers, as payment for products and services. Under these arrangements, we may agree to registerlow prices of the shares for resale soon after their issuance. We may also continue to pay for certain goods and services with equity, which would dilute your interest in the company.

          Sales of a substantial number of shares of our Common Stock underas reported on the OTC Markets Group, Inc. on August 13, 2020. We also considered, pursuant to Item 201 of Reg. SK, the range of high and low bid information for each full quarterly period within the two most recent fiscal years and any of the circumstances described above could adversely affect the market pricesubsequent interim period for our Common Stock and make it more difficult for you to sell shares of our Common Stock at times and prices that you feelwhich financial statements are appropriate.included.

 We do not intend to pay cash dividends on our Common Stock in the foreseeable future.

DILUTION

 Any payment of cash dividends will depend upon our financial condition, results of operations, capital requirements and other factors and will be at the discretion of our board of directors. We do not anticipate paying cash dividends on our Common Stock in the foreseeable future. Furthermore, we may incur additional indebtedness that may severely restrict or prohibit the payment of dividends.

Our Common Stock is subject to "penny stock" regulations and restrictions on initial and secondary broker-dealer sales.

          The Securities and Exchange Commission (SEC) has adopted regulations which generally define "penny stock" to be any listed, trading equity security that has a market price less than $5.00 per share or an exercise price of less than $5.00 per share, subject to certain exemptions. Penny stocks are subject to certain additional oversight and regulatory requirements. Brokers and dealers affecting transactions in our Common Stock in many circumstances must obtain the written consent of a customer prior to purchasing our Common Stock, must obtain information from the customer and must provide disclosures to the customer. These requirements may restrict the ability of broker-dealers to sell our Common Stock and may affect your ability to sell your shares of our Common Stock in the secondary market.

16


As an issuer of “penny stock,” the protection provided by the federal securities laws relating to forward looking statements does not apply to us.

          Although federal securities laws provide a safe harbor for forward-looking statements made by a public company that files reports under the federal securities laws, this safe harbor is not available to issuers of penny stocks. As a result, the Company will not have the benefit of this safe harbor protection in the event of any legal action based upon a claim that the material provided by the Company contained a material misstatement of fact or was misleading in any material respect because of the Company’s failure to include any statements necessary to make the statements not misleading. Such an action could hurt our financial condition.

Risks Related to This Offering

There are substantial risks associated with the Investment Agreement, which could contribute to the decline of the price of our common stock and have a dilutive impact on our existing stockholders.

          In order to have access to capital when needed, we entered into the Investment Agreement with Dutchess. The terms of the Investment Agreement are described under the section captioned “Selling Stockholder.” The sale of our common stock pursuant to White Lion Capital, LLC in accordance with the terms of the Investment Agreementcommon stock purchase agreement will have a dilutive impact on our existing stockholders. Dutchess is not restrictedAs a result, our net loss per share could increase in its ability to resell the shares we issue to them,future periods and any such resale could cause the market price of our common stock tocould decline. Following any decline inIn addition, the marketlower our stock price is at the time we exercise our Purchase Notice, the more shares of our common stock any subsequent advances would require uswe will have to issue a greater number of shares ofto White Lion in order to drawdown pursuant to the common stock in exchange for each dollar advanced.  Although Dutchess is limited to owning 4.99% ofpurchase agreement. If our common stock at any point in time it can sell a portion of its holdingprice decreases during any point in time and receive additional shares. Under these circumstancesthe pricing period, then our existing stockholders would experience greater dilution.

-18-

DIVIDEND POLICY

We have not paid any cash dividends on our capital stock and we do not expect to pay cash dividends in the foreseeable future. We intend to retain future earnings, if any, to provide funds for operations of our business. Our future dividend policy will be determined from time to time by our board of directors.

SELLING STOCKHOLDER

This prospectus relates to the resale from time to time by the selling security holder identified herein of 10,406,591 shares of our Common Stock.

The shares of our Common Stock referred to above are being registered to permit public sales of the shares of Common Stock, and the selling stockholder may offer the shares for resale from time to time pursuant to this prospectus.

The table below sets forth certain information regarding the selling stockholder and the shares of Common Stock offered in this prospectus. The selling stockholder has had no material relationship with us within the past three years.

To our knowledge, the selling stockholder is not a broker-dealer or an affiliate of a broker-dealer. We may require the selling stockholder to suspend the sales of the shares of our Common Stock being offered pursuant to this prospectus upon the occurrence of any event that makes any statement in this prospectus or the related registration statement untrue in any material respect or that requires the changing of statements in those documents in order to make statements in those documents not misleading.

Beneficial ownership is determined in accordance with the rules of the SEC. The selling stockholder’s percentage of ownership of our outstanding shares in the table below is based upon 73,240,897 shares of Common Stock outstanding as of August 13, 2020.

Name of Selling Stockholder Number of
Shares of
Common
Stock
Beneficially
Owned
Before this
Offering (1)
  Percentage
of Common
Stock
Beneficially
Owned
Before this
Offering
  Share of
Common
Stock Offered
in this
Offering
  Shares of
Common Stock Beneficially Owned After this Offering (2)
  Percentage of Common Stock Beneficially Owned After this Offering (2) 
White Lion Capital, LLC (3)  0   0%  10,406,591   0   0%

* Less than 1%.

(1) Under applicable SEC rules, a person is deemed to beneficially own securities which the person has the right to acquire within 60 days through the exercise of any option or warrant or through the conversion of a convertible security. Also under applicable SEC rules, a person is deemed to be the “beneficial owner” of a security with regard to which the person directly or indirectly, has or shares (a) voting power, which includes the power to vote or direct the voting of the security, or (b) investment power, which includes the power to dispose, or direct the disposition, of the security, in each case, irrespective of the person’s economic interest in the security. Each listed selling stockholder has the sole investment and voting power with respect to all shares of Common Stock shown as beneficially owned by such selling stockholder, except as otherwise indicated in the footnotes to the table.

(2) Represents the amount of shares that will be held by the selling stockholder after completion of this offering based on the assumptions that (a) all shares of our Common Stock registered for sale by the registration statement of which this prospectus is part will be sold and (b) no other shares of our Common Stock are acquired or sold by the selling stockholder prior to completion of this offering. However, each selling stockholder may sell all or some of the shares of Common Stock offered pursuant to this prospectus.

(3) Nathan Yee is the Manager of White Lion Capital, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.

-19-

PLAN OF DISTRIBUTION

We are registering the shares of our Common Stock covered by this prospectus to permit the selling stockholder to conduct public secondary trading of such shares from time to time after the date of this prospectus. We will not receive any proceeds from the sale of shares of our common stockCommon Stock by the selling stockholder; however, we will receive the proceeds from the sale of shares of our Common Stock pursuant to our exercise of the purchase notice offered by White Lion.

The selling stockholder may sell all or a portion of the shares of Common Stock beneficially owned by them and offered hereby from time to time directly or through one or more underwriters, broker-dealers or agents. If the shares of Common Stock are sold through underwriters or broker-dealers, the selling stockholder will be responsible for underwriting discounts or commissions or agent’s commissions. The shares of Common Stock may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of the sale (if a public market exists), at varying prices determined at the time of sale, or at negotiated prices. All sales may be effected in transactions, which may involve crosses or block transactions:

on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;
in the over-the-counter market;
in transactions otherwise than on these exchanges or systems or in the over-the-counter market;
ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;
purchases by a broker-dealer as principal and resale by the broker-dealer for its account;
an exchange distribution in accordance with the rules of the applicable exchange;
privately negotiated transactions;
settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a part;
broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share;
through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
under Rule 144, Rule 144A or Regulation S under the Securities Act, if available, rather than under this prospectus;
a combination of any such methods of sale; or
any other method permitted pursuant to applicable law.

Our Common Stock is currently quoted on the OTCQB under the Investment Agreement could encourage short salessymbol “XDSL.” Broker-dealers engaged by third parties, which could contributethe selling stockholder may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the further declineselling stockholder (or, if any broker-dealer acts as agent for the purchaser of our stock price.

Dutchess intendsshares, from the purchaser) in amounts to engagebe negotiated, but, except as set forth in certain hedging transactions that may causea supplement to this prospectus, in the market pricecase of our common stock to decline.an agency transaction not in excess of a customary brokerage commission in compliance with NASD Rule 2440; and in the case of a principal transaction a markup or markdown in compliance with NASD IM-2440.

 

In connection with the distributionsale of our common stockCommon Stock or otherwise, including upon receipt of any put notice from us, Dutchess intends tointerests therein, the selling stockholder may enter into certain hedging transactions with broker-dealers or other financial institutions, pursuant to which such broker-dealers or other financial institutions willmay in turn engage in short sales of our sharesCommon Stock in the course of hedging the positions they assume with Dutchess. If there is an imbalance on the sell side of the market in our common stock, the price of our common stock will decline. Dutchess has no intention of, and is contractually prohibited from, entering into any short sales during the term of the Investment Agreement.

Pursuant to the terms of the Investment Agreement, Dutchess will pay less than the then-prevailing market price for our common stock.

          The common stock to be issued to Dutchess pursuant to the Investment Agreement will be purchased at 94 % of the lowest daily trading price of our common stock during the ten consecutive trading days after the date we request the advance. Dutchess has a financial incentive to sell our common stock upon receiving the shares to realize the profit equal to the difference between the discounted price and the market price. If Dutchess sells the shares, the price of our common stock could decrease.

We may not be able to access sufficient funds pursuant to the terms of the Investment Agreement.

          Our ability to put shares to Dutchess and obtain funds pursuant to the terms of the Investment Agreement is limited, including restrictions on when we may exercise our put rights, restrictions on the amount we may put to Dutchess at any one time, which is determined in part by the trading price of our common stock, and a limitation on Dutchess’ obligation to purchase if such purchase would result in Dutchess beneficially owning more than 4.99% of our common stock. Accordingly, we may not be able to access sufficient funds when needed.” 

We would have to increase our authorized shares of common stock to 6,980,000,000 shares from the current 6 billion shares to have enough shares to exercise the full equity line

          In order to exercise the entire equity line of $10 million, the Company would be required to issue 3,223,806,432 additional shares of its common stock to Dutchess as of December 21, 2011. This would equal approximately 111% of our common stock currently outstanding of approximately 2.8 billion shares.

Our stock price is currently too low to allow us full use of the equity line

Based upon the current capital structure of the Company there are 2,228,283,513 shares of common stock available for issuance  as of December 21, 2011. This will enable the Company to access up to $7,121,594 of the $10 million equity line. In order for the Company to access the full $10 million of the equity line over the next three years the price of the Common Stock would need to equal $.004773 or greater for substantial periods of time during such period. In addition the liquidity or trading volume of the Company’s common stock would have to be sufficient to accommodate the sale in the open market of shares purchased by Dutchess.

There Are further conditions to the equity line that the Company may not be able to  meet

In addition, in order for the Company to draw monies under the Equity Line it must satisfy the following conditions set forth in Section  2D of the Investment Agreement.

Notwithstanding anything to the contrary in this Agreement, the Company shall not be entitled to deliver a      Put Notice and the Investor shall not be obligated to purchase any Shares at a Closing unless each of the following conditions are satisfied:

(1)      a Registration Statement shall have been declared effective and shall remain effective and      available for the resale of all the Registrable Securities (as defined in the Registration Rights       Agreement) at all times until the Closing with respect to the subject Put Notice;

(2)      at all times during the period beginning on the related Put Notice Date and ending on and    including the related Closing Date, the Common Stock shall have been listed on the Principal Market and shall not have been suspended from trading thereon for a period of two (2) consecutive Trading Days during the Open Period and the Company shall not have been notified of any pending or threatened proceeding or other action to suspend the trading of the Common Stock;

(3)      the Company has complied with its obligations and is otherwise not in breach of or in default under this Agreement, the Registration Rights Agreement or any other agreement executed in connection herewith which has not been cured prior to delivery of the Put Notice;

(4)      no injunction shall have been issued and remain in force, or action commenced by a governmental authority which has not been stayed or abandoned, prohibiting the purchase or the issuance of the Securities; and

(5)      the issuance of the Securities pursuant to this Agreement will not violate any shareholder    approval requirements of the Principal Market.”

If any of the events described in clauses (1) through (5) above occurs during a Pricing Period, then     the Investor shall have no obligation to purchase the Common Stock subject to the applicable Put    Notice. 

The equity line, if accessed by the Company will cause significant dilution to existing shareholders as illustrated by the following table.

FORWARD-LOOKING STATEMENTS

          This prospectus contains forward-looking statements that involve risks and uncertainties. We use words such as “may,” “assumes,” “forecasts,” “positions,” “predicts,” “strategy,” “will,” “expects,” “estimates,” “anticipates,” “believes,” “projects,” “intends,” “plans,” “budgets,” “potential,” “continue” and variations thereof, and other statements contained in this prospectus, regarding matters that are not historical facts and are forward-looking statements. Because these statements involve risks and uncertainties, as well as certain assumptions, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to risks inherent in: our early stage of development, including a lack of operating history, lack of profitable operations and the need for additional capital; the development and commercialization of largely novel and unproven technologies and products; our ability to protect, maintain and defend our intellectual property rights; uncertainties regarding our ability to obtain the capital resources needed to continue research and development operations and to conduct research; uncertainty regarding our overall ability to compete effectively in a highly complex, rapidly developing, capital intensive and competitive industry. See “Risk Factors” set forth herein for a more complete discussion of these factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date that they are made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

          Forward-looking statements include our plans and objectives for future operations, including plans and objectives relating to our products and our future economic performance. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions, future business decisions, and the time and money required to successfully complete development and commercialization of our technologies, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Although we believe that the assumptions underlying the forward-looking statements contained herein are reasonable, any of those assumptions could prove inaccurate and, therefore, we cannot assure you that the results contemplated in any of the forward-looking statements contained herein will be realized. Based on the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of any such statement should not be regarded as a representation by us or any other person that our objectives or plans will be achieved.

USE OF PROCEEDS

          We will receive no proceeds from the sale of shares of Common Stock offered by the selling stockholders. . We will receive $25,000 of proceeds upon exercise of the Warrant and proceeds from time to time upon exercise by the Company of the Put under the Equity Line . All proceeds received will be used by the Company as working capital.

DETERMINATION OF OFFERING PRICE

assume. The selling stockholdersstockholder may also sell their shares in the over-the-counter market or otherwise, at market prices prevailing at the time of sale, at prices related to the prevailing market price, or at negotiated prices.

DILUTION

“Dilution” represents the difference between the offering price per share and the net tangible book value per share of our Common Stock immediately after completion of this offering. Net tangible book value per share represents our net tangible assets (our total assets less our total liabilities), divided by the number of shares of Common Stock outstanding at the time of this offering. Our net tangible book value as of September 30, 2011 was -$0.0021. Please refer to the following table presenting the number of shares issued and the corresponding price per share paid before this Offering. Following is a table illustrating the pro forma dilution as of June 30 2011, to investors if 100%, 75%, 50%, or 10% of the Offering is sold.

17


SELLING SECURITY HOLDERS

          The following table details the name of each selling stockholder, the number of shares owned by that selling stockholder, and the number of shares that may be offered by each selling stockholder for resale under this prospectus. The selling stockholders may sell up to 465,076,471 shares of our Common Stock from timeshort and deliver these securities to timeclose out their short positions, or loan or pledge our Common Stock to broker-dealers that in turn may sell these securities. The selling stockholder may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more offerings under this prospectus. Because each selling stockholder may offer all, somederivative securities which require the delivery to such broker-dealer or none of the shares it holds, and because, based upon information provided to us, there are currently no agreements, arrangements, or understandings with respect to the sale of any of the shares, no definitive estimate as to the numberother financial institution of shares that will be heldoffered by each selling stockholder after the offering can be provided. The following table has been prepared on the assumption that all shares offered under this prospectus, will be soldwhich shares such broker-dealer or other financial institution may resell pursuant to parties unaffiliated with the selling stockholders.

Security HolderRelationship toIssuerAmountOwnedPrior toOfferingAmount OfferedAmount Owned AfterOffering
John FifeNone57,236,500                                 185,400,0000
Jay WrightNone3,676,471                                       3,676,4710
Dutchess Opportunity Fund II, LP - Commitment and Transaction feesNone26,000,00026,000,0000
Dutchess Opportunity Fund II, LP - Put feature of Equity LineNone0250,000,0000

* Less than 1%this prospectus (as supplemented or amended to reflect such transaction).

(1) The number and percentage of shares beneficially owned is determined in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, as amended, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rule, beneficial ownership includes any shares as to which the selling stockholders has sole or shared voting power or investment power and also any shares, which the selling stockholders has the right to acquire within 60 days. As of November 30, 2011, the Company had 2,892,510,073 shares of Common Stock issued and outstanding.

(2) Assumes the sale of all shares included in this prospectus.

(3) John Fife has the right to convert a maximum of $557,500 of principal plus a maximum of $14,865 of accrued interest at $.01 per share into 57,236,500 shares of common stock of the Company during the next 60 days under the terms of the Convertible Note. In the alternative the Company must make payments under the Convertible Note in either cash or its common stock as follows: 10 payments of principal of $55,700 per month plus accrued interest at 8% on the unpaid balance in 10 monthly payments from November 30, 2011 through and including August 30, 2012 .The price of the common stock of the Company closed at $.0046 per share on December 2, 2011. If the Company elects to make payments on a timely basis to amortize principal and interest in its common stock the holder will receive approximately a 20% discount from the current market value of the stock. Such a discount based upon a stock price of $.0046 per share would result in the holder receiving approximately 30,374,871 shares of common stock valued at $.0039 per share to cover principal and interest payments for the 60 day period following November 30, 2011. If the Company made timely payments solely in its common stock the 10 monthly payments of principal plus accrued interest from November 30, 2011 through August 30, 2012 the holder would receive a total of approximately 151,556,682shares of common stock assuming the market price continue throughout such period at $.0046 per share. Certain additional shares equal to 33,433,318 are being registered as required under the terms of the Registration Rights Agreement dated as of September 13, 2011 to provide for additional shares, if required, if the market value of the Company’s common stock declines.

(4) The Company has failed to make the payment owed on November 30, 2011 of $57,500 plus accrued interest at 8% equal to $8,375 from September 13, 2011 in either cash or shares of its common stock. As of the date hereof the holder has not declared an event of default or elected to exercise any remedies under the Convertible Note. It is anticipated that upon effectiveness of this Registration Statement the Company will pay such amount in stock of the Company. Such amount would be payable at a 20% discount and at the market value of the stock of $.0046 on December 2, 2011 would result in the payment of approximately 16,891,025 shares of common stock payable to the holder valued at $.0039 per share.

(5) Dutchess Opportunity Fund II, LP will not beneficially own any shares of common stock other than shares issued to the Company to cover commitment fees and transaction costs unless and until the Company exercises a put under the Equity Line. Dutchess Opportunity Fund II, LP is managed by its Senior Partners,  Dutchess Capital Management II, LLC which Douglas Leighton and Michael A. Movelli have deportive power.

18


PLAN OF DISTRIBUTION

Each selling stockholder and any of its pledges, assignees and successors-in-interest may, from time to time, sell any or all of its shares of Common Stock on the Over-the-Counter Bulletin Board or any other stock exchange, market or trading facility on which our shares are traded or in private transactions. These sales may be at fixed or negotiated prices. A selling stockholder may use any one or more of the following methods when selling shares:

19


          The selling stockholders may also sell shares under Rule 144 under the Securities Act of 1933, as amended, if available, rather than under this prospectus.

          A selling stockholder or its pledges, donates, transferees or other successors in interest, may also sell the shares directly to market makers acting as principals and/or broker-dealers acting as agents for themselves or their customers. Such broker-dealers may receive compensation in the form of discounts, concessions or commissions from the selling stockholder and/or the purchasers of shares for whom such broker-dealers may act as agents or to whom they sell as principal or both, which compensation as to a particular broker-dealer might be in excess of customary commissions. Market makers and block purchasers purchasing the shares will do so for their own account and at their own risk. It is possible that a selling stockholder will attempt to sell shares of Common Stock in block transactions to market makers or other purchasers at a price per share which may be below the then market price. A selling stockholder cannot assure that all or any of the shares offered in this prospectus will be issued to, or sold by, the selling stockholder. The selling stockholders and any brokers, dealers or agents upon effectingthat are involved in selling the sale of any of the shares offered in this prospectus, may be deemed to be "underwriters" as that term is defined under“underwriters” within the meaning of the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, or the rules and regulations underin connection with such acts.sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discountsdiscounts. If a selling stockholder is deemed to be an underwriter, the selling stockholder may be subject to certain statutory liabilities including, but not limited to, Sections 11, 12 and 17 of the Securities Act and Rule 10b-5 under the Exchange Act. A selling stockholder who is deemed an underwriter within the meaning of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act. The SEC staff is of the view that a selling stockholder who is a registered broker-dealer or affiliate of a registered broker-dealer may be an underwriter under the Securities Act. In compliance with FINRA guidelines, the maximum commission or discount to be received by an FINRA member or independent broker-dealer may not exceed 8% for the sale of any securities registered hereunder. We will not pay any compensation or give any discounts or commissions to any underwriter in connection with the securities being offered by this prospectus. The selling stockholder has advised us that they have not entered into any written or oral agreements, understandings or arrangements with any underwriter or broker-dealer regarding the sale of our Common Stock. There is no underwriter or coordinating broker acting in connection with the proposed sale of our Common Stock by the selling stockholder.

 

-20-

We are required to pay allcertain fees and expenses incurred by us incident to the registration of the shares, including fees and disbursements of counselshares. We have agreed to indemnify the selling stockholder but excluding brokerage commissions or underwriter discounts.

          The selling stockholders, alternatively, may sell all or any part ofagainst certain losses, claims, damages and liabilities, including liabilities under the shares offered in this prospectus through an underwriter. NoSecurities Act. Each selling stockholder has entered into any agreementin turn agreed to indemnify us for certain specified liabilities.

In order to comply with a prospective underwriterthe securities laws of some states, if applicable, the shares of Common Stock may be sold in these jurisdictions only through registered or licensed brokers or dealers. In addition, in some states the shares of Common Stock may not be sold unless they have been registered or qualified for sale or an exemption from registration or qualification requirements is available and there is no assurance that any such agreement will be entered into.complied with.

 A selling stockholder may pledge its shares to their brokers

Under applicable rules and regulations under the margin provisions of customer agreements. If a selling stockholder defaults on a margin loan, the broker may, from time to time, offer and sell the pledged shares. The selling stockholder andExchange Act, any other persons participatingperson engaged in the sale or distribution of our Common Stock may not simultaneously engage in market making activities with respect to the sharesCommon Stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling stockholder will be subject to applicable provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations under such act,thereunder, including without limitation, Regulation M. These provisionsM, which may restrict certain activities of, and limit the timing of purchases and sales of anyshares of the sharesCommon Stock by the selling stockholder or any other such person. InThe anti-manipulation rules under the event thatExchange Act may apply to sales of Common Stock in the market and to the activities of the selling stockholder is deemed affiliated with purchasers or distribution participants within the meaning ofand its affiliates. Regulation M thenmay restrict the selling stockholder will not be permittedability of any person engaged in the distribution of the Common Stock to engage in short sales of Common Stock. Furthermore, under Regulation M, persons engaged in a distribution of securities are prohibited from simultaneously engaging in market making and certain othermarket-making activities with respect to such securitiesthe particular shares of Common Stock being distributed for a specified period of time priorup to five business days before the commencement of such distributions, subject to specified exceptions or exemptions. Not only is the selling stockholder contractually restricted from engaging in short sales but in the event any such short sale is deemed to be a stabilizing activity, then the selling stockholder will not be permitted to engage in a short sale of our Common Stock. All of these limitationsdistribution. These restrictions may affect the marketability of the shares.

          IfCommon Stock and the selling stockholder notifies us that it has a material arrangementability of any person or entity to engage in market-making activities with a broker-dealer for the resale ofrespect to the Common Stock, then we would be required to amend the registration statementStock. We will make copies of which this prospectus is a part, and file a prospectus supplementavailable to describe the agreements between the selling stockholder and have informed them of the broker-dealer.need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale.

DESCRIPTION OF SECURITIES TO BE REGISTERED

 This prospectus includes 465,076,471

We are offering up to 10,406,591 shares of our Common Stock offered by the selling stockholders which constitutes approximately 16% of out currently outstanding Stock.

Common Stock. Stock

The following description of our Common Stock is intended as a summary only a summary. You should also referand is qualified in its entirety by reference to our certificateAmended and Restated Certificate of incorporationIncorporation, as amended (the “Certificate of Incorporation”) and bylaws,Amended and Restated Bylaws, as amended (“Bylaws”), which have beenare filed as exhibits to the registration statement of which this prospectus forms a part.

 We are

Our authorized to issue 6,000,000,000 shares of Common Stock having aconsists of 500,000,000 shares, par value $0.01 per share, of $0.001 per share. Holderswhich 73,240,897 shares were issued and outstanding as of August 13, 2020.

Each share of our Common Stock areis entitled to one vote for each share held on all matters submitted to a vote of the stockholders. Our stockholders and doare not havepermitted to cumulative voting rights. Accordingly, holders of a majority of the shares of Common Stock entitled to vote in any election of directors may elect all of the directors standing for election.voting. Holders of our Common Stock are entitled to receive proportionatelyratably such dividends, if any, dividends as may be declared by our boardBoard out of directors. Our outstanding shareslegally available funds. However, the current policy of Common Stock are fully paidour Board is to retain earnings, if any, for the operation and non-assessable. Holdersexpansion of sharesour Company. The holders of our Common Stock have no conversion, preemptive, or other subscription, rights, and there are no redemption or sinking fund provisions applicableconversion rights.

-21-

SHARES ELIGIBLE FOR FUTURE SALE

We cannot predict the effect, if any, that market sales of shares of our Common Stock or the availability of shares of our Common Stock for sale will have on the market price of our Common Stock prevailing from time to time. Future sales of our Common Stock in the public market, or the availability of such shares for sale in the public market, could adversely affect market prices prevailing from time to time. The availability for sale of a substantial number of shares of our Common Stock acquired through the exercise of outstanding warrants could materially adversely affect the market price of our Common Stock. In addition, sales of our Common Stock in the public market after the restrictions lapse as described below, or the perception that those sales may occur, could cause the prevailing market price to decrease or to be lower than it might be in the absence of those sales or perceptions.

Rule 144

In general, under Rule 144, any person who is not our affiliate and has held their shares for at least six months, including the holding period of any prior owner other than one of our affiliates, may sell shares without restriction, subject to the availability of current public information about us. In addition, under Rule 144, any person who is not an affiliate of ours and has held their shares for at least one year, including the holding period of any prior owner other than one of our affiliates, would be entitled to sell an unlimited number of shares without regard to whether current public information about us is available. A person who is our affiliate or who was our affiliate at any time during the preceding three months, and who has beneficially owned restricted securities for at least six months, including the holding period of any prior owner other than one of our affiliates, is entitled to sell a number of shares within any three-month period that does not exceed the greater of: (i) 1% of the number of shares of our common stock then outstanding and (ii) if and when the Common Stock.Stock is listed on a national securities exchange, the average weekly trading volume of the Common Stock during the four calendar weeks preceding the date on which notice of such sale was filed under Rule 144.

20


Sales under Rule 144 by our affiliates are also subject to manner of sale provisions and notice requirements, and to the availability of current public information about us.

INTERESTS OF NAMED EXPERTS AND COUNSEL

 The validity of the shares offered hereby will be passed upon for us by Martin Smiley, Esq., EVP, CFO and General Counsel of the Company. With this exception, no

No expert or counsel named in this prospectusthe registration statement as having prepared or certified any part of this prospectusthe registration statement; or having given an opinion uponprovided a report or valuation for use related to the validityregistration statement, are covered persons pursuant to Item 509 of Regulation S-K having disclosable certain relationships with the Company.

INFORMATION WITH RESPECT TO THE REGISTRANT

Overview

mPhase Technologies, Inc., was incorporated in the state of New Jersey in 1979 under the name Tecma Laboratory, Inc. and has subsequently operated under Tecma Laboratories, Inc., and Lightpaths TP Technologies, Inc., until June 2, 1997 when the Company changed its name to mPhase Technologies, Inc.

On January 11, 2019, the Company underwent a major change in management and control. The new management of the securitiesCompany is positioning the Company to be a technology leader in artificial intelligence and machine learning while enabling a more rapid commercial development of its patent portfolio and other intellectual property. The Company’s goal is to generate significant revenue from its artificial intelligence and machine learning technologies.

On February 15, 2019, the Company acquired Travel Buddhi, a software platform to enhance travel via ultra-customization tools that tailor a planned trip experience in ways not previously available.

On June 30, 2019, the Company acquired 99% of the outstanding common shares of Alpha Predictions LLP (“Alpha Predictions”). Alpha Predictions is an India-based technology company that has developed a suite of commercial data analysis products for use across multiple industries. The Company expects the acquisition to result in synergies with its other operating divisions, which will drive revenue growth and innovation.

On May 11, 2020, the Company acquired all of the assets owned, used, or held by CloseComms Limited (“CloseComms”), a United Kingdom based company with offices in Wales (U.K.) and California (U.S.). One of the CloseComms acquired assets is a patented software application platform that can be integrated into a retail customer’s existing Wi-Fi infrastructure, giving the retailer important customer data and enabling AI-enhanced, targeted promotions to drive store traffic and sales.

-22-

Description of Operations

Platform Technology

Artificial Intelligence and Machine Learning

Through its recent acquisitions of CloseComms and Alpha Predictions, the Company has acquired a team of 26 software engineers and data analysis experts capable of enabling the Company to provide products in the artificial intelligence and machine learning areas. The Company has in place and is developing proprietary software to enable customers to enhance their business capabilities by providing sophisticated digital analysis of large volumes of data to provide sophisticated solutions to complex problems. The CloseComms patented software technology can be integrated into a retailer’s existing Wi-Fi infrastructure, giving retailers important customer data and enabling AI-enhanced, targeted promotions to drive store traffic and sales. The Alpha Predictions current product offering includes software covering eight categories: inventory, stock management, marketing optimization, sentiment analysis, customer segmentation and behavior, agro-tech image detection, electrocardiogram automation, and a recommendation engine with multiple uses.

Smart Surfaces

The surface is an important part of virtually every physical object and often plays an overriding role in many processes, beyond mere connectivity and structural support, but more deeply into areas involving chemical and biological interactions. In some instances, the surface provides an easy entry into the chemical or biological systems; in others it protects the internal elements of the object, surrounded by the surfaces.

The Company’s current technology platform is the Smart Surface. By being registeredable to control the surface properties of materials down to the nanometer scale, new and improved devices can be designed and built that may lead to compelling business opportunities. One type of smart surface of particular interest allows properties to be changed in response to an external stimulus.

Initially, the Company’s development focused on Micro Electronic Mechanic Systems (MEMS) devices by manipulating the surface of silicon materials – the same material used to make microelectronic materials and devices. Using physical and chemical processes, the surface of the silicon is modified to make solid porous structures known as membranes. This is where microfluidics comes into play. These membranes can be used to selectively control the flow of liquids through the pores or uponopenings at the micrometer length scale.

Surfaces may be characterized as hydrophilic or hydrophobic depending on whether or not they attract or repel water (or other legal mattersliquids). A hydrophilic surface can be wet and adsorbs water. A hydrophobic surface, on the other hand, cannot be wet. Hydrophilic and hydrophobic surfaces are abundant in connectionnature and in synthetic materials, both organic and inorganic in chemical composition. A familiar example of a hydrophilic surface is a sponge that readily soaks up water. By contrast, many plant leaves and flower petals are hydrophobic, as are insect parts and bird feathers. Synthetic hydrophobic surfaces include Scotchgard™ treated fabric, Teflon® coated metal, or Rain-X® coated glass. On a hydrophobic surface, water beads up and can move around without being absorbed by the solid material that it is resting on.

So-called superhydrophobic surfaces are also found in nature and can now be replicated in the lab. The lotus leaf and rose petal, for example, exhibit super-hydrophobicity. Here water droplets form almost perfect spheres with hardly any contact with the registrationunderlying solid surface. This makes the liquid even easier to move and manipulate. The synthesis of superhydrophobic surfaces has recently been made possible by advances in nanotechnology and the Company is leading the way to better understand and create materials and devices incorporating these unique surface properties.

As the Company’s research and development efforts evolve, in addition to silicon materials, the ability to control the surface properties of materials can be extended to other substances such as polymers, ceramics, metals, and fibers providing opportunities for our platform technology to be used in a range of potential applications such as energy storage and power management for portable electronics and microelectronics, self-cleaning surfaces, filters for water purification or offeringdesalination systems, materials for environmental remediation that separate liquids or solvents, and other situations where the control of the Common Stock was employed oninteraction of a contingency basis, or had, orsolid surface exposed to a liquid is to receive,vitally important.

-23-

Smart NanoBattery

Battery technology has changed little in connectionits fundamentals over the past 150 years. As a result, ordinary batteries begin dissipating energy as soon as they are assembled and therefore have limited shelf life. Chemistries are fixed inside the package so the user cannot interact with the offering, a substantial interest, direct or indirect, in the Company. Nor was any such person connectedcontents to program functionality. The size and form of batteries have not kept pace with the miniaturization of electrical components, microprocessors and integrated circuits. As a result, the optimal implementation of an electronic device is not always achieved. Some batteries contain chemicals that are not considered safe or environmentally friendly (“green”). This makes disposal a potential issue.

The Company is challenging this convention by using their proprietary superhydrophobic porous silicon membrane technology as a promoter, managing or principal underwriter, voting trustee, director, officer or employee.

DESCRIPTION OF BUSINESS

Overview

mPhase, a New Jersey corporation founded in 1996, is a publicly-held company with over 23,000 shareholders and 2,892,510,073 shares of Common Stock outstanding as of November 30, 2011. The Company's Common Stock is traded on the Overbasis to build the Counter Bulletin Board under the ticker symbol XDSL. We are headquartered in Norwalk, Connecticut and also have corporate offices in Little Falls, NJ. mPhase shares office space with Microphase Corporation, a privately held company. Microphase is a leader in the field of radio frequency and filtering technologies within the defense and telecommunications industry. It has been in operation for over 50 years and supports mPhase with both engineering and administrative and financial resources as needed. mPhase is a development stage company specializing in microfluidics, microelectromechanical systems (MEMS) and nanotechnology. mPhase is commercializing its first nanotechnology-enabled product for military and commercial applications - The Smart NanoBattery, a reserve battery providing Power On Command™. The new patented and patent pending prior to initial activation.

Super-hydrophobicity initially keeps the liquid electrolyte physically separated from the solid electrodes of the battery, technology, based onthus preventing the phenomenon of electrowetting, offers a unique waychemical reactions from occurring that cause the battery to store energy and manageprovide power. Features ofThis gives the Smart NanoBattery includethe benefit of potentially infinite shelf life, environmentally friendly design, fast ramp to power, programmable control, and direct integration with microelectronic devices.life.

The platform technology behind the Smart NanoBattery is a porous nanostructured material used to repel and precisely control the flow of liquids. The material has a Smart Surface that can potentially be designed for self-cleaning applications, water purification/desalination, liquid filtration/separation, and environmental cleanup. mPhase has completed a Phase II Small Business Technology Transfer Program (STTR) grant, part of the Small Business Innovation Research (SBIR) program, from the U.S. Army for continued development of a reserve Smart NanoBattery for a critical computer memory application.

Since our inception in 1996, we have been a development-stage company and operating activities have related primarily to research and development, establishing third-party manufacturing relationships and developing product brand recognition. In December of 2007 the Company ceased further activities with respect to its prior telecommunications equipment products which have been treated as a Discontinued Business effective June 30, 2010. Since January of 2008, the Company has focused primarily upon development of our smart reserveA conventional battery and other battery and illuminator products as well as establishing a patent portfolio of intellectual property for “smart surfaces” in the field of nanotechnology.

Description of Operations

Microfluidics, MEMS, and Nanotechnology

In February of 2004, mPhase entered the business of developing new products based on materials whose properties and behavior are controlled at the micrometer and nanometer scales. (For reference, a micrometer or micron is equal one millionth (10-6) of a meter and a nanometer is one billionth (10-9) of a meter – the scale of atoms and molecules. A human hair is approximately 50 microns in diameter, or 50,000 nanometers thick.) The Company has expertise and capabilities in microfluidics, microelectromechanical systems (MEMS), and nanotechnology. Microfluidics refers to the behavior, precise control and manipulation of fluids that are geometrically constrained to a small, typically micrometer scale. MEMS is the integration of mechanical elements, sensors, actuators, and electronics on a common silicon substrate through microfabrication technology. Nanotechnology is the creation of functional materials, devices and systems through control of matter (atoms and molecules)loses some capacity while sitting on the nanometer length scale (1-100 nanometers), and exploitation of novel phenomena and properties (physical, chemical, biological, mechanical, electrical) at that length scale. Inshelf in its Smart NanoBattery, mPhase exploits the physical phenomenon of electrowetting by which a voltage is used to change the wetting properties of a liquid/solid interface at the nanometer scale. Consider water as the liquid. Through electrowetting, mPhase can change a surface from what is referred to as a hydrophobic ("water repelling") state to a hydrophilic ("water attracting") state. In the hydrophobic state, the water beads uppackage or is repelled by the surface. In the hydrophilic state, the water spreads outstored in an electronic or is absorbed by the surface. The ability to electronically control the wetting characteristics of a surface at the nanometer scale forms the basis of mPhase's nanotechnology operations and intellectual property portfolio.

21


In the Smart NanoBattery application, mPhase uses electrowetting as a new technique to activate or literally "turn on" a battery once it is ready to beelectrical device, even before being used for the first time. AtOn the heartother hand, the Smart NanoBattery is built so that it is inactive and remains that way indefinitely until it is turned on. No power is lost to self-discharge or leakage current prior to activation. When needed, the Smart NanoBattery can be activated on command via the phenomenon of electrowetting. The surface properties of the porous silicon membrane are selectively controlled to shift instantly from a superhydrophobic to hydrophilic state. In other words, electrowetting acts as the triggering mechanism.

The Company has successfully fabricated and demonstrated its first 3-volt lithium-based Smart NanoBattery, based on a design allowing either manual or remote activation by the user, the feature known as Power on Command™.

By incorporating the phenomenon of electrowetting on nanostructured surfaces into a revolutionary way of storing energy, the Smart NanoBattery provides power to portable electronic and microelectronic devices exactly when and where it is needed. As a reserve battery it is an augmentation to conventional primary batteries. The nanobattery converts stored chemical energy into usable electrical energy, but in a way that is potentially more reliable, more versatile, more environmentally friendly, and less expensive than conventional primary batteries.

Applications

Artificial Intelligence and Machine Learning

The Company has recently acquired technologies focused on artificial intelligence and machine learning. The related proprietary software enable customers to enhance their business capabilities by providing sophisticated digital analysis of large volumes of data to provide sophisticated solutions to complex problems. The current patented software technology can be integrated into a retailer’s existing Wi-Fi infrastructure, giving retailers important customer data and enabling AI-enhanced, targeted promotions to drive store traffic and sales. Additional product offerings include software covering eight categories: inventory, stock management, marketing optimization, sentiment analysis, customer segmentation and behavior, agro-tech image detection, electrocardiogram automation, and a recommendation engine with multiple uses.

Smart Surfaces and NanoBattery

The Company is exploring military and commercial applications of smart surfaces in which the properties can be accurately and precisely controlled down to the nanometer scale. Electrowetting allows the switching from a hydrophobic to hydrophilic state as a result of an electronic stimulus.

The Smart NanoBattery, the Company’s first smart surface product, has a unique architecture that enables a shelf life of decades, remote activation, programmable control, scalable manufacturing, and adaptability to multiple configurations. The value proposition to the end user is to have a source of energy or power that is literally always ready – reliable, convenient, low cost – a battery guaranteed to work at full capacity when and where you need it.

-24-

The Smart NanoBattery can conceivably supply power “on command” to a wide variety of portable electronic and microelectronic devices used in military, medical, industrial, and consumer applications.

The Company has demonstrated that the battery works in lab tests as well as in a significant field test conducted for the U.S. Army as part of a guided munitions project. The relationship with the Army also included an $850,000 funded project to develop a battery for a mission critical computer memory backup application. The target was a small footprint, 3-volt lithium battery with a minimum shelf life of 20 years and uninterruptible power output during this time period. To the best of the Company’s knowledge, no other battery technology available today can deliver the long-term performance requirements specified by the U.S. Army for this application.

The Smart NanoBattery can potentially be designed to accommodate a variety of sophisticated portable electronic and microelectronic devices including next-generation cell phones, handheld gaming devices, wireless sensor systems, radio frequency identification tags, high-tech flashlights and beacons, health alert alarms, and non-implantable and implantable medical devices such as pacemakers.

Initial applications will address the need to supply emergency and backup power to a range of products for defense and security, with future applications in the commercial and consumer arenas.

Strategic Alliances

Artificial Intelligence and Machine Learning

The Company has recently entered into separate contracts with multiple customers to provide, including but not limited to, software, training, and support services as required. The contracts provide for initial revenue streams as well as subsequent revenue for training, support, updates and maintenance services as provided.

Smart NanoBattery

The Company continued during 2019, together with Picatinny Arsenal, to jointly seek federal funding under SBIR grants to develop additional new products for military small munitions applications. The Company has a strong historic cooperative relationship for product development and testing with Picatinny Arsenal having entered into 3 CRADA’s (Cooperative Research Agreements) with this small munitions testing facility of the U.S. Army The Company seek opportunities with various potential academic partners to obtain further STTR grants for new product research and development.

In 2007, the Company entered into a Cooperative Research and Development Agreement (“CRADA”) with Picatinny Arsenal to test the single cell version of the Smart NanoBattery issuitable for future research and development programs for projectile launched munitions. From 2007 through the first quarter of calendar year 2010, numerous internal laboratory air gun simulation tests were performed, including a porous, nanostructured superhydrophic or superlyophobic membrane designedlive-air gun and fabricated by mPhase. The so-called superhydrophobic membrane applies to water and the superlyophobic membrane applies to nonaqueous or organic liquids such as ethanol or mineral oil. The difference between the two membrane types lies in the nanoscale architecturelive gun fired test at the surface. By virtue of its superhydrophobic or superlyophobic character, the membrane, although porous, is able to physically separate the liquid electrolyte from the solid electrodes so that the battery remains dormant or inactive, thus providing no voltage or current until called upon. This electrolyte-electrode separation gives the battery the feature of potentially unlimited shelf life and the benefit of being always ready when needed, which is not necessarily the case for conventional batteries. Electrowetting alters the liquid/membrane interface so that the liquid is now able to flow over the membrane's surface and rapidly move through the pores where it is able to contact the solid electrode materials located on the other side of the membrane.

mPhase uses MEMS to precisely control the machining of silicon-based materialsUnited States Army’s facility at the micrometer and nanometer scales. This ability has led to the Company's proprietary membrane design that controls the wetting and movement of liquids on a solid surface. mPhase uses microfluidics to control the flow of liquid electrolyte through the porous membrane and this is also the basis for other possible applications such as self-cleaning surfaces, filtration and separation and liquid delivery systems.

History of Nanotechnology Operations

Smart NanoBattery

mPhase Technologies along with Bell Labs jointly conducted research from February 2004 through April of 2007 that demonstrated control and manipulation of fluids on superhydrophobic and superlyophobic surfaces to create a new type of battery or energy storage device with power management features obtained by controlling the wetting behavior of a liquid electrolyte on a solid surface. The scientific research conducted set the ground work for continued developmentAberdeen Proving Grounds, Aberdeen, Maryland. A prototype of the Smart NanoBattery and formedwas the subject of a path to commercializationlive fire test as part of a projectile fired out of an Abrams Tank. The results of the technology for a broad range of market opportunities. During 2005 and 2006,test indicated that the battery team tested modifications and enhancements to the internal design of the battery to optimize its power and energy density characteristics, as well as making engineering improvements that were essential in moving the battery from a zinc-based chemistry to a commercial lithium-based chemistry that can be manufactured on a large scale. The Company began its effortswas activated by entering into a $1.2 million 12 month Development Agreement with the Bell Labs division of Alcatel/Lucent for exploratory research of control and manipulation of fluids on superhydrophobic surfaces to create power cells ( batteries) by controlling wetting behavior of an electrolyte on nanostructured electrode surfaces. The goal was to develop a major breakthrough in battery technology creating batteries with longer shelf lives as the result of no direct electrode contact (meaning no power drain prior to activation). The Company extended its development effort twice for an additional two years ending in March of 2007 and for two additional periods thereafter through July 31, 2007. During this time, the technical focus shifted from trying to separate the liquid electrolyte from nanostructured electrodes to developing a nanostructured membrane that could physically separate the liquid electrolyte from the solid electrodes. mPhase also began working with the Rutgers University Energy Storage Research Group (ESRG) in July of 2005 to conduct contract research in advanced battery chemistries involving lithium.

This work involved characterizing and testing materials that could be used in the mPhase battery. In July of 2007, the relationship shifted to a collaboration focused on developing a memory backup battery needed by the U.S. Army. The work was funded through a Phase I Small Business Transfer grant.

The Company decided in September of 2007 to transfer its development work out of Bell Labs (Alcatel/Lucent) in order to broaden its nanotechnology product commercialization efforts. Prior to such time mPhase was limited to development using zinc-based batteries since Bell Labs did not have facilities to handle lithium chemistry. mPhase continued to work with Rutgers ESRG that has facilities capable of handing lithium battery development and also engaged in work with other companies to supply essential components, fabricate prototypes, and plan manufacturing approaches. These companies included a well-respected silicon foundry and battery manufacturer.

In February of 2008, the Company announced that a prototype of its Smart NanoBattery was successfully deployed in a gun-fired test at the Aberdeen Proving Ground at Maryland. The test was conducted by the U.S. Army Armament Research and Development and Engineering Center (ARDEC) of Picatinny, New Jersey. The battery not only survived the harsh conditions of deployment at a gravitational force in excess of 45,000 g, but was also flawlessly activated in the process.

22


In March of 2008, mPhase announced10,000 G forces indicating that it had been invitedcould supply energy necessary to submitoperate a proposalguidance system for a Phase II STTR grant based upon the successful work it had performed on the Phase I grant to develop a version of the Smart NanoBattey referred to as the multi-cell, micro-array reserve battery for a critical U.S. Army memory backup application. The Phase II grant in the gross amount of $750,000 (net $500,000) was granted to the Company in the middle of September of 2008.small munitions. In March of 2008, the Company also announced the successful transfer to a commercial foundry of certain processes critical to the manufacturing of its Smart NanoBattery. This enabled fabrication of the porous membranes for the multi-cell, micro-array reserve battery mentioned above. The Company successfully manufactured nanostructured membranes at the foundry that are essential to commercial production of the battery. By achieving a series of delayed activations, the shelf-life and continuous run-time of such battery is increased to a period of time in excess of twenty years. In April of 2008, the Company announced that it had successfully activated its first Smart NanoBattery prototype by electrowetting using a hard-wired configuration and a remotely-activated device. Remote activation plays a key role in providing power to wireless sensors systems and RFID tags.

Also, in April of 2008, the Company announced that it had successfully produced its first lithium-based reserve battery with a soft or pouch package and breakable separator (in place of the electrowettable membrane) that relies on mechanical rather than electrical activation to provide Power On Command™. The Company believes that it is a significant milestone in moving from a low energy density zinc-based battery to a higher energy density lithium-based battery towards proving thataddition, the Smart NanoBattery will eventually be economicallydemonstrated extreme resiliency to shock and commercially viable.acceleration since, it survived tests that subjected it to high acceleration of over 30,000 G forces.

In fiscal years ended June 30, 2009 and June 30, 2010, the Company focused upon further development of its Smart Nano Battery under a Phase II STTR grant from the U.S. Army as a potential reserve battery for a back-up computer memory application for a weapons system. The Company completed this Phase II Army grant in the fall of 2010. On November 12 of 2010, the Company announced that it had successfully triggered and activated its first functional multi-cell smart nano battery. Triggering and activation of the cells of the battery were achieved by using the technique of electrowetting or programmable triggering. Triggering was accomplished by applying a pulse of electrical energy to a porous, smart surface membrane located inside each cell in the battery causing the electrolyte to come in contact with the cell’s electrodes, creating the chemical reaction to produce voltage inside of the multi-cell battery. The multi-cell battery consists of a matrix of 12 individual cells populated with an electrode stack consisting of lithium and carbon monofluoride materials with each rated at 3.0 volts. Using a custom designed circuit board for testing, each of the cells in the battery were independently triggered and activated without affecting any of the non-activated cells in the multi-cell configuration. Each cell in the battery has a very long shelf-life prior to triggering.

On February 9, 2011, the Company announced that it had signed a 3 year Cooperative Research and Development Agreement (CRADA)3-year CRADA with the U.S. Army Armament Research, Development, and Engineering Center (ARDEC) at Picatinny, New Jersey, to continue to cooperatively test and evaluate the mPhase Smart NanoBattery, including new design features functionally appropriate for DoD based systems requiring portable power sources. The army researchers are evaluating the prototypes using the Army’s testing facilities at Picatinny Arsenal in New Jersey in order to determine applicability of the technology to gun fired munitions and potentially to incorporate the technologies into research and development and other programs sponsored by Picatinny. The Research Agreement is supported by the Fuze & Precision Armaments Technology Directorate

Emergency Flashlight

On December 5, 2008, mPhase Technologies, Inc. signed a contractDirectorate. In order for significant further research and development to be performed with Porsche Design Gesellschaft m.b.H. in Austria (“Porsche Design Studio”)respect to design a premium version of the AlwaysReady Emergency Flashlight. A pilot program that began in March of 2010 has resulted in the sale of approximately 56 emergency flashlights. The flashlight sold in the pilot program contained mPhase’s proprietary mechanically-activated lithium reserve battery. The battery contains a breakable barrier that separates the solid electrodes from the liquid electrolyte until the battery is manually activated. Unlike traditional batteries, the mPhase battery remains in an inert state with no leakage or self-discharge until activation. The mPhase battery is designed to have an almost infinite shelf life making it ideal for emergency lighting applications. The premium flashlight will be marketed as an accessory for automobile roadside emergency kits.

On January 29, 2009,Smart Nano Battery the Company announced that it had contracted with EaglePicher Technologieswill have to design and manufacture,be successful in small quantities, its mechanically-activated battery that were used in the pilot programobtaining additional congressional funding specifically designated for this type of sales of the Company’s new Emergency Flashlight. EaglePicherbattery. This CRADA was selectedrenewed on March 27, 2014 for the project because of their experience in custom and standardized power solutions for the extreme environments of aerospace and military applications as well as medical and commercial applications.

The reserve battery is a manually activated lithium cell designed to provide Power On Command. The battery remains dormant until “turned on”an additional three-year period by the user. ItArmy. The Company is builtcurrently seeking to enter a new CRADA with the highest standards with a minimum storage lifeU.S. Army, subject to availability of 20 years. Once activated, the reserve battery is expected to deliver the electrical performance of a standard primary CR123 battery usedfunding.

-25-

Products and Services

Since its inception in many portable electronic applications today.

23


EaglePicher Technologies, LLC, along with EaglePicher company, is a world leader in custom and standardized power solutions for the extreme environments of aerospace and military applications as well as medical and commercial applications. The company specializes in design and manufacture of battery cells, battery packaging, battery management systems (BMS), analysis, environmental testing, and energetic devices. Active in battery development and testing since 1922, EaglePicher Technologies has the most experience and broadest capability in battery electrochemistry of any battery supplier.

Owing to cost considerations1996, the Company has decidedbeen focused on the development of intellectual property involving high technology innovative solutions and products with high-growth potential. The Company has previously served as an incubator for exploratory research and initial development for products that are best characterized as having a high risk/high reward profile since they involve exploratory research to utilizeachieve significant scientific breakthroughs from existing products that can have a cost reduced active-reserve battery in its current versionsubstantial economic impact and benefit upon successful commercialization. Beginning on January 11, 2019, the new management of its emergency flashlight product for potential sales after the pilot program. Such active reserve battery alsoCompany has a very long shelf life and enablesshifted the focus to the rapid expansion of profit centers centered around the rapid creation, either by acquisition or fast development of software platforms that will enable the Company to significantly reducegenerate revenue from artificial intelligence and machine learning.

Competitive Business Conditions

The industry of artificial intelligence and machine learning software is highly competitive. Well capitalized companies such as Amazon, Google, IBM and Microsoft are devoting significant resources and capital in developing customer products and solutions using this technology. Such companies have far greater resources than the selling priceCompany. The Company believes, however, that it has assembled a group in India of highly qualified software and technology experts on a very cost-effective basis. The Company is also acquiring entities that have already established customer relationships, revenues and market niches that will enable the Emergency Flashlight.Company to leverage off such capabilities, and where appropriate, enhance its existing technology in the area of “Smart Surfaces” described below.

Artificial Intelligence and Machine Learning Segment

Artificial intelligence is the use of machines to do cognitive work such as problem solving, pattern matching and creating new patterns. Machine learning is a subset of artificial intelligence which refers to training a machine as opposed to simply programming it. Artificial intelligence has the potential to revolutionize nearly all aspects of business across sections and functions. Currently only a small percentage of organizations have deployed artificial intelligence but this is changing quickly. There is a high correlation between organizations that are far along in digitizing their information and those that are ready for products and solutions provided by artificial intelligence and machine learning providers. The Company has been seeking high-end products distributors with which to establish a licensing or distribution agreements in order to maximize potential revenue associated with the product. In March 2011,the Company received an initial order from Porsche Design Group in Germany for mPhase's Porsche design branded mPower Emergency Illuminators to be sold in Porsche Design stores in Germany, Great Britainacquired and the United States and it began shipments of the Emergency Illuminators in April of 2011.

Magnetometer

In March of 2005, the Company entered into a second Development Agreement for 12 months at a cost of $1.2 million with the Bell Labs to develop MEMS-based ultrasensitive magnetic sensor devices, also known as magnetometers, that could be used in military and commercial electronics (e.g., cell phones) for determining location, as well as in portable security and metal detection applications. The agreement was renewed in April of 2006 for another 12 months. Although proven to work in the lab, the magnetometer technology could not be scaled up as quickly and as cost effectively as the Company’s nano battery. The project was suspended in September 2007 so that all technical resources could be allocated to the nano battery project.

Patents and Trademarks

Our Intellectual Property

Various aspects of the mPhase technology are protected by patents either owned directly by the Company or with respect to which the Company has full sub-licensing rights. The Company’s current battery related patent portfolio consists of seven issued patents, of which one is jointly owned with Rutgers University, two are jointly owned with Lucent Technologies and four are licensed from Lucent Technologies. These cover such aspects of the technology as the ability to use electrowetting to create a moveable liquid lens, methodology and apparatus for reducing friction between a fluid and a body, methodology for etching planar silicon substrates to develop a reserve battery device, methodology and apparatus for controlling the flow resistance of a fluid on nanostructured or microstructured surfaces, methodology for creating a structured membrane with controllable permeability, methodology for a nanostructured battery with end of life cells, and methodology for making a multi-cell battery system with multiple chemistries in each individual cell of the battery pack. Some of these patents are specific to the development of a battery device while others are more generalized. The Company also has four patent applications related to the Smart Surfaces technology that have been filed with the United States Patent Office and other foreign patent offices and that are in various stages of examiner review, as well as four additional patent applications related to other Smart Surfaces technologies under review.

The Company has obtained trademark protection for its mPower Emergency Illuminator and mPower on Command, and it currently has one additional trademark application pending.

Employees

          As of November 30, 2011, we had six full-time employees. One employee is directly involved in research and development activities and five are engaged in business development and administration. We also use the services of numerous outside consultants in business and scientific matters. We believe that we have good relations with our employees and consultants.

Competition

          The nanotechnology and battery industries are characterized by rapidly evolving technology and intense competition. Our competitors include major multinational companies, specialty nanotechnology companies and energy storage products companies. Many of these companies are well-established and possess technical, research and development, financial and sales and marketing resources significantly greater than ours. In addition, certain smaller nanotechnology companies have formed strategic collaborations, partnerships and other types of joint ventures with larger, well established industry competitors that afford these companies' potential research and development and commercialization advantages. Academic institutions, governmental agencies and other public and private research organizations are also conducting and financing research activities which may produce products directly competitive to those we are developing. Moreover, many of these competitors may be able to obtain patent protection and begin commercial sales of their products before we do.

24


Research and Development

          Research and development expenses have consisted principally of direct labor and payments made to MKE manufacturing (an approved vendor of Porsche), Porsche Design Studio and Microphase Corporation in connection with the Company’s Emergency Illuminatordeveloping significant product and to Silex, a foundry located in Sweden, as well as other third party vendors involved in the development of the nanotechnology products.

          For the quarters ended September 30, 2011, 2011 and from inception through September 30, 2011 we incurred $41,403, $193,780 and $ 12,298,965 respectively, on research and development.

DESCRIPTION OF PROPERTY

          Our headquarters are located in Norwalk, Connecticut where we lease office space from Microphase Corporation. As of July 1,2011, The lease for this office is month to month at a monthly cost of $3,630 ($43,560 annually). The Company also leases corporate office space in Little Falls, New Jersey. The monthly rent for this property is $2,347 per month ($28,164 annually) and the lease term is likewise month to month.

LEGAL PROCEEDINGS

          From time to time the Company may be involved in various legal proceedings in the ordinary course of business.

25


MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

          This prospectus contains forward-looking statements that involve risks and uncertainties. We use words such as “may,” “assumes,” “forecasts,” “positions,” “predicts,” “strategy,” “will,” “expects,” “estimates,” “anticipates,” “believes,” “projects,” “intends,” “plans,” “budgets,” “potential,” “continue” and variations thereof, and other statements containedcapabilities in this prospectus, regarding matters that are not historical facts and are forward-looking statements. Because these statements involve risks and uncertainties, as well as certain assumptions, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to risks inherent in: our early stage of development, including a lack of operating history, lack of profitable operations and the need for additional capital; the development and commercialization of largely novel and unproven technologies and products; our ability to protect, maintain and defend our intellectual property rights; uncertainties regarding our ability to obtain the capital resources needed to continue research and development operations; uncertainty regarding our overall ability to compete effectively in a highly complex, rapidly developing, [capital intensive] and competitive industry. See “Risk Factors” set forth herein for a more complete discussion of these factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date that they are made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.area.

 Forward-looking statements include our plans and objectives for future operations, including plans and objectives relating to our products and our future economic performance. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions, future business decisions, and the time and money required to successfully complete development and commercialization of our technologies, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Although we believe that the assumptions underlying the forward-looking statements contained herein are reasonable, any of those assumptions could prove inaccurate and, therefore, we cannot assure you that the results contemplated in any of the forward-looking statements contained herein will be realized. Based on the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of any such statement should not be regarded as a representation by us or any other person that our objectives or plans will be achieved.

OVERVIEWBattery Segment

 The following discussion should be read in conjunction with the financial statements and notes thereto included in this prospectus.

          We are a nanotechnology company focused on developing and commercializing reserve batteries and other products with “smart surfaces” in the emerging fields of micro fluid dynamics and nanotechnology. We also develop commercial products with Porsche Design Studio as luxury consumer products and accessories that are targeted for affluent consumers and automobile enthusiasts.

Plan of Operations

While we continue to pursue research and development in connection with our work on smart surfaces, we are increasingly focused on the identification and development of product candidates utilizing our technology in both commercial and military arenas. We do not, however, expect to generate revenue sufficient to cover our expenses for the foreseeable future and expect to continue to fund our operations primarily from outside capital investment, convertible debt financings and private placements . The potential acquisition of EIP may result in the Company achieving an accelerated path to revenues and profitability since it is anticipated, subject to further due diligence, that the energy savings products of EIP will have a shorter time to commercialization and sales.

Strategy

The Company is seeking to identify strategic partners with significant financial resources through the current valuation of its patent portfolio. The Company believes that the design and functionality of its patents as well as its development efforts in the scientific area of microfluidics and “smart surfaces” may provide compelling solutions as part of products and strategies of other companies in the area of energy storage and conservation. The Company intends to cost-reduce its emergency flashlight and selllithium Smart NanoBattery make it in volumes greater than that of the luxury goods product that was designed by Porsche Design Studio for the Company and which is currently being distributed through Porsche Design stores worldwide. In addition, the Company is developing a second automotive product with Porsche Design Studio soon to be announcedunique to the public which is also an automotive energy-related product. Finally the Company intends to continue to pursue acquisitions of privately-held companies that have innovative products that are synergistic with the Company’s strategy of introducing new high-growth products to theportable electronics battery market that will enhance and accelerate the Company’s growth of revenues.

26


Critical Accounting Policies

RESEARCH AND DEVELOPMENT

Researchand development costs are charged to operations as incurred in accordance with Statement of Financial Accounting Standards ("SFAS"), No.2, "Accounting for Research and Development Cost."

OPTIONS, WARRANTS AND OTHER CONVERTIBLE EQUITY INSTRUMENTS

STOCK BASED COMPENSATION

On July 1, 2005, the Company adopted the provisions of Financial Accounting Standards Board Statement "Accounting for Stock Based Compensation". The currently promulgated standards require companies to measure and recognize compensation expense for all employee stock-based payments at fair value over the service period underlying the arrangement. Therefore, the Company is now required to record the grant-date fair value of its stock-based payments (i.e., stock options and other equity-based compensation) in the statement of operations. The fair value of options granted in fiscal year ended June 30, 2009 was estimated as of the date of grant using the Black-Scholes stock option pricing model, based on the following weighted average assumptions: annual expected return of 0%, an average life of 5 years, annual volatility of 80.3% and a risk-free interest rate 3.0% .

MATERIAL EQUITY INSTRUMENTS

The Company has material equity instruments including convertible debentures and convertible notes that are accounted for as derivative liabilities (SEE BELOW) and options and warrants that are evaluated quarterly for potential reclassification as liabilities pursuant to FASB codification topic 815 previously known as EITF 00-19 (SEE ALSO NOTE 8 "Stockholders Equity" under the caption "Other Equity"). The Company utilized a sequencing method prescribed by EITF 00-19, based upon applying shares available to contracts with the earliest inception date first. Duringsegment throughout the fiscal year ended June 30, 2008,2019. To the best of our knowledge, there is no existing product that directly competes with the Smart NanoBattery in terms of its combination of small size and reserve design. As a reserve battery, the Smart NanoBattery remains dormant until it is activated on command. It does not self-discharge or die prior to its first activation, thereby offering extremely long shelf life prior to use as either a primary or backup battery in a device. Shelf life is projected to be in excess of twenty years.

There are numerous thin film batteries based on lithium metal, lithium ion and lithium polymer, as well as other chemistries, used in military devices, portable electronics, RFID tags and wireless sensor networks, that are similar in size to the Smart NanoBattery, often referred to as microbatteries. None of these designs is based on reserve battery architectures. Thin film batteries are manufactured by companies including Cymbet Corporation, Front Edge Technology, Infinite Power Solutions, ITN Energy Systems, Johnson Research and Development Company, KSW Microtec, Lithium Technology Corporation, MPower Solutions, Oak Ridge Micro-Energy, Power Paper, Solicore, VoltaFlex Corporation. Large companies such as Energizer, Ultralife, Varta and Proctor & Gamble are also involved with developing thin film batteries. Thin film battery markets are anticipated to grow substantially as the result of a wide expansion of portable devices in that time frame. With 3.5 billion cell phone users and 67 billion RFID tags per year, it is expected that there will be substantial commercial demand for thin film batteries.

-26-

Traditional reserve batteries are distinct from the mPhase Smart NanoBattery in terms of size and activation mechanism. The market for reserve batteries has largely been limited to the military for supplying power to munitions and other mission-critical electronic devices. The traditional reserve battery tends to be larger and certain types are built by hand and contain mechanical parts to activate the battery. The Smart NanoBattery relies on the phenomenon of electrowetting to initiate activation or a mechanical barrier that can be broken, in the case of the breakable barrier design. Traditional reserve batteries for military applications have been supplied by companies such as EaglePicher, Yardney and Storage Battery Systems, Inc. The Company believes that it may be able to significantly reduce the cost of its Smart Nanobattery with the recent discovery of the potential of “printing” the battery on a form of graphite rather than traditional silicon surface. The Company, through its working relationship with Stevens Institute, began in fiscal year 2012 to investigate the feasibility of the use of graphite which is much stronger, flexible and inexpensive than traditional silicon.

Outsourcing

Artificial Intelligence and Machine Learning

In certain instances, as determined by the Company, reclassified contracts for warrantsthird party vendors are contracted to purchase 12,604,168 shares at fixed prices ranging from $.13 to $.15 per share to liabilities.

The liability was recorded at the fair market value, which estimated value, as restated, was based upon the contractual lifeperform certain development of the free standing warrants, using the Black-Sholes pricing model, based on the following weighted average assumptions: annual expected return of 0%, an average life of 5 years, annual volatility 81% and a risk-free interest rate 2.25% . At the issuance date of the free standing warrants, which warrants were issued during the fourth quarter of fiscal June 30, 2008; the estimated value approximated $1,006,200 and as recalculated on the quarterly measurement dates, at June 30, 2008 the estimated value approximated $433,300. During fiscal year ended 2009, the estimated value was determined to no longer be material. The net change in the liability was credited to the change in derivative value in the Consolidated Statement of Operations for the fiscal years ended June 30, 2008 and 2009 for $572,900 and $433,300, respectively, for each of these periods in accordance FASB Standards Codification Topic 815 (previously known EITF 00-19). Effective May, 2009, warrants to purchase 11,111,112 shares, and effective September, 2009, warrants to purchase 1,493,056 shares; representingCompany’s proprietary software rather than performing all of the contracts for warrants to purchase 12,604,168 shares that were reclassified to liabilities during the fiscal year ended June 30, 2008, were reclassified to permanent equity. Subsequent to September 30, 2009 the Company has not entered into, and presently the Company does not have, any contracts for warrants or other equity instruments subject to reclassification to liabilities as prescribed by FASB Standards Codification Topic 815 (previously known as EITF 00-19).development functions internally.

DERIVATIVE FINANCIAL INSTRUMENTS

Presently promulgated accounting literature requires all derivatives to be recorded on the balance sheet at fair value. The conversion features of the convertible debentures are embedded derivatives and are separately valued and accounted for on our balance sheet with changes in fair value recognized during the period of change as a separate component of other income/expense. Fair values for exchange-traded securities and derivatives are based on quoted market prices. The pricing model we use for determining fair value of our derivatives is the Black-Scholes Pricing Model with a 20 day life for the look-back period of each conversion feature using volatility of 100%. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management's judgment and may impact net income.

REPARATION EXPENSE

As an incentive for additional equity contributions, the Company will, from time to time, adjust the cost of past private purchases of common stock through the issuance of additional shares in such magnitude as to reduce an investor's cost to an average price that more closely approximates current market value. The market value of additional shares issued without cash investment is charged to Reparation Expense, which is included in Other Expenses.

27


Results of Operations

Comparison of Three Months Ended September 30, 2011 and 2010

  3 Months Ended September 30,  3 Months Ended September 30, 
  2011  2010 
  Amount  Amount 
Revenue$ 0 $ 28,808 
Cost of Revenue 571  9,467 
Gross profit (571) 19,341 
Research and development expenses 41,403  193,780 
       
General and administrative expenses 6,888,462  522,994 
       
Non-operating income (expense) 754,895  2,695,795 
       
Net Income (loss)$ (6,179,222)$ 1,994,489 

THREE MONTHS ENDED September 30, 2011 VS. September 30, 2010

REVENUE

Total revenues were $0 for the three months ended September 30, 2011 compared to $28,808 for the three months ended September 30, 2010.

RESEARCH AND DEVELOPMENT

Research and development expenses were $41,403 for the three months ended September 30, 2011 as compared to $193,780 during the comparable period in 2010 or a decrease of $152,377. This decrease in spending is a result of completion of its smart nano battery prototype and its emergency flashlight using its mechanically-activated reserve battery as brought to market in its pilot program Subject to available funds, the Company expects to increase its research and development efforts throughout fiscal years 2011 and 2012. Such research is expected to focus on other applications for “smart surfaces” including the Smart Nano Battery. The initial applications for the nano power cell technology will address the need to supply emergency and reserved power to a wide range of electronic devices for both commercial and defense applications.

GENERAL AND ADMINISTRATIVE EXPENSES

General and administrative (G&A) expenses were $6,888,462 for the three months ending September 30, 2011, up from $522,994 or an increase of $6,365,468 from the comparable period in 2010. Recurring administrative expenses were held in check as the Company has made a concentrated effort to freeze or otherwise reduce administrative costs while it seeks to commercialize its smartnanobattery product capabilities and secure more substantial research funding for possible applications of its “smart surfaces” technology. The increase was due primarily to the award of stock to the officers and directors on August 25, 2011, generating a non-cash charge of $6,520,500. Additionally, there was a non-cash charge of $14,154 for the amortization of deferred compensation from the re-pricing of options on the same date.

OTHER (EXPENSE) AND INCOME

Included in this category for the current quarter are non-cash gains and costs associated with convertible debt that include a non-cash gain for the change in derivative value of $853,496, which when combined with amortization of debt discount costs of $29,042, resulted in a net gain of $824,454 from derivative liabilities associated with the Company’s convertible debt and is not indicative of operating results. Additionally, net interest expense of $70,690 and other income of $1,131 in the current period brought total other income to $771,997. For the same period in the prior fiscal year net other income totaled $2,695,795, consisting primarily of net gains of $2,725,735 from derivative liabilities, reduced by interest expense of $29,940.

NET INCOME AND (LOSS)

The Company recorded a net loss of $6,179,222 for the three months ended September 30, 2011 as compared to net income of $1,994,489 for the three months ended September 30, 2010. This represents a net loss per common share of $0.00 and net income per share (basic and diluted) of $0.00 for the three month periods ended September 30, 2011 and 2010 respectively. The net loss recorded in the current period as compared to the net income reported for the same period last year is directly attributable to the magnitude of the net gain from derivative liabilities associated with the Company’s convertible debt recorded for the three months ended September 30, 2010 and is not indicative of operating results.

28


TWELVE MONTHS ENDED JUNE 30, 2011 VS. JUNE 30, 2010

Revenues. Total revenues for the year ended June 30, 2011 decreased from $ 354,157 in 2010 to $49,210 in 2011. The revenue for the current fiscal year was derived primarily from payments received by the Company under the Phase II STTR grant from the United States Army and from sales of the mPower emergency illuminator.

Cost of sales. Cost of sales decreased $15,744 for the year ended June 30, 2011 to $50, 260. In addition, grants and fees received in connection with our Nanotechnology power cell have relatively low associated cost of sales.

Research and Development.

The Company practices an outsourcing model whereby it contracts with third party vendors to perform research and development rather than performing the bulk of these functions internally. For current development of its SmartNano battery, the Company has outsourced the majority of the work. From February of 2004 through March of 2007, the Company engaged Lucent/Bell Labs (now Nokia) to develop, using the science of nanotechnology, micro power cell arrays creating a structure for zinc batteries that separated the chemicals or electrolytes prior to initial activation. This was done by suspending on nano grass or small spoke-like pieces of silicon a liquid electrolyte taking advantage of a superhydrophobic effect that occurs as a result of the ability to manipulate materials of a very small size or less than 1/50,000 the size of a human hair. The Company has, as a result of outsourcing, been able to have access to facilities, equipment and research capabilities that the Company would not be able to develop on its own given the financial resources and time that would be required to build or acquire such research capabilities. The Company has also been able to achieve key strategic alliances with the U.S. Army to successfully test, under military combat conditions, its SmartBattery design, leading to further validation of its path to product development under a Cooperative Research and Development Agreement (CRADA). In addition, the Company has formed a relationship with Energy Storage Research Group, a center of excellence at Rutgers University, in New Jersey, that has enabled the Company to expand its battery development expenses were $625,417from a zinc to a lithium battery capable of delivering significantly more power. During fiscal years 2009 and 2010, the Company outsourced considerable foundry work for final development of the Smart NanoBattery to Silex, a Swedish company.

During the period from March of 2005 to April of 2007, the Company engaged the Bell Labs division of Lucent Technologies, Inc. to develop a magnetometer or electronic sensor also using the science of nanotechnology. Although the Company has, in order to conserve financial resources, currently suspended further development of its magnetometer product line, we believe that the intellectual property developed from the research to date could be resumed to develop viable military and industrial products depending upon future financial resources of the Company and future competitive market conditions.

Commencing in fiscal year ended June 30, 20112013, the Company has limited product development of its Smart NanoBattery in order to conserve resources. The Company continues through the fiscal year ended June 30, 2019, to protect its intellectual property with respect to the Smart NanoBattery through active management of its patent portfolio.

Patents and Licenses

The Company has filed and intend to file United States patents and/or copyright applications relating to some of our proposed products and technologies, either with our collaborators, strategic partners or on our own. There can be no assurance however, that any of the patents obtained will be adequate to protect our technologies or that we will have sufficient resources to enforce our patents.

-27-

Because we may license our technology and products in foreign markets, we may also seek foreign patent protection for some specific patents. With respect to foreign patents, the patent laws of other countries may differ significantly from those of the United States as compared to $2,203,383the patentability of our products or technology. In addition, it is possible that competitors in both the United States and foreign countries, many of which have substantially greater resources and have made substantial investments in competing technologies, may have applied for, or may in the future apply for and obtain, patents, which will have an adverse impact on our ability to make and sell our products. There can also be no assurance that competitors will not infringe on our patents or will not claim that we are infringing on their patents. Defense and prosecution of patent suits, even if successful, are both costly and time consuming. An adverse outcome in the defense of a patent suit could subject us to significant liabilities to third parties, require disputed rights to be licensed from third parties or require us to cease our operations.

The Company has intellectual property as follows:

Artificial Intelligence and Machine Learning:

The Company is evaluating various aspects of its artificial intelligence and machine learning technologies and will file for protective patents as determined appropriate.

Nano Technology, Micro Electrical Mechanical Systems (MEMS) and Battery Portfolio:

Various aspects of the Company’s technology are protected by patents either owned directly by the Company or with respect to which the Company has sub-licensing rights. The Company’s current battery related patent portfolio consists of ten issued or licensed patents, of which one is jointly owned with Nokia Corporation (formerly Alcatel Lucent Technologies), and five are licensed from Nokia Corporation. These cover such aspects of the technology as the ability to use electrowetting to create a moveable liquid lens, methodology and apparatus for reducing friction between a fluid and a body, methodology for etching planar silicon substrates to develop a reserve battery device, methodology and apparatus for controlling the flow resistance of a fluid on nanostructured or microstructured surfaces, methodology for creating a structured membrane with controllable permeability, methodology for a nanostructured battery with end of life cells, and methodology for making a multi-cell battery system with multiple chemistries in each individual cell of the battery pack. Some of these patents are specific to the development of a battery device while others are more generalized. The Company has four patent applications that are subject to reinstatement, of which three, the Company intends to submit for reinstatement.

Other Patents

In July of 2009, the Company filed for 3 new patents covering the unique design features of its manually-activated lithium reserve battery and emergency flashlight products.

On May 20, 2011, the Company announced that it had been granted a U.S. patent for multi-chemistry battery architecture.

On February 10, 2012 the Company filed a U.S. provisional patent with the USPTO for a Non-Pump Enabled Drug Delivery System.

On February 11, 2013 the provisional patent application was converted to a patent application entitled Drug Delivery System.

We also rely on unpatented proprietary technology, and we can make no assurance that others may not independently develop the same or similar technology or otherwise obtain access to our unpatented technology.

-28-

Research and Development

Artificial Intelligence

Through the recent acquisitions of CloseComms and Alpha Predictions, the Company is able to offer a multitude of services through the use of data analysis. The CloseComms patented software technology can be integrated into a retailer’s existing Wi-Fi infrastructure, giving retailers important customer data and enabling AI-enhanced, targeted promotions to drive store traffic and sales. The Alpha Predictions current product offering includes primary and secondary research, business plans, product and application potential, market potential, demand forecasting, segmentation, targeting, positioning, investment, divestment, data analytics and several optimization techniques. Our team uses its corporate and business level consulting expertise to support and enhance the growth of promising enterprises. Our research team uses the holistic approach that encompasses multiple facets of a business. We have developed a unique approach to problem solving that is time tested.

Our team analyzes every problem or situation through various perspectives. Consulting is multidisciplinary, that is why our team is comprised not only of data analysts but also financial analysts and domain experts, which are able to provide a highly sophisticated digital analysis capability to our business clients including Supply Chain Analysis, Pricing Analysis, Market Entry Analysis and Customer Insight. The Company is able to leverage its personnel and their expertise to develop new proprietary software platforms for data analysis derived from its present experience and expertise gained in servicing its present customer base.

Smart Surfaces

Our Smart NanoBattery and power cell technology research and development was performed by the Bell Labs division of Alcatel/Lucent from February of 2004 through March of 2007 at an aggregate cost of $3.8 million. The Company paid Bell Labs $300,000 covering the period from April 27, 2007 through July 30, 2007, at which time it determined that, in order to develop a lithium battery for higher density energy than zinc, it required facilities capable of handling lithium battery research that Bell Labs does not have. The Company engaged a number of small foundries during fiscal year ended June 30, 2008 for commercialization of its Smart NanoBattery at a cost of approximately $150,000. In fiscal year ended June 30, 2009, the Company engaged Eagle Picher at a cost of $75,000 to design and engineer a prototype of its manually-activated lithium reserve battery and Porsche Design studio at a cost of $79,123 for design of its emergency flashlight product. In addition, the Company secured a Co-Branding Agreement with Porsche Design Studio for its emergency flashlight product. In fiscal year ended June 30, 2010, a decrease of $1,577,966. Such decrease is attributablethe Company paid $950,018 in connection with producing and bringing this product to the Company’s completion of both a mechanically-activated reserve batterymarket, and emergency flashlight in addition to substantial completion of research on its Smart NanoBattery product.

We expect that research and development expenses will continue to increase in the foreseeable future as we add personnel and expand our research for new products. The amount of these increases is difficult to predict due to the uncertainty inherent in the timing and extent of progress in our research programs, and initiation of new products using “smart surfaces”. As our research efforts mature, we will continue to review the direction of our research based on an assessment of the value of possible commercial applications emerging from these efforts. Based on this continuing review, we expect to establish discrete research programs and evaluate the cost and potential for cash inflows from commercializing products, partnering with others or licensing the technologies associated with these programs to third parties.

We believe that it is not possible at this stage to provide a meaningful estimate of the total cost to complete our ongoing projects and bring any proposed products to market. Costs to complete could vary substantially depending upon the products selected for development. It is possible that the completion of these products could be delayed for a variety of reasons, including delays in developing prototypes and manufacturing. Any delay in completion of a product would increase the cost of that product, which would harm our results of operations. Due to these uncertainties, we cannot reasonably estimate the size, nature or timing of the costs to complete, or the amount or timing of the net cash inflows from our current activities. Until we obtain information that enables us to further determine the scope, breadth and number of products that are actually developed using “smart surfaces”, we will not be able to estimate our future expenses related to these products or when, if ever, and to what extent we will receive material cash inflows from resulting products.

General and Administrative Expenses. Selling, general and administrative expenses were $1,823,178 for the year ended June 30, 2011, down from $1,844,776 for the comparable period in 2010, a decrease of $21,598. During fiscal year ended June 30, 2011, the Company incurred non-cash charges amounting$33,254 of expenses in connection with this product. During the fiscal year ended June 30, 2009, the Company engaged Silex, a silicon foundry in Sweden, at a cost of $21,200 for further development of its Smart NanoBattery; payments to $62,945Silex for stock based compensation awarded to officers, employees and consultants. During fiscal year ended June 30, 2010 such chargesin connection with the Smart NanoBattery amounted to $34,313, an increase of $28,632 in fiscal year ended June 30, 2011. This increase was offset by the reduction of salaries of employees in$396,780, and for fiscal year ended June 30, 2011 resultingthey were $40,800.

During fiscal years ended June 30, 2008, June 30, 2009, and June 30, 2010, the Company engaged in lower payroll by approximately $189,000joint research with Rutgers University in connection with a $750,000 STTR Grant from the United States Army for purposes of developing an emergency reserve battery to back-up a computer memory application.

Recent Developments

Financings

On July 31, 2020, we issued a convertible note in the principal amount of $68,000, which note accrues interest at a rate of 8% per annum, matures on July 31, 2021 and is convertible into shares of our common stock at a conversion price as compareddefined in the convertible note, subject to adjustment.

On July 24, 2020, we issued a convertible note in the principal amount of $105,000, which note accrues interest at a rate of 8% per annum, matures on July 24, 2021 and is convertible into shares of our common stock at a conversion price as defined in the convertible note, subject to adjustment.

On June 12, 2020, we issued a convertible note in the principal amount of $103,000, which note accrues interest at a rate of 8% per annum, matures on June 12, 2021 and is convertible into shares of our common stock at a conversion price as defined in the convertible note, subject to adjustment.

On June 2, 2020, we issued a convertible note in the principal amount of $78,000, which note accrues interest at a rate of 8% per annum, matures on June 2, 2021 and is convertible into shares of our common stock at a conversion price as defined in the convertible note, subject to adjustment.

Employees

As of August 13, 2020, the Company had 90 full-time employees and 12 part-time consultants.

-29-

Legal Proceedings

From time to time, we may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in matters may arise from time to time that may harm our business. As of August 13, 2020, except as set forth herein, management believes that there are no claims against us, which it believes will result in a material adverse effect on our business or financial condition.

Effective December 10, 2018, the Company entered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife that was previously in effect. As a result, under the Judgment Settlement Agreement, no shares of the Company’s common stock are issuable or eligible to be converted into. Under the terms of the Judgment Settlement Agreement, the Company was required to pay $15,000 per month from January 15, 2019 through and including February 15, 2020, with a final payment of $195,000 due and payable in March of 2020. The Company made all required payments with the exception of the final payment of $195,000 which was due and payable in March of 2020. On March 19, 2020, Fife notified the Company of the final payment default with respect to the payrollForbearance Agreement, as amended. The Company and Fife are negotiating a structure whereby the Company will be able to make the final payment of $195,000, which may include additional consideration depending on the timing of when the final payment is made. The Company expects to repay Fife the agreed upon balance due as quickly as possible based upon its available capital. The ultimate final payment amount is expected to be less than the liability balance of $762,921 at March 31, 2020.

Properties

Our headquarters is located at 9841 Washingtonian Boulevard, Suite 390, Gaithersburg, MD 20878. The lease for this office, since January 11, 2019; which presently is month to month, is charged at a monthly cost of $1,350 ($16,200 annually).

Corporate History

mPhase Technologies, Inc., was incorporated in the state of New Jersey in 1979 under the name Tecma Laboratory, Inc. and has subsequently operated under Tecma Laboratories, Inc., and Lightpaths TP Technologies, Inc., until June 2, 1997 when the Company changed its name to mPhase Technologies, Inc.

On January 11, 2019, the Company underwent a major change in management and control. The new management of the Company is positioning the Company to be a technology leader in artificial intelligence and machine learning while enabling a more rapid commercial development of its patent portfolio and other intellectual property. The Company’s goal is to generate significant revenue from its artificial intelligence and machine learning technologies.

On February 15, 2019, the Company acquired Travel Buddhi, a software platform to enhance travel via ultra-customization tools that tailor a planned trip experience in ways not previously available.

On June 30, 2019, the Company acquired 99% of the outstanding common shares of Alpha Predictions LLP (“Alpha Predictions”). Alpha Predictions is an India-based technology company that has developed a suite of commercial data analysis products for use across multiple industries. The Company expects the acquisition to result in synergies with its other operating divisions, which will drive revenue growth and innovation.

On May 11, 2020, the Company acquired all of the assets owned, used, or held by CloseComms Limited (“CloseComms”), a United Kingdom based company with offices in Wales (U.K.) and California (U.S.). One of the CloseComms acquired assets is a patented software application platform that can be integrated into a retail customer’s existing Wi-Fi infrastructure, giving the retailer important customer data and enabling AI-enhanced, targeted promotions to drive store traffic and sales.

Our address is 9841 Washingtonian Blvd., #390, Gaithersburg, MD 20878, our telephone number is (301) 329-2700 and our website is www.mphasetech.com. The information on our website is not a part of this prospectus.

-30-

MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Market Information

Our Common Stock is currently quoted on the OTCQB tier of the OTC Markets under the symbol “XDSL”. Any over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.

Stockholders

As of August 13, 2020 we had over 23,000 holders of record of our Common Stock. The number of record holders was determined from the records of our transfer agent and does not include beneficial owners of Common Stock whose shares are held in the names of various security brokers, dealers, and registered clearing agencies.

Dividend Policy

We have not paid any dividends on our Common Stock and do not anticipate paying any such dividends in the near future. Instead, we intend to use any earnings for future acquisitions and expanding our business.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion of our financial condition and results of operations in conjunction with financial statements and notes thereto, as well as the “Risk Factors” and “Description of Business” sections included elsewhere in this prospectus. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this prospectus, particularly in “Risk Factors”.

Overview

Through fiscal year ended June 30, 2010.2018, the Company solely focused on the management of intellectual property associated with the development of innovative power cells and related products through the science of microfluidics, microelectromechanical systems (MEMS) and nano-technology.

On January 11, 2019, the Company underwent a major change in management and control. The new management of the Company is positioning the Company to be a technology leader in artificial intelligence and machine learning while enabling a more rapid commercial development of its patent portfolio and other intellectual property. The Company’s goal is to generate significant revenue from its artificial intelligence and machine learning technologies.

On February 15, 2019, the Company acquired Travel Buddhi, a software platform to enhance travel via ultra-customization tools that tailor a planned trip experience in ways not previously available.

On June 30, 2019, the Company acquired 99% of the outstanding common shares of Alpha Predictions LLP (“Alpha Predictions”). Alpha Predictions is an India-based technology company that has developed a suite of commercial data analysis products for use across multiple industries. The current product offering includes software covering eight categories: inventory, stock management, marketing optimization, sentiment analysis, customer segmentation and behavior, agro-tech image detection, electrocardiogram automation, and a recommendation engine with multiple uses.

On May 11, 2020, the Company acquired all of the assets owned, used, or held by CloseComms Limited (“CloseComms”), a United Kingdom based company with offices in Wales (U.K.) and California (U.S.). One of the CloseComms acquired assets is a patented software application platform that can be integrated into a retail customer’s existing Wi-Fi infrastructure, giving the retailer important customer data and enabling AI-enhanced, targeted promotions to drive store traffic and sales. 

-31-

Nine Months Ended March 31, 2020 Compared to the Nine Months Ended March 31, 2019

Critical Accounting Policies and Estimates

The discussion and analysis of the Company’s financial condition and results of operations are based upon its unaudited consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of these unaudited consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent liabilities. On an on-going basis, management evaluates past judgments and estimates, including those related to bad debts, potential impairment of intangible assets, accrued liabilities and contingencies. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The accounting policies and related risks described in Note 3 of the Company’s Annual Report on Form 10-K as filed with the SEC on October 15, 2019 are those that depend most heavily on these judgments and estimates. As of March 31, 2020, there had been no material changes to any of the critical accounting policies contained therein.

Results of Operations

Continuing Operations

Revenue

Our revenue increased to $22,688,086 for the nine months ended March 31, 2020, compared to $0 for the nine months ended March 31, 2019. The increase is the result of expanding upon a new customer agreement entered into during the fourth quarter of fiscal year 2019. Such new customer agreement accounted for 100% of our total revenue during the nine months ended March 31, 2020, resulting in a significant risk of customer concentration.

Cost of Revenue

Cost of revenue totaled $16,955,320 for the nine months ended March 31, 2020, compared to $0 for the nine months ended March 31, 2019. The increase is the result of generating the increased revenue.

Operating Expenses were reduced across

Our operating expenses, which include software development costs, salaries and benefits, stock-based compensation, legal and professional fees, and general and administrative expenses increased to $20,685,547 for the board, includingnine months ended March 31, 2020, compared to $1,541,960 for the nine months ended March 31, 2019, an increase of $19,143,587. The increase is primarily due to stock-based compensation expense related to the Company’s Chief Executive Officer and Chief Financial Officer, an increase in general and administrative expenses related to salaries of the new Chief Executive Officer and Chief Financial Officer, coupled with increased operating expenses to support the increased operations of the business, partially offset by lower expenses from prior officers for services rendered.

On a reduction in legalcomparative, proforma basis, excluding non-cash stock-based compensation expense related to the Company’s Chief Executive Officer and Chief Financial Officer, our operating expenses increased to $4,369,203 for the nine months ended March 31, 2020, compared to $231,511 for the nine months ended March 31, 2019, an increase of $52,000 and marketing expense$4,137,692. The increase is primarily due to increased operating expenses to support the increased operations of $211,000.the business, partially offset by lower expenses from prior officers for services rendered.

Other (Expense) Income and Expense.

Our other income increased by $244,279, or 175%, for the nine months ended March 31, 2020. The current FYE 2011 reflects non-cash chargesincrease is primarily the result of $0 for reparations, and net settlement income of $8,915. During the prior FYE 2010, reparation expense amounted to $35,530 and net settlement income was $203,940. In addition during FYE 2011, the Company realized a non-cash net gain of approximately $1,866,669 compared to a non-cash net loss of $2,961,939 in FYE 2010 resulting from the issuance and the changes in the derivative liability values relative to convertible debt. The current FYE 2011 includes a gain resulting fromon the change in derivativefair value of $3,836,158derivative liability associated with the convertible promissory notes, partially offset by increases in part by amortization of debt discount, stock issuance costsrelated to the convertible promissory notes and other charges including a $55,000 extension and forbearance fee and a $28,000 intervention fee amounting to $2,319,318. This compares to a gain resulting from the change in derivative value of $356,566 offset in part by amortization of debt discount, stock issuance cost and other charges amounting to $3,318,505 in FYE 2010. During FYE 2011, the Company recorded a $244,496 gain from the settlement of liabilities from discontinued operations.interest expense.

-32-

Net lossLoss from Continuing Operations. mPhase recorded a net loss of $486,391 for the year ended June 30, 2011 as compared to a loss of $7,365,765 for the same period ended June 30, 2010. During FYE 2011, the Company recorded

We had a net loss from continuing operations of $730,887$14,848,135 for the nine months ended March 31, 2020, compared to a net loss of $1,681,593 for the nine months ended March 31, 2019, an increase of $13,166,542. The increase in net loss is primarily driven by the increase in operating expenses and other expense, partially offset by the increase in gross profit, as disclosed above.

On a comparative, proforma basis, excluding non-cash stock-based compensation expense related to the Company’s Chief Executive Officer and Chief Financial Officer, we generated net income from continuing operations of $1,468,209 for the nine months ended March 31, 2020, an increase of $1,839,353. The increase in proforma net income is primarily driven by the increase in gross profit, partially offset by increases in operating expenses and other expense.

Discontinued Operations

For the nine months ended March 31, 2020, there are no revenue, cost of revenue, operating expenses, other income (expense), or net income from continuing operations. For the nine months ended March 31, 2019, loss from discontinued operations of $244,496. This represents a loss per common share of ($.00 ) in 2011 as compared to $(.01) in 2010, based upon weighted average common shares outstanding of 1,402,130,735 and 1,041,685,519 during the periods ending June 30, 2011 and June 30, 2010 respectively.was $14,713.

29


Comparison of Twelve MonthsYear Ended June 30, 2011 and 20102019 Compared to the Year Ended June 30, 2018

Continuing Operations

Revenues

  12 Months Ended June 30,  12 Months Ended June 30, 
  2011  2010 
     % of     % of 
  Amount  Revenue  Amount  Revenue 
Revenue$ 49,210  100.0% $ 354,157  100% 
Cost of Revenue 50,260  -102.0%  66,044  19% 
Gross profit (1,050) -.02%  288,153  81% 
Research and development expenses and 625,417  1,263%  2,203,383  622 % 
             
General and administrative expenses 1,823,178  3,705%  1,884,776  532% 
             
Non-operating income (expense) 1,734,249  3,524%  (3,580,335) -1,011% 
Net loss$ (486,891) -989.0% $ (7,365,745) -2,080% 

LIQUIDITY AND CAPITAL RESOURCES

The following tables sets forth a summary of our cash flows

Our revenue increased to $2,500,000 for the periods indicated below:

Cash Flows

  Quarter ended September 30, 
  2011  2010 
Net cash used in operating activities$ 372,567 $ 457,004 
Net cash used in investing activities 7,129  5,993 
Net cash provided by financing activities 465,249  298,114 
Net increase (decrease) in cash and cash equivalents 85,553  (164,793)
Cash and cash equivalents at the end of the period$ 87,297 $ 63,644 

  Fiscal Year ended June 30, 
  2011  2010 
Net cash used in operating activities$ 1,765,506 $ 3,765,533 
Net cash used in investing activities 5,933  15,000 
Net cash provided by financing activities 1,544,746  3,908,832 
Net increase (decrease) in cash and cash equivalents (226,693) 128,229 
Cash and cash equivalents at the end of the period$ 1,744 $ 228,437 

Through September 30, 2011, the Company had incurred development stage losses totaling approximately $200,823,117 and had cash and cash equivalents of $87,297. At September 30, 2011, mPhase had working capital of ($2,779,599) as compared to working capital of ($29,987) as of September 30, 2010.

The Company has convertible debentures and notes outstanding that enable the Company to raise $100,000-$200,000 per month for a portion of the fiscal year ended June 30, 2011. However conversions into common stock have been very limited since April of 2011 primarily owing2019, compared to the continuing decline in the share price of the Company’s common stock and negative liquidity conditions in the capital markets. Such conditions have resulted in a significant “overhang” of approximately monies funded to the Company together with accrued interest totaling $1,733,637 and not converted into common stock as of September 30, 2011. At the current stock price such convertible debentures and notes are convertible into 438,813,632 shares of the Company’s common stock. Until such amount is successfully converted into common stock and sold by the holders of such convertible instruments, the Company will have limited access to future financing through additional issuances of convertible securities.

30


In addition, on June 23, 2011, the common stock of the Company ceased to be eligible for fast –trading by investors by the Depository Trust Company that handles the clearance of all securities in the United States. As a result the liquidity of the Company’s common stock has contracted and financing the Company exclusively through such instruments may be limited in the future. The Company believes that it may have expanded opportunities for supplemental private placements of equity as a result of its prospective acquisition of EIP since such acquisition may well enhance and accelerate its opportunities for revenue from sales of an additional product line that will enable it to satisfy short-term liquidity. Owing to recent cost-reductions achieved by the Company in payroll and other administrative expenses the Company believes that its short-term liquidity requirements are between $100,000-$125,000 per month.

In the longer term, we estimate that the Company will need to raise approximately $5-10 million of additional capital above the funds anticipated from the monthly funding’s and conversions by holders of revised or replacement convertible securities, to meet longer term liquidity needs through June 30, 2012. Such monies will be necessary primarily to fund future operating expenditures as well as marketing, cost-reductions and commercialization of its Smart NanoBattery, Emergency Flashlight, and a second product being developed$0 for the Company by Porsche Design Studio. Finally, depending upon sales and margins in fiscal year 2012, additional capital may be required to fund a portion of any growth necessary in operations.

31


Cash used in operating activities was $1,765,506 during the twelve months ended June 30, 2011. During such period,2018. The increase is the cash used byresult of a new customer agreement entered into during the fourth quarter of fiscal year 2019.

Operating Expenses

Our operating activities consisted principally ofexpenses increased to $4,265,886 for the net loss ($486,391) plus non-cash credits relatedyear ended June 30, 2019, compared to convertible debt issued and associated changes in derivative value ($2,116,064) reduced by$735,026 for the year ended June 30, 2018, an increase of accounts payable and accrued expenses of $412,144. These amounts are offset in part by non-cash charges$3,530,860, or 480%. The increase is primarily due to stock-based compensation expense recognized during 2019 related to issuancethe Company’s Chief Executive Officer and Chief Financial Officer, an increase in general and administrative expenses related to salaries of common stockthe new Chief Executive Officer and optionsChief Financial Officer, coupled with increased operating expenses to support the increased operations associated with the mPhase Technologies India subsidiary, partially offset by lower expenses from prior officers for services of $126,945.rendered.

During

Other Income (Expenses)

Our other expense, net, decreased by $1,047,524, or 95%, for the twelve-month periodyear ended June 30, 2011,2019. The decrease is primarily the Company raised capital through private placements with accredited investors, wherebyresult of decreases in the Company issued 67,500,000 sharesrealized gain on extinguishment of debt and interest expense.

Net Loss from Continuing Operations

We had a net loss of $1,974,101 for the Company's common stock, generating net proceeds to the Company of $265,500.

During the twelve-month periodyear ended June 30, 2010,2019, compared to net income of $126,734 for the Company raised capital through private placements with accredited investors, wherebyyear ended June 30, 2018, a decrease of $2,100,835. The increase in net loss is primarily driven by the Company issued 30,667,000 sharesincrease in operating expenses and other income (expense), partially offset by the increase in gross profit.

Discontinued Operations

Operating Expenses

Our operating expenses, which include salaries and benefits, selling and promotions, legal and professional fees and general and administrative expenses decreased to $0 for the year ended June 30, 2019, compared to $22,009 for the year ended June 30, 2018. The decrease is due to a declines in selling and marketing and general and administrative expenses.

Other Income (Expense)

Our other income, net, decreased by $190,329 for the year ended June 30, 2019. The decrease is primarily the result of decreases in the realized gain on extinguishment of debt and interest expense.

Net Income from Discontinued Operations

We had net income of $18,940 for the year ended June 30, 2019, compared to net income of $187,170 for the year ended June 30, 2018, a decrease of $168,230. The decrease is primarily driven by the decrease in other income (expense), partially offset by the decrease in operating expenses.

-33-

Critical Accounting Policies

We have identified the policies below as critical to our understanding of the Company's common stock, generating net proceeds to the Company of $225,000.

We believe that it is not possible at this stage to provide a meaningful estimate of the total cost to complete our ongoing projects and bring any proposed products to market. The development of new products using the science of nanotechnology and the discipline of microfluidics is an emerging area and the time for development of future new products is unknown. Costs to complete could vary substantially depending upon the products selected for development. It is possible that the completion and commercialization of these new products could be delayed for a variety of reasons, including difficulties in developing prototypes, delays in manufacturing and the development of new sources of product distribution. Any delay in completion of a product would increase the cost of that product, which would harm our results of our business operations. Due to these uncertainties, we cannot reasonably estimateWe discuss the size, nature nor timing of the costs to complete, or the amount or timing of the net cash inflows from our current activities. Until we have developed a larger number of products, we will not be able to estimate our future expensesimpact and any associated risks related to these programs or when, if ever, and to what extent we will receive cash inflows from resulting products.

Contractual Obligations

          At September 30, 2011,policies on our significant contractual obligations were as follows:

 Less than one yearGreater than one yearTotal
Convertible Noes-JMJ Financial$1,069,035$0$1,069,035
Convertible Notes-John Fife$638,250$0$638,250
Convertible Note-Jay Wright$25,150$0$25,150
Equipment Loan$11,816$13,234$25,050
Total$1,744,251$1,3,234$1,757,485

          We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have a material current or future effect upon our financial condition or results of operations.

SELECTED FINANCIAL DATA

(in thousands except per share data)

The selected financial data set forth below should be read in conjunction with "Management'sbusiness operations throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations"Operations where such policies affect our reported and expected financial results.

In the historicalordinary course of business, we have made a number of estimates and assumptions in preparing our financial statements in conformity with GAAP. Actual results could differ significantly from those estimates and notesassumptions. The following critical accounting policies are those that are most important to the portrayal of our consolidated financial statements. For a summary of our significant accounting policies, including the critical accounting policies discussed below, refer to Note 3 - “Summary of Significant Accounting Policies” included in this annual report. The statement of operations data from October 2, 1996 (date of inception)the notes to June 30, 1997 andconsolidated financial statements for the year ended June 30, 1998,2019 included elsewhere in this prospectus.

We consider the following accounting policies to be those most important to the portrayal of our results of operations and financial condition:

Derivative Instruments

The Company enters into financing arrangements that consist of freestanding derivative instruments or are hybrid instruments that contain embedded derivative features. The Company accounts for these arrangements in accordance with ASC topic 815, Accounting for Derivative Instruments and Hedging Activities as well as related interpretations of this standard. In accordance with this standard, derivative instruments are recognized as either assets or liabilities in the balance sheet and are measured at fair values with gains or losses recognized in earnings. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. The Company determines the fair value of derivative instruments and hybrid instruments based on available market data using appropriate valuation models, considering all of the rights and obligations of each instrument.

The Company estimates fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered consistent with the objective measuring fair values. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques (such as Black-Scholes model) are highly volatile and sensitive to changes in the trading market price of the Company’s common stock. Since derivative financial instruments are initially and subsequently carried at fair values, our income (expense) going forward will reflect the volatility in these estimates and assumption changes.

Convertible Debt Instruments

The Company records debt net of debt discount for beneficial conversion features and warrants, on a relative fair value basis. Beneficial conversion features are recorded pursuant to the Beneficial Conversion and Debt Topics of the Financial Accounting Standards Board (“FASB”) ASC. The amounts allocated to warrants and beneficial conversion rights are recorded as debt discount and as additional paid-in-capital. Debt discount is amortized to interest expense over the life of the debt.

-34-

Liquidity and Capital Resources

At March 31, 2020, we had $8,054 of cash and a working capital surplus of $450,622 as compared to cash of $33,996 and a working capital deficit of $2,440,289 at June 30, 1997 and 1998, are derived from financial statements that have been audited by Schuhalter, Coughlin & Suozzo, LLC, independent auditors, and are included2019.

Net cash used in this document. The statementoperating activities of continuing operations datawas $1,139,499 for the yearsnine months ended June 30, 1999, 2000, and 2001 and the balance sheet dataMarch 31, 2020 as of June 30, 1999, 2000, and 2001 are derived from financial statements that have been audited by Arthur Andersen LLP., independent auditors. The statement of operations data for each year ended June 30, 2002 through June 30, 2009 and the balance sheet data as of June 30, 2002 through June 30, 2009 are derived from financial statements that have been audited by Rosenberg Rich Baker Berman & Company. The statement of operations datacompared to $118,315 for the yearnine months ended June 30, 2010 andMarch 31, 2019.

Net cash used in investing activities of continuing operations was $553 for the balance sheet datanine months ended March 31, 2020 as compared to no net cash used in or provided by investing activities of June 30, 2010 are derived from financial statements that have been audited by Demetrius & Company, L.L.C. The statement ofcontinuing operations for the yearnine months ended June 30, 2011March 31, 2019.

We have financed our operations since inception primarily through proceeds from equity and debt financings. During the balance sheet datanine months ended March 31, 2020, net cash provided by financing activities of continuing operations was $988,800, as compared to $174,454 during the nine months ended March 31, 2019. Our continued operations primarily depend upon our ability to raise additional capital from various sources including equity and debt financings, as well as our revenue derived from operations. We can give no assurances that any additional capital that we are able to obtain will be sufficient to meet our needs or will be on favorable terms. Based on our current plans, we believe that our cash provided from the above sources may not be sufficient to enable us to meet our planned operating needs for the next twelve months.

In addition to revenue derived from operations, we believe that private placements of June 30, 2011 have been audited by Demetrius & Company, L.L.C., independent auditors,our common stock and are included in this document.convertible debt to be issued from time to time will fund our short-term capital needs. At March 31, 2020, we had 100,000,000 authorized shares of common stock of which 13,486,040 shares were issued, 13,312,314 shares were outstanding, and 173,726 shares were to be issued.

32


SUMMARY OPERATING DATA
Year Ended June 30,
(in thousands except per share data)

                 from 
                 inception 
     Fiscal Years Ended June        October 2, 
     30        1996 to 
                 June 30, 
  2007  2008  2009  2010  2011  2011 

Total revenues

$ 44 $ 108 $ 187 $ 354 $ 49 $ 744 

Cost of sales

 0  0  0  66  50  116 

Research and development

 2,505  988  1,256  2,203  626  12,258 

General and administrative

 3,402  4,021  9,554  1,845  1,823  27,230 

Depreciation and amortization

 94  145  34  25  15  578 

Operating loss

 (5,957) (5,046) ( 10,637) (3,785) (2,465)$ (39,438)

Other income (expense), net

 (1,726) 2,379) (3,118) (118) 1,875 $ (8,035)

Interest income (expense)

 (18) (215) (1,321) (3,463) (141)$ (2,628)

Discontinued Operations

 (9,151) (501)    -  245  (144,544)

Net Loss

$ (16,852)$ (3,383)$ (15,096)$ (7,366)$ (486)$ (194,644)

Basic and diluted net loss per share - continuing

$ (0.02)$ (0.01)$ (0.03)$ (.01)$ (.00)  

Basic and diluted net loss per share- discontinued

$ (0.02)$ (0.00)$ (0.00)$ 0.00 $ (.00)  

Shares used in basic and diluted net loss per share

 310,395,562  405,032,339  592,455,950  1,041,685,519  1,402,130,735   

BALANCE SHEET DATA
in $000's

  2007  2008  2009  2010  2011 
Cash and cash equivalents$ 23 $ 16 $ 100 $ 228 $ 2 
Working capital (deficit)$ (3,088)$ (3,853)$ (3,991)$ 201 $ (2,705)
Total assets$ 1,808 $ 2,351 $ 3,489 $ 5,844 $ 235 
Long-term obligations, net of current portion$ 0 $ 1,595 $ 4,433 $ 28 $ 16 
Total stockholders' (deficit)$ (2,754)$ (3,238)$ (5,234)$ (7,884)$ (5,592)

Selected Quarterly Financial Information

The statement of operations data as of the quarterly periods indicated below are derived from unaudited financial statements on Form 10Q filings, and include all adjustments (consisting of normal recurring items) that management considers necessary for a fair presentation of the financial statements.

FISCAL 2012 QUARTERLYThree Months Ended
STATEMENT OF OPERATIONSSeptember 30,
DATA:
(in thousands, except share amounts)
Total revenues$ 0
Costs and Expenses:
Cost of sales1
Research and development41
General and administrative6,888
Depreciation and amortization4
Operating loss(6,934)
Interest expense, Net(71)
Other Income (expense)826
Discontinued operations
Net ( Loss) Income$ (6,179)
Basic net (loss) gain per share- Continuing operations$ 0
Discontinued operations$ 0
Diluted net (loss) gain per share- Continuing operations$ 0
Discontinued operations$ 0
Shares used in basic net loss per share2,053,984,273
Shares used in diluted net loss per shareN/A

FISCAL 2011 QUARTERLY    Three Months Ended    
STATEMENT OF OPERATIONS September 30,  December 31,  March 31,  June 30, 
DATA:            
  (in thousands, except share amounts)         
Total revenues$ 29 $ 1 $ 18 $ 1 
Costs and Expenses:            
Cost of sales 9  5  37  (1)
Research and development 193  141  111  180 
General and administrative 523  446  455  398 
Depreciation and amortization 3  4  4  4 
Operating loss (701) (595) (589) (580)
Interest expense, Net (30) (25) (26) (60)
Other Income (expense) 2,725  (100) (709) (41)
Discontinued operations          245 
Net ( Loss) Income$ 1,994 $ (720) (1,324) (436)
Basic net (loss) gain per share-            
Continuing operations$ 0 $ 0 $ 0 $ 0 
Discontinued operations$ 0 $ 0 $ 0 $ 0 
Diluted net (loss) gain per share-            
Continuing operations$ 0 $ 0 $ 0 $ 0 
Discontinued operations$ 0 $ N/A $ N/A $ N/A 
Shares used in basic net loss per share 1,189,554,845  1,226,037,125  1,456,690,423  1,602,502,264 
Shares used in diluted net loss per share 1,713,140,738  N/A  N/A  N/A 

33



FISCAL 2010 QUARTERLY    Three Months Ended    
STATEMENT OF OPERATIONS September 30,  December 31,  March 31,  June 30, 
DATA:            
  (in thousands, except share amounts)       
Total revenues$ 52 $ 34 $ 142 $ 126 
Costs and Expenses:            
Cost of sales 0  0  2  63 
Research and development 515  579  712  397 
General and administrative 421  489  453  482 
Depreciation and amortization 5  7  7  7 
Operating loss (889) (1041) (1032) (823)
Interest expense, Net (681) (42) (33) (31)
Other Income (expense) 1173  (2417) 1959  (3508)
Discontinued operations 0  0  0  0 
Net ( Loss) Income$ (397)$ (3,500)$ 894 $ (4,362)
Basic net (loss) gain per share-            
Continuing operations$ (0.01)$ (0.01)$ 0.00 $ (0.01)
Discontinued operations$ - $ - $ - $ - 
Diluted net (loss) gain per share-            
Continuing operations$ (0.01)$ (0.01)$ 0.00 $ (0.01)
Discontinued operations$ - $ - $ - $ - 
Shares used in basic net loss per share 934,821,600  934,821,600  1,057,751,508  1,084,251,619 
Shares used in diluted net loss per share 934,821,600  934,821,600  1,534,563,992  1,084,251,619 

Includes certain reclassification from previous reported amounts

FISCAL 2009 QUARTERLY    Three Months Ended    
STATEMENT OF OPERATIONS DATA: September  31-Dec  March  June 30, 
  30,     31,    
 (in thousands, except share amounts)         
Total revenues$ 6 $ 45 $ 44 $ 92 
Costs and Expenses:            
Cost of sales -  -  -  - 
Research and development 388  216  265  386 
General and administrative 6,239  499  430  2,387 
Depreciation and amortization 13  13  4  4 
Operating loss (6,634) (683) (655) (2,685)
Interest expense, Net (39) (61) (74) (1,146)
Other Income (expense) 355  (1,845) 73  (1,702)
Discontinued Operations -  -  -  - 
Net Loss (6,318)$ (2,589)$ (656)$ (5,533)
Basic and diluted net (loss) gain per share-            
Continuing Operations (0.01)$ (0.01)$ - $ (0.01)
Discontinued Operations$ - $ - $ - $ - 
Shares used in basic and diluted net loss per share 452,895,360  452,895,360  671,278,600  786,484,581 

FISCAL 2008 QUARTERLY    Three Months Ended    
           June 
  September     March  30, 
STATEMENT OF OPERATIONS DATA: 30,  December 31,  31,  (As Restated) 
 (in thousands, except share amounts)         
Total revenues$ 35 $ 61 $ 1 $ 10 
Costs and Expenses:            
Cost of sales 0  1  0  0 
Research and development 560  285  277  (134)
General and administrative 1,497  985  576  974 
Depreciation and amortization 34  81  21  9 
Operating loss (2,056) (1,291) (873) (833)
Interest expense, Net (12) (38) (145) (20 
Other Income (expense) (718) 1,436  (2,487) 3,653 
Discontinued Operations -  -  -  (5)
Net (Loss) Income$ (2,786)$ 107 $ (3,505)$ 2,801 
Basic and diluted net (loss) gain per share            
Continuing operations$ (0.01)$ 0 $ (0.01)$ 0 
Discontinued operations$ - $ - $ - $ - 
Shares used in basic and diluted net loss per share 389,791,154  392,557,583  397,367,531  418,881,266 
Includes certain reclassification from previous reported amounts        

34



FISCAL 2007 QUARTERLY    Three months ended    
STATEMENT OF OPERATIONS 30-Sep  31-Dec  31-Mar  30-Jun 
  (in thousands, except share amounts)       
Total revenues$ 30 $ 4 $ 4 $ 5 
Costs and Expenses:            
Cost of sales 0  0  0  0 
Research and development 776  672  488  557 
General and administrative 765  548  642  1,432 
Depreciation and amortization 22  22  23  28 
Operating loss (1,534) (1,238) (1,148)$ (1,238)
Interest expense, Net (4) (8) 1 $ (7)
Other Income (expense) 187  (1,505) (175) (2,035)
Discontinued Operations (2,607) (1,088) (1,942) (2,511)
Net Loss$ (3,958)$ (3,839)$ (3,264)$ (5,791)
Basic and diluted net loss per share            
    Continuing operations$ - $ (0.01)$ - $ (0.01)
    Discontinued operations$ (0.01)$ - $ (0.01)$ (0.01)
Shares used in basic and diluted net 282,306,237  300,483,022  327,195,047  363,823,271 

MARKET PRICE OF AND DIVIDENDS ON REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

(A) MARKET PRICES OF COMMON STOCK.The primary market for mPhase's common stock is the NASDAQ OTC Bulletin Board, where it trades under the symbol "XDSL." The Company became publicly traded through a merger with Lightpaths TP Technologies, formerly known as Tecma Laboratories, Inc. pursuantexpects to an agreement dated February 17, 1997. The following table sets forth the high and low closing prices for the shares for the periods indicated as provided by the NASDAQ's OTCBB System. The quotations shown reflect inter-dealer prices, without retail mark-up, markdown, or commission and may not represent actual transactions. These figures have been adjusted to reflect a 1 for 10 reverse stock split on March 1, 1997.

YEAR/QUARTER HIGH  LOW 
Fiscal year ended June 30, 2004      
First Quarter$ .42 $ .29 
Second Quarter .61  .29 
Third Quarter .69  .38 
Fourth Quarter .46  .29 
Fiscal year ended June 30, 2005      
First Quarter$ .31 $ .21 
Second Quarter .35  .23 
Third Quarter .60  .30 
Fourth Quarter .41  .25 
Fiscal year ended June 30, 2006      
First Quarter$ .29 $ .21 
Second Quarter .32  .15 
Third Quarter .45  .19 
Fourth Quarter .34  .18 
Fiscal year ended June 30, 2007      
First Quarter$ .21 $ .16 
Second Quarter .20  .15 
Third Quarter .24  .15 
Fourth Quarter .19  .09 
Fiscal year ended June 30, 2008      
First Quarter$ .13 $ .07 
Second Quarter .09  .05 
Third Quarter .14  .05 
Fourth Quarter .13  .07 

35



YEAR/QUARTER HIGH  LOW 
First Quarter$ .08 $ .03 
Second Quarter .05  .01 
Third Quarter .04  .01 
Fourth Quarter .05  .01 
Fiscal year ended June 30, 2010      
First Quarter$ .03 $ .02 
Second Quarter .02  .01 
Third Quarter .03  .02 
Fourth Quarter .02  .01 
Fiscal year ended June 30, 2011      
First Quarter$ .0189 $ .0100 
Second Quarter .0147  .0080 
Third Quarter .0105  .0045 
Fourth Quarter .0032  .0123 
Fiscal year ended June 30, 2012      
First Quarter$ .0189 $ .0100 
Second Quarter .0147  .0080 
       
       

Penny Stock Rules

          Our shares of Common Stock are subject to the "penny stock" rules of the Securities Exchange Act of 1934 and various rules under this Act. In general terms, "penny stock" is defined as any equity security that has a market price less than $5.00 per share, subject to certain exceptions. The rules provide that any equity security is considered to be a penny stock unless that security is registered and traded on a national securities exchange meeting specified criteria set by the SEC, authorized for quotation from the NASDAQ stock market, issued by a registered investment company, and excluded from the definition on the basis of price (at least $5.00 per share), or based on the issuer's net tangible assets or revenues. In the last case, the issuer's net tangible assets must exceed $3,000,000 if in continuous operation for at least three years or $5,000,000 if in operation for less than three years or the issuer's averagecontinue generating revenues for each of the past three years must exceed $6,000,000.

          Trading in shares of penny stock is subject to additional sales practice requirements for broker-dealers who sell penny stocks to persons other than established customers and accredited investors. Accredited investors, in general, include individuals with assets in excess of $1,000,000 or annual income exceeding $200,000 (or $300,000 together with their spouse), and certain institutional investors. For transactions covered by these rules, broker-dealers must make a special suitability determination for the purchase of the security and must have received the purchaser's written consent to the transaction prior to the purchase. Additionally, for any transaction involving a penny stock, the rules require the delivery, prior to the first transaction, of a risk disclosure document relating to the penny stock. A broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, and current quotations for the security. Finally, monthly statements must be sent disclosing recent price information for the penny stocks. These rules may restrict the ability of broker-dealers to trade or maintain a market in our Common Stock, to the extent it is penny stock, and may affect the ability of shareholders to sell their shares.

Dividends

          We never paid cash dividends and have no plans to do so in the foreseeable future. Our future dividend policy will be determined by our board of directors and will depend upon a number of factors, including our financial condition and performance, our cash needs and expansion plans, income tax consequences, and the restrictions that applicable laws, our current preferred stock instruments, and our future credit arrangements may then impose.

          Currently under New Jersey law, unless further restricted in its certificate of incorporation, a corporation may declare and pay dividends out of surplus, or if no surplus exists, out of net profits forduring the fiscal year in which the dividend is declared and/or the preceding fiscal year (provided that the amountbeginning July 1, 2019 from its artificial intelligence and machine learning software platforms. The Company does not expect to derive any material revenue from its nanotechnology product development until after a deployment and custom tailoring of capital of the corporation is not less than the aggregate amount of the capital represented by the issued and outstanding stock of all classes having a preference upon the distribution of assets).

36


Securities Authorized for Issuance Under Equity Compensation Planits Smart Nanobattery.

 The following table shows information with respect

We have based our estimate on assumptions that may prove to each equity compensation plan under which the Company's Common Stock is authorized for issuance asbe wrong. We may need to obtain additional funds sooner or in greater amounts than we currently anticipate. Potential sources of the fiscal year ended June 31, 2011.

EQUITY COMPENSATION PLAN INFORMATION

  Number of       
  securities  Weighted  Number of 
  to be issued  average  securities 
  upon  exercise  remaining 
  exercise of  price of  available for 
  outstanding  outstanding  issuance 
  options,  options,  under equity 
  warrants  warrants  compensation 
Plan Category and rights  and rights  plans 
  (a)(1)  (b)  (c)(2) 
Equity compensation plans approved by security holders 110,085,000 $ .0267  -0- 
Equity compensation plans not approved by security holders -0-  -0-  -0- 
          
Total 110,085,000 $ .0267  -0- 

(1) Includes 98,000,000 options re-priced to $.0040 on August 25, 2011

(2)(excluding securities reflected in column (a))

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our exposure to market risk is limited primarily to interest income sensitivity, which is affected by changes in the general level of U.S. interest rates, particularly because a significant portionfinancing include strategic relationships, public or private sales of our investmentssecurities, debt or other sources. We may seek to access the public or private equity markets when conditions are in short term debt securities issued by the U.S. government and institutional money market funds. The primary objective offavorable due to our investment activities is to preserve principal. Due to the nature of our marketable securities, we believe that we are not exposed to any material market risk.long-term capital requirements. We do not have any derivativecommitted sources of financing at this time, and it is uncertain whether additional funding will be available when we need it on terms that will be acceptable to us, or at all. If we raise funds by selling additional shares of common stock or other securities convertible into common stock, the ownership interest of our existing stockholders will be diluted. If we are not able to obtain financing when needed, we may be unable to carry out our business plan. As a result, we may have to significantly limit our operations and our business, financial instruments or foreign currency instruments. If interest rates had varied by 10% in the three months ended March 31, 2011, it would not have had a material effect on ourcondition and results of operations or cash flows for that period.would be materially harmed.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

-35-

DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS, AND CONTROL PERSONS

Our directors are elected at the annual meeting of shareholders to hold office until the annual meeting of shareholders for the ensuing year or until their successors have been duly elected and qualified. Officers are elected annually by the Board of

Directors and serve at the discretion of the Board. No family relationships exist between any of the executive officers or directors.Executive Officers

On October 19, 2007, in connection with the settlement and dismissal of a civil law suit originally filed on November 16, 2005 by the Securities and Exchange Commission in the Federal District Court in the District of Connecticut, the SEC issued a Cease and Desist Order and certain remedial sanctions against two officers of mPhase Technologies, Inc. (the "Company"). The civil suit was filed against Packport.com, Inc. a Nevada corporation, Microphase Corporation, a Connecticut corporation, a company that provides administrative services to the Company and shares common management with the Company, and others. The two officers of the Company were Mr. Ronald A. Durando, President and Chief Executive Officer and Mr. Gustave T. Dotoli, the Chief Operating Officer. The Civil suit by the SEC named as respondents Mr. Durando, Mr. Dotoli and others in connection with their activities as officers and directors of Packetport.com. The cease and desist order from the SEC found that (1) Mr. Durando had violated Section 5 of the Securities Act of 1933, as amended, by making unregistered sales of common stock of Packetport.com.(2) Mr. Durando and Mr. Dotoli had violated Section 16(a) of the Securities Exchange Act of 1934, as amended, and Rule 16(a) thereunder by failing to timely disclose the acquisition of their holdings on Form 3’s and (3) Mr. Durando had violated Section 13(d) of the Securities Exchange Act of 1934, as amended, for failing to disclose the acquisition of more than five percent of the stock of Packetport.com.

37


Under the order Mr. Durando was required to disgorge $150,000 and Mr. Dotoli was required to disgorge $100,000. The Company was not named as a party to the civil suit. More information regarding the detailed terms of the settlement can be found in SEC release No 8858 dated October 18, 2007 promulgated under the Securities Act of 1933 and SEC Release No. 56672 dated October 18,2007 promulgated pursuant to the Securities Exchange Act of 1934.

Mr. Durando and Mr. Dotoli have continued to serve as officers and directors of the Company. Mr Durando and Mr. Dotoli together with Microphase corporation and others, without admitting or denying the findings of the SEC, except as to jurisdiction and subject matter, have consented to the entry of the Order Instituting Cease and Desist Proceedings, Making findings and Imposing a Cease and Desist Order and Remedial Sanctions pursuant to Section 8A of the Securities Exchange Act of 1933 and Section 21C of the Securities Exchange Act of 1934.

The following table sets forth certain information with respect to each person who is an executive officer or director. mPhase'sthe names and ages of the members of our board of directors and our executive officers and directorsthe positions held by each as of September 30, 2010 are as follows:August 13, 2020.

NAMEName AGEAge POSITION(S)Position(s)
Ronald A. Durando 54Chief Executive Officer and Director
Gustave T. Dotoli (2)75Chief Operating Officer and Director
Martin Smiley64Chief Financial Officer
OUTSIDE DIRECTORS    
Anthony H. Guerino (1)(2)Anshu Bhatnagar 6647 Director
Abraham Biderman (1)(2)65Director
Dr. Victor Lawrence63Director

(1)

Member of the Audit Committee

Chief Executive Officer and Chairman
  
(2)

Member of the Compensation Committee

Christopher Cutchens
43Chief Financial Officer

RONALD A. DURANDO

Biographies for the members of our board of directors and our management team are set forth below.

Anshu Bhatnagar – Chief Executive Officer and Chairman

Anshu Bhatnagar has served as our Chief Executive Officer and Chairman of our board of directors since January 11, 2019. In addition, Mr. Bhatnagar is a co-founderfood distribution veteran also CEO and Chairman of mPhasethe Board of Verus International, Inc, another publicly-traded company and previously was the Chief Executive Officer of American Agro Group, an international trading and distribution company that specialized in exporting agricultural commodities and food products from May 2012 to January 2016. Mr. Bhatnagar was also a Managing Member of Blue Capital Group, a real estate oriented multi-family office focused on acquiring, developing, and managing commercial real estate as well as investing in operating businesses from January 2008 to December 2016. He has also owned and operated other successful businesses in technology, construction and waste management. We believe Mr. Bhatnagar is qualified to serve as a member of our board because of his extensive business experience.

Christopher Cutchens – Chief Financial Officer

Christopher Cutches has served as our Chief Financial Officer since June 1, 2019. In addition, Since June 1, 2019, Mr. Cutchens has served as the Company's President, Chief Executive Officer and Director since its inception in October 1996. Since 1994, Mr. Durando has been anFinancial Officer of Microphase Corporation. Mr. Durando is a Director of Microphase Corporation. From 1986-1994, Mr. Durando was PresidentVerus International, Inc., and Chief Executive Officer of Nutley Securities, Inc., a registered broker-dealer. Mr. Durando also served as president of PacketPort until his resignation in February, 2008, when PacketPort merged with Wyndstorm Corporation.

GUSTAVE T. DOTOLIsince June 2018 he has served as mPhase's Chief Operating Officer as well as a Director since October 1996. Prior to joining the Company, Mr. Dotoli was President and CEO of State Industrial Safety, Inc. from 1986-1996. In addition, Mr. Dotoli currently serves as the Vice President of Corporate Development of Microphase Corporation. Mr. Dotoli was also a Director and Vice President of Packet Port. He was formerly the President and Chief Executive Officer of the following corporations: Imperial Electro- Plating, Inc., World Imports USA, Industrial Chemical Supply, Inc., SISCO Beverage, Inc., and Met Pack, Inc. Mr. Dotoli received a B.S. in Industrial Engineering from Fairleigh Dickenson University in 1959.

ANTHONY H. GUERINO has been a member of the Board since February 23, 2000. Since December 1997, Mr. Guerino has been an attorney in private practice in New Jersey. Prior thereto, Mr. Guerino served as a judge of the Newark Municipal Courts for over twenty (20) years, periodically sitting in the Essex County Central Judicial Processing Court at the Essex County Courthouse. Mr. Guerino has been a chairperson for and member of several judicial committees and associations in New Jersey, and has been an instructor for the Seton Hall School of Law's Trial Moot Court Program.

ABRAHAM BIDERMAN has been a member of the Board since August 3, 2000. He currently is the Managing DirectorPartner of Eagle Advisers, Inc,Cutchens Group, LLC, a small investment banking firm.consulting firm specializing in providing operational and financial services to both public and private companies. From 1990 through September 30, 2003,January 2016 until June 2018, Mr. Biderman had been employed by Lipper & Co. as Executive Vice President; Executive Vice President, Secretary and Treasurer of the Lipper Funds; and Co-Manager of Lipper Convertibles, L.P. Prior to joining Lipper & Co. in 1990, Mr. Biderman was Commissioner of the New York City Department of Housing, Preservation and Development from 1988 to 1989 and Commissioner of the New York City Department of Finance from 1986 to 1987. He was Chairman of the New York City Retirement System from 1986 to 1989. Mr. Biderman was Special Advisor to former Mayor Edward I. Koch from 1985 to 1986 and assistant to former Deputy Mayor Kenneth Lipper from 1983 to 1985. Mr. Biderman is a Director of the Municipal Assistance Corporation for the City of New York. Mr. Biderman graduated from Brooklyn College and is a certified public accountant.

38


MARTIN SMILEY was elected on June 28, 2006 to the Board of Directors. He joined mPhaseCutchens served as Executive Vice President, Chief Operating Officer and Financial Officer of MidAmerica Administrative and General Counsel in August 2000.Retirement Solutions, LLC, a private company that provides employee benefit programs to plan sponsors and employees. From January 2013 to January 2016, Mr. Smiley has over twenty years experience as a corporate finance and securities attorney and as an investment banker. Prior to joining the company, Mr. SmileyCutchens served as a Principal at Morrison & Kibbey, Ltd.Executive Vice President and Chief Financial Officer of Aspire Services, LLC (“Aspire”), a mergers and acquisitions and investment banking firm, from 1998April 2012 to 2000, and as a Managing Director for CIBC Oppenheimer Securities from 1994 to 1998. HeJanuary 2013, he served as a Vice President of Investment BankingAccounting and Finance of Aspire. Aspire is a service provider of retirement solutions. In addition, Mr. Cutchens has served in various other capacities including Corporate Controller of Watsco, Inc. (NYSE: WSO); Corporate Controller of Carrier Enterprise, LLC; Director of Corporate Accounting and Financial Reporting and Assistant Corporate Controller of MarineMax, Inc. (NYSE: HZO); and Senior Auditor at Chase Manhattan Bank from 1989 to 1994KPMG LLP. Mr. Cutchens received a Bachelor of Science degree in accounting and as a Vice President and Associate General Counsel for Chrysler Capital Corporation from 1984 to 1989. Mr. Smiley graduated with a B.A.masters degree in Mathematicsaccounting information systems from the University of Pennsylvania and earned his law degree from the University of Virginia School Of Law.

DR VICTOR LAWRENCESouth Florida. Mr. Cutchens is Bachelor Chair Professor of Electrical Engineering and Associate Dean for Special Programsa CPA licensed in the Charles V Schafer, Jr. SchoolState of Engineering, at Stevens InstituteFlorida.

Family Relationships

There are no family relationships among our executive officers and directors.

-36-

Involvement in Certain Legal Proceedings

We are not aware of Technology. Dr. Victor Lawrence is a memberany of our directors or officers being involved in any legal proceedings in the past ten years relating to any matters in bankruptcy, insolvency, criminal proceedings (other than traffic and other minor offenses), or being subject to any of the National Academyitems set forth under Item 401(f) of EngineeringRegulation S-K.

Director Independence

Although our Common Stock is not listed on any national securities exchange, for purposes of independence we use the definition of independence applied by The Nasdaq Stock Market. Accordingly, the sole Director of the Company, Anshu Bhatnagar, does not meet the definition of “independent director” under Rule 4200(A)(15) of the NASD Manual.

Corporate Governance

Board Committees

The Company presently does not have an audit committee, compensation committee or nominating and has workedcorporate governance committee or committee performing similar functions, as management believes that the Company is in an early stage of development to form such committees. The board of directors acts in place of such committees. The Company currently does not have an audit committee financial expert for the information technology and communications field for over thirty years. He is an industry leader in digital communications R&D and services, an entrepreneur, an active member of engineering professional organizations, an author, and a teacher who has extensive international experience. Prior to joining Stevens Institute of Technology,same reason that it does not have board committees.

Dr. Lawrence was Vice President, Advanced Communications Technology, Bell Laboratories, Lucent Technologies. He led the development of technologies that go into the most innovative, reliable, and cost-effective communications networks for leading telecommunications service providers. Earlier, he was Director, Advanced Multimedia Communications at Bell Labs, where he was responsible for systems engineering, exploratory development of multimedia signal processing, transmission, and switching, including speech and audio coding, modems, broadband transmission, ATM switching and protocols, and wireless communication and signal processing. He held a variety of leadership positions in data communications research, digital techniques, and information systems. Dr. Lawrence played a significant role in the development of major international voiceband modem standards, making high-speed data communication over international networks possible and led the development of high-speed modem/fax chip sets that are used in data terminals, computers, and voice terminals for secure communications worldwide. His work on high-speed transceivers for local loop and for premises applications led to the development of a variety of DSL technologies, many of which are deployed today for broadband services. As an entrepreneur, Dr. Lawrence spun off several ventures internal and external to Lucent to maximize the impact of technology developed in his organization.

At each annual meeting of stockholders, the newly elected directors' terms begin on the date of election and qualification, and continue through the next annual meeting following election. Terms may differ in the event a director resigns or is removed from office, or continues until a successor director is elected and qualified.

EXECUTIVE COMPENSATION

The following table sets forth for the compensation paid to our principal executive officer during our fiscal year ended June 30, 2011 and the two previous fiscal years, the compensation earned by mPhase's chief executive officer and the other executive officers whose compensation was greater than $100,000 for services rendered in all capacities to the Company for the year ended June 30, 2011.2019.

SUMMARY                           
EXECUTIVE                           
COMPENSATION                           
NAME&                NON-          
PRINCIPAL          STOCK  OPTION  EQUITY  PENSION       
POSITION YEAR  SALARY  BONUS  AWARDS  AWARDS  INCENTIVE  VALUE  OTHER    TOTAL 
Ronald 2011 $ 160,000 $ 0 $ 0 $0  N/A  N/A $33,728(1)$193,728 
Durando 2010 $ 200,000 $ 0 $ 0 $0  N/A  N/A $56,486(1)$256,486 
Chief Executive 2009 $ 275,718 $ 0 $ 1,541,700(2)$1,944,912(3) N/A  N/A $61,473(1)$3,823,803 
Officer                           
Gustave 2011 $ 144,000 $ 0 $ 0 $0  N/A  N/A $18,610(1)$162,610 
Dotoli 2010 $ 180,000 $ 0 $ 0 $0  N/A  N/A $39,375(1)$219,375 
Chief Operating 2009 $ 229,000 $ 0 $ 913,600(2)$1,166,947(3) N/A  N/A $62,514(1)$2,372,061 
Officer                           
Martin 2011 $ 140,000 $ 0 $ 0 $0  N/A  N/A $16,569 $156,569 
Smiley 2010 $ 175,000 $ 0 $ 0 $0  N/A  N/A $24,536(1)$199,356 
CFO and General 2009 $ 182,292 $ 0 $ 571,000(2)$700,168(3) N/A  N/A  $21,048(1)$1,474,508 
Counsel                           

Name and Position Year Salary  Bonus  Stock Awards  All Other Compensation  Total ($) 
New Management                      
                       
Anshu Bhatnagar                      
Chief Executive Officer 2019 $129,861  $   -  $1,310,449  $2,492,948(1) $3,933,258 
                       

Christopher Cutchens

Chief Financial Officer

 2019 $-  $-  $-  $-  $- 
                       
Old Management                      
                       
Ronald Durando 2019 $-  $-  $-  $-  $- 
Chief Executive Officer 2018 $-  $-  $200,000  $25,678(2) $225,678 
                       
Gustave Dotoli 2019 $-  $-  $-  $-  $- 
Chief Operating Officer 2018 $-  $-  $100,000  $8,623(2) $108,623 
                       
Martin Smiley 2019 $-  $-  $-  $-  $- 
CFO and General Counsel 2018 $-  $-  $100,000  $7,973(2) $107,973 

FOOTNOTES

(1)

Includes $2,492,697 related to stock warrants and $251 of interest on loans to the Company.

(2)Interest on loans to the Company.

(2)

Share grants are valued at the share price on the date the grant was authorized by the board of directors. The shares under the 2009 grant to officers are restricted from resale through August, 2012.

(3)

The fair value of options granted in fiscal year ended 2009 was estimated as of the date of grant using the Black-Scholes stock option pricing model, based on the following weighted average assumptions: annual expected return of 0%, an average life of 5 years, annual volatility of 80.3% and a risk-free interest rate 3.0%.

39


-37-

OUTSTANDING EQUITY AWARDSOutstanding Equity Awards at FISCAL YEAR END JUNEFiscal Year End

At June 30, 20112019, Anshu Bhatnagar, our Chief Executive Officer had earned warrants to acquire 4,985,393 shares of common stock under the provisions of his Warrant Agreement.

  Number of  Equity        Number of       
  Securities  Incentive        shares of       
  underlying  Plan        stock that  Market    
  Unexercised  awards  Option      Option  has not  Value of    
Number of Securities underlying Options  Number of    Exercise    Expiration  been  Shares not  Equity 
Unexercised Options (Exercisable) (Unexercisable)  Securities  Price  Date  vested  vested  Incentive 
Ronald Durando 0  0 $      0  0  0 
President CEO 0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
Gustave Dotoli 0  0 $      0  0  0 
COO 0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 
Martin Smiley 0  0 $      0  0  0 
Executive VP 0  0 $      0  0  0 
CFO Chief Legal 0  0 $      0  0  0 
Council 0  0 $      0  0  0 
  0  0 $      0  0  0 
  0  0 $      0  0  0 

40


COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATIONSubsequent to June 30, 2019, Mr. Bhatnagar earned the maximum number of warrants available under the provisions of the Warrant Agreement to acquire 37,390,452 shares of the Company’s common stock. Furthermore, on July 15, 2020, the Company entered into an exchange agreement with Mr. Bhatnagar, whereby earned and issued warrants to purchase 37,390,452 shares of the Company’s Common Stock pursuant to the terms of that certain Transition Agreement (the “Transition Agreement”) and Warrant Agreement (the “Warrant Agreement”) each between the Company and Mr. Bhatnagar and dated as of January 11, 2019 were forfeited and exchanged for (i) 37,390,452 shares of the Company’s Common Stock and (ii) the cancellation and termination of the Transition Agreement and Warrant Agreement. 

Director Compensation

None.

Employment Agreements

Anshu Bhatnagar Employment Agreement

Mr. Bhatnagar, President and Chief Executive Officer, pursuant to the terms of an Employment Contract, Transition Agreement and a Warrant Agreement, each dated as of January 11, 2019, for a period of 5 years and at a base cash salary of $275,000 per annum. Under the terms of the Employment Contract and Transition Agreement, Mr. Bhatnagar received 2,620,899 Restricted Shares of Common Stock of the Company.

In addition, Mr. Bhatnagar was granted 1,000 shares of a newly-created class of Series A Preferred Stock of the Company that effectively gives him voting control of the Company. As the holder of one thousand (1,000) shares of Series A Preferred Stock, Mr. Bhatnagar shall have the number of votes (identical in every other respect to the voting rights of the holders of Common Stock entitled at any regular or special meeting of shareholders of the Company) equal to such number of shares of Common Stock that is not less than fifty-one (51%) of the vote required to approve any action that New Jersey law provides may or must be approved by vote or consent of the holders of Common Stock or any other securities of the Company entitled to vote. Except as otherwise required by law, the holder of the Series A Preferred Stock shall vote together with the holders of Common Stock on all matters and shall not vote as a separate class. Notwithstanding the foregoing, should the Company enter into a merger agreement with another company and such merger is deemed significant as per SEC Regulation SX Section 3.05 and Section 3.06 Requirements, the Company with seek shareholder approval by a Proxy solicitation in compliance with Federal and State law.

Mr. Bhatnagar has been elected to the Board of Directors of the Company. Under the terms of the Transition Agreement and a cashless Warrant Agreement, Mr. Bhatnagar is able to earn an additional 4% of the outstanding Common Stock of the Company for each $1 million of gross revenues of the Company up to $15 million in such revenues and for a total (including his original grant of the Company’s common stock) not to exceed 80% of the total outstanding common stock of the Company. The purpose of this transaction is to bring in new management to the Company replacing its existing management to continue development of the Company’s patented and patent pending Smart NanoBattery and Drug Delivery Systems. Either directly or through wholly-owned subsidiaries. In addition, Mr. Bhatnagar intends to broaden the Company’s existing lines of business to include diverse lines of business that the Company can manage profitably within reasonable time frames within the Company’s resources.

On June 1, 2019 (the “Effective Date”), the Company entered into an employment agreement (the “Employment Agreement”) with Christopher Cutchens pursuant to which Mr. Cutchens will serve as Chief Financial Officer of the Company. Pursuant to the terms of the Employment Agreement, Mr. Cutchens will receive a base salary of $75,000 per year. Mr. Cutchens’ base salary shall be subject to annual review and increase by the Company beginning on November 1, 2020. Mr. Cutchens shall also be eligible to receive an annual performance-based bonus based upon the attainment of certain goals established by the Company. The bonus shall not exceed 50% of Mr. Cutchens’ then base salary. In addition to the foregoing, Mr. Cutchens received 231,635 shares of the Company’s common stock which shall vest 25% on the six-month, 1 year, 2 year and 3-year anniversaries of the Effective Date. Mr. Cutchens is also entitled to participate in any and all benefit plans in effect for senior executives of the Company, along with vacation, sick and holiday pay in accordance with the Company’s policies established and in effect from time to time.

The membersCompany or Mr. Cutchens may terminate the Employment Agreement at any time and for any reason; provided, however, Mr. Cutchens must provide at least 30 days prior written notice of his termination. In addition, the Company may terminate Mr. Cutchens’ employment with or without Cause (as defined in the Employment Agreement). In the event the Company terminates Mr. Cutchens’ employment without Cause (as defined in the Employment Agreement) and if Mr. Cutchens executes a general release of all claims against the Company and its affiliates, which release is not revoked, then, Mr. Cutchens shall receive the following: (i) if Mr. Cutchens has been employed by the Company between 12 and 23 months, six months of his then base salary; (ii) if Mr. Cutchens has been employed by the Company for at least 24 months, twelve months of his then based salary; and (iii) COBRA benefits. In the event Mr. Cutchens terminates his employment with the Company for any reason, he shall be entitled to receive (i) any portion of his then base salary not paid through the date of termination; (ii) reimbursement of expenses incurred on or prior to the termination date; (iii) any accrued but unused vacation pay; (iii) any pro-rated and unpaid portion of the Compensation Committee during fiscal 2011 wereannual bonus Mr. Dotoli, Biderman and Guerino. Neither Messrs. Biderman nor Mr. Guerino has been an officer or employee of mPhase. NoneCutchens is entitled to as of the Company's directorstermination date; and any amount arising from Mr. Cutchens’ participation in, or executive officers served as a member of the Compensation Committee (or other board committee performing equivalent functions or, in the absence of such committee, the entire Board of Directors) of another entity during fiscal 2011 that has a director or executive officer serving also as a director on mPhase's Board of Directors. Mr. Dotoli, together with Mr. Durando and Mr. Ergul, were collectively controlling shareholders and Directors of Janifast Ltd. In March of 2009, Janifast Ltd. terminated operations.benefits under, any benefit plans.

Employment Agreements

-38-

None

Director Compensation Arrangements

None

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth information as of November 14, 2011 certain information regardingAugust 13, 2020, as to each person or group who is known to us to be the beneficial owner of more than 5% of our outstanding voting securities and as to the security and percentage ownership of each of our shares:executive officers and directors and of all of our officers and directors as a group. As of August 13, 2020, we had 73,240,897 shares of Common Stock issued and outstanding and 1,000 shares of Series A Preferred Stock outstanding.

1

by each person who is known by us to be the beneficial owner of more than five percent (5%) of our outstanding common stock;

2

each of our directors;

3

by each executive officer named in the Summary Compensation Table; and

4

by all of our directors and executive officers

Beneficial ownership is determined under the rules of the SEC and generally includes voting or investment power over securities. Except in cases where community property laws apply or as a group.


AFFILIATES (1 & 2) Shares  Warrants  Options  TOTAL  % 
                
Victor Lawrence 10,100,000    200,000  10,300,000  0.37% 
Anthony Guerino     260,000  260,000  0.01% 
Abraham Biderman 45,226,890    2,160,000  47,386,890  1.71% 
Gustave Dotoli (3) 318,107,805  71,120,800  30,000,000  419,228,605  14.60% 
Ron Durando (3) 452,241,922  108,817,598  50,000,000  611,059,520  20.86% 
Ned Ergul 2,850,000    450,000  3,300,000  0.12% 
Martin Smiley (3) 313,760,629  51,273,018  18,000,000  383,033,647  13.49% 
Microphase Corporation(4) (5) 42,726,686      42,726,686  1.54% 
                
Total Affiliates 1,185,013,932  231,211,415  101,070,000  1,517,295,347  52.71% 

(1) Unless otherwise indicated in the address offootnotes to this table, we believe that each beneficial owner is 587 Connecticut Avenue, Norwalk, Connecticut 06854–1711.

(2) Unless otherwise indicated, mPhase believes that all persons namedstockholder identified in the table havepossesses sole voting and investment power with respect toover all shares of the CompanyCommon stock Shown as beneficially owned by them. The percentage for each beneficial owner listed above is based on 2,769,950,740 shares outstanding on November 14, 2011, and, with respect to each person holding options or warrants to purchase sharesthe stockholder.

Shares of Common Stock that are currently exercisable or convertible within 60 days after November 14, 2011, the number of options and warrantsAugust 13, 2020 are deemed to be outstanding and beneficially owned by the person holding such securities for the purpose of computing such person'sthe percentage beneficial ownership of that person, but are not deemed to betreated as outstanding for the purpose of computing the percentage ownershi pownership of any other person.

Amount and Nature of Beneficial Ownership
Name and Address (1) Common Stock Ownership  

Percentage of

Common

Stock Ownership

  Series A Preferred Stock Ownership  Percentage of Series A Preferred Stock  Percentage of Total Voting Power(2) 
Officers and Directors:                    
Anshu Bhatnagar  40,011,351   54.6%  1,000   100%  54.6%
Christopher Cutchens (3)  115,818   *   -   0%  * 
All Officers and Directors as a Group (2 Persons)  40,127,169   54.8%  1,000   100%  54.8%
5% Stockholders:                    
None                    

* Less than one percent.

(1) Unless otherwise indicated, the address of the stockholder is c/o mPhase Technologies, Inc., 9841 Washingtonian Blvd., Suite 390, Gaithersburg, MD 20878.

(2) Holders of our Common Stock are entitled to one vote per share, holders of our Series A Convertible Preferred Stock are entitled to the number of votes (identical in every other respect to the voting rights of the holders of Common Stock entitled at any regular or special meeting of shareholders of the Company) equal to such number of shares of Common Stock that is not less than fifty-one (51%) of the vote required to approve any action that New Jersey law provides may or must be approved by vote or consent of the holders of Common Stock or any other securities of the Company entitled to vote.

(3) Includes as warrants 108,817,598Excludes 115,817 shares 71,120,800of common stock which vests in two equal installments on June 1, 2021 and June 1, 2022.

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

Related-Party Transactions

Transactions with Microphase Corporation

At June 30, 2019, the Company owed $32,545 to Microphase for previously leased office space at its Norwalk location and for certain research and development services and shared administrative personnel from time to time, all through December 31, 2015.

Transactions with Former Director

A former outside Director, received 200,000 shares of the Company’s common stock valued at $100,000 pursuant to a resolution of the Company’s Board dated November 28, 2017, whereby such shares would be issued when enough authorized shares became available. The liability for this award was included in accrued expenses at June 30, 2018. The shares of the Company’s common stock were issued during the year ended June 30, 2019.

During the year ended June 30, 2019, a former outside Director’s affiliated firms converted $186,000 of accrued fees into 372,000 shares and 58,132,124 shares issuable for unpaid compensation$132,234 of a note and loans plus accrued interest if converted,into 276,205 shares of the Company’s common stock. At June 30, 2019, there was no outstanding balance for Messrs. Durando, Dotoliaccrued fees or for a note with accrued interest.

Effective October 1, 2018, the Company reversed to additional paid in capital $7,500 of accrued finders’ fees waved by Eagle Strategic Advisers and Smiley respectively. Such conversions are subjectno amount of such fees was accrued to availability of authorized shares. On April 27, 2009, and amended as of August 25, 2011; the board of directors consolidated all amounts outstanding for all obligations to the officers, including unpaid compensation, and authorized the issuance of new notes with a term of five years, an interest rate of 12% and a conversion featurethis former outside Director’s affiliated firm at a price of $.0040 on amounts outstanding plus accrued interest thereon. June 30, 2019.

During the fiscal years ended June 30, 2009 , June 30, 20102019 and in the three months ended September 30, 2011,2018 the Company recorded $914,060 , $82,609$1,959 and $2,360, respectively,$7,895 of beneficialaccrued interest expense with respect to the conversion feature.

(4) Messrs. Ergul and Durando and certain members of their families may be deemed to exercise shared majority voting and dispositive power for Microphase Corporation through their indirect ownership interests in Microphase Holding Company, LLC which owns 88.4% of Microphase common stock. The holding company is owned 43.9% by the Ergul Family Limited Partnership, which is wholly owned by Mr. Ergul, his wife and daughters, and 50% by Edson Realty Inc. which is 83% owned by Mr. Durando, 12% by Mr. Ergul and 5% by three unrelated shareholders. Mr. Durando owns an additional 1.6% of Microphase common stock in his individual name.

(5) Includes 26,666,667 shares issued in June 2009 in connection with which the Company, during the quarter ended September 30, 2009, recorded $586,667 in beneficial interest expense in respect of the conversion of $200,000 of accounts payable.on this loan.

 41

-39-


CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND CORPORATE GOVERNANCE

Material Related Party Transactions With Officers

The Company has material related party transactions. The Company incurs costs for engineering, design and production of prototypes and certain administrative functions from Microphase Corporation. Prior to March, 2008, it had purchased finished goods, primarily consisting of DSL splitter shelves and filters, from Janifast Limited. The Company also incurred costs in the past for obtaining transmission rights for a product it had planned to develop within its incorporated joint venture, mPhase Television. Net, in which the Company owned a 56.5% interest. This line of business has been discontinued.

Mr. Durando, President and CEO of mPhase, owns a controlling interest and is a director and President of Janifast Limited. Mr. Durando and Mr. Dotoli are officers of Microphase Corporation. Mr. Dotoli was also a shareholder of Janifast Limited prior to its discontinuing operations in March of 2009. Mr. Ergul owns a controlling interest and is a director of Microphase Corporation and is a director and shareholder of Janifast Limited. Microphase Corporation and Janifast Ltd. are significant shareholders of mPhase.

Mr. Abraham Biderman is a Managing Director of Eagle Advisers, Inc., a firm that performs investment banking services for the Company and was employed until September 30, 2003, by our former investment banking firm Lipper & Company.

Management believes the amounts charged to the Company by Microphase, Janifast Ltd., mPhase Television. Net and Hart Telephone are commensurate with amounts that would be incurred if outside parties were used. The Company believes Microphase Corporation has the ability to fulfill its obligations to the Company without further support from the Company.

Directors that were significant shareholders of Janifast Limited prior to its ceasing operations in March of 2009 included Messrs. Durando and Dotoli.

Summary of compensation to related parties for the Three Months Ended September 30, 2011

  Durando  Dotoli  Smiley  Biderman  Lawrence  Microphase  Total 

Consulting / Salary

$37,500 $34,167 $33,333          $105,000 

Interest

$13,116 $8,679 $6,337          $28,132 

Rent

               $10,890 $10,890 

G&A

               $2,301 $2,301 

R&D

                  $0 

Finders Fees

         $8,000       $8,000 

Stock based compensation (shares issued)*

$2,488,500 $1,858,500 $1,858,500 $252,000 $63,000    $6,520,500 

Stock based compensation (previously issued options repriced)**

$173,316 $103,990 $62,394          $339,700 

Total compensation

$2,712,432 $2,005,336 $1,960,564 $260,000 $63,000 $13,191 $7,014,523 

Common stock issued August 25, 2011*
Options issued (5years @ 5 cents in September, 2008 repriced @ $.0040; the incremental cost of $339,700 to amortized through September 18, 2013)

Summary of compensation to related parties for the Three Months Ended September 30, 2010

  Durando  Dotoli  Smiley  Biderman  Lawrence  Microphase  Total 
Consulting / Salary$40,000 $36,000 $35,000          $111,000 
Interest$9,044 $4,989 $4,477          $18,510 
Rent               $9,000 $9,000 
G&A               $1,529 $1,529 
R&D                  $0 
Finders Fees                  $0 
Total compensation$49,044 $40,989 $39,477 $0 $0 $10,529 $140,039 

42


Summary of compensation to related parties for the Twelve Months Ended June 30, 2011

  Durando  Dotoli  Smiley  Biderman  Microphase  Total 
Consulting / Salary$ 160,000 $144,000 $140,000       $444,000 
Interest$ 33,728 $ 18,610 $ 16,569       $ 68,907 
Rent         $  $ 36,000 $ 36,000 
G&A         $  $ 9,356 $ 9,356 
R&D               $ 0 
Finder’s Fees         $ 24,500    $ 24,500 
Total compensation$ 193,728 $162,610 $156,569  24,500 $ 45,356 $ $582,763 

Summary of compensation to related parties for the Twelve Months Ended June 30, 2010

  Durando  Dotoli  Smiley  Biderman  Microphase  Total 
Consulting / Salary$ 200,000 $180,000 $175,000       $ 555,000 
Interest$ 56,483 $ 39,375 $ 24,356       $ 120,214 
Rent            $ 36,000 $ 36,000 
G&A            $ 9,936 $ 9,936 
R&D            $ 337,500 $ 337,500 
Finder’s Fees         $ 25,000    $ 25,000 
Total compensation$ 256,483 $219,375 $199,356 $ 25,000 $ 383,436 $1,083,650 

           Total Notes          
Summary of payables to related parties as of September 30, 2011 Durando  Dotoli  Smiley  Payable  Biderman  Microphase  Total 
Notes payable$270,479 $155,306 $118,030 $543,815       $543,815 
Due to Officers / Affiliates            $150,000 $31,433 $181,433 
Interest Payable$164,791 $129,177 $87,062 $381,030       $381,030 
                      
Total Payable to Officers / Affiliates$435,270 $284,483 $205,092 $924,845 $150,000 $31,433 $1,106,278 

Summary of payables to related parties as of June 30, 2011

  Durando  Dotoli  Smiley  Payable  Biderman  Microphase  Total 
Notes payable$ 263,479 $ 148,306 $ 111,030 $ 522,815 $     $ 522,815 
Due to Officers / Affiliates             150,000 $ 27,242 $ 177,242 
Interest Payable$ 151,685 $ 120,498 $ 80,725 $$352,909 $     $ 352,909 
Total Payable to Officers / Affiliates$ 415,164 $ 268,804 $ 191,755 $$875,724 $ 150,000 $ 27,242 $1,052,966 

Summary of payables to related parties as of June 30, 2010

           Total          
           Notes          
  Durando  Dotoli  Smiley  Payable  Biderman  Microphase  Total 
Notes payable$ 301,479 $ 166,306 $ 119,030 $ 586,815       $ 586,815 
Due to Officers / Affiliates$ 0 $ 0 $ 0 $ 0    $ 19,214 $ 19,214 
Interest Payable$ 117,957 $ 101,888 $ 64,157 $ 284,002 $ 150,000    $ 434,002 
Total Payable to Officers / Affiliates$ 419,436 $ 268,194 $ 183,187 $ 870,817 $ 150,000 $ 19,214 $ 1,040,031 

In July of 2009, Microphase Corporation converted $200,000 of Accounts Payable owed by the Company into common stock valued at $.0075 per share (26,666,667 shares). Such price was determined based upon the price of private placements of equity by the Company during such period.

On October 7, 2009, the Company paid Messrs. Durando, Dotoli and Smiley $45,000, $45,000 and $25,000 respectively in reduction of amounts owed to them by the Company for unpaid compensation and bridge loans.

43


During the twelve months ended June 30, 2010, the Company incurred finders’ fees of $25,000 with Mr. Biderman’s affiliated firm of Palladium Capital Advisors. Mr. Biderman was employed until September 30, 2003, by our former investment banking firm, Lipper & Company. As of June 30, 2010, the Company owed Palladium Capital Advisors $25,000 in unpaid finders’ fees.

During the twelve months ended June 30, 2011, the Company incurred additional finders’ fees of $24,500 with Mr. Biderman’s firm Eagle Strategic Advisers.

During the twelve months ended June 30, 2007, Mr. Biderman, through his affiliated firm of Palladium Capital Advisors, earned finder's fees of $520,000 in connection with the raising of approximately $5 million in various equity transactions during the year.

In addition, atAt various points during past fiscal year ended June 30, 2007, Messrs. Durando, Dotoli and Smileyyears certain officers of the Company provided $650,000 in bridge loans to the Company which was evidenced by individual promissory notes. During December 2006, Messrs. Durandonotes and Dotoli agreed to convert their notes, in the amounts of $130,000 and $200,000 respectively, to a deferred compensation arrangement,so as to provide working capital to the repayment termsCompany. All of which have not been specified. Mr. Smiley has extended bridge loansthese notes accrue interest at the rate of 6% per annum, and are payable on demand. During the fiscal years ended June 30, 2019 and 2018, the officers advanced $144,557 and $77,326 to provide working capital to the Company of $160,000, evidenced byand $15,467 and $44,274 has been charged for interest on loans from officers.

At June 30, 2019 and 2018, these outstanding notes including accrued interest totaled $58,165 and $777,712, respectively. At June 30, 2019 and 2018, these promissory notes for $101,000 and a $60,000 note with a 12% rate of interest. In summary as of June 30, 2007, bridge loans outstanding were $85,000, $75,000 and $161,000 to the Messrs. Durando, Dotoli and Smiley, respectively. Allare convertible into shares of the foregoing promissory notes were payable on demand and only the $161,000 payable to Mr. Smiley remained outstanding in June 2008. As of June 30, 2010, only $110,030 payable to Mr. Smiley remained outstanding.

During the 12 month period ended June 30, 2006, Eagle Advisers, an investment banking firm founded by Mr. Biderman earned fees and reimbursement expenses of approximately $782,568 in connection with services in regard to private placements of the Company'sCompany common stock, and warrants and raised a total of $5,820,652 net of such fees for the Company.if available.

During the fiscal year ended June 30, 2006, Mr. Edward Suozzo, a consultant of the Company, converted $50,000 of accounts payable owed by the Company into 331,8642019, Messrs. Durando, Dotoli and Smiley received 800,000 shares of common stock, pluswhich were valued at $400,000, Mr. Biderman a 5 year warrant to purchase 277,778former outside Director received 200,000 shares of common stock, which were valued at $.18 per share. During fiscal year ended June 30, 2005, Mr. Suozzo converted $20,000 of accounts payable owed by the Company into 100,000$100,000 and strategic consultants received 150,000 shares of common stock, pluswhich were valued at $75,000. In the aggregate, this group received a 5 year warrant to purchase 100,000total of 1,150,000 shares of common stock, which was valued at $.25 per share.

During fiscal year ended$575,000 and included in accrued expenses at June 30, 2006, Microphase Corporation and Janifast Corp., both related parties, respectively converted $369,000 and $171,000 of accounts payable owed by the Company into 2,050,000 and 950,000 shares of common stock plus a 5 year warrant to purchase 2,050,000 and 950,000 shares of common stock at $.18 per share.2018.

Effective June 30, 2004, the Company was $473,787 in arrears with respect to a promissory note issued to Piper Rudnick LLP plus other legal fees of $118,773.36. It should be noted that Piper & Rudnick, the Company’s outside counsel, received such promissory note in March of 2002 plus two warrants that expired in March 8, 2007 in exchange for cancellation of certain payables. Such warrants had conversion rights into our common stock for a total of 2,233,490 shares that had been registered under a Form S-1 Registration Statement, and were cashless. On September 3, 2003, in exchange for reducing the total payable to $550,000, the Company paid $10,000 in cash to Piper and issued an additional cashless warrant for $150,000 worth of the Company's common stock valued at $.25 per share. The remaining $300,000 payable had the following future payment schedule: payments of $25,000 each on December 1, 2004, March 1, 2005, June 1, 2005, September 1, 2005, March 1, 2006, June 1, 2006 and September 1, 2006, a payment of $50,000 on December 1, 2005, and a payment of $75,000 due on December 1, 2006. On August 30, 2004, the Company paid $100,000 to Piper & Rudnick, LLP in connection with the renegotiation of a Payment Agreement effective June 30, 2004. Under the terms of the renegotiated Payment Agreement, the Company agreed to payments of $25,000 each on December 1, 2004, March 1, 2005, June 1, 2005 and September 1, 2005 and a payment of $50,000 on December 1, 2006 plus $25,000 payments on March 1, 2006, June 1, 2006, September 1, 2006 and a final payment of $75,000 payment on December 1, 2007. In addition, Piper & Rudnick LLP agreed to convert $150,000 of such payable into a 5 year cashless warrant to purchase the Company's common stock at $.25 per share. The Company has made all of the above payments except for $65,000 of the $75,000 due December 1, 2006, that is presently in arrears.

44


Necdet F. Ergul, Ronald A. Durando and Gustave T. Dotoli are executive officers and shareholders of Microphase and Ronald Durando and Gustave T. Dotoli served as president and vice- president of PacketPort.com., respectively until Packetport.com merged with Wyndstorm Corporation in February of 2008, at which time Mr. Durando and Mr. Dotoli resigned from their respective positions..

On November 26, 1999, PacketPort, Inc., a company owned 100% by Mr. Durando, acquired a controlling interest in Linkon Corp., which subsequently changed its name to PacketPort.com, Inc. In connection with this transaction, Mr. Durando transferred 350,000 shares of our common stock to PacketPort, Inc.

Transactions with Microphase Corporation

mPhase's President and Chairman of the Board of the Company are also employees of Microphase. On May 1, 1997, the Company entered into an agreement with Microphase whereby it would use office space as well as the administrative services of Microphase, including the use of accounting personnel. This agreement for fiscal year 2011 required mPhase to pay Microphase $3,000 per month. Microphase also charges fees for specific projects on a project-by-project basis. During the year ended June 30, 2011 and for the period of time from mPhase's inception (October 2, 1996) to June 30, 2011, $45,356 and $9,477,961, respectively, have been charged to expense or inventory under these Agreements and is included in “discontinued operations” in the accompanying consolidated statements of operations. Management believes that amounts charged to the Company by Microphase are commensurate with amounts that would be incurred if outside third parties were used. The Company is obligated to pay a 3% royalty to Microphase on revenues from its proprietary Traverser Digital Video and Data Delivery System and DSL component products.

Mr. Durando, President and CEO of mPhase, owns a controlling interest and is a director and President of Janifast Limited. Mr. Durando and Mr. Dotoli are officers of Microphase Corporation. Mr. Dotoli was also a shareholder of Janifast Limited prior to its discontinuing operations in March of 2009. Mr. Ergul owns a controlling interest and is a director of Microphase Corporation and is a director and shareholder of Janifast Limited. Microphase Corporation is a significant shareholder of the Company. Janifast Limited had been a significant shareholder of the Company until September 17, 2009, when it transferred to Mr. Durando 11,735,584 shares, representing all the shares of the Company held by Janifast, in partial consideration of the cancellation of loan obligations to Mr. Durando in connection with the plan of its liquidation.

Transactions with Janifast

Janifast Ltd., a Hong Kong corporation manufacturer, had produced components for our now discontinued Traverser_ DVDDS product. Necdet F. Ergul, Ronald A. Durando and Gustave T. Dotoli are controlling shareholders of Janifast Ltd. with an aggregate ownership interest of greater than 75% of Janifast Ltd. Mr. Durando is Chairman of the Board of Directors and Mr. Ergul is a Director of Janifast. Janifast Ltd. ceased operations in March, 2009, and the Company has had no transactions with Janifast during or since its fiscal year ended June 30, 2010.

Reparation Shares issued to related parties

During the fiscal year ended June 30, 2006,2019, the Company issued 3,931,3823,898,733 shares of common stock, with 329,553 shares to be issued, to a number of related parties and strategic consultants in connection with prior services provided to the Company. The shares issued were valued at $728,434 and 4,504,542 shares valued at $834,633 for reparation of investments of $200,000 for 1,000,000 shares and $250,000 for 1,250,000 shares made during$1,883,445. During the fiscal year ended June 30, 2005 by Janifast and Microphase, respectively, concurrently on the same terms reparations2018, there were no shares of common stock issued to other investors of the same private placements.related parties or strategic consultants.

During the fiscal year ended June 30, 2007, Janifast was issued 769,231 shares valued at $138,462 for reparation2019, the Company incurred $9,000 of an investment of $171,000 for 950,000 shares issued for an investment made inexpense related to legal and consulting services provided by Mr. Smiley, the Company’s former CFO and legal counsel.

During the fiscal year ended June 30, 2006, concurrently on2019, the same terms reparations wereCompany issued 2,620,899 (“Signing Shares”) shares of common stock to other investors of the same private placement.

Transactions with Other Related Parties

In March 2000, mPhase acquired a 50% interest in mPhaseTelevision.Net (formerly Telco Television Network, Inc.), an incorporated joint venture. This percentage was increased to approximately 57% in fiscal year 2001. Alpha Star International, Inc. currently owns the remaining joint venture interest. The joint venture has been inactive for a period of five years and is in the process of being dissolved.

45


Mr. Durando,its President and CEO, of mPhase, owned a controlling interest and was a director and President of Janifast Limited. Mr. Durando and Mr. Dotoli are officers of Microphase Corporation. Mr. Dotoli was also a shareholder of Janifast Limited prior to its discontinuing operations in March of 2009. Mr. Ergul owns a controlling interest and is a director of Microphase Corporation and is a director and shareholder of Janifast Limited.

Microphase Corporation is a significant shareholder of the Company. Janifast Limited had been a significant shareholder of the Company until September 17, 2009, when it transferred to Mr. Durando 11,735,584 shares, representing all the shares of the Company held by Janifast, in partial consideration of the cancellation of loan obligations to Mr. DurandoBhatnagar, in connection with the plancommencement of its liquidation.his employment with the Company. The grant date fair value of $1,310,449 is based upon the closing price of the Company’s common stock on January 11, 2019, and is included in stock-based compensation expense within the consolidated statement of operations.

Director Independence

On June 1, 2019, the Company granted 231,635 shares of common stock to Mr. Cutchens, the Company’s Chief Financial Officer. The common stock will vest 25% on the six month, 1 year, 2 year, and 3 year anniversaries of the grant date. The Company recorded $16,464 of stock-based compensation expense during the year ended June 30, 2019, related to this common stock grant. During the year ended June 30, 2018, the Company did not issue any common stock to employees or officers.

During the year ended June 30, 2019, the Company charged to expense and included in accrued expenses at June 30, 2019, $129,861 and $6,691 of compensation expense and related fringe costs for amounts due under the employment contract to Mr. Bhatnagar as our President and CEO, as well as $7,621 for facility use and support costs at our Maryland office, to Verus International, Inc. (ticker symbol “VRUS”) a publicly-held company, for which Mr. Bhatnagar is also the President and CEO.

Conversion Feature and Conversions of Debt to Officers’

The Company complies withamortized the standardsremaining $91,177 deferred charge balance to beneficial conversion feature interest expense for the year ended June 30, 2019. At June 30, 2019, there is no deferred charges for beneficial conversion feature interest expense remaining.

LEGAL MATTERS

Unless otherwise indicated, Mailander Law Office, Inc., San Diego, California, has passed upon the validity of "independence" prescribed by rules set forth by the National Association of Securities Dealers ("NASD"). Accordingly, a director will only qualify as an "independent director" if, in the opinionshares of our BoardCommon Stock to be sold in this offering.

EXPERTS

The financial statements of Directors, that person does notmPhase Technologies, Inc. for the year ended June 30, 2019 and June 30, 2018 have a material relationship with our company which would interfere withbeen included herein in reliance upon the exercisereports of Assurance Dimensions, independent judgmentregistered public accounting firm, upon the authority of said firm as experts in carrying out the responsibilities of a director. A director who is, or at any time during the past three years, was employed by the Company or by any parent or subsidiary of the Company, shall not be considered independent. Accordingly, Anthony Guerinoaccounting and Victor Lawrence meet the definition of "independent director" under Rule 4200(A)(15) of the NASD Manual; Abraham Biderman, Ronald A. Durando, Gustave T. Dotoli and Martin Smiley do not.

ADDITIONAL INFORMATIONauditing.

 Federal securities laws require us to file information with the Commission concerning our business and operations. Accordingly, we file annual, quarterly, and special reports, and other information with the Commission. You can inspect and copy this information at the public reference facility maintained by the Commission at 100 F Street, NE, Washington, D.C. 20549.

-40-

 You can get additional information about the operation of the Commission's public reference facilities by calling the Commission at 1-800-SEC-0330. The Commission also maintains a web site (http://www.sec.gov) at which you can read or download our reports and other information.

WHERE YOU CAN FIND MORE INFORMATION

 

We have filed with the CommissionSEC a registration statement on Form S-1 under the Securities Act of 1933 with respect to the Common Stock being offered hereby. As permitted by the rules and regulations of the Commission, this prospectus. This prospectus does not contain all of the information set forth in the registration statement of which this prospectus is a part and the exhibits and schedules thereto.to such registration statement. For further information with respect to mPhase and the Common Stock offered hereby, reference is madeby this prospectus, we refer you to the registration statement of which this prospectus is a part and the exhibits to such exhibitsregistration statement. Statements contained in this prospectus as to the contents of any contract or any other document are not necessarily complete, and schedules. Ain each instance, we refer you to the copy of the contract or other document incorporated by reference or filed as an exhibit to the registration statement of which this prospectus is a part. Each of these statements is qualified in all respects by this reference.

You may read and copy the exhibitsregistration statement of which this prospectus is a part, as well as our reports, proxy statements and schedules thereto, may be inspected without chargeother information, at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for more information about the operation of the Public Reference Room. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including mPhase Technologies, Inc. The SEC’s Internet site can be found at http://www.sec.gov. You may also request a copy of these filings, at no cost, by writing us at mPhase Technologies, Inc., 9841 Washingtonian Blvd., Suite 390, Gaithersburg, MD 20878 or telephoning us at (301) 329-2700.

We are subject to the information and reporting requirements of the Exchange Act, and, in accordance with this law, file periodic reports, proxy statements and other information with the SEC. These periodic reports, proxy statements and other information are available for inspection and copying at the SEC’s public reference facilities maintained byand the Commission at the addresses set forth above, and copies of all or any partwebsite of the registration statementSEC referred to above. We also maintain a website at www.mphasetech.com. You may be obtained from such offices upon paymentaccess these materials free of the fees prescribed by the Commission. In addition, the registration statement may be accessed at the Commission’s web site.

46


DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

          Our directors and officers are indemnified by our bylaws against amounts actually and necessarily incurred by them in connection with the defense of any action, suit or proceeding in whichcharge as soon as reasonably practicable after they are a party by reason of beingelectronically filed with, or having been directors or officers of the Company. Our certificate of incorporation provides that none of our directors or officers shall be personally liable for damages for breach of any fiduciary duty as a director or officer involving any act or omission of any such director or officer. Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended, may be permitted to such directors, officers and controlling persons pursuantfurnished to, the foregoing provisions, or otherwise, we have been advised that in the opinion of the Securities and Exchange Commission such indemnificationSEC. Information contained on our website is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

          In the event thatnot a claim for indemnification against such liabilities, other than the payment by us of expenses incurred or paid by such director, officer or controlling person in the successful defense of any action, suit or proceeding, is asserted by such director, officer or controlling person in connection with the securities being registered, we will, unless in the opinion of counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

LEGAL MATTERS

          The validity of the shares offered hereby will be passed upon for us by Martin Smiley, Esq., EVP, CFO and General Counsel of the Company.

EXPERTS

          The consolidated financial statements of mPhase Technologies, Inc. as of June 30, 2011 and June 30, 2010 have been audited by Demetrius & Company, L.L.C. and the financial statements for the fiscal year ended June 30, 2009, included in this registration statement on Form S-1, have been audited by Rosenberg, Rich, Baker & Berhman, independent auditors, as stated in their reports appearing with the financial statements. These financial statements are included in reliance upon the reports of each of Demetrius & Company, L.L.C. and Rosenberg, Rich Baker and Berhman given upon the authority of said firms as experts in accounting and auditing.

47


FINANCIAL STATEMENT SCHEDULES

(a)       The following documents are filed as part of this Form S-1 Consolidated Financial Statementsprospectus and the inclusion of our website address in this prospectus is an inactive textual reference only.

-41-

 

10,406,591 Shares of Common Stock

PROSPECTUS

August 14, 2020

mPHASE TECHNOLOGIES, INC.

FINANCIAL STATEMENTS

TABLE OF CONTENTS

 PAGEPage
Report of Demetrius & Company LLCIndependent Registered Public Accounting Firm49F-1
Report of Rosenberg Rich Baker Berman & Company50
Report of Arthur Andersen LLP51
Report of Schuhalter, Coughlin & Suozzo, PC52
Consolidated Balance Sheets as of June 30, 20112019 and 2010201853F-2
Consolidated Statements of Operations for the years endedYears Ended June 30, 20102019 and 2011 and for the period from inception (October 2, 1996) through June 30, 2011201854F-3
Consolidated Statements of Operations for the three months ended September 30, 2010 and 2011 and for the period from inception (October 2, 1996) through September 30, 2011(unaudited)55
Consolidated StatementsStatement of Changes in Stockholders'Stockholders’ (Deficit) Equity (Deficit) for the period from inception (October 2, 1996) toYears Ended June 30, 19972019 and for each of the fourteen years in the period ended June 30, 2011201856-65F-4
Consolidated Statements of Changes in Stockholders' Equity (Deficit) From July 1, 2011 to September 30, 2011 (unaudited)66
Consolidated Statements of Cash Flows for the years endedYears Ended June 30, 20102019 and 2011 and2018F-5
Notes to Consolidated Financial Statements for the period from inception (October 2, 1996) throughYears Ended June 30, 2011, as restated2019 and 201867F-6
Consolidated Balance Sheets as of March 31, 2020 (unaudited) and June 30, 2019 (audited)F-38
Consolidated Statements of Operations for the Nine Months Ended March 31, 2020 and 2019 (unaudited)F-39
Consolidated Statement of Changes in Stockholders’ Equity (Deficit) for the Nine Months Ended March 31, 2020 and 2019 (unaudited)F-40
Consolidated Statements of Cash Flows for the three months ended September 30, 2010Nine Months Ended March 31, 2020 and 2011 and for the period from inception (October 2, 1996) through September 30, 2011(unaudited)2019 (unaudited)68F-41
Notes to Consolidated Financial Statements for the Nine Months Ended March 31, 2020 and 2019 (unaudited)69F-43

(2)      Financial Statement Schedules
           None.

48


-43-

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Report of Independent Registered Public Accounting Firm

To Thethe Board of Directors

and
Shareholders Stockholders of mPhase Technologies, Inc.

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of mPhase Technologies, Inc.(a New Jersey corporation in the development stage) and its subsidiaries (the Company) as of June 30, 20102019 and 20112018, and the related consolidated statements of operations, changes in stockholders’ equity (deficit)deficit, and cash flows for each of the two years then ended. in the two-year period ended June 30, 2019, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2019 and 2018, and the results of its operations and its cash flows for each of the years in the two-year period ended June 30, 2019, in conformity with accounting principles generally accepted in the United States of America.

Explanatory Paragraph – Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has a history of net losses, has negative working capital at June 30, 2019, has incurred recurring negative cash flow from operating activities, and has an accumulated deficit which raises substantial doubt to continue as a going concern. Management’s plans concerning these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidatedthe Company’s financial statements based on our audit.audits. We did not auditare a public accounting firm registered with the financial statements of mPhase Technologies, Inc. forPublic Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the period from inception to June 30, 2009. Those statements were audited by other auditors whose reports have been furnished to usCompany in accordance with the U.S. federal securities laws and our opinion, insofar as it relates to amounts for the period from inception to June 30, 2009, included in the cumulative totals, is based solely upon the reportapplicable rules and regulations of the other auditors.Securities and Exchange Commission and the PCAOB.

We conducted our auditaudits in accordance with the standards of the Public Company Accounting Oversight Board (United States).PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included considerationAs part of our audits, we are required to obtain an understanding of internal control over financial reporting, as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence supportingregarding the amounts and disclosures in the financial statements. An auditOur audits also includes assessingincluded evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects,presentation of the financial position of mPhase Technologies, Inc.and subsidiaries as of June 30, 2010 and 2011 and the results of their operations and their cash flows for the two years then ended in conformity with accounting principles generally accepted in the United States of America.

The accompanying consolidated financial statements have been prepared assuming that mPhase Technologies, Inc.and subsidiaries will continue as a going concern. As shown in the financial statements, the Company has experienced significant losses and negative operating cash flows resulting in a working capital deficiency and shareholders’ deficit. These conditions raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are more fully described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Demetrius & Company, L.L.C.
Wayne, New Jersey
September 12, 2011

49


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and
Stockholders of mPhase Technologies, Inc.

We have audited the accompanying consolidated balance sheet of mPhase Technologies, Inc. (a New Jersey corporation and is in the development stage) and subsidiaries as of June 30, 2009, and the related consolidated statements of operations, changes in stockholders’ equity (deficit) and cash flows for the year then ended, for the period from July 1, 2001 to June 30, 2009. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We did not audit the financial statements of mPhase Technologies, Inc. for the period from inception to June 30, 2001. Those statements were audited by other auditors.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.statements. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, based on our audits, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of mPhase Technologies, Inc. and subsidiaries as of June 30, 2009, and the results of its operations and its cash flows for the year then ended and for the period from July 1, 2001 to June 30, 2009, in conformity with accounting principles generally accepted in the United States of America.

/s/ Assurance Dimensions
Certified Public Accountants
We have served as the Company’s auditor since 2016.
Coconut Creek, Florida
October 15, 2019

Rosenberg Rich Baker Berman & Company

Somerset, New Jersey

F-1

September 25, 2009, (April 20, 2010 as to “Other Equity” included in Note 8)mPHASE TECHNOLOGIES, INC.

50


REPORT OF INDEPENDENT PUBLIC ACCOUNTANTSCONSOLIDATED BALANCE SHEETS

To the Board of Directors and Stockholders of mPhase Technologies, Inc.:

  June 30, 2019  June 30, 2018 
Assets        
Current Assets        
Cash $33,996  $261 
Accounts receivable, net  2,526,155   - 
Prepaid expenses  8,820   - 
Total Current Assets  2,568,971   261 
Property and equipment, net  11,048   - 
Goodwill  6,020   - 
Intangible asset - purchased software, net  3,025,801   - 
Other assets  3,058   800 
Total Assets $5,614,898  $1,061 
         
Liabilities and Stockholders’ Equity (Deficit)        
Current Liabilities        
Accounts payable $366,274  $421,056 
Accrued expenses  3,368,801   1,273,569 
Due to related parties  65,459   226,045 
Notes payable to officers  25,251   777,912 
Convertible notes payable, net of discount  2,351   - 
Notes payable to director and investor  -   133,274 
Current portion, liabilities in arrears with convertible features  109,000   997,698 
Current portion, liabilities in arrears - judgement settlement agreement (Note 9)  855,660   - 
Derivative liability  133,669   - 
Liabilities of discontinued operations  82,795   163,976 
Total Current Liabilities  5,009,260   3,993,530 
         
Commitments and Contingencies (Note 15)        
         
Stockholders’ Equity (Deficit)        
Preferred stock, $0.01 par value; 1,000 shares authorized and 1,000 shares and no shares issued and outstanding at June 30, 2019 and June 30, 2018, respectively  10   - 
Common stock, $0.01 par value; 25,000,000 shares authorized and 11,689,078 and 3,372,103 shares issued and outstanding at June 30, 2019 and June 30, 2018, respectively  116,890   33,721 
Additional paid-in-capital  214,007,203   207,652,502 
Common stock to be issued  115,388   - 
Accumulated deficit  (213,633,853)  (211,678,692)
Total Stockholders’ Equity (Deficit)  605,638   (3,992,469)
Total Liabilities and Stockholders’ Equity (Deficit) $5,614,898  $1,061 

We have audited the accompanying consolidated balance sheets of mPhase Technologies, Inc. (a New Jersey corporation in the development stage) and subsidiaries as of June 30, 2001 and 2000, and the related consolidated statements of operations, changes in stockholders’ equity and cash flows for each of the three years in the period ended June 30, 2001 and for the period from inception (October 2, 1996) to June 30, 2001. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We did not audit the financial statements of mPhase Technologies, Inc. for the period from inception to June 30, 1998. Such amounts are included in the cumulative from inception to June 30, 2001 totals of the statements of operations, changes in stockholders’ equity and cash flows and reflect total net loss of 6 percent of the related cumulative totals. Those statements were audited by other auditors whose report has been furnished to us and our opinion, insofar as it relates to amounts for the period from inception to June 30, 1998, included in the cumulative totals, is based solely upon the report of the other auditors.

We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits and the report of other auditors provide a reasonable basis for our opinion.

In our opinion, based on our audits and the report of other auditors, the financial statements referred to above present fairly, in all material respects, the financial position of mPhase Technologies, Inc. and subsidiaries as of June 30, 2001 and 2000, and the results of their operations and their cash flows for each of the three years in the period ended June 30, 2001 and for the period from inception to June 30, 2001, in conformity with accounting principles generally accepted in the United States.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to thenotes are an integral part of these consolidated financial statements the Company has suffered recurring losses from operations and is in a working capital deficit position that raises substantial doubt about its ability to continue as a going concern. Management’s plans concerning these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty..

Arthur Andersen LLP
Stamford, Connecticut
October 12, 2001

PURSUANT TO SEC RELEASE NO. 33-8070 AND RULE 437A UNDER THE SECURITIES ACT OF 1933, AS AMENDED, mPHASE TECHNOLOGIES, INC. HAS NOT RECEIVED WRITTEN CONSENT AFTER REASONABLE EFFORT TO USE THIS REPORT. THIS REPORT IS A COPY OF A PREVIOUSLY ISSUED ARTHUR ANDERSEN LLP REPORT. THIS REPORT HAS NOT BEEN REISSUED BY ARTHUR ANDERSEN LLP. WITH RESPECT TO THIS INSTANT 10K/A, YOU WILL NOT BE ABLE TO RECOVER AGAINST ARTHUR ANDERSEN LLP UNDER SECTION 11 OF THE SECURITIES ACT FOR ANY UNTRUE STATEMENTS OF A MATERIAL FACT CONTAINED IN THE FINANCIAL STATEMENTS AUDITED BY ARTHUR ANDERSEN LLP OR ANY OMISSIONS TO STATE A MATERIAL FACT REQUIRED TO BE STATED THEREIN.

51


REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

To the Board of Directors and Stockholders of mPhase Technologies, Inc.:

We have audited the statements of operations, changes in stockholders’ equity, and cash flows for the period October 2, 1996 (date of inception) through June 30, 1998 of mPhase Technologies, Inc. (a development stage company). These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the financial statements based on our audit.

We conducted our audit in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, such financial statements present fairly, in all material respects, the results of its operations and its cash flows for the period of October 2, 1996 (date of inception) through June 30, 1998 in conformity with generally accepted accounting principles.

Schuhalter, Coughlin & Suozzo, PC
Raritan, New Jersey

January 28, 1999

52


mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Balance Sheets

  June 30,  June 30,  September 30, 
  2010  2011  2011 

 

       (unaudited) 

ASSETS

         

CURRENT ASSETS

         

Cash

$228,437 $1,744 $87,297 
Accounts Receivable 122,478       

Stock subscription receivable

 -  50,000  - 

Inventory

 98,807  102,532  101,302 

Prepaid and other current assets

 208,707  35,242  37,215 

Current Portion, Notes receivable- (Note 8 )

 2,700,000  -  - 

TOTAL CURRENT ASSETS

$3,358,429 $189,518 $225,814 

 

         

Property and equipment, net

 62,311  45,114  46,936 

Notes receivable, net of contra reserve for utilization of corresponding Convertible Debenture agreement with La Jolla of $600,000 at June 30, 2010 - (Note 8 )

 2,464,000  -  - 

TOTAL ASSETS

$5,884,740 $234,632 $272,750 

 

         

LIABILITIES AND STOCKHOLDERS' DEFICIT

         

CURRENT LIABILITIES

         

Accounts payable

$539,444 $735,145 $754,526 

Accrued expenses

 390,203  162,038  199,416 

Due to related parties

 169,214  177,242  181,433 

Notes payable, related parties

 870,817  875,724  924,846 

Short term notes

 65,000  65,000  65,000 

Accounts Payable and Accrued Expenses-Discontinued Activities

 1,112,872  868,376  868,376 

Current Portion, Long term debt

 10,352  11,486  11,816 

TOTAL CURRENT LIABILITIES

$3,157,902 $2,895,011 $3,005,413 

 

         

Long term portion Equipment loan

 27,703  16,315  13,234 

 

         

OTHER OBLIGATIONS CONVERTIBLE TO EQUITY- (Note 8 )

         

Convertible debt derivative liability

 5,966,149  1,664,575  953,218 

Convertible debentures, net of discount of $2,628,739, $300,000 and $258,598 on June 30, 2010 & 2011 and September 30, 2011, respectively

 4,577,710  1,250,505  1,350,701 

 

         

COMMITMENTS AND CONTINGENCIES -(Note 11)

         

 

         

STOCKHOLDERS' DEFICIT

         

Common stock, par value $.01, 2,000,000,000, 6,000,000,000 and 6,000,000,000 shares authorized, 1,163,751,952 , 1,628,502,264 and 2,710,250,740 shares issued and outstanding at June 30, 2010 & 2011 and September 30, 2011, respectively

 11,637,519  16,285,022  27,102,507 

Additional paid in capital

 174,683,294  172,775,132  169,004,373 

Deferred Compensation

 -  -  (325,546)

Deficit accumulated during development stage

 (194,157,564) (194,643,955) (200,823,177)

Less-Treasury stock, 13,750 shares at cost

 (7,973) (7,973) (7,973)

TOTAL STOCKHOLDERS' DEFICIT

 ($7,844,724) ($5,591,774) ($5,049,816)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

$5,884,740 $234,632 $272,750 

CONSOLIDATED STATEMENTS OF OPERATIONS

  For the Years Ended 
  June 30, 
  2019  2018 
Revenue $2,500,000  $- 
Cost of revenue  -   - 
Gross Profit  2,500,000   - 
General and administrative expenses  4,265,886   735,026 
Operating loss  (1,765,886)  (735,026)
Other Income (Expense):        
Interest expense  (210,594)  (246,162)
Loss on change in fair value of derivative liability  (30,508)  - 
Initial derivative expense  (25,161)  - 
Amortization of debt discount  (2,260)  - 
Amortization of deferred financing costs  (90)  - 
Gain on extinguishment of debt  60,398   1,107,922 
Total Other Income (Expense)  (208,215)  861,760 
(Loss) Income from continuing operations before income taxes  (1,974,101)  126,734 
Income taxes  -   - 
(Loss) Income from continuing operations  (1,974,101)  126,734 
Discontinued operations (Note 16)        
Income from discontinued operations  18,940   187,170 
Net (loss) income $(1,955,161) $313,904 
         
(Loss) Income per common share:        
(Loss) Income from continuing operations per common share - basic $(0.23) $0.04 
         
(Loss) Income from continuing operations per common share - diluted $(0.23) $0.04 
         
Income from discontinued operations per common share - basic $0.00  $0.06 
         
Income from discontinued operations per common share - diluted $0.00  $0.05 
         
(Loss) Income per common share - basic $(0.23) $0.09 
         
(Loss) Income per common share - diluted $(0.23) $0.09 
         
Weighted average shares outstanding – basic  8,505,508   3,336,811 
         
Weighted average shares outstanding – diluted  8,505,508   3,600,000 

The accompanying notes are an integral part of these consolidated financial statements.

53


F-3

mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Statements of Operations

        Date of 
  For the FYE June 30,  Inception to 
        June 30, 
  2010  2011  2011 
          

REVENUES

$ 354,157 $ 49,210 $ 743,639 

COSTS AND EXPENSES

         

Cost of Sales

 65,704  50,260  115,964 

 

         

Research and Development (including non-cash stock related charges of $0, $0 and $205,733 for FYE 2010 & 2011 and inception to date respectively)

 2,203,383  625,417  12,257,562 

 

         

General and Administrative (including non-cash stock related charges of $34,313, $62,945 and $12,754,354 for FYE 2010 & 2011 and inception to date respectively)

 1,844,776  1,823,178  27,230,052 

Depreciation and Amortization

 25,704  15,491  578,330 

 

         

TOTAL COSTS AND EXPENSES

 4,139,567  2,514,346  40,181,908 

OPERATING LOSS

$ (3,785,410)$ (2,465,136)$ (39,438,269)

OTHER INCOME (EXPENSE)

         

Interest (Expense)

 (786,805) (141,335) (2,627,585)

Net Reparation, Impairment and Other Income (Expense)

 168,409  8,915  (6,584,112)

Net Charges related to Convertible Debt

 (2,961,939) 1,866,669  (1,450,176)

TOTAL OTHER INCOME (EXPENSE)

 (3,580,335) 1,734,249 $ (10,661,873)

Loss From Continuing Operations, before Income Taxes

$ (7,365,745)$ (730,887)$ (50,100,142)

Income (Loss) From Discontinued Operations,

         

Net of Income Taxes of $0 in 2010 and 2011, offset by benefit from tax loss carry forwards of $0 in 2010 and 2011 (including non-cash stock related charges of $0, $0 and $57,515,718 for FYE 2010 & 2011 and inception to date respectively)

 -  244,496  (144,543,813)

Income Taxes

 -  -  - 

Net Loss

$ (7,365,745)$ (486,391)$ (194,643,955)

Net loss per share from:

         

Continuing Operations

$ (0.01)$ (0.00)   

Discontinued Operations

$ - $ -    

Weighted Average Number of Shares Outstanding;

         

Basic and Diluted

 1,041,685,519  1,402,130,735    

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY

FOR THE YEARS ENDED JUNE 30, 2019 AND 2018

  Preferred Stock  Common Stock  Additional  Common       
     $.01 Par     $.01 Par  Paid in  Stock to be  Accumulated  Stockholders’ 
  Shares  Value  Shares  Value  Capital  Issued  Deficit  Deficit 
Balance June 30, 2017  -  $            -   3,552,943  $35,529  $207,448,124  $                -  $(211,992,596) $    (4,508,943)
Issuance of Common Stock to accredited investors in private placements, net of $9,000 fees          360,000   3,600   77,400           81,000 
Beneficial Conversion Feature Interest Expense Charged to Additional Paid in Capital                  121,570           121,570 
Return to treasury of shares cancelled by significant shareholders          (540,840)  (5,408)  5,408           - 
Net Income                          313,904   313,904 
Balance June 30, 2018  -  $-   3,372,103  $33,721  $207,652,502  $-  $(211,678,692) $(3,992,469)
Reversal of accrued fees from private placements to accredited investors                  7,500           7,500 
Issuance of Common Stock to accredited investors in private placements          640,000   6,400   153,600           160,000 
Beneficial Conversion Feature Interest Expense Charged to Additional Paid in Capital                  91,177           91,177 
Issuance of Common Stock for accrued services          1,150,000   11,500   563,500           575,000 
Issuance of Common Stock for the conversion of Related Party debts and Strategic Vendor payables          3,898,733   38,987   1,762,070           1,801,057 
Issuance of Common Stock in connection with employment contract          2,620,899   26,209   1,284,240           1,310,449 
Warrants earned under employment contract                  2,492,697           2,492,697 
Issuance of Preferred Stock in connection with employment contract  1,000   10           (10)          - 
Common stock to be issued for the conversion of Related Party debts and Strategic Vendor payables                      115,388       115,388 
Issuance of Common Stock in connection with reverse split for fractional shares and adjustments          7,343   73   (73)          - 
Net Loss                          (1,955,161)  (1,955,161)
Balance June 30, 2019  1,000  $10   11,689,078  $116,890  $214,007,203  $115,388  $(213,633,853) $605,638 

The accompanying notes are an integral part of these consolidated financial statements.

54


F-4

mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Statements of Operations

 

 For the Three Months Ended  Date of 

 

       Inception to 

 

 September 30,  September 30,  September 30, 

 

 2010  2011  2011 

 

 (Unaudited)  (Unaudited)  (Unaudited) 

 

         

REVENUES

$ 28,808 $ 0 $ 743,639 

 

         

COSTS AND EXPENSES

         

 

         

Cost of Sales

 9,467  571  116,535 

 

         

Research and Development (including non-cash stock related charges of $0, $0 and $205,733 for the three months ended September 30, 2010 & 2011 and inception to date respectively)

 193,780  41,403  12,298,965 

 

         

General and Administrative (including non-cash stock related charges of $62,945, $6,520,500 and $19,274,854 for the three months ended September 30, 2010 & 2011 and inception to date respectively)

 522,994  6,888,462  34,118,514 

 

         

Depreciation and Amortization

 3,873  3,681  582,011 

 

         

TOTAL COSTS AND EXPENSES

 730,114  6,934,117  47,116,025 

 

         

OPERATING LOSS

$ (701,306)$ (6,934,117)$ (46,372,386)

 

         

OTHER INCOME (EXPENSE)

         

Interest (Expense)

 (29,940) (70,690) (2,698,275)

Net Reparation, Impairment and Other Income (Expense)

 0  1,131  (6,582,981)

Net Credits (Charges) related to Convertible Debt

 2,725,735  824,454  (625,722)

 

         

TOTAL OTHER INCOME (EXPENSE)

 2,695,795  754,895  (9,906,978)

 

         

Income (Loss) From Continuing Operations, before Income Taxes

$ 1,994,489 $ (6,179,222)$ (56,279,364)

 

         

Income (Loss) From Discontinued Operations,

         

    Net of Income Taxes of $0 in 2010 and 2011,
    offset by benefit from tax loss carryforwards of $0 in 2010 and 2011
    (including non-cash stock related charges of $0, $0 and $57,515,718 for the
    three months ended September 30, 2010 & 2011 and inception to date respectively)

 -  -  (144,543,813)

 

         

Income Taxes

 -  -  - 

 

         

Net Income (Loss)

$ 1,994,489 $ (6,179,222)$ (200,823,177)

 

         

Net loss per share from:

         

 Continuing Operations-Basic

$ 0.00 $ (0.00)   

 Discontinued Operations-Basic

$ - $ -    

 

         

 Continuing Operations-Diluted

$ 0.00  N/A    

 Discontinued Operations-Diluted

$ -  N/A    

 

         

Weighted Average Number of Shares Outstanding;

         

 Basic

 1,189,554,845  2,053,984,273    

 Diluted

 1,713,140,738  N/A    

CONSOLIDATED STATEMENTS OF CASH FLOWS

  For the Years Ended 
  June 30, 
  2019  2018 
Cash flows from operating activities:        
Net (loss) income $(1,955,161) $313,904 
Adjustments to reconcile net (loss) income to net cash from operating activities:        
Depreciation and amortization  -   683 
Gain on extinguishment of debt  (60,398)  (1,107,922)
Amortization of deferred financing costs  90   - 
Amortization of debt discount  2,260   - 
Initial derivative expense  25,161   - 
Loss on change in fair value of derivative liability  30,508   - 
Amortization of deferred compensation and beneficial conversion interest expense  91,177   121,570 
Stock-based compensation  3,819,610   - 
Changes in operating assets and liabilities:        
Increase in prepaid expenses  (1,332)  - 
Increase in other assets  (2,258)  - 
Increase in accounts receivable  (2,500,000)  - 
Increase in accounts payable and accrued expenses  346,373   755,048 
Net cash (used in) provided by operating activities of continuing operations  (203,970)  83,283 
Net cash used in operating activities of discontinued operations  -   (256,511)
Net cash used in operating activities  (203,970)  (173,228)
         
Cash flows from investing activities:        
Payments toward Travel Buddhi purchased software intangible  (55,000)  - 
Capitalized software development costs  (4,852)  - 
Net cash used in investing activities of continuing operations  (59,852)  - 
         
Cash flows from financing activities:        
Proceeds from issuance of convertible notes payable, net  53,000   - 
Proceeds from notes payable to related parties  144,557   78,404 
Proceeds from issuance of common stock, net of finder’s fees  193,000   81,000 
Due to related party - Eagle  -   9,000 
Proceeds of demand note - Investor  -   2,000 
Repayments under settlement agreement  (93,000)  - 
Repayments of notes payable to related parties  -   (1,078)
Net cash provided by financing activities of continuing operations  297,557   169,326 
Net cash used by financing activities of discontinued operations  -   - 
Net cash provided by financing activities  297,557   169,326 
         
Net increase (decrease) in cash  33,735   (3,902)
Cash at beginning of period  261   4,163 
         
Cash at end of period $33,996  $261 
         
Supplemental disclosure:        
Cash paid for interest $-  $9,684 
         
Supplemental disclosure of non-cash investing and financing activities:        
         
Reversal of accrued fees from private placements to accredited investors $7,500  $- 
         
Acquisition of Travel Buddhi purchased software intangible under promissory note payable, net of payments $60,281  $- 
         
Acquisition of Alpha Predictions under promissory note payable $1,438  $- 
         
Issuance of Common Stock for accrued services        
Value $575,000  $- 
Shares  1,150,000   - 
         
Issuance of Common Stock for the conversion of Related Party debts and Strategic Vendor payables        
Value $1,801,057  $- 
Shares  3,898,733   - 

The accompanying notes are an integral part of these consolidated financial statements.

55


F-5

mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
CONSOLIDATED STATEMENTS OF CHANGES IN
STOCKHOLDERS’ EQUITY (DEFICIT)
FOR THE PERIOD FROM INCEPTION (OCTOBER 2, 1996)
TO JUNE 30, 1997 AND FOR EACH OF THE FOURTEEN YEARS
IN THE PERIOD ENDED JUNE 30, 2011

  Common       
  Stock     Additional 
     Par Value  Treasury  Paid-In 
  Shares  0.01  Stock  Capital 

Balance, October 2, 1996(date of inception).

 1,140,427 $ 11,404    $ 459,753 

Issuance of common stock of Tecma Laboratories, Inc., for 100% of the Company.

 6,600,000  66,000    (537,157)

Issuance of common stock, in private placement, net of offering costs of $138,931

 594,270  5,943    752,531 

Net loss

            

Balance, June 30, 1997

 8,334,697 $ 83,347    $ 675,127 

Issuance of common stock with warrants, in private placement, net of offering costs of $84,065

 999,502  9,995    791,874 

Issuance of common stock for services

 300,000  3,000     147,000 

Issuance of common stock in connection with investment in unconsolidated subsidiary

 250,000  2,500    122,500 

Repurchase of 13,750 shares of common stock

       (7,973)   

Issuance of common stock with warrants in private placement, net of offering costs of $121,138

 1,095,512  10,955    659,191 

Issuance of common stock for financing services

 100,000  1,000     (1,000)

Issuance of common stock in consideration for 100% of the common stock of Microphase Telecommunications, Inc.

 2,500,000  25,000    1,685,000 

Net loss

            

Balance, June 30, 1998

 13,579,711 $ 135,797 $ (7,973)$ 4,079,692 

The accompanying notes are an integral part of these Consolidated Financial Statements.

56


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
CONSOLIDATED STATEMENTS OF CHANGES IN
STOCKHOLDERS' EQUITY (DEFICIT)
FOR THE PERIOD FROM INCEPTION (OCTOBER 2, 1996)
TO JUNE 30, 1997 AND FOR EACH OF THE FOURTEEN YEARS
IN THE PERIOD ENDED JUNE 30, 2011

                    Total 
           Additional        Stockholders 
  Common  Par  Treasury  Paid-In  Deferred  Accumulated  Equity 
     Value                
  Stock  0.01  Stock  Capital  Compensation  Deficit  (Deficit) 
  Shares                   

Balance, June 30, 1998

 13,579,711 $ 135,797 $ (7,973)$4,079,692 $ 0 $ (5,122,305)$(914,789)

Issuance of common stock with warrants in private placements, net of offering

 3,120,000  31,200    2,981,800      3,013,000 

Issuance of common stock for services

 1,599,332  15,993    8,744,873      8,760,866 

Issuance of common stock with warrants in private placement, net of offering

 642,000  6,420    1,553,227      1,559,647 

Issuance of common stock in private placement, net of offering costs of $679,311

 4,426,698  44,267    10,343,167      10,387,434 

Issuance of stock options for services

       7,129,890      7,129,890 

Issuance of warrants for services

          16,302        16,302 

Deferred employee stock option compensation

         (140,000)   (140,000)

Net loss

                (22,838,344) (22,838,344)

Balance, June 30, 1999

 23,367,741 $ 233,677 $(7,973)$ 34,848,951   $ (140,000)$(27,960,649)$6,974,006 

Issuance of common stock and options in settlement

 75,000  750    971,711      972,461 

Issuance of common stock upon exercise of warrants and options

 4,632,084  46,321    5,406,938      5,453,259 

Issuance of common stock in private placement, net of cash offering costs of $200,000

 1,000,000  10,000    3,790,000      3,800,000 

Issuance of common stock in private placement, net of cash offering costs of $466,480

 1,165,500  11,655    9,654,951      9,666,606 

Issuance of common stock for services

 1,164,215  11,642    8,612,265      8,623,907 

Issuance of options for services

          9,448,100        9,448,100 

Deferred employee stock option compensation

       1,637,375  (1,637,375)    

Amortization of deferred employee stock option compensation

         551,707    551,707 

Net loss

                (38,161,542) (38,161,542)

Balance, June 30, 2000

 31,404,540 $ 314,045  (7,973)$ 74,370,291   $ (1,225,668)$  (66,122,191)$7,328,504 

The accompanying notes are an integral part of these Consolidated Financial Statements.

57


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
CONSOLIDATED STATEMENTS OF CHANGES IN
STOCKHOLDERS' EQUITY (DEFICIT)
FOR THE PERIOD FROM INCEPTION (OCTOBER 2, 1996)
TO JUNE 30, 1997 AND FOR EACH OF THE FOURTEEN YEARS
IN THE PERIOD ENDED JUNE 30, 2011

                    Total 
  Common        Additional        Stockholders 
  Stock  ParValue  Treasury  Paid-In  Deferred  Accumulated  Equity 
  Shares  0.01  Stock  Capital  Compensation  Deficit  (Deficit) 

Balance, June 30, 2000

 31,404,540 $ 314,045 $ (7,973)$74,370,291 $(1,225,668)$ (66,122,191)$7,328,504 

 

                     

Issuance of common stock upon exercise of options

 320,000  3,200    324,300      327,500 

Issuance of common stock with warrants in private placements, net of cash offering costs of $512,195

 4,329,850  43,298    7,766,547      7,809,845 

Issuance of common stock for services

 450,000  4,500    1,003,125      1,007,625 

Issuance of options and warrants for services

       5,849,585      5,849,585 

Deferred employee stock option compensation

       607,885  (607,885)    

Amortization of deferred employee stock option compensation

         1,120,278    1,120,278 

Issuance of common stock in settlement of debt to directors and related parties

 4,840,077  48,402    2,371,637      2,420,039 

Net Loss

                (23,998,734) (23,998,734)

 

                     

Balance June 30, 2001

 41,344,467 $ 413,445 $ (7,973)$92,293,370 $(713,275)$ (90,120,925)$1,864,642 

 

                     

Issuance of Common stock with warrants in private placement

 6,980,643  69,807    1,903,943      1,973,750 

Issuance of Common stock for services

 2,976,068  29,760    1,169,241      1,199,001 

Issuance of options and warrants for services

       1,877,937      1,877,937 

Cancellation of unearned options to former employees

       (140,802) 140,802     

Amortization of deferred employee stock option compensation

         548,550    548,550 

Issuance of common stock and warrants in settlement of debt to related parties and strategic vendors

 7,492,996  74,930    2,663,728      2,738,658 

Sale of Common stock to certain Officers and Directors in private placement

 2,000,000  20,000    980,000      1,000,000 

Issuance of Common stock upon exercise of options

 13,334  133    3,867  4,000     

Net Loss

                (11,249,387) (11,249,387)

Balance, June 30, 2002

 60,807,508 $ 608,075 $ (7,973)$ 100,751,284   $ (23,923)$ (101,370,312)$(42,849)

The accompanying notes are an integral part of these Consolidated Financial Statements.

58


mPHASE TECHNOLOGIES, INC.
CONSOLIDATED STATEMENT OF CHANGES IN
SHAREHOLDERS' EQUITY (DEFICIT)
FOR THE PERIOD FROM INCEPTION (OCTOBER 2, 1996)
TO JUNE 30, 1997 AND FOR EACH OF THE FOURTEEN YEARS
IN THE PERIOD ENDED JUNE 30, 2011

                    Total 
  Common  Par     Additional        Stockholders 
  Stock  Value  Treasury  Paid-In  Deferred  Accumulated  Equity 

 

 Shares  0.01  Stock  Capital  Compensation  Deficit  (Deficit) 

Balance, June 30, 2002

 60,807,508 $ 608,075 $ (7,973)$ 100,751,284 $(23,923)$ (101,370,312) $(42,849)

Issuance of Common stock with warrants in private placement, net of Cash offering costs of $124,687

 4,296,680  42,967    1,121,351      1,164,318 

Issuance of Common stock for services

 426,000  4,260    107,985      112,245 

Issuance of options and warrants for services

       274,100      274,100 

Amortization of deferred employee stock option compensations

         23,923    23,923 

Issuance of common stock and warrants in settlement of debt to related parties and strategic vendors

 5,923,333  59,233    1,826,329      1,885,562 

Net Loss

                (6,646,185) (6,646,185)

Balance, June 30, 2003

 71,453,521 $ 714,535 $ (7,973)$ 104,081,049 $0 $ (108,016,497 $(3,228,886)

Issuance of common stock with warrants in private placement, net of cash offering costs of $313,200

 15,177,973  151,779    4,322,934      4,474,713 

Issuance of common stock for services

 924,667  9,247    238,153      247,400 

Issuance of options and warrants for services

       1,067,393      1,067,393 

Issuance of common stock pursuant to exercise of warrants

 1,233,334  12,333    304,467      316,800 

Issuance of common stock and warrants in settlement of debt to related parties and strategic vendors

 110,467  1,105    1,962,099      1,963,204 

Net Loss

                (7,758,586) (7,758,586)

Balance, June 30, 2004

 88,899,962 $ 888,999 $ (7,973)$ 111,976,095 $0 $ (115,775,083)$(2,917,962)

The accompanying notes are an integral part of these Consolidated Financial Statements.

59


mPHASE TECHNOLOGIES, INC. CONSOLIDATED STATEMENT
OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)
FOR THE PERIOD FROM INCEPTION (OCTOBER 2, 1996)
TO JUNE 30, 1997 AND FOR EACH OF THE FOURTEEN YEARS IN THE PERIOD ENDED JUNE 30, 2011

           Additional     Total 
  Common  Par Value  Treasury  Paid-In  Accumulated  Stockholders 
  Stock  0.01  Stock  Capital  Deficit  Equity 
  Shares              (Deficit) 

Balance, June 30, 2004

 88,899,962 $ 888,999 $ (7,973)$ 111,976,095 $ (115,775,083)$ (2,917,962)

Issuance of Shares in Private Placement

 39,853,661  398,535    6,888,553    7,287,088 

Issuance of in connection with exercise of warrants

 3,637,954  36,380    644,229    680,609 

Conversion of Debt to Common stock and warrants

 3,895,171  38,952    1,174,134    1,213,086 

Options Awarded to Consultants

          2,191,043     2,191,043 

Options Awarded to Officers

          625,290     625,290 

Issuance of shares to Officers and consultants for services

 1,151,000  11,510    322,500    334,010 

Exercise of cashless warrants

 4,949,684  49,499     (49,499)      

Exercise of warrants by officers

 1,770,400  17,704           17,704 

Reparation of Private Placement Offering

 891,000  8,910    176,811    185,721 

Net Loss

             (11,234,324) (11,234,324)

Balance June 30, 2005

 145,048,832 $ 1,450,489 $ (7,973)$ 123.949,156 $ (127,009,407)$ (1,617,735)

Issuance of common stock pursuant to the exercise of warrants, net of cash expenses of $108,000

 15,720,120  157,201    2,850,523    3,007,724 

Issuance of common stock with warrants in private placements, net of cash expenses of $674,567

 72,786,897  727,868     9,329,781     10,057,649 

Issuance of common stock for services

 11,500,000  115,000    2,324,000    2,439,000 

Conversion of related party and strategic vendor debts to common stock and warrants

 3,331,864  33,319    556,681    590,000 

Stock options awarded to consultants, employees and officers

       3,837,423    3,837,423 

Issuance of additional shares and warrants to effect revised pricing on previous private offering charged to expense

 29,848,271  298,483    5,232,021    5,530,504 

Net loss

             (24,450,650) (24,450,650)

Balance, June 30, 2006

 278,235,984 $ 2,782,360 $ (7,973)$ 148,079,585 $ (151,460,057)$ (606,085)

The accompanying notes are an integral part of these Consolidated Financial Statements.

60


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
CONSOLIDATED STATEMENTS OF CHANGES IN
STOCKHOLDERS' EQUITY (DEFICIT)
FOR THE PERIOD FROM INCEPTION (OCTOBER 2, 1996)
TO JUNE 30, 1997 AND FOR EACH OF THE FOURTEEN YEARS
IN THE PERIOD ENDED JUNE 30, 2011

                    Total 
           Additional        Shareholders 
    $ .01 Stated  Treasury  Paid in  Deferred  Accumulated  (Deficit) 
  Shares  Value  Stock  Capital  Compensation  Deficit  Equity 

Balance June 30, 2006

 278,235,984 $ 2,782,360 $ (7,973)$148,079,585   $ (151,460,057$(606,085)

Issuance of common stock pursuant to the exercise of warrants (net of cash expenses of $150,000)

 14,740,669 $ 147,406 $  $1,922,261     $2,069,667 

Issuance of common stock in private placements, (net of cash expenses of $216,134)

 47,958,060 $ 479,581 $  $5,711,788     $6,191,369 

Issuance of common stock for services

 18,172,983 $ 181,730 $  $ 2,486,885 $(627,250)  $2,041,365 

Conversion of related party and strategic vendor debt to common stock

 6,073,728 $ 60,737 $  $930,972     $991,709 

Issuance of additional shares and warrants to effect repricing

 22,664,580 $ 226,646 $  $1,647,374     $1,874,020 

Stock options awarded to employees and officers

    $  $1,321,853     $1,321,853 

Deferred stock compensation

            213,166   $213,166 

Net Loss

              $(16,851,562)$(16,851,562)

Balance June 30, 2007

 387,846,004 $ 3,878,460 $ (7,973)$162,100,718 $(414,084)$ (168,311,619)$(2,754,498)

61


mPHASE TECHNOLOGIES, INC. CONSOLIDATED STATEMENT
OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)
FOR THE PERIOD FROM INCEPTION (OCTOBER 2, 1996)
TO JUNE 30, 1997 AND FOR EACH OF THE FOURTEEN YEARS IN THE PERIOD ENDED JUNE 30, 2011

           Additional        Total 
           Paid        Shareholder 
     $.01 Par  Treasury  in  Deferred  Accumulated  (Deficit) 

 

 Shares  Value  Stock  Capital  Compensation  Deficit  Equity 

Balance June 30, 2007

 387,846,004 $ 3,878,460 $ (7,973)$162,100,718 $(414,084)$(168,311,619)$(2,754,498)

Issuance of common stock in private placements net of $116,253 offering cost

 24,600,000 $ 246,000   $898,247   $   1,144,247 

Exercise of Warrants net of Offering Cost $72,222

 11,111,113 $ 111,111   $538,889   $   650,000 

Contingent liability recorded on warrant exercise above

 1,019,200 $ 10,192    (1,006,200)     (1,006,200)

Common shares in settlement of accrued expenses

      $89,808   $   100,000 

Issuance of additional shares effect repricing

 4,663,741 $ 46,637   $345,401   $   392,038 

Stock options/ warrants awarded to employees and investors

      $85,682   $   85,682 

Stock based compensation

 1,000,000  10,000   $90,192    $   100,192 

Amortization of deferred stock compensation

         414,084 $   414,084 

Investment in Granita

        $514,000    $   514,000 

Conversion of debt

 4,904,942 $ 49,050   $192,073    $   241,123 

Cost related to convertible debt financing

 5,250,000 $ 52,500   $212,500   $   265,000 

Net Loss

               $ (3,383,821)$(3,383,821)

Balance June 30, 2008

 440,395,000 $ 4,403,950 $(7,973)$164,061,310    0 $ (171,695,440)$(3,238,153)

The accompanying notes are an integral part of these Consolidated Financial Statements.

62


mPHASE TECHNOLOGIES, INC. CONSOLIDATED STATEMENT OF CHANGES IN
SHAREHOLDERS' EQUITY (DEFICIT)
FOR THE PERIOD FROM INCEPTION (OCTOBER 2, 1996)
TO JUNE 30, 1997 AND FOR EACH OF THE FOURTEEN YEARS IN THE PERIOD ENDED JUNE 30, 2011

                 Total 
           Additional     Shareholders 
     $01 Par  Treasury  Paid in  Accumulated  (Deficit) 
  Shares  Value  Stock  Capital  Deficit  Equity 

Balance June 30, 2008

 440,395,000 $ 4,403,950 $ (7,973)$ 164,061,310 $ (171,695,440)$ (3,238,153)

Issuance of common stock in private placements net of offering cost ($80,000)

 72,333,333 $ 723,333   $ (3,333)  $ 720,000 

Issuance of additional shares effect repricing

 19,522,000 $ 195,220   $ 236,952   $ 432,172 

Stock options/ warrants awarded to employees and investors

      $ 4,071,348   $ 4,071,348 

Stock based compensation

 61,750,000 $ 617,500    $ 2,908,115    $ 3,525,615 

Vendor settlements

 (1,926,470) ($19,265)   $ 19,265    $ 0 

Beneficial Conversion feature of Notes Payable, including $914,060 on Officers' Notes Payable

      $ 1,028,560   $ 1,028,560 

Forgiveness of related party debt

         $ 19,336    $ 19,336 

Conversion of debt securities and interest

 278,346,019 $ 2,783,459   $ 519,874   $ 3,303,333 

Net Loss

            $ (15,096,379)$ (15,096,379)

Balance June 30, 2009

 870,419,882 $ 8,704,197 $ (7,973)$ 172,861,427 $ (186,791,817)$ (5,234,168)

The accompanying notes are an integral part of these consolidated financial statements.

63


mPHASE TECHNOLOGIES, INC.
CONSOLIDATED STATEMENT OF CHANGES IN
SHAREHOLDERS' EQUITY (DEFECIT)
FOR THE PERIOD FROM INCEPTION (OCTOBER 2, 1996)
TO JUNE 30, 1997 AND EACH OF THE FOURTEEN YEARS IN THE PERIOD ENDED JUNE 30, 2011

  Common Stock     Additional       Total 
    $.01 Par  Treasury  Paid in  Accumulated  Shareholders 

 

 Shares  Value  Stock  Capital  Deficit  (Deficit) 

Balance June 30, 2009

 870,419,882 $ 8,704,197 $ (7,973)$ 172,861,427 $ (186,791,819)$ (5,234,168)

Conversions of Convertible

                  

Debentures plus accrued interest

 232,723,736  2,327,238  -  1,088,012  -  3,415,250 

Conversions of Accounts Payable

 26,666,667  266,667  -  (66,667  -  200,000 

Issuance of common stock in private placements net of offering cost ($25,000)

 30,666,667  306,667  -  (81,667  -  225,000 

Issuance of Common Stock for Services

 1,575,000  15,750    18,563    34,313 

Issuance of Common Stock for Reparations

 1,700,000  17,000    18,530    35,530 

Beneficial Conversion feature of Officers' Notes Payable and conversion of accounts payable

 -  -  -  669,276  -  669,276 

Cancellation of Capital Notes in Subsidiary issued in connection with equity

       175,820    175,820 

Net Loss for the Year Ended June 30, 2010

 -  -  -  -  (7,365,745  (7,365,745)

Balance June 30, 2010

 1,163,751,952 $ 11,637,519 $ (7,973)$ 174,683,294 $ (194,157,564)$ (7,844,724)

The accompanying notes are an integral part of these consolidated financial statements.

64


mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENT OF CHANGES IN
SHAREHOLDERS' EQUITY (DEFICIT)
FOR THE PERIOD FROM INCEPTION (OCTOBER 2, 1996)
TO JUNE 30, 1997 AND EACH OF THE FOURTEEN YEARS IN THE PERIOD ENDED JUNE 30, 2011

  Common Stock             
           Additional     Shareholders' 
     $ .01 Par  Treasury  Paid in  Accumulated  (Deficit) 
  Shares  Value  Stock  Capital  Deficit  Equity 

 

                  

Balance July 1, 2010

 1,163,751,952 $ 11,637,519 $ (7,973)$174,683,294 $ (194,157,564)$(7,844,724)

 

                  

Conversions of Convertible Debentures plus accrued interest

 382,175,312  3,821,753    (1,474,857)   2,346,896 

 

                  

Issuance of Common Stock for Services

 15,075,000  150,750    (23,805)   126,945 

 

                  

Issuance of Common Stock to accredited investors in private placement, net of $29,500 fees

 67,500,000  675,000    (409,500)   265,500 

 

                  

Net Loss for the Year Ended June 30, 2011

         (486,391) (486,391)

 

                  

Balance June 30, 2011

 1,628,502,264  16,285,022  (7,973) 172,775,132 $ (194,643,955) (5,591,774)

The accompanying notes are an integral part of these consolidated financial statements.

65


mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENT OF CHANGES IN
SHAREHOLDERS' EQUITY (DEFICIT)
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2011
(Unaudited)

  Common Stock                
                    Shareholders' 
     $.01 Par  Treasury  Additional Paid in    Deferred  Accumulated  (Deficit) 
  Shares  Value  Stock  Capital  Compensation  Deficit  Equity 

Balance June 30, 2011

 1,628,502,264 $ 16,285,022 $ (7,973)$ 172,775,132 $ - $ (194,643,955)$ (5,591,774)

 

                     

Conversions of Convertible Debentures plus accrued interest

 26,748,476  267,485  -  (155,279) -  -  112,206 

 

                     

Issuance of Common Stock for Services

 1,035,000,000  10,350,000  -  (3,829,500) -  -  6,520,500 

 

                     

Deferred stock compensation

 -  -  -  339,700  (339,700) -  - 

Beneficial Conversion feature of Notes Payable, including $2,320 on Officers' Notes Payable

       2,320      2,320 

Issuance of Common Stock to accredited investors in private placement, net of $8,000 fees

 20,000,000  200,000  -  (128,000)   -  72,000 

 

                     

Amortization of deferred stock compensation

 -  -  -  -  14,154  -  14,154 

 

                     

Net Loss for the Three Months Ended September 30, 2011

 -  -  -  -  -  (6,179,222) (6,179,222)

Balance September 30, 2011

 2,710,250,740 $ 27,102,507 $ (7,973)$ 169,004,373 $ (325,546)$ (200,823,177)$ (5,049,816)

The accompanying notes are an integral part of these consolidated financial statements.

66


mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Statements of Cash Flows

        2-Oct-96 
  Fiscal Year Ended  (Date of 

 

       Inception) 

 

 June 30,  June 30,  To June 30, 

 

 2010  2011  2011 

Cash Flow From Operating Activities:

         

Net Income (Loss) From Continuing Operations

 ($7,365,745) ($730,887) ($50,100,142)

Net Income (Loss) From Discontinued Operations

$ 0 $ 244,496  ($144,543,813)

Adjustments to reconcile net loss to net cash used in operating activities:

         

Depreciation and amortization

 37,356  23,130  7,460,786 

(Gain) loss on debt extinguishments

 (147,238) (257,911) (1,342,519)

Non-cash charges relating to issuance of common stock, common stock options and warrants

 34,313  126,945  70,378,689 

Reparation charges

 35,530  -  8,264,264 

Derivative Value and Debt Discount charges

 2,961,939  (1,883,669) 2,083,327 

Write off of Granita Inventory/ Sovereign Investment

    -  615,910 

Other non cash charges including amortization of deferred compensation and beneficial conversion interest expense

 669,276  -  2,712,901 

Changes in assets and liabilities:

         

Accounts receivable

 (76,413) 122,478  427,876 

Inventories

 (98,807) (3,725) (613,003)

Prepaid expenses and Other current assets

 (55,071) 173,465  45,819 

Other

       906,535 

Accounts payable, Accrued expenses, Deferred revenue

 256,441  412,144  8,978,468 

Due to/from related parties

         

Microphase / Janifast//Lintel

 (17,114) 8,028  5,500,801 

Officers and Other

 -  -  1,711,357 

Net cash used in operating activities

 ($3,765,533) ($1,765,506) ($87,512,744)

Cash Flow from Investing Activities:

         

Payments related to patents and licensing rights

 -  -  (450,780)

Purchase of fixed assets

 (15,000) (5,933) (3,308,493)

Investment in Sovereign

 -  -  (110,000)

Net Cash (used) in investing activities

 ($15,000) ($5,933) (3,869,273)

Cash Flow from Financing Activities:

         

Proceeds from issuance of common stock, exercises of warrants, net of finder’s fees

 225,000  215,500  83,139,379 

Payment of short term notes & equipment loans

 (6,993) (10,254) (1,298,799)

Advances from Microphase

 -  -  347,840 

Issuance of Convertible Debentures

 500,000  -  766,500 

Net Proceeds (Repayment) from notes payable related parties

 (595,175) (64,000) (424,659)

Proceeds from the collection of Notes Receivable under securities purchase agreements

 3,786,000  1,403,500  8,339,500 

Sale of minority interest in Granita subsidiary

 -  -  514,000 

Net cash provided by financing activities

 3,908,832  1,544,746  91,383,761 

 

         

Net increase (decrease) in cash

$ 128,299  ($226,693)$ 1,744 

CASH AND CASH EQUIVALENTS, beginning of period

$ 100,138 $ 228,437 $ 0 

CASH AND CASH EQUIVALENTS, end of period

$ 228,437 $ 1,744  1,744 

The accompanying notes are an integral part of these consolidated financial statements.

67


mPHASE TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Statements of Cash Flows
(Unaudited)

        2-Oct-96 
  Three Months Ended  (Date of Inception) 
  September 30,  September 30,  To September 30, 
  2010  2011  2011 

Cash Flow From Operating Activities:

         

Net Income (Loss) From Continuing Operations

$1,994,489  ($6,179,222) ($56,279,364)

Net Income (Loss) From Disontinued Operations

$0 $0  ($144,543,813)

Adjustments to reconcile net loss to net cash used in operating activities:

      

Depreciation and amortization

 6,786  4,176 $7,220,466 

(Gain) loss on debt extinguishments

 -  -  ($1,098,023)

Non-cash charges relating to issuance of common stock, common stock options and warrants

 62,945  6,520,500 $76,899,189 

Reparation charges

 -  - $8,264,264 

Derivative Value and Debt Discount charges

 (2,725,735) (824,454)$1,258,873 

Write off of Granita Inventory/ Sovereign Investment

 -  - $615,910 

Other non cash charges including amortization of deferred compensation and beneficial conversion interest expense

 -  17,845 $2,730,746 

Changes in assets and liabilities:

         

Accounts receivable

 33,253  - $427,876 

Inventories

 (46,654) 1,230  ($611,773)

Prepaid expenses and Other current assets

 (39,757) (1,214)$44,605 

Other

 -  - $906,535 

Accounts payable, Accrued expenses, Deferred revenue

 259,641  84,381 $9,062,849 

Due to/from related parties

         

Microphase / Janifast//Lintel

 (1,972) 4,191 $5,504,992 

Officers and Other

 -  - $1,711,357 

Net cash used in operating activities

 ($457,004) ($372,567) ($87,885,311)

Cash Flow from Investing Activities:

         

Payments related to patents and licensing rights

 -  -  ($450,780)

Purchase of fixed assets

 (5,933) (7,129) ($3,315,622)

Investment in Sovereign

 -  -  ($110,000)

Net Cash (used) in investing activities

 ($5,933) ($7,129) ($3,876,402)

Cash Flow from Financing Activities:

         

Proceeds from issuance of common stock, exercises of warrants, net of finders fees

 -  122,000 $83,261,379 

Payment of short term notes & equipment loans

 (2,456) (2,751) ($1,301,550)

Advances from Microphase

 -  - $347,840 

Issuance of Convertible Debentures

 -  325,000 $1,091,500 

Net Proceeds (Repayment) from notes payable related parties

 -  21,000  ($403,659)

Proceeds from the collection of Notes Receivable under securities purchase agreements

 300,600  - $8,339,500 

Sale of minority interest in Granita subsidiary

 -  - $514,000 

Net cash provided by financing activities

 298,144  465,249  91,849,010 

 

         

Net increase (decrease) in cash

 ($164,793)$85,553 $87,297 

 

         

CASH AND CASH EQUIVALENTS, beginning of period

$228,437 $1,744    

CASH AND CASH EQUIVALENTS, end of period

$63,644 $87,297 $87,297 

The accompanying notes are an integral part of these consolidated financial statements.

68


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2011 (Unaudited for September 30, 2011 information)2019

1.

NOTE 1: ORGANIZATION AND NATURE OF BUSINESS

mPhase Technologies, Inc. (“mPhase” or the “Company”) was initially incorporated in New Jersey in 1979 under the name Tecma Laboratory, Inc. In 1987, the Company changed its name to Tecma Laboratories, Inc. As Tecma Laboratories, Inc., the Company was primarily engaged in the research, development and exploration of products in the skin care field. On February 17, 1997, the Company acquired Lightpaths, Inc., a Delaware corporation, which was engaged in the development of telecommunications products incorporating DSL technology, and the Company changed its name to Lightpaths TP Technologies, Inc.

On May 5, 1997, the Company completed a reverse merger with Lightpaths TP Technologies, Inc. and thereafter changed its name to mPhase Technologies, Inc. on June 2, 1997.

mPhase, a New Jersey corporation founded in 1996, is a publicly-held company with over 23,000 shareholders and approximately 1.63 billion11,689,078 shares of common stock outstanding asand 461,553 shares of common stock to be issued at June 30, 2011.2019. The Company'sCompany’s common stock is traded on the Over the Counter Bulletin BoardOTC Pink Quotation System under the ticker symbol XDSL.

The Company is in the development stage and historically hasfrom inception through June 30, 2010 focused much of its efforts in the commercial deployment of its TV+ products for delivery of broadcast IPTV, and DSL component products which include POTS splitters. Beginning in 2004, the Company added a new line of power cell batteries and electronic sensors (magnetometers) being developed through the use of nanotechnology. Since mPhase is in the development stage, the accompanying consolidated financial statements should not be regardednano-technology. The Company discontinued its TV+ line of products as typical for normal operating periods.of June 30, 2010 as well as its electronic sensor products.

In recent years, the Company has shifted its primary business focus to the development of innovative power cells and related products through the science of microfluidics, microelectromechanical systems (MEMS) and nano- technology.nano-technology. Using these disciplines, it has developed a battery that has a significantly longer shelf life prior to activation than conventional batteries. In addition, such battery product, unlike conventional batteries, is capable of disposal after use without harm to the environment.

On April 17, 2007, This technology is a significant technology and business of the Company announced that it had formed AlwaysReady, Inc., a New Jersey Corporation, as a new wholly-owned subsidiary.today. Presently the Company is pursuing strategic alternatives to best monetize its patent portfolio, including partnering to exploit its opportunities for its drug delivery system. The Company plannedis seeking to transfer allengage a grant and project proposal consultant to obtain government funding available under the Departments of its nanotechnology assetsDefense and appropriate liabilities to such company so as to separate its nanotechnology product line from its IPTV product. Although management and staffHomeland Security including The Department of AlwaysReady Inc were hired the Company funded all operations of Always Ready, Inc. to date and no assets or liabilities have been transferred.

On June 20, 2007, the Company announced the formation of a new subsidiary, Granita Media, Inc. ("Granita"Defense Ordnance Technology Consortium (“DOTC”), a Delaware corporation, to promoteSmall Business Innovative Research (“SBIR”), Cooperative Research and developDevelopment Agreements (“CRADA”) and similar programs for targeted applications for its IPTV product line including targeted advertising and middleware solution. Capitalization of Granita amounted to $514,000 of equity, provided by employees and independent investors. During FYE June 30, 2008, related assets and liabilities were transferred to Granita and its results consolidated into the these financial statements. Additional funding was to have been arranged from outside institutional financing and potentially involve the sale of up to 10% of the common stock of Granita with mPhase retaining 90% of the stock of Granita. Owing to very challenging conditions in the capital markets, Granita was unable to raise funds necessary to operate as a self sufficient enterprise and fund the additional software development necessary for a targeted advertising enhancement capability of its TV+ solution. In order to conserve financial resources, all employees of Granita were either terminated or had resigned by December 31, 2007. (See also footnote 6.) As of June 30, 2011, the Company has treated Granita as a discontinued business.smart nano-battery applications.

We are headquartered in Norwalk, Connecticut with offices in Little Falls, NJ. mPhase shares common office space with Microphase Corporation, a privately held company in which the CEO of the company owns a minority interest. Microphase is a leader in the field of radio frequency and filtering technologies within the defense and telecommunications industry. It has been in operation for over 50 years and has supported mPhase with engineering, administrative and financial resources.

69


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2011 (Unaudited2019

NOTE 1: ORGANIZATION AND NATURE OF BUSINESS (continued)

On January 11, 2019, the Company underwent a major change in management and control. The new management of the Company is positioning the Company to be a technology leader in artificial intelligence and machine learning while enabling a more rapid commercial development of its patent portfolio and other intellectual property. Artificial Intelligence is just simple math executed on an enormous scale. The more instances and calculations a system can process, the more possible it is for September 30, 2011 information)that system to emulate human-like cognitive abilities. With the advent of cloud infrastructure, GPU-accelerated processing and deep learning architectures, it is now commercially viable to perform this math at such speeds and efficiency that Artificial Intelligence (human-like cognitive abilities) can be embedded directly into business operations, platform architectures, business services and customer experiences. The Company’s goal is to generate significant revenue from its artificial intelligence and machine learning technologies.

2. LOSSES DURING THE DEVELOPMENT STAGE AND MANAGEMENT'S PLANS

ThroughmPower Technologies, Inc. is a New Jersey corporation and is a wholly-owned consumer products subsidiary of mPhase Technologies, Inc. This subsidiary had its last significant sale of Jump products during the first quarter of fiscal 2017 and this product line is reflected as discontinued operations within these consolidated financial statements. Medds, Inc., is a Wyoming corporation and is a wholly-owned subsidiary of mPhase Technologies, Inc. Medds, Inc., was formed to capitalize on opportunities for the Company’s drug delivery system.

The Company is presently headquartered 9841 Washingtonian Blvd., Suite 390, Gaithersburg, MD 20878.

NOTE 2: GOING CONCERN

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

The Company has incurred a net loss of $1,955,161 and has incurred negative cash flows from operations of $203,970 for the year ended June 30, 2011, the Company incurred development stage losses totaling approximately $194,643,955 and at2019. At June 30, 2011 had working capital of $(2,705,943). Funding in our traditional capital markets was difficult during FYE 2010 and 2011.

Through September 30, 2011,2019, the Company had incurred cumulative (a) development stage losses totaling $(200,823,177), (b) stockholders'a working capital deficit of ($5,049,816),$2,440,289, and (c) negative cash flowan accumulated deficit of $213,633,853. It is management’s opinion that these facts raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from operations equalthe date of this filing, without additional debt or equity financing. The consolidated financial statements do not include any adjustments relating to ($87,885,311).the recoverability and classification of recorded asset amounts nor to the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

The Company was able to enter into convertible debt arrangements and private placements of equity with accredited independent investors to provide liquidity and capital resources during the year. Such arrangements have provided the Company with cash in the amounts of $4,511,000 and $1,619,000 during FYE 2010 and 2011 respectively. These arrangements will likely need to be revised to continue to provide a portion of the working capital anticipated to be needed during the nextpreceding two fiscal year.years. In addition, and from time to time during FYE 2010fiscal years 2019 and 2011,2018, the Company raised necessary working capital viathrough bridge loans from officersofficers. During the years ended June 30, 2019 and 2018, the Company received net proceeds from private placements with accredited investors of equity. Such loans have subsequently received partial repayments (see notes payable to officers-discussed in Note 9).$193,000 and $81,000, respectively.

The Company is currently focused on the continued development and commercialization of its "Always Ready" battery product using the science of nanotechnology. The Company believes that such battery has a much longer shelf life than conventional batteries and will have significant commercial and military applications. The Company is also actively working on the commercialization and marketing of its emergency flashlight, the mPower Emergency Illuminator. The Company has suspended development of its magnetometer sensor devices and discontinued all activities related to its IPTV business. It is unclear whether any intellectual property related to those operations will have significant value.mPHASE TECHNOLOGIES, INC.

The Company's ability to continue as a going concern and its future success is dependent upon its ability to raise capital in the near term to: (1) satisfy its current obligations, (2) continue its research and development efforts, and (3) successfully develop, market and sell its products. The Company believes that it will be able to complete the necessary steps inNOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 2: GOING CONCERN (continued)

In order to meet its cash flow requirements throughout fiscal 2011working capital needs through the next twelve months and continue its developmentto fund the growth of our nanotechnology, artificial intelligence, and commercialization efforts.

However, there can be no assurance that mPhase will generate sufficient revenues to provide positive cash flows from operations or that sufficient capital will be available, when required, to permitmachine learning technologies, the Company may consider plans to realizeraise additional funds through the issuance of equity or debt. Although the Company intends to obtain additional financing to meet its plans. The accompanying consolidated financial statements do not includecash needs, the Company may be unable to secure any adjustmentsadditional financing on terms that might result from the outcome of this uncertainty.are favorable or acceptable to it, if at all.

3.

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION

Basis of Consolidation

The consolidated financial statements for the years ended June 30, 2019 and 2018, include the accountsoperations of mPhase and its wholly-owned subsidiaries, mPower Technologies, Inc., Medds, Inc., mPhase Technologies India Private Limited effective March 19, 2019, and majority owned subsidiaries. Significant inter-companyAlpha Predictions LLP effective June 30, 2019. All significant intercompany accounts and transactions have been eliminated in the consolidation.

USE OF ESTIMATES

Foreign Currency Translation and Transactions

The functional currency of our operations in India is the Indian Rupee. Foreign currency denominated assets and liabilities are translated into U.S. dollars at the exchange rates in effect at the balance sheet date, and income and expense items are translated at the average exchange rates in effect during the applicable period. The aggregate effect of foreign currency translation is recorded in accumulated other comprehensive income/loss in our consolidated balance sheets. Our net investment in our Indian operations is recorded at the historical rate and the resulting foreign currency translation adjustments are included in accumulated other comprehensive income/loss in our consolidated balance sheets. From the effective date of our India subsidiaries, mPhase Technologies India Private Limited and Alpha Predictions LLP, through June 30, 2019, foreign currency translation gains were not significant and did not have a material impact on the consolidated balance sheets or consolidated statements of operations.

Use of Estimates

The preparation of consolidated financial statements in conformity with accounting principles generally accepted accounting principlesin the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. If actual results significantly differ from the Company’s estimates, the Company’s financial condition and results of operations could be materially impacted. Significant estimates include the collectability of accounts receivable, accrued expenses, valuation of derivative liabilities, stock-based compensation, and the deferred tax asset valuation allowance.

RECLASSIFICATIONS

Certain reclassifications have been made in the prior period consolidated financial statements to conform to the current period presentation.

70


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2011(Unaudited for September 30, 2011 information)2019

3.

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Continued)(continued)

STOCK BASED COMPENSATION

On July 1, 2005,Concentrations of Credit Risk

Credit Risk

Financial instruments which potentially subject the Company adoptedto concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company maintains cash and cash equivalents with three financial institutions. Deposits held with the provisionsfinancial institutions may exceed the amount of Financialinsurance provided by the Federal Deposit Insurance Corporation on such deposits, but may be redeemed upon demand. The Company performs periodic evaluations of the relative credit standing of the financial institutions. With respect to accounts receivable, the Company monitors the credit quality of its customers as well as maintain an allowance for doubtful accounts for estimated losses resulting from the inability of customers to make required payments.

Revenue Risk

Agreements which potentially subject the Company to concentrations of revenue risk consist principally of one customer agreement. For the years ended June 30, 2019 and 2018, this one customer accounted for 100% and 0% of our total revenue, respectively. At June 30, 2019 and 2018, this one customer accounted for 99% and 0% of our total accounts receivable, respectively.

Cash and Cash Equivalents

For purposes of balance sheet presentation and reporting of cash flows, the Company considers all unrestricted demand deposits, money market funds and highly liquid debt instruments with an original maturity of less than 90 days to be cash and cash equivalents. There were no cash equivalents at June 30, 2019 or 2018.

Accounts Receivable

The Company regularly reviews outstanding receivables and provides for estimated losses through an allowance for doubtful accounts. In evaluating the level of established loss reserves, the Company makes judgments regarding its customers’ ability to make required payments, economic events, and other factors. As the financial condition of these parties change, circumstances develop or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for potential credit losses, and such losses traditionally have been within its expectations. The Company has determined no allowance for doubtful accounts is required at June 30, 2019 or 2018.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Property and Equipment

All expenditures on the acquisition for property and equipment are recorded at cost and capitalized as incurred, provided the asset benefits the Company for a period of more than one year. Expenditures on routine repairs and maintenance of property and equipment are charged directly to operating expense. The property and equipment is depreciated based upon its estimated useful life after being placed in service, which is 3 to 5 years. When equipment is retired, sold or impaired, the resulting gain or loss is reflected in earnings. The Company incurred depreciation expense of $0 and $683 for the years ended June 30, 2019 and 2018, respectively.

Impairment of Long-Lived Assets

In accordance with Accounting Standards Board Statement “AccountingCodification (“ASC”) 360-10, “Property, Plant, and Equipment”, the Company periodically reviews its long- lived assets for Stock Based Compensation"impairment whenever events or changes in circumstances indicate that requires companies to measure and recognize compensation expense for all employee stock-based payments atthe carrying amount of the assets may not be fully recoverable. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value overand its book value. For the service period underlying the arrangement. Therefore,years ended June 30, 2019 and 2018, the Company did not impair any long-lived assets.

Goodwill and Intangible Assets

Goodwill is now required to recordrecorded when the grant-date fair value of its stock-based payments (i.e., stock options and other equity-based compensation) in the statement of operations. Effective, July 1, 2005, the Company adopted the promulgated authority "modified prospective" method, and has recorded aspurchase price paid for an expenseacquisition exceeds the fair value of all stock based grants to employees after such date.the net identified tangible and intangible assets acquired. The Company hasevaluates goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate that the carrying value may not restatedbe recoverable. The Company tests goodwill for impairment by first comparing the fair value of the reporting unit to its operating results for any prior fiscal year end or quarter.

PROPERTY AND EQUIPMENT

Property and equipmentcarrying value. If the fair value is recorded at cost. Depreciationdetermined to be less than the carrying value, a second step is provided onperformed to measure the straight-line method overamount of impairment loss. On June 30, 2020, we will perform our annual evaluation of goodwill impairment to determine if the estimated useful lives of three to five years.

REVENUE RECOGNITION

As required, mPhase has adopted the Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, "Revenue Recognition in Financial Statements," which provides guidelines on applying generally accepted accounting principles to revenue recognition based on the interpretations and practicesfair value of the SEC. The Company recognizes revenue onreporting unit exceeds its research grant contract upon delivery of milestones defined in the contract, at the fixed predetermined price under the contract in which payment is reasonably expected as enumerated in SAB104.carrying value.

RESEARCH AND DEVELOPMENT

Research and Development cost are charged to operations when incurred. The amounts charged to expense for continuing operations for the years ended 2010, 2011 and inception to date were $2,203,383, $625,417 and $12,257,562; and the amounts charged to expense for continuing operations were $ 193,780, $41,403 and $12,298,965 for the three months ended September 30, 2010, 2011 and inception to date to September 30, 2011, respectively.

PATENTS AND LICENSES

Patents and licenses are capitalized when mPhasethe Company determines there will be a future benefit derived from such assets and are stated at cost. Amortization is computed using the straight-line method over the estimated useful life of the asset, generally five years. AmortizationAs of June 30, 2019, and 2018, the book value of patents and licenses of $214,383, has been fully amortized and no amortization expense was $0, and $0recorded for the years ended June 30, 20102019 and 2011, respectively. 2018.

Capitalized Software Development Costs

The Company follows the provisions of ASC 350-40, “Internal Use Software.” ASC 350-40 provides guidance for determining whether computer software is internal-use software, and on accounting for the proceeds of computer software originally developed or obtained for internal use and then subsequently sold to the public. It also provides guidance on capitalization of the costs incurred for computer software developed or obtained for internal use. The Company expenses all costs incurred during the preliminary project stage of its development, and capitalizes the costs incurred during the application development stage. Costs incurred relating to upgrades and enhancements to the software are capitalized if it is determined that these upgrades or enhancements add additional functionality to the software. Costs incurred to improve and support products after they become available are charged to expense as incurred.

Capitalized software development costs are amortized on a straight-line basis over the estimated useful lives, currently three years. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets.

As of June 30, 2008,2019, the book value of such assets has been fully amortized.

INVENTORIES

The Company uses the First In First Out method (FIFO) to account for inventory which is carried at the lowerpurchased and developed technology of market value or cost. As of June 30, 2007, inventory consisted primarily of component parts being assembled on location in anticipation of deployment of specific IPTV systems. Appropriate reserves have been taken to assure that the cost of such inventory does not exceed the value of the underlying contract. During$3,025,801, included two technology platforms, a machine learning platform and an artificial intelligence platform. For the year ended June 30, 2008, the Company determined that the value2019 and 2018, there was no amortization of inventory related to IPTV had been impaired and charged to earnings all associated amounts ($505,910).either purchased technology platforms.

As

Fair Value of June 30, 2010 and June 30, 2011, the inventory related to the Emergency Flashlight was valued at $98,807 and $102,532, respectively. As of September 30, 2011 inventory was valued at $101,302.Financial Instruments

71


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Continued)

LONG-LIVED ASSETS

The Company reviews long-term assetsaccounts for impairment whenever events or circumstances indicate that the carrying amount of those assets may not be recoverable. The Company also assesses these assets for impairment based on their estimated future cash flows.

REPARATION EXPENSE

As an incentive for additional equity contributions, the Company will from time to time, adjust the cost of past private purchases of common stock through the issuance of additional shares in such magnitude as to reduce an investor’s cost to an average price that more closely approximates current market value. The marketfair value of additional shares issued without cash investment is charged to Reparation Expense, which is included in Other Expenses. Reparations expenses have amounted to $35,530, $0 and $8,299,794 for the years ended 2010, 2011 and inception to date to June 30, 2011; and $0, $0 and $8,299,794 for the three months ended September 30, 2010, 2011 and inception to date to September 30, 2011, respectively.

LOSS PER COMMON SHARE, BASIC AND DILUTED

mPhase accounts for net loss per common sharefinancial instruments in accordance with the requirements FASB Earnings Per Share. Basic loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing net loss adjusted for income or loss that would result from the assumed conversion of potential common shares from contracts that may be settled in stock or cash by the weighted average number of shares of common stock, common stock equivalentsASC topic 820, “Fair Value Measurements and potentially dilutive securities outstanding during each period. The Company had warrants and options and convertible debentures (if funded in full – see note 8) outstanding at June 30, 2011, convertible into, respectively, approximately 21,480,837 and 113,720,000 and 792,273,901 shares of the Company's common stock based upon the conversion terms at June 30, 2011. The Company has also granted a conversion feature to certain officers for notes outstanding, giving these note holders the right to convert principal and interest outstanding, subject to availability, into 116,763,169 shares of the Company’s common stock based on a $.0075 per share conversion price (see note 13)Disclosures” (ASC 820), formerly SFAS No. 157 “Fair Value Measurements”. The inclusion of the warrants and potential common shares to be issued in connection with convertible debt have an anti-dilutive effect on diluted loss per share and have been omitted in such computation. The Company had warrants to purchase 19,323,974 shares of its common stock and options to purchase 110,085,000 shares of its common stock outstanding at September 30, 2011, as well as convertible debentures and convertible notes plus accrued interest thereon held by officers of the Company convertible into approximately407,966,329and 231,211,415 shares of the Company's common stock based upon the conversion terms at September 30, 2011.

BUSINESS CONCENTRATIONS AND CREDIT RISK

To date, the Company's products have been sold to a limited number of customers, earlier primarily in the telecommunications and defense industry and recently including some sales of the Emergency Illuminator. In fiscal year ended 2010, revenue continued to be derived from US Army research contracts as well as from sales by the Company of the Company’s mPower Flashlight and battery products. In fiscal year ended 2011, revenue was derived from research contracts with the U.S. Army and sales of the Company’s mPower emergency illuminator. Throughout the year, cash balances that the Company maintains at financial institutions may exceed the Federal Deposit Insurance Corporation insurance limitation of up to $250,000. Cash balances exceeded FDIC insured limits at times throughout the years ended June 30, 2010 and 2011 and the three months ended September 30, 2011.

BASIS OF PRESENTATION

The Consolidated Balance Sheet at September 30, 2011 was derived from unaudited interim financial statements that do not include all disclosures required by accounting principles generally accepted in the United States of America. The other information in the Consolidated Statements of Operations & Consolidated Statements of Cash Flows for the three months ended September 30, 2010 and 2011 and for the period from inception (October 2, 1996) through September 30, 2011 and the Consolidated Statements of Changes in Stockholders' Equity (Deficit) From July 1, 2011 to September 30, 2011 is unaudited but, in the opinion of management, reflects all adjustments necessary for a fair presentation of the results for the periods covered. All such adjustments are of a normal recurring nature unless disclosed otherwise. These condensed financial statements, including notes, have been prepared in accordance with the applicable rules of the Securities and Exchange Commission and do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial statements. These condensed financial statements should be read in conjunction with the financial statements and additional information as contained in our Annual Report on Form 10-K for the year ended June 30, 2011.

72


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2010 (Unaudited for September 30, 2011 information)

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Continued)

MATERIAL EQUITY INSTRUMENTS

The Company has material equity instruments including convertible debentures and convertible notes that are accounted for as derivative liabilities (SEE BELOW) and options and warrants that are evaluated quarterly for potential reclassification as liabilities pursuant to current accounting guidance.

DEBT DISCOUNTS

Costs incurred with parties who are providing the actual long-term financing, which generally may include the value of warrants, fair value of the derivative conversion feature, or the intrinsic value of conversion features associated with the underlying debt, are reflected as a debt discount. These costs and discounts are generally amortized over the life of the related debt.

DERIVATIVE FINANCIAL INSTRUMENTS

Derivatives are recorded on the balance sheet at fair value. The conversion features of the convertible debentures are embedded derivatives and are separately valued and accounted for on our balance sheet with changes in fair value recognized during the period of change as a separate component of other income/expense. Fair values for exchange-traded securities and derivatives are based on quoted market prices. The pricing model we use for determining fair value of our derivatives is the Black-Scholes Pricing Model. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management's judgment and may impact net income. During the fiscal years ended June 30, 2010 and June 30, 2011, the Company utilized an expected life of 20 days based upon the look-back period of its convertible debentures and notes and a volatility of 100%.

INCOME TAXES

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. At June 30, 2011, the Company had a full valuation allowance against its deferred tax assets.

ESTIMATED FAIR VALUE OF FINANCIAL INSTRUMENTS

The Company's financial instruments include cash, accounts payable, long term debt, line of credit, convertible debt and due to related parties. Management believes the estimated fair value of cash, accounts payable and debt instruments at June 30, 2011 approximate their carrying value as reflected in the balance sheets due to the short-term nature of these instruments or the use of market interest rates for debt instruments. Fair value of due to related parties cannot be determined due to lack of similar instruments available to the Company.

NEW ACCOUNTING PRONOUNCEMENTS

In May 2011, the Financial Accounting Standards Board issued ASU 2011-04 Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS (“ASU 2011-04”), which is intended to result in convergence between U.S. GAAP and International Financial Reporting Standards requirements for measurement of, and disclosures about, fair value. ASU 2011-04 clarifies or changes certain fair value measurement principles and enhances the disclosure requirements particularly for Level 3 fair value measurements. The new guidance is effective for our third quarter of the fiscal year ending June 30, 2012, and we do not expect its adoption to have a material effect on our financial position or results of operations.

In June 2011, the Financial Accounting Standards Board issued ASU 2011-05 Presentation of Comprehensive Income, which makes the presentation of items within other comprehensive income (“OCI”) more prominent. The new standard will require companies to present items of net income, items of OCI and total comprehensive income in one continuous statement or two separate consecutive statements, and companies will no longer be allowed to present items of OCI in the statement of shareholders’ equity. Reclassification adjustments between OCI and net income will be presented separately on the face of the financial statements. The new guidance is effective for our fiscal year ending June 30, 2013, and we do not expect its adoption to have a material effect on our financial position or results of operations.

73


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Continued)

  For the FYE June 30,       
SUPPLEMENTAL CASH FLOW INFORMATION 2010  2011  For the three months September 30, 
        2010  2011 
           (Unaudited) 

           Statement of Operation Information:

            

Fee on Amendment to Convertible Debt Arrangement

$ 0  $55,000 $ 0 $ 0 

Interest Received from Notes Receivable

$ 275,000 $218,500 $ 74,400 $ 0 

Interest Accrued Unpaid

$ 324,229 $57,983 $ 60,028 $ 38,413 

 

            

           Non Cash Investing and Financing Activities:

            

Interest Paid (net interest income)

$ 27,412 $9,181 $ 0 $ 0 

Stock issued in settlement of accrued expenses and accounts payable

$ 200,000 $0 $ 0 $ 0 

Beneficial Conversion of Officers’ Notes and Conversion of Accounts Payable

$ 669,276 $0 $ 0 $ 2,320 

Convertible Debt issued for Notes Receivable

$ 6,400,000 $0 $ 0 $ 0 

Conversion of Convertible Debt and Related Expenses

$ 3,415,520 $ 2,346,896 $ 650,587 $ 112,206 

Reversal of note payable to former Granita employee (Footnote 7) to equity

$ 175,820 $0 $ 0 $ 0 

4. PROPERTY AND EQUIPMENT

Property and equipment, at cost, consist of the following:

  June 30,    September 
  2010  2011  30, 2011 
        (Unaudited) 
Research Equipment$ 36,452 $ 42,385 $ 48,383 
Office and Marketing 142,280  142,280  142,280 
Gross Cost 178,732  184,665  190,663 
                 Less Accumulated         
Depreciation (116,421) (139,551) (143,727)
                 Net Property and Equipment$ 62,311 $ 45,114 $ 46,936 

Depreciation expense for the years ended June 30, 2010 and 2011 totaled $37,356 and $23,130 respectively, of which $11,652 and $7,639 respectively, relates to research laboratory and testing equipment included in research and development expense.

Depreciation expense for the three months ended September 30, 2010 and 2011 totaled $6,786 and $4,176 respectively, of which $2,913and $ 495 respectively, relates to research laboratory and testing equipment included in research and development expense.

5. ACCRUED EXPENSES

Accrued expenses consist of the following as of each Balance Sheet date: June 30,    
  2010  2011  September 
        30, 2011 
        (Unaudited) 
Accrued Interest- Convertible Debentures$ 324,229 $ 87,983 $ 126,396 
Other Expenses$ 65,994 $ 74,055 $ 73,020 
Total$ 390,203 $ 162,038 $ 199,416 

74


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

6. GRANITA MEDIA

Effective July 1, 2007, the Company formed Granita Media, Inc. to separate its IPTV business and facilitate the raising of capital. Pursuant to an arrangement with four employees of mPhase, such employees were terminated from mPhase as of July 1, 2007 and became employees of Granita Media Inc and invested solely in the common stock of Granita Media Inc. Under the arrangement, each of the four employees was required to invest $125,000 in exchange for an aggregate 2% equity interest in Granita Media, Inc, with mPhase continuing to own 98% of the Company. The four employees contributed a total of $339,000 of the total $500,000 equity investment required from them and raised from third party investors another $175,000 for a total of $514,000. Granita Media has 19,000,000 shares of common stock outstanding of which 18,000,000 was owned by mPhase Technology and 1,000,000 was being held for issuance to the four employees and the third party investors pending an agreement among such persons of the allocation of such shares. Under the terms of the arrangement between mPhase and the four employees, such employees were authorized to sell up to 7.99% of additional equity in the Company for a total of not less than $2,000,000 of additional capital by December 31, 2007. As noted above, the employees raised a total of $175,000 of outside capital only and pursuant to the arrangement, such employees either resigned or were terminated by mPhase together with several lower level employees of Granita. A dispute arose between Granita Media and one of the former employees with respect to a sum of approximately $176,000 included in short term loans. It is the Company's position that such sums were voluntarily advanced to fund operating expenses after July 1, 2007. Since the four employees/officers of Granita Media were required to cover operating expenses of Granita Media after July 1, 2007 through equity investments either directly or from third parties, the Company took the position that neither such amount nor any related interest and fees are owed to the employee. In addition, the Company had substantial rights of offset for unpaid rent with respect to the portion of its Little Falls office occupied by Granita Media after July 1, 2007. Granita Media, Inc. ceased operations in December of 2007. In the fourth quarter of fiscal year 2010, the Company elected to treat Granita Media, Inc. as a discontinued operation.

7. SHORT TERM NOTES PAYABLE

Short term debt is comprised of the following:

  June 30,  June 30,  September 
  2010  2011  30, 2011 
        (Unaudited) 

Note payable to Granita Employee (See note #6) Note payable to law firm bearing 8% interest, originally monthly installments of $5,000 per month commencing in June 2002 and continuing through December 1, 2003 with a final payment of principal plus accrued interest due at maturity on December 31, 2003, this note was in arrears as of June 30, 2004 and the company negotiated a new settlement arrangement as of August 31, 2004. Under such settlement agreement, the Company made a $100,000 cash payment and gave a cashless warrant to purchase $150,000 worth of common stock valued at $.25 per share. In addition, the Company agreed to pay $25,000 on each of December 1, 2004, March 1, 2005, June 1, 2005, September 1, 2005 and $50,000 on December 1, 2005. Thereafter, the Company was obligated to pay $25,000 on each of March 1, 2006, June 1, 2006, September 1, 2006 with a final payment of $75,000 on December 1, 2006, of which $10,000 was paid in 2008. The Company is currently in default with respect to the remainder.

$ 0 $ 0 $ 0 

Total Short Term Notes

$ 65,000 $ 65,000 $ 65,000 

 

$ 65,000 $ 65,000 $ 65,000 

75


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY

mPhase initially authorized capital of 50,000,000 shares of common stock with no par value. On February 23, 2000, the Board of Directors proposed, and on May 22, 2000 the shareholders approved, an increase in the authorized capital to 150,000,000 shares of common stock. On June 15, 2004, a Special Meeting of Shareholders of the Company approved a proposal by the Company to amend the Company's Certificate of Incorporation under New Jersey law to increase the authorized shares of common stock from 150 million to 250 million shares and change the par value of all shares of common stock from no par to $0.01 par stock. Effective June 2005, June 2006, and June 2008, the Company received authorization to increase the number of authorized shares to 500 million, 900 million and 2 billion, respectively. A further increase in the number of authorized shares of common stock to 6 billion was approved at a Special Meeting of Shareholders of the Company held on June 29, 2011.

Long Term Convertible Debentures / Note Receivable / Debt Discount and related Interest

The Company has entered into eleven separate convertible debt arrangements with activity through and as of June 30, 2010 and June 30, 2011 with independent investors, and seven arrangements with activity through and as of September 30, 2011, included in our balance sheets for those dates under the caption“OTHER OBLIGATIONS CONVERTIBLE TO EQUITY”.

General

The economic substance of convertible debt arrangements entered into beginning December 2007 was to provide the Company with needed liquidity to supplement the private equity markets.

The form of the transaction generally involves the following:

  • The receipt of cash.
  • The issuance of a note payable from mPhase.
  • The issuance of a note receivable due to mPhase.
  • A Securities Purchase Agreement.
  • The note payable contains conversion features which permit the holder to convert debt into equity. Such debt is eligible to be converted into the Company's common stock immediately, thus requiring the recording of the entire liability upfront. Finally, to encourage conversion, a discount from market value is offered.
  • The aggregate amount of notes payable exceeds the amount of cash received. As "Consideration" for this difference the Company takes back a secured note receivable. Security is generally liquid investments of the investor.
  • The note receivable provides a commitment to fund mPhase. The notes are secured and collateralized and carry terms which are different from the related note payable and no right of offset exists.

A summary of our arrangements for notes payable and notes receivable under convertible debt and debenture agreements with activity through and as of June 30, 2010 and June 30, 2011 is as follows:

Arrangement #1 (Golden Gate Investors)

In December, 2007, the Company received proceeds of $500,000 under a Securities Purchase Agreement. This transaction involves three related agreements: 1) a Securities Purchase Agreement, dated as of December 11, 2007, which may under certain circumstances permit the Company to draw up to $1.5 million of funds; 2) a convertible debenture in the amount of $1.5 million, with an interest rate of 7 ¼% and a maturity date of December 11, 2010; and 3) a secured note receivable in the amount of $1.0 million, with an interest rate of 8 ¼ % and a maturity date of February 1, 2011 due from the holder of the convertible debenture. In March of 2009, by mutual consent of the parties, the Securities Purchase Agreement was terminated. Total draws under this facility were $1.5 million.

As of June 30, 2008 $950,000 was included in notes receivable under this arrangement. During FYE 2009, $1,365,000 of such debt was converted into 74,368,943 shares of common stock and the Company received a total of $950,000 under the provisions of the related note receivable. As of June 30, 2009 all notes receivable had been paid and all debt converted. No further obligations exist by either party.

76


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

Arrangement #2 ( St. George Investments, LLC)

In February 2008, the Company entered into a convertible debenture transaction which involved the receipt of $500,000 cash, a note payable of $550,000 and the issuance of 3,250,000 shares of stock. The relative fair value of the shares was $105,000. The terms of the debenture provide for a 7.5% interest rate, a due date of February 2012 and conversion privileges equal to 75% of the three lowest trading price over the 20 day period prior to conversion. During FYE 2009, $614,209 of such debt and related interest was converted into 60,536,482 shares of common stock. As of June 30, 2009, all debt had been converted and no further obligation exists by either party.

Arrangement #3 (JMJ Financial, Inc.)

In April, 2008, the Company received proceeds of $300,000 under a Securities Purchase Agreement. This transaction involves three related agreements: 1) a Securities Purchase Agreement which may under certain circumstances permit the Company to draw up to $1,000,000 of funds; 2) two convertible debentures totaling $1,450,000, with a one-time interest factor of 12% ($132,000) and a maturity date of March 25, 2011; and 3) a secured note receivable in the amount of $1.0 million, with a onetime interest factor of 13.2 % and maturity dates of March 25, 2012 due from the holders of the convertible debentures. The note receivable is collateralized by $1 million of Blue Chip Stocks. Conversion of outstanding debentures into common shares is at the option of the holder. The number of shares into which this debenture can be converted is equal to the dollar amount of the debenture divided by 75% of the lowest trade price during the 20 day trading period prior to conversion.

As of June 30, 2008, $1,000,000 was included in notes receivable under this arrangement. During FYE 2009, $964,250 of such debt and related interest was converted into 100,951,309 shares of common stock. In addition, the Company received $650,000 cash payments of the note receivable. As of June 30, 2009, the face value of the note receivable was $350,000 plus interest of $132,000 included in other current assets and the note payable was $527,750 plus interest of $132,000 included in accrued expenses and an FMV adjustment of $115,801. As of June 30, 2010 both the note receivable and note payable were converted in full and funded in full.

Arrangement #4 (JMJ Financial, Inc.)

On December 31, 2008, the Company entered into a second agreement with JMJ Financial. This transaction involves: 1) a convertible debenture in the amount of $1.1 million, plus a one-time interest factor of 12% ($132,000) and a maturity date of December 31, 2011, and 2) a secured note receivable in the amount of $1.0 million, plus a one-time interest factor of 13.2 % ($132,000) and maturity date of December 31, 2012 due from the holder of the convertible debentures. Conversion of outstanding debentures into common shares is at the option of the holder. The number of shares into which this debenture can be converted is equal to the dollar amount of the debenture divided by 75% of the lowest trade price during the 20 day trading period prior to conversion.

As of June 30, 2009, $1,000,000 was included in notes receivable under this arrangement. During FYE 2010 the Company collected the $1,000,000 note receivable plus $132,000 of accrued interest on this note. The FMV addition to this debt during FYE 2010 was $307,899.On June 30, 2009 the derivative value of this security was calculated to be $444,552. During the year ended June 30, 2010, amortization of debt discount amounted to $508,821 reducing the debt discount balance also to zero.

Arrangement #5 (LaJolla Cove Investors, Inc.)

On Sept 11, 2008, the Company received proceeds of $200,000 under a Securities Purchase Agreement. This transaction involves three related agreements: 1) a Securities Purchase Agreement which may under certain circumstances permit the Company to draw up to $2,000,000 of funds; 2) a convertible debenture totaling $2,000,000, with an interest rate of 7 1/4% and a maturity date of September 30, 2011; and 3) a secured note receivable in the amount of $1,800,000, with an interest rate of 8 1/4% and maturity dates of September 30, 2011 due from the holders of the convertible debentures. In addition, the holder of the debenture is related to the holder in Arrangement #1. Conversion of outstanding debentures into common shares is similar to the terms of Arrangement #1. As of FYE 2009, $190,000 of debt was converted into 21,714,285 shares of common stock. On June 30, 2009 and June 30, 2010 the note receivable balance was $1,800,000, the note payable was $1,810,000 and the FMV addition $387,228 for which the Company recorded a reserve for utilization against each of $600,000. As of June 30, 2010, the derivative value of this security was calculated to be $1,114,768.

77


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

On March 16, 2011, the holder and the Company entered into a termination agreement whereby $1,800,000 of the principal of both the note receivable and the convertible debenture, plus $90,291 in accrued interest receivable and $84,175 in accrued interest payable, was cancelled. Additionally in connection with the termination, the Company paid the holder $17,000 and assigned to a consultant engaged by the Company the unconverted portion of the convertible debenture in the amount of $10,000 which had been fully funded in cash and which remained outstanding at March 31, 2011 and the derivative value of the remaining security was calculated to be $3,468 As of June 30, 2011, this value was calculated to be $3,442. During the year ended June 30, 2011, amortization of debt discount amounted to $282,774, reducing the balance to $0.

Arrangement #6 (JMJ Financial, Inc.)

On August 19, 2009, the Company issued a 12% convertible note maturing on August 10, 2012 in the principal amount of $1,870,000 to JMJ Financial for a purchase price of $1,700,000. The Company initially received $250,000 in cash as partial payment of the purchase price for the convertible note plus a 13.2% secured promissory note maturing on August 10, 2012 in the amount of $1,450,000. As of June 30, 2010, the Company has received a total of $1,523,500 cash and has issued 109,920,635 shares of common stock to the holder upon conversions. The remaining $570, 900 of cash to be received from the holder plus accrued and unpaid interest is convertible into shares of common stock at the option of the holder. Upon receipt, in full, of cash by the Company equaling the purchase price of the convertible note plus interest or any portion thereof payable through maturity, the holder may convert such portion of the total amount of interest funded that would accrue to maturity into additional shares of common stock . The number of shares into which this convertible note can be converted is equal to the dollar amount of the debenture divided by 75% of the lowest trading price during the 20 day trading period prior to conversion. Based upon the price of the Company’s common stock on June 30, 2010 of $.0162 per share the holder could convert the remaining principal amount plus interest of this convertible note into approximately 46,987,654 shares of common stock. At the commitment date, the derivative value of the embedded conversion feature of such security was $1,080,395 and the debt discount was valued at $1,250,395. As of June 30, 2011, this value was calculated to be $0. During the year ended June 30, 2011, the holder converted $346,501 of principal and $224,400 of interest into 66,172,223 shares of common stock and amortization of debt discount amounted to $222,081, reducing the balance to $0.

Arrangement #7 (JMJ Financial, Inc.)

On September 30, 2009, the Company issued a 12% convertible note maturing on September 23, 2012 in the principal amount of $1,200,000 to JMJ Financial for a purchase price of $1,100,000. The Company initially received $150,000 in cash as partial payment of the purchase price for the Convertible Note plus a 13.2% secured promissory note maturing on August 10, 2012 in the amount of $950,000. Through June 30, 2011the Company has received a total of $1,200,000 of principle and $144,000 of interest for full funding of the purchase price of this note. Upon receipt, in full, of cash by the Company equaling the purchase price of the convertible note plus interest or any portion thereof payable through maturity, the holder may convert such portion of the total amount of interest funded that would accrue to maturity into additional shares of common stock .The number of shares into which this convertible note can be converted is equal to the dollar amount of the note divided by 75% of the lowest trading price during the 20 day trading period prior to conversion.

Based upon the price of the Company’s common stock on June 30, 2010 of $.0162 per share the holder could convert the remaining principal amount plus interest of this convertible note into approximately 110,617,784 shares of common stock.

At the commitment date, the derivative value of the embedded conversion feature of such security was $480,000 and the debt discount was valued at $580,000. As of June 30, 2011, this value was calculated to be $0. During the twelve months ended June 30, 2011, the holder converted $1,200,000 of principle and $144,000 of interest into 240,722,223 shares of common stock and the amortization of debt discount amounted to $386,668, reducing the debt and debt discount balances to $0.

78


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

Arrangement #8 (JMJ Financial, Inc.)

On November 17, 2009, the Company received a total of $186,000 of proceeds in connection with a new financing agreement with JMJ Financial. This transaction consists of the following: 1) a convertible note in the amount of $1,200,000 plus a one-time interest factor of 12% ($144,000) and a maturity date of September 23, 2012 and (2) a secured promissory note in the amount of $1,100,000 plus a one-time interest rate factor of 13.2% ($144,000 each) and a maturity date of September 23, 2012 due from the holder of the convertible note. Conversion of outstanding principal into shares of common stock is at the option of the holder. The number of shares into which this note can be converted is equal to the dollar amount of the note divided by 75% of the lowest trade price during the 20 day trading period prior to conversion.

To date the Company has received a total of $639,500 in cash and has issued 10,000,000 shares of common stock to the holder upon conversions of $33,750. The remaining $604,600 of cash to be received from the holder plus accrued and unpaid interest is convertible into shares of common stock at the option of the holder. Upon receipt, in full, of cash by the Company equaling the purchase price of the convertible note plus interest or any portion thereof payable through maturity, the holder may convert such portion of the total amount of interest funded that would accrue to maturity into additional shares of common stock . Based upon the price of the Company’s common stock on June 30, 2011 of $.0073 per share the holder could convert the remaining principal amount plus interest of this convertible note into approximately 222,142,857 shares of common stock at the full contract value; of which the derivative liability associated with this arrangement is calculated.

The Company and the holder are presently negotiating potential amendments to this agreement, and funding and conversions have not occurred since April, 2011. For accounting purposes the note receivable has been fully reserved, and the liability is recorded, when netted against the debt discount and cumulative conversions, at the amount funded. Based upon the price of the Company’s common stock on June 30, 2011, the net liability of this note is convertible into approximately 115,380,952 shares of common stock. At the commitment date, the derivative value of the embedded conversion feature of such security was $536,000 and the debt discount was valued at $636,000. As of June 30, 2011, this value was calculated to be $472,773. During the year ended June 30, 2011, the holder converted $33,750 of principal into 10,000,000 shares of common stock and amortization of debt discount amounted to $412,332, reducing the debt discount balance to $100,000.

Arrangement #9 (JMJ Financial, Inc.)

On December 15, 2009, the Company entered into a new financing agreement with JMJ Financial that consists of the following: 1) a convertible note issued by the Company in the amount of $1,500,000 plus a one-time interest factor of 12% ($180,000) and a maturity date of December15, 2012 and (2) a secured promissory note in the amount of $1,400,000 plus a one-time interest rate factor of 13.2% ($180,000 ) and a maturity date of December 15, 2012 due from the holder of the convertible note. To date the Company has received a total of $300,000 cash and has issued no shares of common stock to the holder upon conversions. The remaining $1,280,000 of cash to be received from the holder plus accrued and unpaid interest is convertible into shares of common stock at the option of the holder. Upon receipt, in full, of cash by the Company equaling the purchase price of the convertible note plus interest or any portion thereof payable through maturity, the holder may convert such portion of the total amount of interest funded that would accrue to maturity into additional shares of common stock. The number of shares into which this convertible note can be converted is equal to the dollar amount of the note divided by 75% of the lowest trade price during the 20 day trading period prior to conversion. Based upon the price of the Company’s common stock on June 30, 2011 of $.0073 per share the holder could convert the remaining principal amount plus interest of this convertible note into approximately 285,714,286 shares of common stock at the full contract value; of which the derivative liability associated with this arrangement is calculated.

The Company and the holder are presently negotiating potential amendments to this agreement, and funding and conversions have not occurred since April, 2011. For accounting purposes the note receivable has been fully reserved, and the liability is recorded, when netted against the debt discount and cumulative conversions, at the amount funded. Based upon the price of the Company’s common stock on June 30, 2011, the net liability of this note is convertible into approximately 38,095,238 shares of common stock..At the commitment date, the derivative value of the embedded conversion feature of such security was $542,714 and the debt discount was valued at $642,714. As of June 30, 2011, this value was calculated to be $607,994. During the year ended June 30, 2011, amortization of debt discount amounted to $418,552, reducing the balance to $100,000.

79


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

Arrangement #10 (JMJ Financial, Inc.)

On April 5, 2010, the Company entered into a new financing agreement with JMJ Financial that consists of the following: 1) a convertible note issued by the Company in the principal amount of $1,200,000 plus a one-time interest factor of 12% ($144,000) and a maturity date of December 15, 2012, and (2) a secured promissory note from the holder of the convertible note in the amount of $1,100,000 plus a one-time interest rate factor of 13.2% ($144,000 each) and a maturity date of December 15, 2012. To date the Company has received a total of $100,000 cash and has issued no shares of common stock to the holder upon conversions. The remaining $1,144,000 of cash to be received from the holder plus accrued and unpaid interest is convertible into shares of common stock at the option of the holder. Upon receipt, in full, of cash by the Company equaling the purchase price of the convertible note plus interest or any portion thereof payable through maturity, the holder may convert such portion of the total amount of interest funded that would accrue to maturity into additional shares of common stock .The number of shares into which this convertible note can be converted is equal to the dollar amount of the note divided by 75% of the lowest trade price during the 20 day trading period prior to conversion. Based upon the price of the Company’s common stock on June 30, 2011 of $.0073 per share the holder could convert the remaining principal amount plus interest of this convertible note into approximately 228,571,429 shares of common stock at the full contract value; of which the derivative liability associated with this arrangement is calculated.

The Company and the holder are presently negotiating potential amendments to this agreement, and funding and conversions have not occurred since April, 2011. For accounting purposes the note receivable has been fully reserved, and the liability is recorded, when netted against the debt discount and cumulative conversions, at the amount funded. Based upon the price of the Company’s common stock on June 30, 2011, the net liability of this note is convertible into approximately 19,047,619 shares of common stock. At the commitment date, the derivative value of the embedded conversion feature of such security was $421,891 and the debt discount was valued at $521,891. As of June 30, 2011, this value was calculated to be $486,795. During the year ended June 30, 2011, amortization of debt discount amounted to $378,761, reducing the balance to $100,000.

Arrangement #11 (J. Fife)

On March 5, 2010, the Company entered into an new financing agreement with J. Fife that consist of a convertible note issued by the Company in the principal amount of $550,000 bearing interest at 7.5% per annum in which the Company received $495,000 cash up front. The Convertible Note has a maturity date of one year from the date of issuance. In addition, the Company had committed to issue in the future 2 additional promissory notes each in the principal amount of $275,000 each with an interest rate of 7.5% each upon the receipt of $250,000 of cash funding in exchange for such notes. The issuance of each of such notes was expected to take place upon the full conversion of the holder of its previous note into common stock of the Company. As of June 30, 2011, the 2 additional promissory notes are expected to be cancelled as part of a new extension and forbearance agreement the Company is presently renegotiating with the holder. Conversion of each of the Convertible Notes into common stock of the Company is at the option of the holder at a price equal to the dollar amount of the note being converted divided by 75% of the three lowest volume weighted average prices during the 20 day trading period immediately preceding the date of conversion. At the time of the transaction (March 5, 2010) the derivative value of this security was calculated to be $193,767 and the debt discount was valued at $243,767. As of June 30, 2010 and 2011, this liability was estimated to be $396,291 and $78,059, respectively, creating a non-cash credit to earnings of $318,232 in fiscal 2011. During the year ended June 30, 2011, the holder converted $398,245 of principal into 65,280,866 shares of common stock and amortization of debt discount amounted to $ 227,621, reducing the balance of the debt discount to $0.

80


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

On October 22, 2010, the Company entered into a Forbearance Agreement with this convertible note holder in which the lender agreed not to convert any additional amounts under the convertible notes until January 15, 2011, in exchange for increasing the original principal amount of those notes by 10% from $550,000 to $605,000 resulting in a charge of $55,000 for debt extension fees corresponding with the addition to the note principal. At the time of the October 22, 2010 transaction, the embedded conversion feature of this security for this incremental liability and loan discount was calculated to be $20,005. On June 30, 2011, given the changes in the Company’s stock price during the 20 day look-back period for June 30, 2011, this estimated liability decreased to $15,556; a decrease for the period from October 22, 2010 through June 30, 2011 of $4,449, creating a non-cash credit to earnings for the period ended June 30, 2011 of that amount. During the same period ended June 30, 2011, amortization of debt discount amounted to $20,005 reducing the balance to $0. Also, as of June 30, 2011, $30,000 of additional interest was accrued and $28,000 intervention fees were added to principle on the original note, consistent with the terms of a new extension and forbearance agreement the Company is presently renegotiating with the holder. This note which was originally scheduled to mature March 4, 2011 is expected to be extended to June 30, 2012. These increases in the convertible note will also be convertible into common stock of the Company at the option of the holder at a price equal to the dollar amount of the note being converted divided by 75% of the three lowest volume weighted average prices during the 20 day trading period immediately preceding the date of conversion. Based upon the price of the Company's common stock on June 30, 2011 of $.0073 per share, the holder could convert the remaining principal amount plus interest of this convertible note into approximately 55,845,329 shares of common stock

The following table summarizes notes receivable under convertible debt and debenture agreements as of June 30, 2010 and June 30, 2011:

  June 30, 2010  June 30, 2011 
  Amount  Amount 
Arrangement #5- LaJolla Cove Investors, Inc.$ 1,800,000 $ - 
less: reserve for utilization -LaJolla Cove Investors, Inc$ (600,000)$ - 
Arrangement #7 - JMJ Financial, Inc$ 950,000 $ - 
Arrangement #8 - JMJ Financial, Inc$ 914,000 $ - 
Arrangement #9 - JMJ Financial, Inc$ 1,100,000 $ - 
Arrangement #10 - JMJ Financial, Inc$1,000,000 $ - 
           total notes receivable$ 5,164,000 $ - 
           less: current portion, expected to be drawn within a year$(2,700,000)$ - 
                                     Notes Receivable-long term portion$ 2,464,000 $ - 

The following table summarizes notes payable under convertible debt and debenture agreements as of June 30, 2010 and June 30, 2011:

  June 30, 2010    June 30, 2011 
  Amount    Amount 
Arrangement #5- LaJolla Cove Investors, Inc.$ 1,810,000  (**1 ) 10,000 
less: reserve for utilization -LaJolla Cove Investors, Inc$ (600,000)$  - 
Arrangement #6 - JMJ Financial, Inc$ 346,500 $  - 
Arrangement #7 - JMJ Financial, Inc$ 1,200,000 $  - 
Arrangement #8 - JMJ Financial, Inc$ 1,200,000 $  705,750 
Arrangement #9 - JMJ Financial, Inc$ 1,500,000 $  400,000 
Arrangement #10 - JMJ Financial, Inc$ 1,200,000 $  200,000 
Arrangement #11 - J. Fife$ 550,000  (**2 ) 234,755 
           total notes payable$ 7,206,500 $  1,550,505 
           less: unamortized debt discount$ (2,628,790)$  (300,000)
                                 Convertible Notes payable-long term portion$ 4,577,710 $  1,250,505 

(**1) INCLUDES BALANCE DUE TO ASSIGNEE SUBSEQUENT TO SETTLEMENT OF MARCH 17, 2011
(**2) INCLUDES INCREMENTAL LIABILITY SUBSEQUENT TO AMENDMENT DATED OCTOBER 22, 2010

81


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

A summary of our arrangements for notes payable and notes receivable under convertible debt and debenture agreements with activity from July1, 2010 to and as of September 30, 2011 is as follows:

Arrangement #1(La Jolla Cove Investors, Inc.)

On Sept 11, 2008, the Company received proceeds of $200,000 under a Securities Purchase Agreement from La Jolla Cove Investors, Inc. This transaction involves three related agreements: 1) a Securities Purchase Agreement which may under certain circumstances permit the Company to draw up to $2,000,000 of funds, 2) a convertible debenture totaling $2,000,000, with an interest rate of 7 1/4% and a maturity date of September 30, 2011, and 3) a secured note receivable in the amount of $1,800,000 with an interest rate of 8 1/4% and maturity date of September 30, 2011 due from the holder of the convertible debenture.

Conversion of outstanding debentures into common shares is at the option of the holder at a price equal to the dollar amount of the debenture divided by the lesser of $.35 per share or 80% of the three lowest volume weighted average prices during a 20 day trading period. At the time of the transaction (September 11, 2008), the derivative value of this security was calculated to be $1,176,471. On June 30, 2011, the derivative value of this security was calculated to be $3,468.

On March 16, 2011, the holder and the Company entered into a termination agreement whereby $1,800,000 of the principal, for both the note receivable and the convertible debenture, plus $90,291 in accrued interest receivable and $84,175 in accrued interest payable, was cancelled. Additionally in connection with the termination, the Company paid the holder $17,000 and assigned to a consultant engaged by the Company the unconverted portion of the convertible debenture in the amount of $10,000, which had been fully funded in cash and which was converted in full together with accrued interest of $500 for 2,560,976 shares of common stock during the quarter ended September 30, 2011 and as of September 30, 2011, this convertible note has been satisfied in full.

Arrangement #2 (JMJ Financial, Inc.)

On November 17, 2009, the Company received a total of $186,000 of proceeds in connection with a new financing agreement with JMJ Financial. This transaction consists of the following: 1) a convertible note payable in the amount of $1,200,000 plus a one-time interest factor of 12% ($144,000) and a maturity date of September 23, 2012, and (2) a secured promissory note receivable in the amount of $1,100,000 plus a one-time interest rate factor of 13.2% ($144,000 each) and a maturity date of September 23, 2012 due from JMJ Financial. Conversion of outstanding principal into shares of common stock is at the option of the holder. The number of shares into which this note can be converted is equal to the dollar amount of the note divided by 75% of the lowest trade price during the 20 day trading period prior to conversion.

At the commitment date, the derivative value of the embedded conversion feature of such security was $536,000 and the debt discount was valued at $636,000. As of June 30, 2011, this value was calculated to be $472,773. During the year ended June 30, 2011 the holder converted $33,750 of principal into 10,000,000 shares of common stock and amortization of debt discount amounted to $412,332, reducing the debt discount balance to $100,000. On September 30, 2011, given the changes in the Company’s stock price during the 20 day look-back period for September 30, 2011, this estimated liability had decreased to $235,517, a decrease this period of $237,206, creating a non-cash credit to earnings for the three months ended September 30, 2011 of that amount. During the three month period ended September 30, 2011, the Company reduced the note payable and debt discount by $42,000 in proportion with the amount funded to the total original funding commitment and amortization of debt discount amounted to $11,600 reducing the balance to $43,400. Also during the three months ended September 30, 2011 $54,456 of principle was converted into 14,187,500 shares of common stock. As of September 30, 2011, this convertible note has $609,294 outstanding.

Based upon the price of the Company’s common stock on June 30, 2011 of $.0073 per share the holder could convert the remaining principal amount plus interest of this convertible note into approximately 222,142,857 shares of common stock at the full contract value; of which the derivative liability associated with this arrangement is calculated. Based upon the price of the Company’s common stock on September 30, 2011 of $.0047 per share the holder could convert the remaining principal amount plus interest of this convertible note into approximately 277,948,500 shares of common stock at the full contract value; of which the derivative liability associated with this arrangement is calculated.

The Company and the holder negotiated amendments to this agreement, and funding and conversions did not occur between April, 2011 and September, 2011, when the agreement was revised to have a floor conversion price of $.0040. For accounting purposes the note receivable has been fully reserved, and the liability is recorded, when netted against the debt discount and cumulative conversions, at the amount funded. Based upon the price of the Company’s common stock on June 30, 2011, the net liability of this note is convertible into approximately 115,380,952 shares of common stock. Based upon the price of the Company’s common stock on September 30, 2011, the net liability of this note is convertible into approximately 152,323,500 shares of common stock.

82


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

Arrangement #3 (JMJ Financial, Inc.)

On December 15, 2009, the Company entered into a new financing agreement with JMJ Financial that consists of the following: 1) a convertible note issued by the Company in the amount of $1,500,000 plus a one-time interest factor of 12% ($180,000) and a maturity date of December15, 2012, and (2) a secured promissory note receivable in the amount of $1,400,000 plus a one-time interest rate factor of 13.2% ($180,000 ) and a maturity date of December 15, 2012 due from JMJ Financial. The number of shares into which this convertible note can be converted is equal to the dollar amount of the note divided by 75% of the lowest trade price during the 20 day trading period prior to conversion. To date the Company has received a total of $300,000 cash and has issued no shares of common stock to the holder upon conversions.

At the time of the transaction, the derivative value of the embedded conversion feature of this security was calculated to be $542,714. As of June 30, 2011, this value was calculated to be $607,994. During the year ended June 30, 2011 amortization of debt discount amounted to $418,552, reducing the debt discount balance to $100,000. On September 30, 2011, given the changes in the Company’s stock price during the 20 day look-back period for September 30, 2011, this estimated liability had decreased to $317,753, a decrease this period of $290,241, creating a non-cash credit to earnings for the three months ended September 30, 2011 of that amount. During the three month period ended September 30, 2011, the Company reduced the note payable and debt discount by $79,000 in proportion with the amount funded to the total original funding commitment and amortization of debt discount amounted to $3,600 reducing the balance to $17,400. As of September 30, 2011, this convertible note has $321,000 outstanding.

Based upon the price of the Company’s common stock on June 30, 2011 of $.0073 per share the holder could convert the remaining principal amount plus interest of this convertible note into approximately 285,714,286 shares of common stock at the full contract value; of which the derivative liability associated with this arrangement is calculated. Based upon the price of the Company’s common stock on September 30, 2011 of $.0047 per share the holder could convert the remaining principal amount plus interest of this convertible note into approximately 375,000,000 shares of common stock at the full contract value; of which the derivative liability associated with this arrangement is calculated.

The Company and the holder negotiated amendments to this agreement, and funding and conversions did not occur between April, 2011 and September, 2011, when the agreement was revised to have a floor conversion price of $.0040. For accounting purposes the note receivable has been fully reserved, and the liability is recorded, when netted against the debt discount and cumulative conversions, at the amount funded. Based upon the price of the Company’s common stock on June 30, 2011, the net liability of this note is convertible into approximately 38,095,238 shares of common stock. Based upon the price of the Company’s common stock on September 30, 2011, the net liability of this note is convertible into approximately 80,250,000 shares of common stock.

Arrangement #4 (JMJ Financial, Inc.)

On April 5, 2010, the Company entered into a new financing agreement with JMJ Financial that consists of the following: 1) a convertible note issued by the Company in the principal amount of $1,200,000 plus a one-time interest factor of 12% ($144,000) and a maturity date of December 15, 2012, and (2) a secured promissory note receivable from JMJ Financial in the amount of $1,100,000 plus a one-time interest rate factor of 13.2% ($144,000) and a maturity date of December 15, 2012. The number of shares into which this convertible note can be converted is equal to the dollar amount of the note divided by 75% of the lowest trade price during the 20 day trading period prior to conversion. To date the Company has received a total of $100,000 cash and has issued no shares of common stock to the holder upon conversions.

At the time of the transaction, the derivative value of the embedded conversion feature of this security was calculated to be $421,891 and at June 30, 2011, the estimated liability was calculated to be $486,795. During the year ended June 30, 2011 amortization of debt discount amounted to $378,761, reducing the debt discount balance to $100,000. On September 30, 2011, given the changes in the Company’s stock price during the 20 day look-back period for September 30, 2011, this estimated liability had decreased to $254,203, a decrease this period of $232,592, creating a non-cash credit to earnings for the three months ended September 30, 2011 of that amount. During the three month period ended September 30, 2011, the Company reduced the note payable and debt discount by $91,000 in proportion with the amount funded to the total original funding commitment and amortization of debt discount amounted to $1,543 reducing the balance to $7,457. As of September 30, 2011, this convertible note has $109,000 outstanding.

83


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

Based upon the price of the Company’s common stock on June 30, 2011 of $.0073 per share the holder could convert the remaining principal amount plus interest of this convertible note into approximately 228,571,429 shares of common stock at the full contract value; of which the derivative liability associated with this arrangement is calculated. Based upon the price of the Company’s common stock on September 30, 2011 of $.0047 per share the holder could convert the remaining principal amount plus interest of this convertible note into approximately 300,000,000 shares of common stock at the full contract value; of which the derivative liability associated with this arrangement is calculated.

The Company and the holder negotiated amendments to this agreement, and funding and conversions did not occur between April, 2011 and September, 2011, when the agreement was revised to have a floor conversion price of $.0040. For accounting purposes the note receivable has been fully reserved, and the liability is recorded, when netted against the debt discount and cumulative conversions, at the amount funded. Based upon the price of the Company’s common stock on June 30, 2011, the net liability of this note is convertible into approximately 19,047,619 shares of common stock. Based upon the price of the Company’s common stock on September 30, 2011, the net liability of this note is convertible into approximately 27,250,000 shares of common stock.

Arrangement #5 (J. Fife)

On March 3, 2010, the Company entered into a financing agreement with J. Fife that consisted of a convertible note issued by the Company in the principal amount of $550,000 bearing interest at 7.5% per annum in which the Company received $495,000 cash up front. The convertible note has a maturity date of 4 years from the date of issuance. In addition, the Company has committed to issue in the future 2 additional promissory notes each in the principal amount of $275,000, each with an interest rate of 7.5% and each upon the receipt of $250,000 of cash funding in exchange for such notes. The issuance of each of such notes is expected to take place upon the full conversion by the holder of its previous note into common stock of the Company. Conversion of each of the convertible notes into common stock of the Company is at the option of the holder at a price equal to the dollar amount of the note being converted divided by 75% of the three lowest volume weighted average prices during the 20 day trading period immediately preceding the date of conversion.

At the time of the transaction, the embedded conversion feature of this security was calculated to be $193,767 and the loan discount totaled $243,767 and at June 30, 2011, the estimated liability was calculated to be $78,065 and the debt discount had been amortized to $0. Also during the year ended June 30, 2011 approximately $30,000 of additional interest and $28,000 of intervention fees were added to the note balance for exceeding the first anniversary and the curtailment of conversions in April, 2011. On September 30, 2011, given the changes in the Company’s stock price during the 20 day look-back period for September 30, 2011 and conversions during the period this estimated liability had decreased to $28,069, a decrease this period of $49,996, creating a non-cash credit to earnings for the three months ended September 30, 2011 of that amount.

On October 22, 2010 the Company entered into a Forbearance Agreement with holder J. Fife in which J. Fife agreed not to convert any additional amounts under the convertible notes until January 15, 2011 in exchange for increasing the original principal amount of those notes by 10% from $550,000 to $605,000. This increase in the convertible notes is also convertible into common stock of the Company at the option of the holder at a price equal to the dollar amount of the note being converted divided by 75% of the three lowest volume weighted average prices during the 20 day trading period immediately preceding the date of conversion.

At the time of the transaction, the embedded conversion feature of this security for this incremental liability and loan discount was calculated to be $20,005 and at June 30, 2011, the estimated liability was calculated to be $15,556 and the debt discount had been amortized to $0. On September 30, 2011, given the changes in the Company’s stock price during the 20 day look-back period for September 30, 2011, this estimated liability decreased to $11,651, a decrease for the period from June 30, 2011 through September 30, 2011 of $3,905 creating a non-cash charge to earnings for the quarter ended September 30, 2011 of that amount.

84


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

On September 13, 2011 the Company entered into a second Forbearance Agreements with John Fife restructuring the investment. Under the terms of the Forbearance Agreement the agreed principal and accrued interest amount of the Convertible Note outstanding was $328,000 and the two additional promissory notes were cancelled. The Convertible Note which originally scheduled to mature March 4, 2011was extended until June 30, 2012 and a floor of $.0040 was put in the conversion price feature. Increases in the principal amount of the convertible note are also be convertible into common stock of the Company at the option of the holder at a price equal to the dollar amount of the note being converted divided by 75% of the three lowest volume weighted average prices during the 20 day trading period immediately preceding the date of conversion. During the three months ended September 30, 2011 $47,250 of principle was converted into 10,000,000 shares of common stock.

As of September 30, 2011, this convertible note has a total of $187,505 of principle and $93,245 of accrued interest outstanding, convertible into 46,876,218 shares of common stock.

Arrangement #6 (J. Wright)

On August 11, 2011 the Company issued to Jay Wright a Convertible Note plus a Warrant in a Private Placement pursuant to Section 4(2) of the Securities Act of 1933 and received $25,000 in gross proceeds. The instrument is in the principal amount of $25,000 and matures on February 11, 2011. Interest only is payable at the rate of 1% per month by the Company to the holder until maturity. The Convertible Note may be converted into common stock of the Company at $.0068 per share, provided, however, such price may be adjusted downward if the Company issues any common stock below such price. The Warrant gives the holder the right for a period of 5 years to purchase up to 3,676,471 shares of the Company’s common stock also at $.0068 per share subject also to a downward adjustment to provide anti-dilution protection.

All proceeds received in connection with the above financing have been used by the Company as working capital.

At the time of the transaction, the embedded conversion feature of this security and the warrant was calculated to be $4,660 and the loan discount totaled the same. On September 30, 2011, given the changes in the Company’s stock price during the 20 day look-back period for September 30, 2011 and conversions during the period this estimated liability had increased to $8,411, an increase this period of $3,751, creating a non-cash charge to earnings for the three months ended September 30, 2011 of that amount. During the three month period ended September 30, 2011 amortization of debt discount amounted to $1,306 reducing the balance to $3,354.

As of September 30, 2011, this convertible note has $25,000 of principle and $400 of accrued interest outstanding, convertible into 6,250,000 shares of common stock.

Arrangement #7 (St. George Investments)

On September 13, 2011, the Company issued a second Convertible Note to John Fife founder and president of St. George Investments, in a Private Placement pursuant to Section 4(2) of the Securities Act of 1933. The initial principal amount of the first funded tranche of the Convertible Note was $357,500 and the Company received cash proceeds of $300,000. A second tranche of the Convertible Note in the amount of $200,000 cash is funded upon the filing by the Company of a Registration Statement on Form S-1 with the Securities and Exchange Commission providing for the registration of 185,400,000 shares of common stock that may be converted into from time to time by the holder of the Convertible Note. The instrument is convertible into the Company’s common stock at 75% of the volume weight average price of the stock based upon the average of the three lowest trading days in the 20 day trading period immediately preceding such conversion. Absent an effective Registration Statement, the holder of the Convertible Note may not sell any common stock prior to 6 months from the date of funding of each of the respective tranches of such instrument under Rule 144 of the Securities Act of 1933.

All proceeds received in connection with the above financing have been used by the Company as working capital.

At the time of the transaction, the embedded conversion feature of this security and the warrant was calculated to be $137,481 and the loan discount totaled 194,981. On September 30, 2011, given the changes in the Company’s stock price during the 20 day look-back period for September 30, 2011 and conversions during the period this estimated liability had decreased to $97,614, a decrease this period of $39,868, creating a non-cash credit to earnings for the three months ended September 30, 2011 of that amount. During the three month period ended September 30, 2011 amortization of debt discount amounted to $10,993 reducing the balance to $183,987. As of September 30, 2011, this convertible note has $357,500 of principle and $1,250 of accrued interest outstanding, convertible into 95,016,611 shares of common stock.

85


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

The following table summarizes notes payable under convertible debt and debenture agreements as of June 30, 2011 and September 30, 2011 (unaudited):

  June 30, 2011  September 30, 2011 
     (unaudited)��
  Amount  Amount 
Arrangement #1- LaJolla Cove Investors, Inc. (…1)$ 10,000 $ - 
     less: reserve for utilization -LaJolla Cove Investors, Inc$ - $ - 
Arrangement #2 - JMJ Financial, Inc$ 705,750 $ 609,294 
Arrangement #3 - JMJ Financial, Inc$ 400,000 $ 321,000 
Arrangement #4 - JMJ Financial, Inc$ 200,000 $ 109,000 
Arrangement #5 - J. Fife$ 234,755 $ 187,505 
Arrangement #6 - Jay Wright$ - $ 25,000 
Arrangement #7 - St. George Investments$ - $ 357,500 
             total notes payable$ 1,550,505 $ 1,350,701 
             less: unamortized debt discount$ (300,000)$ (258,598)
                           Convertible Notes payable-long term portion$ 1,250,505 $ 1,092,103 

During the three months ending September 30, 2011 and 2010, the following transactions impacted stockholders equity

Private Placements

During the three months ended September 30, 2011, the Company issued 20 million shares of its common stock in connection with private placements pursuant to Rule 506 of Regulation D of the Securities Act of 1933, as amended, raising gross proceeds of $80,000 and paying finder’s fees in the amount of $8,000. The proceeds were used by the Company as working capital.

During the three months ended September 30, 2010, the Company did not issue any shares of its common stock in connection with private placements.

Stock Based Compensation

During the three months ended September 30, 2011, the Company issued 1,035,000,000 shares of common stock to officers and directors, valued at $ 6,520,500, the entire amount of which is included general and administrative expenses in theConsolidated Statements of Operations for that period. Also during the three months ended September 30, 2011, the Company issued no shares of its common stock to consultants and the Board of Directors revised the exercise price of options to purchase up to 98,000,000 shares of common stock previously granted to officers inSeptember, 2008 (originally exercisable for 5 years with an exercise price of 5 cents per share). The exercise price of options to purchase up to 98,000,000 shares was revised to $.0040; the incremental cost of $339,700 was recorded as deferred compensation which will be amortized to expense through September 18, 2013.

During the three months ended September 30, 2010, the Company did not issue any stock-based compensation, warrants or options to officers or employees and issued 5,075,000 shares of its common stock to consultants valued at $62,945, the entire amount of which is included general and administrative expenses in theConsolidated Statements of Operations for that period.

Conversion of Debt Securities

During the three months ended September 30, 2011, $112,206 of convertible debt and accrued interest thereon was converted into 26,748,476 shares of common stock.

During the three months ended September 30, 2010, $650,587 of convertible debt and accrued interest thereon was converted into 72,133,538 shares of common stock.

86


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

During the fiscal year ending June 30, 2011, the following transactions impacted stockholders equity

Private Placements

During the fiscal year ended June 30, 2011, the Company received $ 265,500 of net proceeds from the issuance of 67,500,000 shares of common stock in private placements with accredited investors, which included $50,000 of stock subscriptions that were collected on July 6, 2011. The aggregate cost of such placements was $ 29,500.

Stock Based Compensation

The Company did not issue any awards of common stock or options to Officers, Directors or Employees during the fiscal year ended June 30, 2011.

Conversion of debt securities

During the fiscal year ended June 30, 2011, $ 2,346,896 of debt was converted into 382,175,312 shares of common stock to holders of Convertible Notes.

Reparations

The Company did not issue any shares to investors for reparations.

During the fiscal year ending June 30, 2010, the following transactions impacted stockholders equity

Private Placements

During the fiscal year ended June 30, 2010, the Company received $225,000 of net proceeds from the issuance of 30,666,667 shares of common stock in private placements with accredited investors. The aggregate cost of such placements was $25,000.

Stock Based Compensation

The Company did not issue any awards of common stock or options to Officers, Directors or Employees during the fiscal year ended June 30, 2010. The Company issued 1,575,000 shares of common stock to various vendors and consultants valued at a total of $34,313 based upon the market price of the common stock on various different dates to such persons during the period.

Conversion of debt securities

During the fiscal year ended June 30, 2010, $3,415,250 of debt was converted into 232,723,736 shares of common stock to holders of Convertible Notes. In addition the Company issued 26,666,667 shares of common stock to Microphase Corporation for the conversion of $200,000 of previously outstanding accounts payable at $.0075 per share. The price was based upon the price offered to investors in concurrent private placements with accredited investors during this period. The Company recorded an addition to interest expense on this beneficial conversion feature.

Reparations

On November 19, 2009, an investor received 1,700,000 shares of common stock valued at $35,530 for reparation of a prior investment of $50,000 for the issuance of 5,000,000 shares of common stock.

87


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

During the Fiscal Year Ended June 30, 2009 the following transactions impacted stockholders equity

Private Placements

During the quarter ended September 30, 2008, the Company issued 4,000,000 shares of its common stock at $.05 per share in private placements, generating net proceeds of $180,000. Related to this transaction was the issuance of 3,862,000 shares as reparations shares to effect re-pricing at a cost estimated to be $216,689.

No private placements occurred in the quarter ending December 31, 2008.

During the quarter ended March 31, 2009, the Company issued 35,000,000 shares of its common stock at $.01 per share in private placements generating net proceeds of $315,000. Related to these transactions was the issuance of 7,660,000 shares as reparations shares to effect re-pricing, costing an estimated $99,483.

During the quarter ended June 30, 2009, the Company issued 33,333,333 shares of its common stock at $.0075 per share in private placements generating gross proceeds of $225,000. Related to these transactions was the issuance of 2,000,000 shares as reparations shares to effect re-pricing, costing an estimated $64,000 and finder's fees of $25,000.

Also during the quarter ended June 30, 2009, the Company issued 20,775,000 shares in settlement of $169,875 of prior promissory notes payable plus accrued interest and incurred a beneficial conversion of $114,500.

Stock Based Compensation

During the three months ended September 30, 2008, the Company issued 5 year options to purchase 104,675,000 shares of common stock at $.05 per share. The value of such options was estimated to be $4,071,348 using the Black Scholes method, based on an assumed volatility of 78% and an interest rate of 1.5% . In addition, 61,750,000 shares of common stock valued at $3,525,615 were issued to employees and consultants. (See note 3.)

No such transactions occurred in the quarters ending December 31, 2008 and March 31, 2009.

During the quarter ended June 30, 2009, the Company granted 3 officers of the Company the right to convert an aggregate of $1,465,992 of loans and accrued and unpaid compensation and accrued interest into common stock of the Company at a price of $.0075 per share.

Conversion of debt securities

During the fiscal year ended June 30, 2009, $3,303,333 of debt was converted into 278,346,019 shares of common stock. Included in this amount is $112,500 of notes payable to a related party which were sold to an investor for $112,500 cash and subsequently converted into 15,000,000 shares of the Company's common stock valued at $.0075 per share. Additionally $57,375 of prior notes plus accrued interest outstanding was settled by the issuance of 5,775,000 shares of common stock. All other debt converted involved long term convertible debentures.

88


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

Reparations

During the year ended June 30, 2009, the Company issued certain shares to effect re-pricing of prior private placements and to induce new investments as summarized of the following table:

     REPARATION     PRIOR  NEW  NEW  TOTAL 
DATE    SHARES  VALUE  INVESTMENT    INVESTMENT    INVESTMENT      
                 SHARES    
9/30/2008 INVESTOR 1  3,862,000 $216,689 $1,000,000  $200,000  4,000,000 $ 216,689 
3/25/2009 INVESTOR 2  7,660,000  $99,483  $520,000  $150,000  15,000,000 $ 99,483 
4/15/2009 INVESTOR*3  1,000,000  $12,000  $1,126,723 $-  - $ 12,000 
5/15/2009 INVESTOR*3  1,000,000 $20,000 $ $-  - $ 20,000 
6/15/2009 INVESTOR*3  1,000,000 $20,000 $ $  - $ 20,000 
6/29/2009 INVESTOR 4  5,000,000 $64,000 $250,000  $50,000  5,000,000 $ 64,000 
TOTALS    19,522,000 $432,172 $2,896,723  $400,000  24,000,000 $ 431,172 
                      
Note: INVESTOR*3  3,000,000 $52,000          $ 52,000 
                       REPARATION of INVESTOR 3 was for conversion of debt                

BENEFICIAL CONVERSION FEATURE

In April 2009, the Board of Directors authorized the right for the officers to convert into shares of the Company's common stock officers' loans discussed in Note 9, plus accrued interest thereon, at any time for the next five years providing such shares are issued, outstanding and available, at a conversion price of $.0075. The officers' notes plus accrued interest are convertible into approximately 116,763,169 shares of the Company's common stock based upon the conversion terms at June 30, 2011 (see note 13).

Other Equity

During the years ended June 30, 2008 and 2009, the Company reevaluated warrants contracts to purchase 13,104,168 shares at fixed prices ranging from $.05 to $.15 per share originally issued during fiscal year ended June 30, 2008 pursuant to FASB Standards Codification Topic 815 (previously known as EITF 00-19). Such reevaluation was to review if the Company should record an additional derivative liability which would be recordable if the other convertible instruments the Company has outstanding, primarily the convertible debentures discussed above, would limit or prevent the Company from honoring the conversion of these fixed price warrants during their contract term. The evaluation was performed on a contract by contract basis on equity instruments subject to FASB Standards Codification Topic 815 (previously known as EITF 00-19), namely warrants discussed above and the convertible debenture agreements. The Company utilized a sequencing method prescribed by FASB Standards Codification Topic 815 (previously known as EITF 00-19), applying shares available to contracts with the earliest inception date first.

During the fiscal year ended June 30, 2008, the Company reclassified contracts for warrants to purchase 12,604,168 shares at fixed prices ranging from $.13 to $.15 per share to contingent liabilities. Contracts for warrants to purchase 11,111,112 shares of the Company’s common stock at $.14 per share were reclassified to permanent equity in May of 2009, and contracts for warrants to purchase 1,604,168 shares of the Company’s common stock at fixed prices ranging from $.13 to $.15 per share were reclassified to permanent equity in September, 2009. The liability was recorded at the fair market value, such estimated value, as restated, was based upon the contractual life of the free standing warrants, using the Black Sholes pricing model, based on the following weighted average assumptions: annual expected return of 0%, an average life of 5 years, annual volatility of 81% and a risk-free interest rate 2.25% . At the issuance date of the free standing warrants, which warrants were issued during the fourth quarter of fiscal June 30, 2008, the estimated value approximated $1,006,200 and, as recalculated on the quarterly measurement dates, at June 30, 2008 the estimated value approximated $433,300. During the fiscal year ended 2009, the estimated value was determined to no longer be material. The net change in the contingent liability was credited to the change in derivative value in the Consolidated Statement of Operations for each of the fiscal years ended June 30, 2008 and 2009 for $572,900 and $433,300, respectively, in accordance FASB Standards Codification Topic 815 (previously known as EITF 00-19).

Subsequent to September 30, 2009, the Company has not entered into, and presently the Company does not have, any have contracts for warrants or other equity instruments subject to reclassification to liabilities as prescribed by FASB Standards Codification Topic 815 (previously known EITF 00-19) until August 10, 2011 when it entered into a Convertible Note for $25,000 which concurrently provided the note holder a warrant and recorded an additional derivative liability for the warrant.

89


mPHASE TECHNOLOGIES, INC
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

8. STOCKHOLDERS' EQUITY-(continued)

STOCK OPTIONS

A summary of the stock option activity for the years ended June 30, 2010 and 2011 pursuant to the terms of both plans, which include incentive stock options and non-qualified stock options, is set forth on the below:

  Number of  Weighed 
  Options  Average 
     Exercise 
     Price 
Outstanding at June 30, 2009 145,293,000 $ 0.11 
Granted 0    
Exercised 0    
Cancelled/Expired (7,775,000) (0.25)
Outstanding at June 30, 2010 137,518,000 $ .087 
Granted 0    
Exercised 0    
Cancelled/Expired (23,798) (.21)
Outstanding at June 30, 2011 113,720,000 $ $.063 

The fair value of options granted in fiscal year ended June 30, 2009 was estimated as of the date of grant using the Black-Scholes stock option pricing model, based on the following weighted average assumptions: annual expected return of 0%, an average life of 5 years, annual volatility of 80.3% and a risk-free interest rate of 3.0% in the year 2009.

The following summarizes information about stock options outstanding at June 30, 2011:

RANGE OF EXERCISE NUMBER  WEIGHTED  WEIGHTED  NUMBER  WEIGHTED 
PRICE OUTSTANDING  AVERAGE  AVERAGE  EXERCISABLE  AVERAGE 
     REMAINING  EXERCISE     EXERCISE 
     CONTRACTUAL  PRICE     PRICE 
    LIFE             
$.00-$.05 103,475,000  2.2 $ .05  103,475,000 $ .050 
$.05-$.21 10,245,000  .7 $ .195  10,245,000 $ .195 
Totals          113,720,000 $ .063 

During the quarter ended & at September 30, 2011; options to purchase 3,635,000 & 110,085,000 shares; expired & remain outstanding.

WARRANTS

During the fiscal year ended June 30, 2011, the Company issued no warrants and warrants covering 83,711,665 shares of common stock expired. During the fiscal year ended June 30, 2010, the Company issued no warrants, and warrants covering 40,953,943 shares of common stock expired. As of June 30, 2011 and 2010, warrants covering 21,480,837 and 105,192,502 shares respectively remained outstanding with a weighted average exercise price of $ 0.063 and $0.21, respectively.

The following summarizes information about warrants outstanding at June 30, 2011:

  NUMBER  WEIGHTED  WEIGHTED  NUMBER  WEIGHTED 
RANGE OF EXERCISE OUTSTANDING  AVERAGE  AVERAGE  EXERCISABLE  AVERAGE 
PRICE    REMAINING  EXERCISE     EXERCISE 
     CONTRACTUAL  PRICE     PRICE 
     LIFE          
$.00-$.15 13,104,168  1.8 $ .1350  13,104,168 $ .1350 
$16-$.21 8,376.669  .5 $ .1816  8,376,669 $ .1816 
Total          21,480,837 $ .1532 

During the quarter ended & at September 30, 2011; warrants to purchase 3,676,471, 6,208,334 & 19,323,974 shares; were issued, expired & remain outstanding.

90


mPHASE TECHNOLOGIES, INC
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

9. RELATED PARTY TRANSACTIONS

Mr. Durando, the President and CEO of mPhase, together with Mr. Ergul own a controlling interest and are officers of Janifast Limited. Mr. Durando and Mr. Dotoli are officers of Microphase Corporation. Mr. Ergul, retiredASC 820 defines “fair value” as the chairman of the board of mPhase in Nov 2007, owns a controlling interest and is a director of Microphase Corporation.

Mr. Abraham Biderman was employed until September 30, 2003, by our former investment-banking firm, Lipper & Company.

During the fiscal year ended June 30, 2007, Mr. Biderman's current firm, Eagle Advisers, Inc., as a finder of money generated finders’ fees of $520,000, as well as additional administrative and occupancy charges of $43,400. In 2008, Mr. Biderman was paid $188,472 in finders’ fees. During fiscal years ended June 30, 2009 and June 30, 2010 Mr. Biderman charged finders’ fees of $80,000 and $25,000 respectively. During the year ended June 30, 2011, Mr. Biderman charged finders’ fees of $24,500.

During fiscal year ended June 30, 2009, Messrs. Durando, Dotoli and Smiley provided no net bridge loans to the Company.

As of June 30, 2010, bridge loans outstanding, including accrued interest thereon, from Mr. Smiley equaled $183,187. As of June 30, 2010, Mr. Durando and Mr. Dotoli were owed unpaid compensation plus accrued interest thereon at 12% per annum equal to $419,436 and $268,194, respectively. On October 7, 2009, the Company paid Messrs. Durando, Dotoli and Smiley $45,000, $45,000 and $25,000 respectively in reduction of amounts owed to them by the Company for unpaid compensation and bridge loans.

In April 2009, the Board of Directors authorized the right for the officers to convert such loans plus accrued interest thereon at any time for the next five years into common shares provided such shares are issued, outstanding and available, at a conversion price of $.0075, which price is comparable to that of private placements during the period. The Company recorded beneficial conversion interest expense of $914,060, $82, 609 and $0 during the years ended June 30, 2009, June 30, 2010 and June 30, 2011, respectively, on the conversion feature based upon principal at the commitment date and accrued interest through June 30 of 2009, 2010 and 2011, respectively. On August 25, 2011, the Board amended the conversion feature of these officers’ loans to a conversion price of $.0040. During the three months ended September 30, 2011 the Company recorded beneficial conversion interest expense of $2,320.

As of June 30, 2011 and September 30, 2011, outstanding bridge loans from Mr. Smiley, including accrued interest thereon, amounted to $191,755 and $205,092, respectively. All of the promissory notes are payable on demand. As of June 30, 2011 and September 30, 2011, unpaid compensation owing to Mr. Durando and Mr. Dotoli, plus accrued interest thereon at 12% per annum, equaled $415,164 and $268,204 and $435,270 and $284,483 respectively. All of the promissory notes are payable on demand. The officers' notes plus accrued interest are convertible into approximately 116,763,169 and 231,211,415 shares of the Company's common stock based upon the conversion terms at June 30, 2011 and September 30, 2011, respectively.

MICROPHASE

The Company leases office space from Microphase at both its Norwalk and Little Falls location. As of July 1, 2011, rental expense is $3,630 and $2,347 per month at Norwalk and Little Falls, respectively. In addition, Microphase provides certain research and development services and shares administrative personnel from time to time.

During the year ended June 30, 2011, Microphase Corporation charged the Company $36,000 for rent and $9,356 for administrative expenses.

During the year ended June 30, 2010, Microphase Corporation charged the Company $36,000 for rent and $9,936 for administrative expenses and $337,500 development fees related to the Emergency Flashlight product launch included in research and development expenses. Additionally, in July 2009 Microphase Corporation converted $200,000 of accounts payable into 26,666,667 shares of the Company's common stock at $.0075 per share. Such price was determined based upon the price of private placements of equity by the Company during such period. The Company recorded beneficial conversion interest expense of $586.667 relating to this conversion. During the three months ended September 30, 2010 and September 30, 2011 and from inception (October 2, 1996), $10,529, $13,191 and $9,491,152, respectively, have been charged to expense. As a result of the foregoing transactions, as of September 30, 2011, the Company had a $31,433 payable to Microphase.

91


mPHASE TECHNOLOGIES, INC
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

9. RELATED PARTY TRANSACTIONS -(continued)

JANIFAST

During the year ended June 30, 2000, mPhase advanced money to Janifast Limited, which is owned by U.S. Janifast Holdings, Ltd, a related party of which three directors of mPhase are significant shareholders, in connection with the manufacturing of POTS Splitter shelves and DSL component products.

During the years ended June 30, 2003, 2004 and 2005 and the period from inception (October 2, 1996) to June 30, 2005, there had been $174,959, $2,771,925, 1,536,494 and $15,001,105, respectively, of invoices for products and services that had been charged to inventory or expense and is included in “discontinued operations” in the accompanying statements of operations.

During the year ended June 30, 2007, Janifast agreed to convert $108,000 of debt into 830,000 shares of common stock and received 769,231 additional shares of stock as reparations.

In March of 2009, Janifast Ltd. ceased operations owing to its financial condition and the global downturn in the capital markets.

STRATEGIC VENDORS

On August 30, 2004, the Company paid $100,000 in cash to Piper Rudnick LLP, outside legal counsel to the Company, as part of a renegotiated settlement agreement that was originally effective as of March 31, 2002. The Company was in arrears with respect to payments due under the original settlement agreement and as part of the renegotiated agreement agreed to make the following payments:

a.

$25,000 on each of December 1, 2004, March 2005, June 1, 2005, September 1, 2005 and a $50,000 payment on December 1, 2005. Thereafter the Company is obligated to pay $25,000 on each of March 1, 2006, June 1 2006, and September 1, 2006 with a final payment of $75,000 of December 1, 2006.

b.

The Company also delivered a 5 year cashless warrant to purchase $150,000 worth of common stock at $.25 per share.

The warrant was valued pursuant to EITF 96-18, the ascribed value of the warrant minus the debt cancelled, resulting in a loss of $40,500.

Equity Conversions of Debt and Other Financial Instruments with Related Parties

During the fiscal years ended June 30, 2010 and June 30, 2011, there were limited equity conversions of debt or other financial instruments with related parties.

  2010  2011 
Janifast:      
Number of shares None  None 
Number of warrants None  None 
Amount converted to equity$ None $ None 
Microphase Corporation:      
Number of shares 26,666,667  None 
Number of warrants 0  None 
Amount converted to equity$ 200,000 $ None 
Total Related Party Conversions      
Number of shares 26,666,667  None 
Number of warrants 0  None 
Amount converted to equity$ 200,000 $ None 

92


mPHASE TECHNOLOGIES, INC
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

9. RELATED PARTY TRANSACTIONS -(continued)

Summary of compensation to related parties for the Twelve Months Ended June 30, 2011

  Durando  Dotoli  Smiley  Biderman  Microphase  Total 
Consulting / Salary$ 160,000 $ 144,000 $ 140,000       $ 444,000 
Interest$ 33,728 $ 18,610 $ 16,569       $ 68,907 
Rent            $ 36,000 $ 36,000 
G&A            $ 9,356 $ 9,356 
R&D               $ 0 
Finder’s Fees         $ 24,500    $ 24,500 
Total compensation$ 193,728 $ 162,610 $ 156,569 $ 24,500 $ 45,356 $ 582,763 

Summary of compensation to related parties for the Twelve Months Ended June 30, 2010

  Durando  Dotoli  Smiley  Biderman  Microphase  Total 
Consulting / Salary$ 200,000 $ 180,000 $ 175,000       $ 555,000 
Interest$ 56,483 $ 39,375 $ 24,356       $ 120,214 
Rent            $ 36,000 $ 36,000 
G&A            $ 9,936 $ 9,936 
R&D            $ 337,500 $ 337,500 
Finder’s Fees         $ 25,000    $ 25,000 
Total compensation$ 256,483 $ 219,375 $ 199,356 $ 25,000 $ 383,436 $ 1,083,650 

Summary of compensation to related parties for the Three Months Ended September 30, 2011 (unaudited)

 

 Durando  Dotoli  Smiley  Biderman  Lawrence  Microphase  Total 

Consulting / Salary

$37,500 $34,167 $33,333          $105,000 

Interest

$13,116 $8,679 $6,337          $28,132 

Rent

               $10,890 $10,890 

G&A

               $2,301 $2,301 

R&D

                  $0 

Finders Fees

         $8,000       $8,000 

Stock based compensation (shares issued)*

$2,488,500 $1,858,500 $1,858,500 $252,000 $63,000    $6,520,500 

Stock based compensation (previously issued options repriced)**

$173,316 $103,990 $62,394          $339,700 

Total compensation

$2,712,432 $2,005,336 $1,960,564 $260,000 $63,000 $13,191 $7,014,523 

Common stock issued August 25, 2011*

Options issued (5years @ 5 cents in September, 2008 repriced @ $.0040; the incremental cost of $339,700 to amortized through September 18, 2013)

Summary of compensation to related parties for the Three Months Ended September 30, 2010 (unaudited)

  Durando  Dotoli  Smiley  Biderman  Lawrence  Microphase  Total 
Consulting / Salary$40,000 $36,000 $35,000          $111,000 
Interest$9,044 $4,989 $4,477          $18,510 
Rent               $9,000 $9,000 
G&A               $1,529 $1,529 
R&D                  $0 
Finders Fees                  $0 
Total compensation$49,044 $40,989 $39,477 $0 $0 $10,529 $140,039 

93


mPHASE TECHNOLOGIES, INC
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

9. RELATED PARTY TRANSACTIONS -(continued)

Summary of payables to related parties as of June 30, 2011

           Total          
           Notes          
  Durando  Dotoli  Smiley  Payable  Biderman  Microphase  Total 
Notes payable$ 263,479 $148,306 $111,030 $ 522,815       $ 522,815 
Due to Officers / Affiliates            $ 150,000 $ 27,242 $ 177,242 
Interest Payable$ 151,685 $120,498 $ 80,725 $ 352,909       $ 352,909 
Total Payable to Officers / Affiliates$ 415,164 $268,804 $191,755 $ 875,724 $ 150,000 $ 27,242 $ 1,052,966 

Summary of payables to related parties as of June 30, 2010

           Total          
           Notes          
  Durando  Dotoli  Smiley  Payable  Biderman  Microphase  Total 
Notes payable$ 301,479 $166,306 $119,030 $ 586,815       $ 586,815 
Due to Officers / Affiliates$ 0 $ 0 $ 0 $ 0    $ 19,214 $ 19,214 
Interest Payable$ 117,957 $101,888 $ 64,157 $ 284,002 $ 150,000    $ 434,002 
Total Payable to Officers / Affiliates$ 419,436 $268,194 $183,187 $ 870,817 $ 150,000 $ 19,214 $ 1,040,031 

Summary of payables to related parties as of September 30, 2011 (unaudited)          Total Notes          
  Durando  Dotoli  Smiley  Payable  Biderman  Microphase  Total 
Notes payable$270,479 $155,306 $118,030 $543,815       $543,815 
Due to Officers / Affiliates            $150,000 $31,433 $181,433 
Interest Payable$164,791 $129,177 $87,062 $381,030       $381,030 
                      
Total Payable to Officers / Affiliates$435,270 $284,483 $205,092 $924,845 $150,000 $31,433 $1,106,278 

EXECUTIVE COMPENSATION AWARD DURING QUARTER ENDED SEPTEMBER 30, 2011(UNAUDITED)

On August 25, 2011, the Board of Directors awarded Messrs Ronald A. Durando, CEO, Gustave T. Dotoli, COO and Martin Smiley, EVP, 395,000,000, 295,000,000 and 295,000,000 restricted shares of common stock of the Company and awarded Messrs. Abraham Biderman and Victor Lawrence, as Directors 40and 10 million restricted shares of common stock of the Company.

In addition, previous 5 year option awards issued on September 18, 2008 to Messrs. Durando, Dotoli and Smiley were re-priced to $.0040 per share from $.05 per share covering 50,000,000 shares, 30,000,000 shares and 18,000,000 shares of common stock of the Company respectively. The revised exercise price of options to purchase up to 98,000,000 shares to $.0040 resulted in an incremental cost of $339,700 which was recorded as deferred compensation which will be amortized to expense through September 18, 2013. Additionally on August 25, 2011, the Board amended the conversion feature of officers loans discussed earlier in this Note 9, with a conversion price of $.0075 originally set in April 2009, to a revised conversion price of $.0040.

94


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

NOTE 10 - INCOME TAXES

The accompanying consolidated balance sheet includes the following components of deferred taxes under the liability method:

The accompanying consolidated balance sheet includes the following components of deferred taxes under the liability method:

  2010  2011 
Deferred Tax Liabilities      
                                     Property and equipment -  - 
                                     Accrued expenses -  - 
Deferred Tax Assets      
                                     Net operating loss carry forward$ 40,728,080 $ 44,185,925 
                                     Accrued expenses -  - 
  40,728,080  44,185,925 
Net Deferred Tax Asset 40,728,080  44,185,925 
                                     Valuation allowance (40,787,080  (44,185,925)
 $ - $ - 

At June 30, 2011, the Company has federal net operating loss carry forwards of approximately $ 111.6 million and $ 110.7 million to offset future federal and state income taxes, respectively, which expire at various times from 2016 through 2030. The federal net operating loss carry forwards may be subject to the separate return loss limitation rules and IRC section 382 limitations due to changes in ownership. The Company has assessed the evidence of its forecasted future operations against the potential likelihood of the realization of the deferred tax assets to make the determination that the Company will not utilize these carry forwards and has recorded a valuation allowance against the net deferred tax asset.

The Company has a loss of $ $7,365,745 in 2010 and $486,391 in 2011. Deferred income taxes relate principally to the use of net operating loss carry forwards; these can differ from computations based upon book losses for the use for tax purposes of accelerated depreciation methods and the difference in the book and tax basis of certain stock based compensation.

The provision for income taxes from continuing operations differs from taxes that would result from applying Federal statutory rates because of the following:

     Year ended June 30,    
  2010          
  Amount  Percent  Amount  Percent 
Taxes at Federal Statutory Rate$ (2,504,470) (34.0%)$(148,373) (34.0)%
State Taxes Net of Federal Tax (407,285) (5.60%) (24,438) (5.60)%
Benefit Utilization of NOL            
Tax Credits            
Valuation Allowance 2,911,715  39.6%  172,811  39.6% 
Other-non deductible stock based compensation- restricted shares and unexercised options$--$--

95


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

11. COMMITMENTS AND CONTINGENCIES

COMMITMENTS

The Company had a lease obligation for the rental of office space in Little Falls New Jersey until May 1, 2011. The current annual obligation under such lease requires rent of $2,347 per month ($28,164 annually) for the year beginning June 1, 2011 and ending May 31, 2012.

mPhase has entered into various agreements with Georgia Tech Research ("GTRC") and its affiliate, Georgia Tech Applied Research Corporation ("GTARC"), pursuant to which the Company receives technical assistance in developing the commercialization of its Digital Video and Data Delivery System. The amount incurred by the Company for GTRC technical assistance with respect to its research and development activities during the years ended 2009, 2010 and 2011 totaled $0, $0 and $0 respectively, and $13,539,952 from the period from inception through June 30, 2011, all of which is included in “discontinued operations”.

CONTINGENCIES

The Company has offered and sold convertible notes to JMJ Financial in the aggregate principal amount plus accrued interest of $10,270,400 through June 30, 2011. Such convertible notes provide cash funding to the Company of up to $9,500,600. Through June 30, 2011 and September 30, 2011, approximately $6,472,000 of cash has been received by the Company, $5,936,150 and $5,990,606 of which of which has been converted by JMJ Financial through June 30, 2011 and September 30, 2011, respectively, into a substantial number of shares of common stock without registration under the Securities Act of 1933, as amended, or qualification under state securities laws. The Company believes that any sales of common stock by JMJ are in full compliance with Rule 144 of the Securities Act of 1933, as amended, and has obtained an opinion of outside counsel regarding such compliance.

Nevertheless, it is possible such compliance could be challenged in the future by either regulatory agencies or shareholders. In particular, questions regarding the economic risk of JMJ Financial with respect to the collateral required under the secured note delivered by JMJ Financial in payment of the purchase price for the Company's convertible note could be raised since the secured note contains a prepayment provision allowing JMJ to prepay such note, in full, by returning the convertible note. If a court of law determines that any offer or sale of common stock of the Company received in a conversion by JMJ Financial was not in compliance with Rule 144 then JMJ could be deemed to be an underwriter. The result would be that the Company would have been engaged in a primary offering of common stock through an underwriter in violation of the registration requirements of the Securities Act of 1933, as amended.

The Securities Act of 1933, as amended, requires that any claim for rescission be brought within one year of the violation. The time periods within which claims for rescission must be brought under state securities laws vary and may be two years or more from the date of the violation. At June 30, 2011 and September 30, 2011, approximately 395 million shares of our outstanding common stock issued in respect of our convertible note transactions with JMJ Financial could be subject to rescission with a potential liability approximating $4.08 and $4.171 million, including a liability of approximately $448,000 and $538,800 for interest at 10% per annum, respectively.

12. FAIR VALUE MEASUREMENTS

Effective July 1, 2008, we adopted Statement of Financial Accounting Standards No. 157,Fair Value Measurements(SFAS 157), which provides a framework for measuring fair value under GAAP. SFAS 157 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. SFAS 157 requires

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

ASC 820 also describes three levels of inputs that valuation techniques maximize the use of observablemay be used to measure fair value:

Level 1: Observable inputs and minimize the use of unobservable inputs. SFAS 157 also establishes a fair value hierarchy, which prioritizes the valuation inputs into three broad levels.

Financial assets and liabilities valued using level 1 inputs are based onthat reflect unadjusted quoted market prices within active markets. Financial assets and liabilities valued using level 2 inputs are based primarily on quoted prices for identical assets or liabilities traded in active markets.

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3: Inputs that are generally unobservable. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

Financial instruments consist principally of cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities, due to related parties, and current and long-term debt. The carrying amounts of such financial instruments in the accompanying balance sheets approximate their fair values due to their relatively short-term nature. The fair value of short and long-term debt is based on current rates at which the Company could borrow funds with similar remaining maturities. The carrying amounts approximate fair value with the exception of the fair value of due to related parties as the fair value cannot be determined due to a lack of similar instruments available to the Company. It is management’s opinion that the Company is not exposed to any significant currency or credit risks arising from these financial instruments.

Revenue Recognition

Revenue is derived from the sale of artificial intelligence and machine learning focused technology products. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. In the event any discounts, sales incentives, or similar arrangements are agreed to with a customer, such amounts are estimated at time of sale and deducted from revenue. Sales taxes and other similar taxes are excluded from revenue (see Note 7).

Share-Based Compensation

The Company computes share based payments in accordance with ASC 718-10, Compensation (“ASC 718-10”) and Staff Accounting Bulletin (“SAB”) No. 107, Share-Based Payment No. 107 (“SAB 107”). The Company has applied the provisions of SAB 107 in its adoption of ASC 718-10. The Company accounts for non-employee share-based awards in accordance with ASC Topic 505-50, Equity Based Payments to Non-Employees. The Company estimates the fair value of stock options and warrants by using the Black-Scholes option pricing model.

F-11

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Derivative Instruments

The Company enters into financing arrangements that consist of freestanding derivative instruments or are hybrid instruments that contain embedded derivative features. The Company accounts for these arrangements in accordance with ASC topic 815, Accounting for Derivative Instruments and Hedging Activities as well as related interpretations of this standard. In accordance with this standard, derivative instruments are recognized as either assets or liabilities in activethe balance sheet and are measured at fair values with gains or inactive markets. For certain long-term debt,losses recognized in earnings. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. The Company determines the fair value wasof derivative instruments and hybrid instruments based on present valueavailable market data using appropriate valuation models, considering all of the rights and obligations of each instrument.

The Company estimates fair values of derivative financial instruments using various techniques using inputs derived principally or corroborated from(and combinations thereof) that are considered consistent with the objective measuring fair values. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market data. Financial assetsrisks that it embodies and liabilities using level 3 inputs were primarily valued using management's assumptions about the assumptionsexpected means of settlement. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market participants would utilizefactors. In addition, option-based techniques (such as Black-Scholes model) are highly volatile and sensitive to changes in pricing the asset or liability. Valuation techniques utilized to determinetrading market price of the Company’s common stock. Since derivative financial instruments are initially and subsequently carried at fair values, our income (expense) going forward will reflect the volatility in these estimates and assumption changes.

Convertible Debt Instruments

The Company records debt net of debt discount for beneficial conversion features and warrants, on a relative fair value basis. Beneficial conversion features are consistently applied.recorded pursuant to the Beneficial Conversion and Debt Topics of the Financial Accounting Standards Board (“FASB”) ASC. The amounts allocated to warrants and beneficial conversion rights are recorded as debt discount and as additional paid-in-capital. Debt discount is amortized to interest expense over the life of the debt.

96


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2011(Unaudited for September 30, 2011 information2019

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (continued)

)Income Taxes

12. FAIR VALUE MEASUREMENTS-(continued)

The Company accounts for income taxes in accordance with Accounting for Income Taxes, as clarified by ASC 740-10, Accounting for Uncertainty in Income Taxes (“ASC 740”). Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities and net operating loss and tax credit carryforwards given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which the Company operates, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more likely than not” criteria of ASC 740. At June 30, 2019 and 2018, the Company had a full valuation allowance against its deferred tax assets.

ASC 740 requires that the Company recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the “more-likely-than-not” threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company’s tax returns for its June 30, 2019, 2018, 2017, and 2016 tax years may be selected for examination by the taxing authorities as the statute of limitations remains open.

The Company recognizes expenses for tax penalties and interest assessed by the Internal Revenue Service and other taxing authorities upon receiving valid notice of assessments. The Company has received no such notices for the years ended June 30, 2019 and 2018.

Earnings Per Share

In accordance with the provisions of FASB ASC Topic 260, Earnings per Share, basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the weighted average number of shares of common stock outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating EPS on a diluted basis.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

In computing diluted EPS, only potential common shares that are dilutive, those that reduce EPS or increase loss per share, are included. The effect of contingently issuable shares are not included if the result would be anti-dilutive, such as when a net loss is reported. Therefore, basic and diluted EPS are computed using the same number of weighted average shares for the year ended June 30, 2019, as we incurred a net loss for this period. At June 30, 2019, there were outstanding warrants to purchase up to 4,985,394 shares of the Company’s common stock, and notes payable held by a third party and former officer with convertible features that if converted, would total 232,750 shares of the Company’s common stock, which may dilute future EPS. At June 30, 2018, the Company had notes payable held by third parties and notes, unpaid wages, and fees due to officers and directors, with convertible features that if converted, would total 5,524,765 shares of the Company’s common stock, which may dilute future EPS.

Recently Adopted Accounting Standards

Effective July 1, 2018, the Company adopted Revenue from Contracts with Customers (Topic 606) (“ASC 606”). The new guidance sets forth a new five-step revenue recognition model which replaces the prior revenue recognition guidance in its entirety and is intended to eliminate numerous industry-specific pieces of revenue recognition guidance that have historically existed in US GAAP. The underlying principle of the new standard is that a business or other organization will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects what it expects to receive in exchange for the goods or services. The standard also requires more detailed disclosures and provides additional guidance for transactions that were not addressed completely in the prior accounting guidance. The Company adopted ASC 606 using the modified retrospective method, which did not have an impact on its consolidated financial statements. The Company expects the impact to net income of the new standard will be immaterial on an ongoing quarterly and annual basis. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. Refer to Note 7 for additional information regarding the Company’s adoption of ASC 606.

Effective July 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which provides clarification on classifying a variety of activities within the statement of cash flows. The Company determined the adoption of ASU 2016-15 did not have a material impact on its consolidated financial statements.

Effective July 1, 2018, the Company adopted ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business (“ASU 2017-01”), which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of businesses. The Company determined the adoption of ASU 2017-01 did not have a material impact on its consolidated financial statements.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Effective July 1, 2018, the Company adopted ASU 2017-09, Compensation – Stock Compensation (Topic 718): Scope of Modification Accounting (“ASU 2017-09”), which clarifies and reduces both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, Compensation – Stock Compensation, to a change to the terms or conditions of a share-based payment award. The Company determined the adoption of ASU 2017-09 did not have a material impact on its consolidated financial statements.

Recently Issued Accounting Standards Not Yet Adopted

In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”). The standard amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will be effective beginning in the first quarter of fiscal 2020. Early adoption of ASU 2016-02 is permitted. The new leases standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. In September 2017, the FASB issued ASU 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842, which amends certain aspects of the new lease standard. The Company is currently evaluating the impact of adopting ASU 2016-02 and ASU 2017-13 on the Company’s financial position, results of operations or cash flows.

In July 2017, the FASB issued ASU 2017-11, Update to Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. The amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, including adoption in an interim period, however, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments in Part II of this update do not require any transition guidance because those amendments do not have an accounting effect. The ASU makes limited changes to the guidance on classifying certain financial instruments as either liabilities or equity. The ASU is intended to improve (1) the accounting for instruments with “down-round” provisions and (2) the readability of the guidance in ASC 480 on distinguishing liabilities from equity by replacing the indefinite deferral of certain pending content with scope exceptions. The standard is effective for the Company as of July 1, 2019, with early adoption permitted. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement, to modify the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concept Statement, including the consideration of costs and benefits. The standard is effective for the Company as of July 1, 2020, with early adoption permitted. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

In August 2018, the FASB issued ASU 2018-13, to modify the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concept Statement, including the consideration of costs and benefits. The standard is effective for the Company as of July 1, 2020, with early adoption permitted. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on the accompanying consolidated financial statements.

NOTE 4: PROPERTY AND EQUIPMENT

At June 30, 2019 and 2018, the Company’s property and equipment consist of the following:

  June 30, 
  2019  2018 
Computer equipment $11,048  $- 
Research equipment  48,383   48,383 
Office and marketing  151,118   151,118 
Property and equipment, at cost  210,549   199,501 
Less: accumulated depreciation  (199,501)  (199,501)
Property and equipment, net $11,048  $- 

The Company recorded $0 and $683 of depreciation expense for the years ended June 30, 2019 and 2018, respectively. There was no property and equipment impairments recorded for the years ended June 30, 2019 and 2018.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 5: BUSINESS ACQUISITION

On June 30, 2019, the Company acquired 99% of the outstanding common shares of Alpha Predictions LLP (“Alpha Predictions”). Alpha Predictions is an India-based technology company that has developed a suite of commercial data analysis products for use across multiple industries. The Company expects the acquisition to result in synergies with its other operating divisions, which will drive revenue growth and innovation.

The goodwill of $6,020 arising from the acquisition consists largely of the synergies expected from combining the operations of the Company and Alpha Predictions.

The following table belowsummarizes the consideration paid for Alpha Predictions and the fair values of the assets acquired and liabilities assumed recognized at the acquisition date.

Consideration    
Cash $1,438 
Fair value of total consideration transferred  1,438 
     
Recognized amounts of identifiable assets acquired and liabilities assumed    
Cash  3,127 
Accounts receivable  26,155 
Prepaid expenses  7,488 
Property and equipment  11,048 
Intangible asset – purchased software  2,905,668 
Accounts payable  (26,067)
Accrued expenses and other current liabilities  (2,924,288)
Income tax provision, current  (7,713)
Total identifiable net assets  (4,582)
Goodwill $6,020 

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 5: BUSINESS ACQUISITION (continued)

The Company is currently evaluating the fair values of the assets acquired and liabilities assumed. The preliminary estimates and measurements are, therefore, subject to change during the measurement period. The acquired intangible asset – developed software was recognized at fair value as of the acquisition date. It is provisionally subject to a useful life of 3 years, pending further evaluation of the underlying software.

The fair value of the one-percent noncontrolling interest in Alpha Predictions was determined to be immaterial, based on extrapolation of the price paid by the Company for its controlling interest and consideration of any potential control premiums.

Acquisition-related costs expensed by the Company were immaterial for the fiscal years ended June 30, 2019 and 2018.

The revenue and net loss of the combined entity had the acquisition date been July 1, 2017, are as follows:

  For the Years Ended 
  June 30, 
  2019  2018 
Supplemental pro forma:        
Revenue $4,554,594  $1,245,556 
(Loss) Income $(2,959,165) $(829,656)

Supplemental pro forma amounts were calculated after applying adjustments to reflect amortization of acquired intangible asset – purchased software that would have been charged had the acquisition date been July 1, 2017.

NOTE 6: INTANGIBLE ASSET – PURCHASED SOFTWARE, NET

Intangible asset – Purchased Software, net, is comprised of the following at:

  June 30, 
  2019  2018 
Purchased software $3,025,801  $      - 
Less: accumulated amortization  -   - 
Purchased software, net $3,025,801  $- 

F-18

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 6: INTANGIBLE ASSET – PURCHASED SOFTWARE, NET (continued)

Intangible asset – Purchased Software consists of the following two developed software technologies:

Alpha Predictions purchased software $2,905,668 
Travel Buddhi purchased software  120,133 
Total purchased software $3,025,801 

The Alpha Predictions developed software was acquired as further described in Note 5. The Travel Buddhi developed software was acquired on February 15, 2019, for $115,281 and included all rights, software, and code of the technology platform. During the fiscal year ended June 30, 2019, $55,000 of the Travel Buddhi purchase price was paid and $60,281 remained outstanding. At June 30, 2019, the Travel Buddhi technology platform has not been placed in service, but is expected to be during fiscal year 2020.

Developed software costs are amortized on a straight-line basis over three years. Amortization of developed software costs is included in depreciation and amortization within the consolidated statements of operations.

There was no amortization expense related to purchased software for the fiscal years ended June 30, 2019 and 2018.

Future amortization expense related to the existing net carrying amount of developed software at June 30, 2019 is expected to be as follows:

Fiscal year 2020 $1,008,600 
Fiscal year 2021  1,008,600 
Fiscal year 2022  1,008,601 
  $3,025,801 

NOTE 7: REVENUE

The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Software and product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring software and products. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Sales taxes and other similar taxes are excluded from revenue.

The adoption of ASC 606 resulted in no impact to the individual financial statement line items of the Company’s audited consolidated statements of operations during the year ended June 30, 2019.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 7: REVENUE (continued)

For the year ended June 30, 2019, the Company was subject to revenue and accounts receivable concentration risk as one customer accounted for 100% and 99% of revenue and accounts receivable, respectively. Additionally, for the year ended June 30, 2019, the Company was subject to geography concentration risk as its single revenue generating customer is located in India.

NOTE 8: ACCRUED EXPENSES

Accrued expenses is comprised of the following at:

  June 30, 
  2019  2018 
Accrued interest $104,179  $72,638 
Accrued wages  208,353   395,582 
Other expenses  150,601   88,154 
Accrued payment for acquired technology intangible asset  2,905,668   - 
Accrued stock bonus  -   575,000 
Total accrued expenses, continuing operations $3,368,801  $1,131,374 
         
Total accrued expenses, discontinued operations $-  $142,195 

NOTE 9: SHORT TERM NOTES PAYABLE

Short term notes payable is comprised of the following:

  June 30, 
  2019  2018 
Note payable, John Fife (dba St. George Investors)/Judgment Settlement Agreement [1] $855,660  $885,365 
Note payable, former director (Eagle) [2]  -   130,274 
Note payable, investor [3]  -   3,000 
Note payable, finance company - discontinued liability [4]  -   39,468 
Total short-term notes payable $855,660  $1,058,107 

[1] effective December 10, 2018, the Company entered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife that was previously in effect. As a result, under the Judgment Settlement Agreement, no shares of the Company’s common stock are issuable or eligible to be converted into. Under the terms of the Judgment Settlement Agreement, the Company is required to pay $15,000 per month from January 15, 2019 through and including February 15, 2020, with a final payment of $195,000 due and payable in March of 2020. The Company has made all payments required as of the date hereof. Failure to make any of the payments, when due, will result in an additional debt obligation, inclusive of principal and interest at the date of default ($570,660 as of June 30, 2019), to be immediately due and payable by the Company.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 9: SHORT TERM NOTES PAYABLE (continued)

[2] during fiscal year 2019 $132,234 of principal and accrued interest was converted into 276,205 shares of the Company’s common stock

[3] during fiscal year 2019 $3,000 of principal was converted into 12,000 shares of the Company’s common stock

[4] during fiscal year 2019 $25,000 of principal and accrued interest was refinanced by a new convertible note payable dated June 19, 2019 (see Note 10) and the balance of $18,776 was forgiven by the lender and is recognized as income from discontinued operations within the consolidated statements of operations

NOTE 10: Convertible Debt Arrangements

JMJ Financial

During April 2017, the Company received a judgment from the Federal District Court of Northern Illinois Eastern Division in its favor dismissing a claim by River North Equity which negated two notes River North Equity purchased from JMJ Financial. At June 30, 2017, the amount recorded as a current liability for the two notes and accrued interest thereon subject to the River North Equity claim was $1,046,416. Such amount was included in the amount recorded as a current liabilities for all three convertible notes and accrued interest thereon previously issued to JMJ Financial which totaled $1,212,940 on that date. As a result of the proceeding, on July 17, 2017, the Company recorded the cancellation of the two notes assigned to River North from JMJ Financial for a total of $693,060 of principal and $358,534 accrued interest thereon. This resulted in a $1,051,594 gain from the extinguishment of debt during the year ended June 30, 2018. At June 30, 2019, this debt was reclassified to current liabilities as current portion, liabilities in arrears – judgment settlement agreement.

At June 30, 2019 and 2018, the amount recorded in current liabilities for the one convertible note and accrued interest thereon due to JMJ Financial was $193,287 and $178,521, respectively. During the fiscal years ended June 30, 2019 and 2018 the Company recorded $14,766 and $17,175, respectively of interest for the outstanding convertible note.

As of June 30, 2019 and 2018, the aggregate remaining amount of convertible securities held by JMJ could be converted into 9,664 and 8,926 shares, respectively, with a conversion price of $20.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 10: Convertible Debt Arrangements (continued)

John Fife (dba St. George Investors) / Fife Judgment

Effective December 10, 2018, the Company entered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife that was previously in effect. As a result, under the Judgment Settlement Agreement, no shares of the Company’s common stock are issuable or eligible to be converted into. Under the terms of the Judgment Settlement Agreement, the Company is required to pay $15,000 per month from January 15, 2019 through and including February 15, 2020, with a final payment of $195,000 due and payable in March of 2020. The Company has made all payments required as of the date hereof. Failure to make any of the payments, when due, will result in an additional debt obligation, inclusive of principal and interest at the date of default ($570,660 as of June 30, 2019), to be immediately due and payable by the Company.

During the year ended June 30, 2018, the Company did not make any repayments to Fife under the Forbearance obligation, as amended. The value of the forbearance debt obligation on June 30, 2018 was $885,365.

MH Investment Trust II

On April 10, 2019 the Company repaid $3,000 that was accepted as payment, in full, for the convertible promissory note to M.H. Investment Trust II. At the time of the payment, the outstanding principal balance and accrued interest was $3,333 and $3,737, respectively. As a result of the settlement payment, the Company recognized a gain on extinguishment of debt of $4,070.

At June 30, 2018 the note balance was $3,333 and accrued interest was $3,118 accruing at 12% per annum, was due under this convertible promissory note.

Power Up Lending

On June 19, 2019, the Company entered into a Securities Purchase Agreement with Power Up Lending Group (“Lender”) and issued an 8% convertible promissory note in the principal amount of $78,000 to the Lender with a maturity date of June 19, 2020. The Company received proceeds in the amount of $45,800, with $25,000 refinancing a prior convertible promissory note due to the Lender that had been in default, $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Note and $4,200 being paid to the Company’s Transfer Agent to satisfy an outstanding balance. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to certain ratchet provisions contained in the convertible promissory note the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $103,161, deferred financing costs of $3,000 and debt discount of $75,000. The deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $78,000 and $188, respectively, at June 30, 2019. The aggregate balance of the convertible promissory note, net of deferred financing costs and debt discount at June 30, 2019 was $2,351.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 10: Convertible Debt Arrangements (continued)

Notes payable under convertible debt and debenture agreements, net is comprised of the following:

  June 30, 
  2019  2018 
JMJ Financial $109,000  $109,000 
John Fife (dba St. George Investors) / Fife Judgment  -   885,365 
MH Investment Trust II  -   3,000 
Power Up Lending  2,351   - 
Total convertible debt arrangements, net $111,351  $997,365 

At June 30, 2019 and 2018, accrued interest on these convertible notes of $84,475 and $72,638, respectively, is included within accrued expenses of the consolidated balance sheets.

NOTE 11: DERIVATIVE LIABILITY

The Company evaluates its convertible instruments, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under ASC Topic 815, “Derivatives and Hedging.” The result of this accounting treatment is that the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operation as other income (expense). Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under ASC Topic 815 are reclassified to liabilities at the fair value of the instrument on the reclassification date.

The following table presents a reconciliation for liabilitiesof the derivative liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) from June 30, 2018 to June 30, 2019, as there was no derivative liability at June 30, 20102017:

  Conversion feature derivative liability 
June 30, 2018 $- 
Initial fair value of derivative liability recorded as debt discount  75,000 
Initial fair value of derivative liability recorded as deferred financing costs  3,000 
Initial fair value of derivative liability charged to other expense  25,161 
Loss on change in fair value included in earnings  30,508 
June 30, 2019 $133,669 

F-23

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 11: DERIVATIVE LIABILITY (continued)

Total derivative liability at June 30, 2019 and 2011:

  Fair Value Measurements       
  Using       
  Significant       
  Unobservable Inputs (Level       
  3)     
  Derivative Liability       
  June 30,  June 30,  September 30, 
  2010  2011  2011 
        (Unaudited) 
Balance at July 1, 2009, 2010 and 2011$ 2,380,816 $ 5,966,149 $ 1,664,575 
Increase (Decrease) in Derivative and associated liabilities 356,566  (1,911,669) (853,499)
Debt discounts 3,228,767  (2,389,905) 142,141 
Balance at June 30, 2010 and 2011 & September 30, 2011$ 5,966,149 $ 1,664,575 $ 953,218 

Financial instruments are considered Level 3 when their values are determined using pricing models, discounted cash flow methodologies or similar techniquesJune 30, 2018 amounted to $133,669 and at least one significant model assumption or input is input is unobservable. Level 3 financial instruments also include those for which the determination of$0, respectively. The change in fair value requires significant management judgment or estimation.

Someincluded in earnings of $30,508 is due in part to the quoted market price of the Company’s financial instruments are not measuredcommon stock decreasing from $1.00 at fair value on a recurring basis but are recordedJune 30, 2018 to $0.85 at amounts that approximate fair valueJune 30, 2019, coupled with substantially reduced conversion prices due to their liquid or short-term nature, such as cash and cash equivalents, receivables and payables.the effect of “ratchet” provisions incorporated within the convertible notes payable.

We have determined that it is not practical to estimate

The Company used the fair value of our notes payable because of their unique nature and the costs that would be incurred to obtain an independent valuation. We do not have comparable outstanding debt on which to base an estimated current borrowing rate or other discount ratefollowing assumptions for purposes of estimatingdetermining the fair value of the notes payableconvertible instruments granted under the binomial pricing model with Binomial simulations at June 30, 2019:

Expected volatility  1,872.2%
Expected term  11.5 months 
Risk-free interest rate  1.92%
Stock price $0.85 

NOTE 12: STOCKHOLDERS’ EQUITY (DEFICIT)

The total number of shares of all classes of stock that the Company shall have the authority to issue is 100,001,000 shares consisting of 100,000,000 shares of common stock, $0.01 par value per share, of which 11,689,078 are issued and weoutstanding and 461,553 are to be issued at June 30, 2019 and 1,000 shares of preferred stock, par value $0.01 per share of which 1,000 shares have not been able to develop a valuation model that can be applied consistently in a cost efficient manner. These factors all contribute to the impracticabilitydesignated as Series A Super Voting Preferred of estimating the fair value of the notes payable. At Septemberwhich 1,000 are issued and outstanding at June 30, 2011, the carrying value of the notes payable and accrued interest for convertible agreements and officers’ notes was approximately $2.276 million. The JMJ convertible notes, which are due at various times through December 2012, yield an interest rate of 12%. Refer to Note 3 of these financial statements for more information about the Company’s notes payable.2019.

13. SUBSEQUENT EVENTS

On July 1, 2011,January 4, 2019 the Company filed an amendment to its Amended Certificate of Incorporation with the Secretary of State of New Jersey increasing itsaccepted an Amendment to the Company’s Certificate of Incorporation providing for the increase in authorized shares of common stock to 6125 billion shares.shares and the change to no par value.

On July 28, 2011,March 21, 2019, the Company announced that it entered into a letterCompany’s Board of intent (LOI)Directors approved 1) an amendment to acquire Energy Innovative Products, Inc. (EIP), a developerthe Company’s Amended and Restated Certificate of proprietary technologies for reducing energy usage in refrigeration and cooling systems,Incorporation, as well as equipment utilizing AC induction motors. EIP, based in Fairfield, NJ, uses patented and patent pending solutionsamended (the “Certificate of Incorporation”) to offer a seriesi) decrease the number of products that control voltage and current used by compressor systems, including those in refrigeration decks, HVAC wall units, commercial refrigeration systems, and consumer equipment. The company, founded in 2008, believes its technology is uniquely positioned to capitalize on each of these multi-billion dollar market opportunities by allowing legacy systems to achieve Energy Star status as well as compliance with emerging standards by the United States Department of Energy (DOE) and other regulatory bodies. In the United States alone, there are several million legacy refrigerated vending machines used by major beverage companies. The Company, subject to further due diligence, believes that EIP's solution is the only one certified for Energy Star status and able to deliver a significant reduction in power consumption by vending machines without reducing efficiency or cooling and without requiring a change-out in the unit's refrigeration deck. Governmental and power company rebates are available to support the purchase of EIP's products in several states. The terms of the deal include the issuance of common shares and warrants for an 81% stake in EIP. The transaction is expected to become a Definitive Agreement by the end of 2011 and close no later than January 31, 2011.

97


mPHASE TECHNOLOGIES, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2011(Unaudited for September 30, 2011 information)

13. SUBSEQUENT EVENTS-(continued)

On August 12, 2011, the Company issued a $25,000 Convertible Note with a 6 month maturity convertible into 3,676,471authorized shares of common stock of the Company at a price of $.0068to 25,000,000 shares from 125,000,000,000 shares and ii) increase the par value to $0.01 per share, plus a 5 year warrantand 2) granting discretionary authority to purchase at $.0068 per share an additional 3,676,471the Company’s Board of Directors to amend the Certificate of Incorporation to effect one or more consolidations of the issued and outstanding shares of common stock of the Company, pursuant to Rule 506 Regulation Dwhich the shares of the Securities Actcommon stock would be combined and reclassified into one share of 1933,as amended, in a Private Placement to one accredited investor. The Convertible Note pays interestcommon stock at a rateratio of 1% per month. The1-for-5,000 (the “Reverse Stock Split”). On May 17, 2019, the Company is using $12,500filed a Certificate of Amendment to its Certificate of Incorporation to decrease its authorized common stock from 125,000,000,000 shares to 25,000,000 shares. Effective May 22, 2019 the proceeds to fundCompany completed a loan to EIP prior to the closing1-for-5,000 reverse split of an expected 81% interest in EIP and $12,500 as additional working capital for the Company.its common stock.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 12: STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

On August 24, 201127, 2019, the Company issued 10,000,000 shares of its common stock to one Accredited Investor in a private placement pursuant to Rule 506 of Regulation D of the Securities Act of 1933, as amended, in a Private Placement. The Company received gross proceeds of $40,000 and paid a $4,000 placement fee to Eagle Advisers, Inc. The proceeds will be used as working capital by the Company.

On August 25, 2011, theCompany’s Board of Directors awarded Messrs Ronald A. Durando, CEO, Gustave T. Dotoli, COOapproved an amendment to the Company’s Amended and Martin Smiley, EVP, 395,000,000, 295,000,000 and 295,000,000 restrictedRestated Certificate of Incorporation, as amended (the “Certificate of Incorporation”) to increase the number of authorized shares of common stock of the Company and awarded Messrs. Abraham Biderman and Victor Lawrence, as Directors 40,000,000 and 10 million restrictedto 100,000,000 shares from 25,000,000 shares. On September 4, 2019, the Company filed a Certificate of Amendment to its Certificate of Incorporation to increase its authorized common stock from 25,000,000 shares to 100,000,000 shares.

Common Stock

Private Placements

During the year ended June 30, 2019, the Company received $193,000 of net proceeds from the issuance of 640,000 shares of common stock and 132,000 shares of common stock to be issued in private placements with accredited investors, incurring no finder’s fees.

During the Company. In addition, previous 5 year option awards issued on September 18, 2008 toended June 30, 2018, the Company received $81,000 of net proceeds from the issuance of 360,000 shares of common stock in private placements with accredited investors, incurring finder’s fees of $9,000.

Stock Award Payable

During the year ended June 30, 2019, Messrs. Durando, Dotoli and Smiley were re-priced to $.0040 per share from $.05 per share covering 50,000,000 shares, 30,000,000 shares and 18,000,000received 800,000 shares of common stock, of the Company respectively. Additionally, the Board amended the conversion feature of officers loans discussed in Note 9, originally withwhich were valued at $400,000, Mr. Biderman a conversion price of $.0075 in April 2009, to a conversion price of $.0040.

On September 13, 2011, the Company entered into a second Forbearance Agreements with John Fife restructuring the investment. Under the terms of the Forbearance Agreement the agreed principal amount of the Convertible Note outstanding was $328,000 and the two additional promissory notes were cancelled. As of September 30, 2011, $47,200 of the outstanding balance has been converted into 10,000,000former outside Director received 200,000 shares of common stock, leavingwhich were valued at $100,000 and strategic consultants received 150,000 shares of common stock, which were valued at $75,000. In the aggregate, this group received a remaining outstanding balancetotal of $280,800. Based upon1,150,000 shares of common stock, which were valued at $0.50 per share or $575,000, based on the closing price of the Company’s common stock on September 24, 2018. At June 30, 2018, the $575,000 was included in accrued expenses.

Stock Based Compensation

During the year ended June 30, 2019, the Company issued 2,620,899 (“Signing Shares”) shares of common stock to its President and CEO, Mr. Bhatnagar, in connection with the commencement of his employment with the Company. The grant date fair value of $1,310,449 is based upon the closing price of $.0047the Company’s common stock on January 11, 2019, and is included in stock-based compensation expense within the consolidated statement of operations.

On June 1, 2019, the Company granted 231,635 shares of common stock to Mr. Cutchens, the Company’s Chief Financial Officer. The common stock will vest 25% on the six month, 1 year, 2 year, and 3 year anniversaries of the grant date. The Company recorded $16,464 of stock-based compensation expense during the year ended June 30, 2019, related to this common stock grant.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 12: STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

During the year ended June 30, 2018, the Company did not issue any common stock to employees or officers.

Conversion of Debt Securities

During the fiscal year ended June 30, 2019, the Company issued 3,898,733 shares of common stock and had 329,553 shares of common stock to be issued to a number of related parties and strategic consultants in connection with prior services provided to the Company. The shares issued were valued at $1,883,445. During the fiscal year ended June 30, 2018, there were no shares of common stock issued to related parties or strategic consultants. 

During the fiscal years ended June 30, 2019 and 2018, there were no conversions by JMJ Financial, John Fife (dba St. George Investors) / Fife Judgment, MH Investment Trust II, or Power Up Lending.

Reserved Shares

The convertible promissory note entered into with Power Up Lending by the Company on June 19, 2019, requires the Company to reserve 1,258,064 shares of its Common Stock for potential future conversions under such instruments.

At June 30, 2019, 7,202 shares of the Company’s Common Stock remain subject to be returned to the Company’s treasury for cancellation. Such shares were not sold as part of 8,000 shares of the Company’s Common Stock that was advanced during fiscal year 2014 under an Equity Line of Credit.

Retired Shares

During the year ended June 30, 2019, there were no shares of the Company’s Common Stock returned for retirement or otherwise.

During the year ended June 30, 2018, 540,840 outstanding shares of the Company’s Common Stock were returned to the Company by Mr. Smiley (273,445 shares) and Patricia Dotoli, the spouse of Gus Dotoli (267,395 shares) to provide the Company with sufficient authorized but unissued shares of stock and enable the Company to have additional authorized shares of its Common Stock to complete present private placements to provide operating capital for the Company.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 12: STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

Common Stock Warrants

Warrant Agreement – Earned Warrants

Mr. Bhatnagar, the Company’s President and CEO, is entitled to receive warrants to acquire 4% of the outstanding fully diluted common stock of the Company (the “Earned Warrants”) each time the Company’s revenue increases by $1,000,000. The exercise price of the Earned Warrants is equal to $0.50 per share and he may not receive shares whereby Signing Shares and Earned Warrants exceed 80% of the fully diluted common stock of the Company (“Warrant Cap”).

Warrant Agreement – Accelerated Warrants

Mr. Bhatnagar, the Company’s President and CEO, shall immediately receive the remaining amount of warrants necessary to acquire up to 80% of the outstanding fully diluted common stock of the Company (“Accelerated Warrants”) when either of the following occur:

a)the Company completes a stock or asset purchase of Scepter Commodities, LLC; or
b)the Company completes a stock or asset purchase of any other entity, either of which, in the aggregate, together with prior revenue increases achieved by the Company, results in the consolidated revenues of the Company being not less than $15,000,000; or
c)the Company grows a similar business organically within mPhase to include contracts generating revenues in excess of $15,000,000; or
d)the Company meets the listing requirements of either the NYSE or NASDAQ

As of the year ended June 30, 2019, as the Company’s revenue achieved $2,500,000, Mr. Bhatnagar earned warrants to acquire 4,985,394 shares of the Company’s common stock under the provisions of the Warrant Agreement. At June 30, 2019, there remains approximately 32,400,000 shares of the Company’s common stock that Mr. Bhatnagar can earn. 

For the year ended June 30, 2019, the Company recognized $2,492,697 of stock-based compensation expense related to the earned warrants. At June 30, 2019, there remains approximately $16,200,000 of stock-based compensation expense that the Company expects to recognize over the next six months.

The Company estimates the fair value of each option award on the date of grant using a black-scholes option valuation model that uses the assumptions noted in the table below. Because black-scholes option valuation models incorporate ranges of assumptions for inputs, those ranges are disclosed. Expected volatilities are based on the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model; separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding; the range given below results from certain groups of employees exhibiting different behavior. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The following assumptions were utilized during 2019:

Expected volatility21,779.77%
Weighted-average volatility21,779.77%
Expected dividends0%
Expected term (in years)5.0
Risk-free rate2.52%

The following table sets forth common stock purchase warrants outstanding at June 30, 2019:

  Warrants  

Weighted Average

Exercise Price

  Intrinsic Value 
Outstanding, June 30, 2018  -  $-  $       - 
Warrants earned  

4,985,394

   0.50   - 
Warrants forfeited  -   -   - 
Outstanding, June 30, 2019  

4,985,394

  $0.50  $- 
             
Common stock issuable upon exercise of warrants  

4,985,394

  $0.50  $- 

   Common Stock Issuable Upon Exercise of Warrants Outstanding  Common Stock Issuable Upon Warrants Exercisable 

Range of Exercise

Prices

  Number Outstanding at June 30, 2019  Weighted Average Remaining Contractual Life (Years)  Weighted Average Exercise Price  Number Exercisable at June 30, 2019  Weighted Average Exercise Price 
$0.50   

4,985,394

   4.75  $0.50   4,985,394  $      0.50 
     

4,985,394

   4.75  $0.50   

4,985,394

  $0.50 

Settlement and New Funding Share Reserves

The Company agreed to reserve a total of 3,000,000 shares of its common stock of which 532,040 shares of common stock were reserved for and issued concurrently for the conversion of 75% of outstanding accounts payables to officers’ and a director (discussed below), 1,967,960 shares of common stock were reserved to reduce liabilities outstanding December 31, 2018 (“Settlement Reserve”), and 500,000 shares of common stock were reserved to fund continuing operations (“Funding Reserve”). At June 30, 2019, 1,225,949 shares of common stock remained available from the initial Settlement Reserve to settle prior liabilities and 185,063, shares of common stock remained available from the Funding Reserve to fund continuing operations.

F-27

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 12: STOCKHOLDERS’ DEFICIT (Continued)

  Settlement Reserve  Funding
Reserve
 
Initial Shares of Common Stock to Establish Reserve  1,967,960   500,000 
Shares issued concurrently to transition agreement for the conversion of 75% strategic vendors, outstanding December 31, 2018  (61,200)  - 
Shares available upon execution of the Transition Agreement dated January 11, 2019  1,906,760   500,000 
Shares issued subsequent to a “Change in Control” to accredited investors in private placements through June 30, 2019  (680,811)  (314,937)
Shares of Common Stock available at June 30, 2019  1,225,949   185,063 

Prior Liabilities – Settlement Reserve

1,967,960 shares of the Company’s common stock have been reserved to settle the debts of the Company that were outstanding at December 31, 2018, in the following priority; the Judgement Settlement Agreement (formerly Fife forbearance Agreement), JMJ Financial, Inc., MH Investment Trust, Power Up Lending Ltd, as well as other liabilities satisfactory to the CEO of the Company and the Company (as per Section 2(a) of the Reserve Agreement concurrent with “Change in Control Agreements”, dated January 11, 2019). At June 30, 2019, 1,225,949 shares of common stock remain available under this reserve category.

Officer’s and Director’s – Conversion Share Reserve

532,040 shares of the Company’s common stock were reserved for the conversion of 75% of payables to officers’ and a director that were outstanding December 31, 2018, (as per Section 2(a) of the Reserve Agreement concurrent with “Change in Control Agreements”, dated January 11, 2019). All these shares were issued effective December 31, 2018 and no shares remain available under this reserve category.

Continuing Operations Share Reserve

500,000 shares of the Company’s common stock were reserved as per Section 2(c) to be sold at a price, not less than $0.25 per share in periodic Private Placements, (as per Section 2(a) of the Reserve Agreement concurrent with “Change in Control Agreements”, dated January 11, 2019). At June 30, 2019, 185,063 shares of common stock remain available under this reserve category.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 12: STOCKHOLDERS’ DEFICIT (Continued)

Final Adjustment for Liabilities Eliminated by Settlement Reserve

To the extent Company does not eliminate the above-mentioned liabilities by July 11, 2019, or the cost to do so requires more than the funding provided by the Warrant Cap pertaining to Warrants to be issued to Mr. Bhatnagar, the Settlement Reserve shares shall be increased by that number of shares at $0.25, which equals the amount of the remaining liabilities.

Series A Preferred Stock

On January 11, 2019, the Company issued 1,000 shares of Series A Preferred Stock to Mr. Bhatnagar as the Company’s new President and CEO, to effectuate voting control of the Company pursuant to the terms of the Transition Agreement. The Series A Preferred shares were recorded at par value, are not tradeable, and have a nominal liquidation value.

NOTE 13: RELATED PARTY TRANSACTIONS

Microphase Corporation

At June 30, 2019, the Company owed $32,545 to Microphase for previously leased office space at its Norwalk location and for certain research and development services and shared administrative personnel from time to time, all through December 31, 2015.

Former Director

Mr. Biderman, a former outside Director, received 200,000 shares of the Company’s common stock valued at $100,000 pursuant to a resolution of the Company’s Board dated November 28, 2017, whereby such shares would be issued when enough authorized shares became available. The liability for this award was included in accrued expenses at June 30, 2018. The shares of the Company’s common stock were issued during the year ended June 30, 2019.

During the year ended June 30, 2019, Mr. Biderman, a former outside Director’s affiliated firms of Palladium Capital Advisors and Eagle Strategic Advisers converted $186,000 of accrued fees into 372,000 shares and $132,234 of a note and accrued interest into 276,205 shares of the Company’s common stock. At June 30, 2019, there was no outstanding balance for accrued fees or for a note with accrued interest.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 13: RELATED PARTY TRANSACTIONS (continued)

Effective October 1, 2018, the Company reversed to additional paid in capital $7,500 of accrued finders’ fees waved by Eagle Strategic Advisers and no amount of such fees was accrued to this former outside Director’s affiliated firm at June 30, 2019.

During the fiscal years ended June 30, 2019 and 2018 the Company recorded $1,959 and $7,895 of accrued interest on this loan.

Transactions With Officers

At various points during past fiscal years certain officers of the Company provided bridge loans to the Company evidenced by individual promissory notes and deferred compensation so as to provide working capital to the Company. All of these notes accrue interest at the rate of 6% per annum, and are payable on demand. During the fiscal years ended June 30, 2019 and 2018, the officers advanced $144,507 and $77,326 to provide working capital to the Company and $15,467 and $44,274 has been charged for interest on loans from officers.

At June 30, 2019 and 2018, these outstanding notes including accrued interest totaled $58,165 and $777,712, respectively. At June 30, 2019 and 2018, these promissory notes are convertible into shares of the Company common stock, if available.

During the fiscal year ended June 30, 2019, Messrs. Durando, Dotoli and Smiley received 800,000 shares of common stock, which were valued at $400,000, Mr. Biderman a former outside Director received 200,000 shares of common stock, which were valued at $100,000 and strategic consultants received 150,000 shares of common stock, which were valued at $75,000. In the aggregate, this group received a total of 1,150,000 shares of common stock, which was valued at $575,000 and included in accrued expenses at June 30, 2018.

During the fiscal year ended June 30, 2019, the Company issued 3,898,733 shares of common stock and had 329,553 shares to be issued to a number of related parties and strategic consultants in connection with prior services provided to the Company. The shares issued were valued at $1,883,445. During the fiscal year ended June 30, 2018, there were no shares of common stock issued to related parties or strategic consultants.

During the fiscal year ended June 30, 2019, the Company incurred $9,000 of expense related to legal and consulting services provided by Mr. Smiley, the Company’s former CFO and legal counsel.

F-30

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 13: RELATED PARTY TRANSACTIONS (Continued)

During the fiscal year ended June 30, 2019, the Company issued 2,620,899 (“Signing Shares”) shares of common stock to its President and CEO, Mr. Bhatnagar, in connection with the commencement of his employment with the Company. The grant date fair value of $1,310,449 is based upon the closing price of the Company’s common stock on January 11, 2019, and is included in stock-based compensation expense within the consolidated statement of operations.

On June 1, 2019, the Company granted 231,635 shares of common stock to Mr. Cutchens, the Company’s Chief Financial Officer. The common stock will vest 25% on the six month, 1 year, 2 year, and 3 year anniversaries of the grant date. The Company recorded $16,464 of stock-based compensation expense during the year ended June 30, 2019, related to this common stock grant.

During the year ended June 30, 2018, the Company did not issue any common stock to employees or officers.

Conversion Feature and Conversions of Debt to Officers’

The Company amortized the remaining $91,177 deferred charge balance to beneficial conversion feature interest expense for the year ended June 30, 2019. At June 30, 2019, there is no deferred charges for beneficial conversion feature interest expense remaining.

NOTE 14: INCOME TAXES

The Company accounts for income taxes taking into account deferred tax assets and liabilities which represent the future tax consequences of the differences between financial statement carrying amounts of assets and liabilities versus the tax basis of assets and liabilities. Under this method, deferred tax assets are recognized for deductible temporary differences, and operating loss and tax credit carryforwards. Deferred liabilities are recognized for taxable temporary differences. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The impact of tax rate changes on deferred tax assets and liabilities is recognized in the year the change is enacted. Due to recurring losses, the Company’s tax provision for the years ended June 30, 2019 and 2018 was $0.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 14: INCOME TAXES (continued)

At June 30, 2019 and 2018, the difference between the effective income tax rate and the applicable statutory federal income tax rate is summarized as follows:

  June 30, 
  2019  2018 
Statutory federal rate  (21.0)%  (21.0)%
State income tax rate, net of federal benefit  (7.2)%  (7.2)%
Permanent differences, including stock based compensation and beneficial conversion interest expense  28.9%  

29.0

%
Change in valuation allowance  (0.7)%  (0.8)%
Effective tax rate  -%  -%

At June 30, 2019 and 2018, the Company’s deferred tax assets were as follows:

  June 30, 
  2019  2018 
Deferred tax liability        
Property and equipment $     -  $     - 
Total deferred tax liability $-  $- 

  June 30, 
  2019  2018 
Deferred tax asset        
Federal and state net operating loss carry forward $26,156,755  $27,672,065 
Other temporary differences  -   - 
Total deferred tax asset  26,156,755   

27,672,065

 
Net deferred tax asset  26,156,755   27,672,065 
Less: valuation allowance  (26,156,755)  (27,672,065)
  $-  $- 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences will become deductible. The Company considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. The Company has recorded a full valuation allowance against its net deferred tax assets because it is not currently able to conclude that it is more likely than not that these assets will be realized. The amount of deferred tax assets considered to be realizable could be increased in the near term if estimates of future taxable income during the carryforward period are increased. The valuation allowance decreased by $1,515,310 and $14,977,935 during the fiscal years ended June 30, 2019 and 2018, respectively, as a result of a reduction in the total NOL carry forwards due to expiring loss years.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 14: INCOME TAXES (continued)

As of June 30, 2019, the Company has federal net operating loss carryforwards of approximately $105,200,000 and approximately $56,500,000 to offset future federal and state income taxes. Net operating loss carryforwards expire through 2038. Under the Internal Revenue Code Section 382, certain stock transactions which significantly change ownership, including the sale of stock to new investors, the exercise of options to purchase stock, or other transactions between shareholders could limit the amount of net operating loss carryforwards that may be utilized on an annual basis to offset taxable income in future periods.

At June 30, 2019 and 2018, the Company had no material unrecognized tax benefits and no adjustments to liabilities or operations were required. The Company does not expect that its unrecognized tax benefits will materially increase within the next twelve months. The Company did not recognize any interest or penalties related to uncertain tax positions at June 30, 2019 and 2018.

NOTE 15: COMMITMENTS AND CONTINGENCIES

Commitments

Effective May 1, 2019, the Company relocated its corporate office to 9841 Washingtonian Blvd., Suite 390, Gaithersburg, MD 20878, and incurs rent expense of $1,350 per month, which is payable to a related party. The lease term with the related party is a month-to-month arrangement.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 15: COMMITMENTS AND CONTINGENCIES (continued)

Judgement Settlement Agreement

Effective December 10, 2018, the Company entered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife that was previously in effect. As a result, under the Judgment Settlement Agreement, no shares of the Company’s common stock are issuable or eligible to be converted into. Under the terms of the Judgment Settlement Agreement, the Company is required to pay $15,000 per month from January 15, 2019 through and including February 15, 2020, with a final payment of $195,000 due and payable in March of 2020. The Company has made all payments required as of the date hereof. Failure to make any of the payments, when due, will result in an additional debt obligation, inclusive of principal and interest at the date of default ($570,660 as of June 30, 2019), to be immediately due and payable by the Company (see Note 10).

Contracts and Commitments Executed Pursuant to the Transition Agreement

In the transaction whereby, Mr. Bhatnagar acquired control of the Company on January 11, 2019, the Company entered into material commitments including an employment agreement and a warrant agreement (see Note 12).

Contingencies

Judgment Settlement Agreement

Effective December 10, 2018, the Company entered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife that was previously in effect. As a result, under the Judgment Settlement Agreement, no shares of the Company’s common stock are issuable or eligible to be converted into. Under the terms of the Judgment Settlement Agreement, the Company is required to pay $15,000 per month from January 15, 2019 through and including February 15, 2020, with a final payment of $195,000 due and payable in March of 2020. The Company has made all payments required as of the date hereof. Failure to make any of the payments, when due, will result in an additional debt obligation, inclusive of principal and interest at the date of default ($570,660 as of June 30, 2019), to be immediately due and payable by the Company (see Note 10).

Should the Company satisfy the liability as described within the Judgement Settlement Agreement above, the Company would realize a gain on such settlement of approximately $580,000.

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 15: COMMITMENTS AND CONTINGENCIES (continued)

Amounts Contingent upon Certain Terms of Change in Control Agreements Effective January 11, 2019

To the extent Company does not eliminate the certain liabilities within six months of the effective date, the Warrant Cap for warrants issued to Mr. Bhatnagar shall increase by such number of shares at a price of $0.25 to equal the amount of the remaining liability.

The Change in Control Agreements, effective January 11, 2019, also have certain provisions that may accelerate the warrant “earn out” formula contained in the Transition Agreement.

NOTE 16: DISCONTINUED OPERATIONS

The Company has classified the operating results and associated assets and liabilities from its Jump line of products, which ceased generating material revenue during the first quarter of fiscal year 2017, as Discontinued Operations in the Consolidated Financial Statements for the Fiscal Years ended June 30, 2019 and 2018.

The assets and liabilities associated with discontinued operations included in our Consolidated Balance Sheets were as follows:

  June 30, 2019  June 30, 2018 
  Discontinued  Continuing  Total  Discontinued  Continuing  Total 
Assets                        
Current Assets                        
Cash $-  $33,996  $33,996  $-  $261  $261 
Accounts receivable, net  -   2,526,155   2,526,155   -   -   - 
Prepaid expenses  -   8,820   8,820   -   -   - 
Total Current Assets  -   2,568,971   2,568,971   -   261   261 
Property and equipment, net  -   11,048   11,048   -   -   - 
Goodwill  -   6,020   

6,020

   -   -   - 
Intangible asset - developed software, net  -   3,025,801   3,025,801   -   -   - 
Other assets  -   3,058   3,058   -   800   800 
Total Assets $-  $5,614,898  $5,614,898  $-  $1,061  $1,061 
                         
Liabilities                        
Current Liabilities                        
Accounts payable $82,795  $366,274  $449,069  $124,508  $421,056  $545,564 
Accrued expenses  -   3,368,801   3,368,801   

-

   

1,273,569

   1,273,569 
Due to related parties  -   65,459   65,459   -   226,045   226,045 
Notes payable to officers  -   25,251   25,251   -   777,912   777,912 
Convertible notes payable, net  -   2,351   2,351   -   -   - 
Notes payable to director and investor  -   -   -   -   133,274   133,274 
Note payable to finance company  -   -   -   39,468   -   39,468 
Liabilities in arrears with convertible features  -   109,000   109,000   -   997,698   997,698 
Liabilities in arrears - judgement settlement agreement (Note 9)  -   855,660   855,660   -   -   - 
Derivative liability  -   133,669   133,669   -   -   - 
Total Current Liabilities $82,795  $4,926,465  $5,009,260  $

163,976

  $3,829,554  $3,993,530 

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 16: DISCONTINUED OPERATIONS (Continued)

The revenues and expenses associated with discontinued operations included in our Consolidated Statements of Operations were as follows:

  Year Ended 
  June 30, 
  2019  2018 
  Discontinued  Continuing  Total  Discontinued  Continuing  Total 
Revenue $-  $2,500,000  $2,500,000  $-  $-  $- 
Cost of revenue  -   -   -   -   -   - 
Gross Profit  -   2,500,000   2,500,000   -   -   - 
General and administrative expenses  -   4,265,886   4,265,886   22,009   735,026   757,035 
Operating loss  -   (1,765,886)  (1,765,886)  (22,009)  (735,026)  (757,035)
Other Income (Expense):                        
Interest expense  (11,508)  (210,594)  (222,102)  (41,957)  (246,162)  (288,119)
Loss on change in fair value of derivative liability  -   (30,508)  (30,508)  -   -   - 
Initial derivative expense  -   (25,161)  (25,161)  -   -   - 
Amortization of debt discount  -   (2,260)  (2,260)  -   -   - 
Amortization of deferred financing costs  -   (90)  (90)  -   -   - 
Gain on extinguishment of debt  30,448   60,398   90,846   250,570   1,107,922   1,358,492 
Other income  -   -   -   566   -   566 
Total Other Income (Expense)  18,940   (208,215)  (189,275)  209,179   861,760   1,070,939 
Income (Loss) before income taxes  18,940   (1,974,101)  (1,955,161)  187,170   126,734   313,904 
Income taxes  -   -   -   -   -   - 
Net income (loss) $18,940  $(1,974,101) $(1,955,161) $187,170  $126,734  $313,904 

mPHASE TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2019

NOTE 17: SUBSEQUENT EVENTS

From July 1, 2019 through September 30, 2019, the Company issued 64,800 shares of its common stock to a number of related parties and strategic consultants in connection with prior services provided to the Company. The shares issued were valued at $16,200.

On July 30, 2019, the Company entered into a Securities Purchase Agreement dated as of July 30, 2019 with Power Up Lending Group (“Lender”), and issued an 8% Convertible Promissory Note in the principal amount of $53,000 to the Lender with a maturity date of July 30, 2020. The Company received net proceeds in the amount of $50,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Note.

On August 27, 2019, the Company’s Board of Directors approved the filing of an amendment (the “Amendment”) to the Company’s Certificate of Incorporation to increase the authorized shares of common stock from 25 million shares to 100 million shares pursuant to Section 14A:7-2(4) of the Business Corporation Law of the State of New Jersey. The Amendment was filed with the State of New Jersey on September 4, 2019.

On September 5, 2019, the Company entered into a Securities Purchase Agreement dated as of September 5, 2019 with Power Up Lending Group (“Lender”), and issued an 8% Convertible Promissory Note in the principal amount of $53,000 to the Lender with a maturity date of September 5, 2020. On September 9, 2019, the Company received net proceeds in the amount of $46,800 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Note and $3,200 being paid to the Company’s Transfer Agent to satisfy an outstanding balance.

On September 24, 2019, the Company entered into a Securities Purchase Agreement dated as of September 24, 2019 with accredited investors (“Lenders”), and issued 8% Convertible Promissory Notes in the principal amount of $124,200 (including an aggregate of $9,200 in original issue discounts) to the Lenders with maturity dates of September 24, 2020. On September 27, 2019, the Company received net proceeds in the amount of $112,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Notes.

mPhase Technologies, Inc.

Consolidated Balance Sheets

  March 31, 2020  June 30, 2019 
   (Unaudited)     
Assets        
Current Assets        
Cash $8,054  $33,996 
Accounts receivable, net  6,409,386   2,526,155 
Prepaid expenses  437   8,820 
Other assets  227,486   - 
Total Current Assets  6,645,363   2,568,971 
Property and equipment, net  10,678   11,048 
Goodwill  6,020   6,020 
Intangible asset - purchased software, net  2,117,009   3,025,801 
Other assets  12,792   3,058 
Total Assets $8,791,862  $5,614,898 
         
Liabilities and Stockholders’ Equity        
Current Liabilities        
Accounts payable $3,560,910  $366,274 
Accrued expenses  796,434   3,368,801 
Contract liabilities  170,449   - 
Due to related parties  88,907   65,459 
Notes payable to officers  26,420   25,251 
Convertible notes payable, net  253,712   2,351 
Liabilities in arrears with convertible features  109,000   109,000 
Liabilities in arrears - judgement settlement agreement (Note 7)  762,921   855,660 
Derivative liability  343,193   133,669 
Liabilities of discontinued operations  82,795   82,795 
Total Current Liabilities  6,194,741   5,009,260 
         
Commitments and Contingencies (Note 12)        
         
Stockholders’ Equity        
Preferred stock, $0.01 par value; 1,000 shares authorized, issued and outstanding at March 31, 2020 and June 30, 2019  10   10 
Common stock, $0.01 par value; 100,000,000 shares authorized, 13,486,040 shares issued and 13,312,314 shares outstanding at March 31, 2020, and 11,689,078 shares issued and outstanding at June 30, 2019  133,123   116,890 
Additional paid-in-capital  230,811,941   214,007,203 
Common stock to be issued  8,725   115,388 
Accumulated other comprehensive income  125,310   - 
Accumulated deficit  (228,481,988)  (213,633,853)
Total Stockholders’ Equity  2,597,121   605,638 
Total Liabilities and Stockholders’ Equity $8,791,862  $5,614,898 

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

F-38

mPhase Technologies, Inc.

Consolidated Statements of Operations

(Unaudited)

  For the Three Months Ended  For the Nine Months Ended 
  March 31,  March 31, 
  2020  2019  2020  2019 
Revenue $7,556,507  $-  $22,688,086  $- 
Cost of revenue  5,624,876   -   16,955,320   - 
Gross Profit  1,931,631   -   5,732,766   - 
Operating Expenses:                
Software development costs  16,905   -   2,126,942   - 
General and administrative expenses  694,554   1,422,737   18,558,605   1,541,960 
Total Operating Expenses  711,459   1,422,737   20,685,547   1,541,960 
Operating Income (Loss)  1,220,172   (1,422,737)  (14,952,781)  (1,541,960)
Other (Expense) Income:                
Interest expense  (76,817)  (14,027)  (172,470)  (147,936)
Gain on change in fair value of derivative liability  505,649   -   976,049   - 
Initial derivative income (expense)  12,231   -   (245,572)  - 
Amortization of debt discount  (248,685)  (1,843)  (421,590)  (7,976)
Amortization of deferred financing costs  (11,944)  -   (19,473)  - 
Amortization of original issue discount  (8,466)  -   (12,298)  - 
Gain on debt extinguishments  -   -   -   16,279 
Total Other Income (Expense)  171,968   (15,870)  104,646   (139,633)
Income (Loss) from continuing operations before income taxes  1,392,140   (1,438,607)  (14,848,135)  (1,681,593)
Income taxes  -   -   -   - 
Income (Loss) from continuing operations  1,392,140   (1,438,607)  (14,848,135)  (1,681,593)
Discontinued operations (Note 13)                
Loss from discontinued operations  -   (3,805)  -   (14,713)
Net income (loss) $1,392,140  $(1,442,412) $(14,848,135) $(1,696,306)
                 
Comprehensive income (loss):                
Unrealized gain on currency translation adjustment  92,178   -   125,310   - 
Comprehensive income (loss) $1,484,318  $(1,442,412) $(14,722,825) $(1,696,306)
                 
Income (Loss) per common share:                
Income (loss) from continuing operations per common share – basic $0.11  $(0.13) $(1.18) $(0.22)
                 
Income (loss) from continuing operations per common share – diluted $0.02  $(0.13) $(1.18) $(0.22)
                 
Loss from discontinued operations per common share – basic and diluted $-  $(0.00) $-  $(0.01)
                 
Income (loss) per common share – basic $0.11  $(0.13) $(1.18) $(0.23)
                 
Income (loss) per common share – diluted $0.02  $(0.13) $(1.18) $(0.23)
                 
Weighted average shares outstanding – basic  13,107,042   10,943,154   12,562,668   7,496,294 
                 
Weighted average shares outstanding – diluted  53,270,177   10,943,154   12,562,668   7,496,294 

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

F-39

mPhase Technologies, Inc.

Consolidated Statements of Stockholders’ Equity (Deficit)

For the Nine Months Ended March 31, 2020 and 2019

(Unaudited)

  Preferred Stock  Common Stock             
  Shares  $0.01 Par Value  Shares  $0.01 Par Value  

Additional
Paid in

Capital

  Common
Stock to
be Issued
  Accumulated
Comprehensive
Income
  

Accumulated

Deficit

  

Stockholders’

Equity

 
Balance June 30, 2019  1,000  $10   11,689,078  $116,890  $214,007,203  $115,388  $-  $(213,633,853) $605,638 
                                     
Issuance of common stock to accredited investors in private placements          380,000   3,800   91,200   (30,500)          64,500 
Issuance of common stock for the conversion of related party debts and strategic vendor payables          294,654   2,947   70,716   (73,663)          - 
Warrants earned under employment contract                  9,970,787               9,970,787 
Other comprehensive income                          54,694       54,694 
Net loss                              (10,305,511)  (10,305,511)
Balance September 30, 2019  1,000  $10   12,363,732  $123,637  $224,139,906  $11,225  $54,694  $(223,939,364) $390,108 
                                     
Issuance of common stock to accredited investors in private placements          10,000   100   2,400   130,000           132,500 
Issuance of common stock for accrued services          62,000   620   14,880               15,500 
Restricted shares issued under employment contract          57,909   579   106,078               106,657 
Warrants earned under employment contract                  6,231,742               6,231,742 
Other comprehensive loss                          (21,562)      (21,562)
Net loss                              (5,934,764)  (5,934,764)
Balance December 31, 2019  1,000  $10   12,493,641  $124,936  $230,495,006  $141,225  $33,132  $(229,874,128) $920,181 
                                     
Issuance of common stock to accredited investors in private placements          739,577   7,396   275,104   (132,500)          150,000 
Issuance of common stock for services related to private placements          11,003   110   (110)              - 
Issuance of common stock for conversions of convertible promissory notes          68,093   681   18,319               19,000 
Stock-based compensation for restricted shares of common stock under employment contract                  23,622               23,622 
Other comprehensive income                          92,178       92,178 
Net income                              

1,392,140

   1,392,140 
Balance March 31, 2020  1,000  $10   13,312,314  $133,123  $230,811,941  $8,725  $

125,310

  $

(228,481,988

) $

2,597,121

 

  Preferred Stock  Common Stock         
  Shares  $0.01 Par Value  Shares  $0.01 Par Value  

Additional
Paid in

Capital

  

Accumulated

Deficit

  

Stockholders’

Deficit

 
Balance June 30, 2018  -  $-   3,372,103  $33,721  $207,652,502  $(211,678,692) $(3,992,469)
                             
Issuance of common stock to accredited investors in private placements          40,000   400   9,600       10,000 
Beneficial conversion feature interest expense charged to additional paid in capital                  91,177       91,177 
Issuance of common stock for accrued services          1,150,000   11,500   563,500       575,000 
Issuance of common stock for the conversion of related party debts and strategic vendor payables          3,305,492   33,055   1,619,691       1,652,746 
Net loss                      (197,645)  (197,645)
Balance September 30, 2018  -  $-   7,867,595  $78,676  $209,936,470  $(211,876,337) $(1,861,191)
                             
Reversal of accrued fees from private placements to accredited investors                  7,500       7,500 
Issuance of common stock to accredited investors in private placements          80,000   800   19,200       20,000 
Issuance of common stock for the conversion of related party debts and strategic vendor payables          593,240   5,932   142,378       148,310 
Net loss                      (56,249)  (56,249)
Balance December 31, 2018  -  $-   8,540,835  $85,408  $210,105,548  $(211,932,586) $(1,741,630)
                             
Issuance of common stock to accredited investors in private placements          320,000   3,200   76,800       80,000 
Issuance of common stock in connection with employment contract          2,620,899   26,209   1284,240       1,310,449 
Issuance of preferred stock in connection with employment contract  1,000  $1           (1)      - 
Net loss                      (1,442,412)  (1,442,412)
Balance March 31, 2019  1,000  $1   11,481,734  $114,817  $211,466,587  $(213,374,998) $(1,793,593)

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

F-40

mPhase Technologies, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

  For the Nine Months Ended 
  March 31, 
  2020  2019 
Cash flows from operating activities:        
Net loss $(14,848,135) $(1,696,306)
Adjustments to reconcile net loss to net cash from operating activities:        
Stock-based compensation  16,316,344   1,310,449 
Depreciation and amortization  700,387   - 
Amortization of debt discount  421,590   7,976 
Initial derivative expense  245,572   - 
Amortization of deferred financing costs  19,473   - 
Amortization of original issue discount  12,298   - 
Gain on change in fair value of derivative liability  (976,049)  - 
Gain on debt extinguishments  -   (16,279)
Amortization of deferred compensation and beneficial conversion interest expense  -   91,177 
Changes in operating assets and liabilities:        
Increase in accounts receivable  (3,883,231)  - 
Increase in other assets  (9,734)  - 
Decrease (increase) in prepaid expenses  8,383   (3,686)
Increase in contract liabilities  170,449   - 
Increase in accounts payable and accrued expenses  683,154   188,354 
Net cash used in operating activities of continuing operations  (1,139,499)  (118,315)
Net cash used in operating activities of discontinued operations  -   (31,056)
Net cash used in operating activities  (1,139,499)  (149,371)
         
Cash flows from investing activities:        
Capital expenditures  (553)  - 
Net cash used in investing activities of continuing operations  (553)  - 
Net cash used in investing activities of discontinued operations  -   - 
Net cash used in investing activities  (553)  - 
         
Cash flows from financing activities:        
Proceeds from issuance of convertible notes payable, net  940,000   - 
Proceeds from sale of common stock, net of finder’s fees  347,000   110,000 
Proceeds from notes payable to related parties  37,800   93,046 
Repayments of notes payable to related parties  (32,000)  (588)
Repayments under settlement agreement  (120,000)  (28,004)
Repayments of convertible notes payable  (184,000)  - 
Net cash provided by financing activities of continuing operations  988,800   174,454 
Net cash provided by financing activities of discontinued operations  -   - 
Net cash provided by financing activities  988,800   174,454 
         
Effect of foreign exchange rate changes on cash  125,310   - 
Net (decrease) increase in cash  (25,942)  25,083 
Cash at beginning of period  33,996   261 
Cash at end of period $8,054  $25,344 
         
Supplemental disclosure:        
Cash paid for interest $83,064  $21,393 

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

F-41

  For the Nine Months Ended 
  March 31, 
  2020  2019 
Supplemental disclosure of non-cash operating activities:      
       
Initial fair value of derivative liability recorded as debt discount $940,001  $- 
         
Supplemental disclosure of non-cash investing and financing activities:        
         
Issuance of Common Stock for accrued services        
Value $15,500  $575,000 
Shares  62,000   1,150,000 
         
Issuance of Common Stock for the conversion of Related Party debts and Strategic Vendor payables        
Value $73,663  $1,801,056 
Shares  294,654   3,898,732 
         
Issuance of Common Stock for services related to private placements        
Value $11,250  $- 
Shares  11,003   - 
         
Issuance of Common Stock for conversions of convertible promissory notes        
Value $19,000  $- 
Shares  68,093   - 

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

F-42

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 1: NATURE OF BUSINESS AND BASIS OF PRESENTATION

Organization and Nature of Business

mPhase Technologies, Inc., including its wholly-owned subsidiaries, are collectively referred to herein as “mPhase,” “XDSL”, “Company,” “us,” or “we.”

The Company was incorporated in the state of New Jersey in 1979 under the name Tecma Laboratory, Inc. and has subsequently operated under Tecma Laboratories, Inc., and Lightpaths TP Technologies, Inc., until June 2, 1997 when the Company changed its name to mPhase Technologies, Inc.

On January 11, 2019, the Company underwent a major change in management and control. The new management of the Company is positioning the Company to be a technology leader in artificial intelligence and machine learning while enabling a more rapid commercial development of its patent portfolio and other intellectual property. The Company’s goal is to generate significant revenue from its artificial intelligence and machine learning technologies.

On February 15, 2019, the Company acquired Travel Buddhi, a software platform to enhance travel via ultra-customization tools that tailor a planned trip experience in ways not previously available.

On June 30, 2011,2019, the holderCompany acquired 99% of the outstanding common shares of Alpha Predictions LLP (“Alpha Predictions”). Alpha Predictions is an India-based technology company that has developed a suite of commercial data analysis products for use across multiple industries. The Company expects the acquisition to result in synergies with its other operating divisions, which will drive revenue growth and innovation.

Basis of Presentation

The consolidated unaudited financial information furnished herein reflects all adjustments, consisting only of normal recurring items, which in the opinion of management, are necessary to fairly state the Company’s financial position, results of operations and cash flows for the dates and periods presented and to make such information not misleading. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been omitted pursuant to rules and regulations of the Securities and Exchange Commission (the “SEC”); nevertheless, management of the Company believes that the disclosures herein are adequate to make the information presented not misleading.

The consolidated unaudited financial statements for the nine months ended March 31, 2020 and 2019 include the operations of mPhase and its wholly-owned subsidiaries, mPower Technologies, Inc., Medds, Inc., mPhase Technologies India Private Limited effective March 19, 2019, and Alpha Predictions LLP effective June 30, 2019. All significant intercompany accounts and transactions have been eliminated in the consolidation.

These consolidated unaudited financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended June 30, 2019, contained in the Company’s Annual Report on Form 10-K filed with the SEC on October 15, 2019. The results of operations for the nine months ended March 31, 2020, are not necessarily indicative of results to be expected for any other interim period or the fiscal year ending June 30, 2020.

Impact of COVID-19 Pandemic

A novel strain of coronavirus, COVID-19, surfaced during December 2019 and has spread around the world, including to the United States. During March 2020, COVID-19 was declared a pandemic by the World Health Organization. The COVID-19 pandemic has resulted in, and is likely to continue to result in, significant economic disruption. Although these disruptions are expected to be temporary, significant uncertainty exists concerning the magnitude of the impact and duration of the COVID-19 pandemic. As the Company cannot predict the scope or duration of the COVID-19 pandemic, any anticipated negative financial impact to its results of operations cannot be reasonably estimated but could ultimately be material and last for an extended period of time.

F-43

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 2: GOING CONCERN

The accompanying unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

The Company has incurred negative cash flows from operations of $1,139,499 for the nine months ended March 31, 2020. At March 31, 2020, the Company had a working capital surplus of $450,622, and an accumulated deficit of $228,481,988. It is management’s opinion that these facts raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date of this report, without additional debt or equity financing. The unaudited consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts nor to the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

In order to meet its working capital needs through the next twelve months from the date of this report and to fund the growth of the nanotechnology, artificial intelligence, and machine learning technologies, the Company may consider plans to raise additional funds through the issuance of equity or debt. Although the Company intends to obtain additional financing to meet its cash needs, the Company may be unable to secure any additional financing on terms that are favorable or acceptable to it, if at all.

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Reclassifications

Certain reclassifications of prior year amounts have been made to enhance comparability with the current year’s consolidated financial statements, including, but not limited to, presentation of certain items within the consolidated statement of cash flows.

Foreign Currency Translation and Transactions

The functional currency of our operations in India is the Indian Rupee. Foreign currency denominated assets and liabilities are translated into U.S. dollars at the exchange rates in effect at the balance sheet date, and income and expense items are translated at the average exchange rates in effect during the applicable period. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the consolidated statements of comprehensive income (loss), as other comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Indian Rupee to U.S. dollars after the balance sheet date.

Use of Estimates

The preparation of consolidated unaudited financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenues and expenses for the reporting period. Actual results could differ from those estimates. If actual results significantly differ from the Company’s estimates, the Company’s financial condition and results of operations could be materially impacted. Significant estimates include the collectability of accounts receivable, valuation of intangible assets, accrued expenses, valuation of derivative liabilities, stock-based compensation, and the valuation reserve for income taxes.

Concentrations of Credit Risk

Credit Risk

Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company maintains cash and cash equivalents with three financial institutions. Deposits held with the financial institutions may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation on such deposits, but may be redeemed upon demand. The Company performs periodic evaluations of the relative credit standing of the financial institutions. With respect to accounts receivable, the Company monitors the credit quality of its customers as well as maintain an allowance for doubtful accounts for estimated losses resulting from the inability of customers to make required payments.

Revenue Risk

Agreements which potentially subject the Company to concentrations of revenue risk consist principally of one customer agreement. For the nine months ended March 31, 2020 and 2019, this one customer accounted for 100% and 0% of our total revenue, respectively. At March 31, 2020 and June 30, 2019, this one customer accounted for 100% and 99% of our total accounts receivable, respectively.

Cash and Cash Equivalents

For purposes of balance sheet presentation and reporting of cash flows, the Company considers all unrestricted demand deposits, money market funds and highly liquid debt instruments with an original maturity of less than 90 days to be cash and cash equivalents. There were no cash equivalents at March 31, 2020 and June 30, 2019.

F-44

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Accounts Receivable

The Company regularly reviews outstanding receivables and provides for estimated losses through an allowance for doubtful accounts. In evaluating the level of established loss reserves, the Company makes judgments regarding its customers’ ability to make required payments, economic events and other factors. As the financial condition of these parties change, circumstances develop or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for potential credit losses and such losses traditionally have been within its expectations. At March 31, 2020 and June 30, 2019, the Company determined there was no requirement for an allowance for doubtful accounts.

Goodwill and Intangible Assets

Goodwill is recorded when the purchase price paid for an acquisition exceeds the fair value of the net identified tangible and intangible assets acquired. The Company evaluates goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate that the carrying value may not be recoverable. The Company tests goodwill for impairment by first comparing the fair value of the reporting unit to its carrying value. If the fair value is determined to be less than the carrying value, a second step is performed to measure the amount of impairment loss. On June 30, 2020, we will perform our annual evaluation of goodwill impairment to determine if the estimated fair value of the reporting unit exceeds its carrying value.

Patents and licenses are capitalized when the Company determines there will be a future benefit derived from such assets and are stated at cost. Amortization is computed using the straight-line method over the estimated useful life of the asset, generally five years. As of March 31, 2020 and June 30, 2019, the book value of patents and licenses of $214,383, has been fully amortized and no amortization expense was recorded for the nine months ended March 31, 2020 and 2019.

Capitalized Software Development Costs

The Company follows the provisions of ASC 350-40, “Internal Use Software.” ASC 350-40 provides guidance for determining whether computer software is internal-use software, and on accounting for the proceeds of computer software originally developed or obtained for internal use and then subsequently sold to the public. It also provides guidance on capitalization of the costs incurred for computer software developed or obtained for internal use. The Company expenses all costs incurred during the preliminary project stage of its development, and capitalizes the costs incurred during the application development stage. Costs incurred relating to upgrades and enhancements to the software are capitalized if it is determined that these upgrades or enhancements add additional functionality to the software. Costs incurred to improve and support products after they become available are charged to expense as incurred.

Capitalized software development costs are amortized on a straight-line basis over the estimated useful lives, currently three years. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets.

At March 31, 2020, the book value of purchased and developed technology of $2,817,396, included two technology platforms, a machine learning platform and an artificial intelligence platform. For the nine months ended March 31, 2020 and 2019, amortization expense which is included in general and administration expenses within the consolidated statements of operations, was $700,387 and $0, respectively.

Fair Value of Financial Instruments

The Company accounts for the fair value of financial instruments in accordance with ASC topic 820, “Fair Value Measurements and Disclosures” (ASC 820), formerly SFAS No. 157 “Fair Value Measurements”. ASC 820 defines “fair value” as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

ASC 820 also describes three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs that reflect unadjusted quoted prices for identical assets or liabilities traded in active markets.

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3: Inputs that are generally unobservable. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

Financial instruments consist principally of cash, accounts receivable, prepaid expenses, due from affiliates, accounts payable, accrued liabilities, due to related parties, and other current liabilities. The carrying amounts of such financial instruments in the accompanying balance sheets approximate their fair values due to their relatively short-term nature. The fair value of short and long-term debt is based on current rates at which the Company could borrow funds with similar remaining maturities. The carrying amounts approximate fair value. It is management’s opinion that the Company is not exposed to any significant currency or credit risks arising from these financial instruments.

F-45

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Revenue Recognition

Revenue is derived from the sale of artificial intelligence and machine learning focused technology products. The Company recognizes revenue when obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. In the event any discounts, sales incentives, or similar arrangements are agreed to with a customer, such amounts are estimated at time of sale and deducted from revenue. Sales taxes and other similar taxes are excluded from revenue (see Note 6).

Share-Based Compensation

The Company computes share based payments in accordance with the provisions of ASC Topic 718, Compensation – Stock Compensation and related interpretations. As such, compensation cost is measured on the date of grant at the fair value of the share-based payments. Such compensation amounts, if any, are amortized over the respective vesting periods of the grants. The Company estimates the fair value of stock options and warrants by using the Black-Scholes option pricing model.

Derivative Instruments

The Company enters into financing arrangements that consist of freestanding derivative instruments or are hybrid instruments that contain embedded derivative features. The Company accounts for these arrangements in accordance with ASC Topic 815, Accounting for Derivative Instruments and Hedging Activities as well as related interpretations of this standard. In accordance with this standard, derivative instruments are recognized as either assets or liabilities in the balance sheet and are measured at fair values with gains or losses recognized in earnings. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. The Company determines the fair value of derivative instruments and hybrid instruments based on available market data using appropriate valuation models, considering all of the rights and obligations of each instrument.

The Company estimates fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered consistent with the objective measuring fair values. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques (such as Black-Scholes model) are highly volatile and sensitive to changes in the trading market price of the Company’s common stock. Since derivative financial instruments are initially and subsequently carried at fair values, our income (expense) going forward will reflect the volatility in these estimates and assumption changes.

Convertible Debt Instruments

The Company records debt net of debt discount for beneficial conversion features and warrants, on a relative fair value basis. Beneficial conversion features are recorded pursuant to the Beneficial Conversion and Debt Topics of the Financial Accounting Standards Board (“FASB”) ASC. The amounts allocated to warrants and beneficial conversion rights are recorded as debt discount and as additional paid-in-capital. Debt discount is amortized to interest expense over the life of the debt.

F-46

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Income Taxes

The Company accounts for income taxes in accordance with Accounting for Income Taxes, as clarified by ASC 740-10, Accounting for Uncertainty in Income Taxes (“ASC 740”). Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities and net operating loss and tax credit carryforwards given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year-to-year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which the Company operates, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more likely than not” criteria of ASC 740.

ASC 740 requires that the Company recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the “more-likely-than-not” threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company’s tax returns for its June 30, 2019, 2018, and 2017 tax years may be selected for examination by the taxing authorities as the statute of limitations remains open.

The Company recognizes expenses for tax penalties and interest assessed by the Internal Revenue Service and other taxing authorities upon receiving valid notice of assessments. The Company has received no such notices for the tax years ended June 30, 2019 and 2018.

Earnings Per Share

In accordance with the provisions of FASB ASC Topic 260, Earnings per Share, basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the weighted average number of shares of common stock outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating EPS on a diluted basis.

In computing diluted EPS, only potential common shares that are dilutive, those that reduce EPS or increase loss per share, are included. The effect of contingently issuable shares are not included if the result would be anti-dilutive, such as when a net loss is reported. Therefore, basic and diluted EPS are computed using the same number of weighted average shares for the three months ended March 31, 2019 and nine months ended March 31, 2020 and 2019, respectively, as we incurred a net loss for those periods. At March 31, 2020, as we incurred net income for the period, dilutive shares included 37,390,452 shares of the Company’s common stock related to warrants and 2,772,684 shares of the Company’s common stock related to convertible promissory notes, assuming exercise of such warrants and conversion of such convertible promissory notes occurred at January 1, 2020, as the exercise price of the warrants and conversion price of the convertible promissory notes were less than the average market price of the Company’s common stock for the three months ended March 31, 2020. Additionally, for dilutive EPS purposes for the three months ended March 31, 2020, the assumed conversion of such convertible promissory notes at January 1, 2020, reduced the net income amount used in the dilutive EPS computation by $280,822 as a result of the net impact of interest that would not have been incurred during the period as well as original issue discounts, deferred financing costs, debt discounts, and derivative liability balances that would not have been required at March 31, 2020.

F-47

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Recently Adopted Accounting Standards

Effective July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2016-02, Leases (“ASU 2016-02”). The standard amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. The new leases standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. In September 2017, the FASB issued ASU 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842, which amends certain aspects of the new lease standard. The Company determined the adoption of ASU 2016-02 did not have a material impact on its consolidated financial statements.

Effective July 1, 2019, the Company adopted ASU 2017-11, Update to Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. The ASU makes limited changes to the guidance on classifying certain financial instruments as either liabilities or equity. The ASU is intended to improve (1) the accounting for instruments with “down-round” provisions and (2) the readability of the guidance in ASC 480 on distinguishing liabilities from equity by replacing the indefinite deferral of certain pending content with scope exceptions. The Company determined the adoption of ASU 2017-11 did not have a material impact on its consolidated financial statements.

Recently Issued Accounting Standards Not Yet Adopted

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement, to modify the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concept Statement, including the consideration of costs and benefits. The standard is effective for the Company as of July 1, 2020, with early adoption permitted. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

In August 2018, the FASB issued ASU 2018-13, to modify the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concept Statement, including the consideration of costs and benefits. The standard is effective for the Company as of July 1, 2020, with early adoption permitted. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on the accompanying unaudited consolidated financial statements.

F-48

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 4: BUSINESS ACQUISITION

On June 30, 2019, the Company acquired 99% of the outstanding common shares of Alpha Predictions LLP (“Alpha Predictions”). Alpha Predictions is an India-based technology company that has developed a suite of commercial data analysis products for use across multiple industries. The Company expects the acquisition to result in synergies with its other operating divisions, which will drive revenue growth and innovation.

The goodwill of $6,020 arising from the acquisition consists largely of the synergies expected from combining the operations of the Company and Alpha Predictions.

The following table summarizes the consideration paid for Alpha Predictions and the fair values of the assets acquired and liabilities assumed recognized at the acquisition date.

Consideration   
Cash $1,438 
Fair value of total consideration transferred  1,438 
     
Recognized amounts of identifiable assets acquired and liabilities assumed    
Cash  3,127 
Accounts receivable  26,155 
Prepaid expenses  7,488 
Property and equipment  11,048 
Intangible asset – purchased software  2,905,668 
Accounts payable  (26,067)
Accrued expenses and other current liabilities  (2,924,288)
Income tax provision, current  (7,713)
Total identifiable net assets  (4,582)
Goodwill $6,020 

The Company is currently evaluating the fair values of the assets acquired and liabilities assumed. The preliminary estimates and measurements are, therefore, subject to change during the measurement period. The acquired intangible asset – purchased software was recognized at fair value as of the acquisition date. It is provisionally subject to a useful life of 3 years, pending further evaluation of the underlying software.

The fair value of the one-percent noncontrolling interest in Alpha Predictions was determined to be immaterial, based on extrapolation of the price paid by the Company for its controlling interest and consideration of any potential control premiums.

F-49

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 5: INTANGIBLE ASSET – PURCHASED SOFTWARE, NET

Intangible asset – Purchased Software, net, is comprised of the following at:

  March 31,  June 30, 
  2020  2019 
Purchased software $2,817,396  $3,025,801 
Less: accumulated amortization  (700,387)  - 
Purchased software, net $2,117,009  $3,025,801 

Intangible asset – Purchased Software consists of the following two software technologies:

Alpha Predictions purchased software $2,697,668 
Travel Buddhi purchased software  119,728 
Total purchased software $2,817,396 

The Alpha Predictions purchased software was acquired as further described in Note 4. The Travel Buddhi purchased software was acquired on February 15, 2019, for $115,281 and included all rights, software, and code of the technology platform. During the fiscal year ended June 30, 2019, $55,000 of the Travel Buddhi purchase price was paid and $60,281 remains outstanding. At March 31, 2020, the Travel Buddhi technology platform has not been placed in service, but is expected to be during the first quarter of fiscal year 2021.

Purchased software costs are amortized on a straight-line basis over three years. Amortization of purchased software costs is included in general and administration expenses within the consolidated statements of operations.

For the three and nine months ended March 31, 2020, amortization expense was $216,109 and $700,387, respectively. There was no amortization expense related to purchased software for the three and nine months ended March 31, 2019.

Future amortization expense related to the existing net carrying amount of purchased software at March 31, 2020 is expected to be as follows:

Remainder of fiscal year 2020 $221,920 
Fiscal year 2021  927,590 
Fiscal year 2022  927,590 
Fiscal year 2023  39,909 
  $2,117,009 

F-50

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 6: REVENUE FROM CONTRACTS WITH CUSTOMERS

The following table presents our revenue disaggregated by category within our single reporting segment:

  For the Three Months Ended  For the Nine Months Ended 
  March 31,  March 31, 
  2020  2019  2020  2019 
Subscription $6,180,000  $-  $18,540,000  $- 
Service and support  881,606   -   2,626,674   - 
Application development and implementation  494,901   -   1,521,412   - 
Revenue $7,556,507  $-  $22,688,086  $- 

For the three and nine months ended March 31, 2020, the Company was subject to revenue concentration risk as one customer accounted for 100% of our total revenue for both periods.

Subscription and Application Development and Implementation Revenue

The Company recognizes revenue when, or as, it satisfies a performance obligation to a customer. The Company primarily has one performance obligation, which includes the combined promise to develop, implement, and license customized software. Payment terms for the software include one-time application development and implementation fees, which are generally billed on a time-and-materials basis over the development and implementation period, plus fixed license subscription fees, which may either be billed in full upfront or in monthly installments over the license period, which is generally three years. All of these fees are allocated to the single performance obligation of providing software to the customer.

The performance obligation is fully satisfied at the point in time when the customer has taken control of the completed software, which is when physical possession of the software has transferred to the customer, the customer is able to use and benefit from the software, and the contractual license period has begun. Since the Company has no further obligation to the customer once control of the software has transferred, the Company recognizes revenue in full for all of the development and implementation fees at that point in time. Subscription fees are also recognized when control of the software has transferred to the customer but only to the extent such fees are contractually guaranteed to the Company. Any future monthly subscription fees that the Company would not have a contractually guaranteed right to collect in the event of early termination of the contract are instead recognized as revenue on a straight-line basis over the license period.

Service and Support Revenue

Certain contracts also contain a second performance obligation for service and support. This performance obligation includes the promise to provide future updates, upgrades, and enhancements to the software over the license period, if and when they occur. Service and support fees are fixed as a percentage of total contract value and billed in monthly installments over the license period. The Company recognizes service and support fee revenue over time, on a straight-line basis over the license period, as the customer receives such services on a generally uniform basis throughout the license period.

Allocation of the Transaction Price

Prices allocated to each performance obligation generally correspond with the contractually stated prices, since they equal standalone selling price. In some cases, services may be discounted, which requires the company to allocate the transaction price based on relative standalone selling price. The Company estimates standalone selling price based on comparable industry practices and the costs and margins involved in providing services to its customers.

Contract Liabilities

Contract liabilities include amounts billed to the customer in excess of revenue recognized and are presented as contract liabilities on the consolidated balance sheets. At March 31, 2020 and June 30, 2019 contract liabilities totaled $170,449 and $0, respectively.

Practical Expedient

The Company has elected a practical expedient to omit certain disclosures about the transaction price allocated to remaining performance obligations for contracts with terms of one year or less.

NOTE 7: LIABILITIES IN ARREARS – JUDGEMENT SETTLEMENT AGREEMENT

Liabilities in arrears – judgement settlement agreement is comprised of the following:

  March 31,  June 30, 
  2020  2019 
Note payable, John Fife (dba St. George Investors) / Fife Forbearance [1] $762,921  $855,660 
Total liabilities in arrears – judgement settlement agreement $762,921  $855,660 

[1] effective December 10, 2018, the Company entered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife that was previously in effect. As a result, under the Judgment Settlement Agreement, no shares of the Company’s common stock are issuable or eligible to be converted into. Under the terms of the Judgment Settlement Agreement, the Company was required to pay $15,000 per month from January 15, 2019 through and including February 15, 2020, with a final payment of $195,000 due and payable in March of 2020. The Company made all required payments with the exception of the final payment of $195,000 which was due and payable in March of 2020. The Company and Fife are negotiating a structure whereby the Company will be able to make the final payment of $195,000, which may include additional consideration depending on the timing of when the final payment is made. The Company expects to repay Fife the agreed upon balance due as quickly as possible based upon its available capital. The ultimate final payment amount is expected to be less than the liability balance of $762,921 presented as liabilities in arrears – judgement settlement agreement on the consolidated balance sheets.

F-51

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 8: Convertible Debt Arrangements

JMJ Financial

At March 31, 2020 and June 30, 2019, the amount recorded in current liabilities for this one convertible note and accrued interest thereon due to JMJ Financial was $205,199 and $193,287, respectively. During the nine months ended March 31, 2020 and 2019 the Company recorded $11,911 and $10,952, respectively of interest for the outstanding convertible note.

As of March 31, 2020 and June 30, 2019, the aggregate remaining amount of convertible securities held by JMJ could be converted into 10,260 and 9,664 shares, respectively, with a conversion price of $20.

Accredited Investors

On June 19, 2019, the Company entered into a securities purchase agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $78,000 to the Lender with a maturity date of June 19, 2020. The Company received net proceeds in the amount of $45,800, with $25,000 refinancing a prior convertible promissory note due to the Lender that had been in default, $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory note and $4,200 being paid to the Company’s Transfer Agent to satisfy an outstanding balance. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $103,161, deferred financing costs of $3,000 and debt discount of $75,000. The deferred financing costs and debt discount are being amortized over the term of the note. During December 2019, the Company paid-off the aggregate balance of the convertible promissory note, including accrued interest and prepayment penalty.

On July 30, 2019, the Company entered into a securities purchase agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $53,000 to the Lender with a maturity date of July 30, 2020. The Company received net proceeds in the amount of $50,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory note. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $114,380, deferred financing costs of $3,000 and debt discount of $50,000. The deferred financing costs and debt discount are being amortized over the term of the note. During January 2020, the Company paid-off the aggregate balance of the convertible promissory note, including accrued interest and prepayment penalty.

On September 5, 2019, the Company entered into a securities purchase agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $53,000 to the Lender with a maturity date of September 5, 2020. On September 9, 2019, the Company received net proceeds in the amount of $46,800 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory note and $3,200 being paid to the Company’s Transfer Agent to satisfy an outstanding balance. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $104,860, deferred financing costs of $3,000 and debt discount of $50,000. The deferred financing costs and debt discount are being amortized over the term of the note. During February 2020, the Company paid-off the aggregate balance of the convertible promissory note, including accrued interest and prepayment penalty.

F-52

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 8: Convertible Debt Arrangements (continued)

On September 24, 2019, the Company entered into a securities purchase agreement with accredited investors (“Lenders”) and issued 8% convertible promissory notes in the principal amount of $124,200 (including an aggregate of $9,200 in original issue discounts) to the Lenders with maturity dates of September 24, 2020. On September 27, 2019, the Company received net proceeds in the amount of $112,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory notes. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $208,335, original issue discount of $9,200, deferred financing costs of $3,000 and debt discount of $112,000. The original issue discount, deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $106,200 and $5,129, respectively, at March 31, 2020. The aggregate balance of the convertible promissory note, net of original issue discount, deferred financing costs and debt discount at March 31, 2020 was $46,312.

On December 2, 2019, the Company entered into a securities purchase agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $200,000 (including a $7,500 original issue discount) to the Lender with a maturity date of December 2, 2020. On December 2, 2019, the Company received net proceeds in the amount of $182,500 as a result of $10,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory note. This convertible debenture converts at the greater of (i) $0.50 per share or (ii) 60% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $200,000, original issue discount of $7,500, deferred financing costs of $10,000 and debt discount of $182,500. The original issue discount, deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $200,000 and $5,260, respectively, at March 31, 2020. The aggregate balance of the convertible promissory note, net of original issue discount, deferred financing costs and debt discount at March 31, 2020 was $65,753.

On December 2, 2019, the Company entered into a securities purchase agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $78,000 to the Lender with a maturity date of December 2, 2020. On December 4, 2019, the Company received net proceeds in the amount of $75,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory note. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $78,629, deferred financing costs of $3,000 and debt discount of $75,000. The deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $78,000 and $2,052, respectively, at March 31, 2020. The aggregate balance of the convertible promissory note, net of deferred financing costs and debt discount at March 31, 2020 was $25,644.

On December 2, 2019, the Company entered into a securities purchase agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $135,000 (including a $6,750 original issue discount) to the Lender with a maturity date of December 2, 2020. On December 3, 2019, the Company received net proceeds in the amount of $122,000 as a result of $6,250 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory note. This convertible debenture converts at the greater of (i) $0.50 per share or (ii) 60% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $135,000, original issue discount of $6,750, deferred financing costs of $6,250 and debt discount of $122,000. The original issue discount, deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $135,000 and $3,551, respectively, at March 31, 2020. The aggregate balance of the convertible promissory note, net of original issue discount, deferred financing costs and debt discount at March 31, 2020 was $44,384.

F-53

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 8: Convertible Debt Arrangements (continued)

On December 17, 2019, the Company entered into a securities purchase agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $81,000 (including a $6,000 original issue discount) to the Lender with a maturity date of December 17, 2020. On December 17, 2019, the Company received net proceeds in the amount of $73,500 as a result of $1,500 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory note. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $81,599, original issue discount of $6,000, deferred financing costs of $1,500 and debt discount of $73,500. The original issue discount, deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $81,000 and $1,864, respectively, at March 31, 2020. The aggregate balance of the convertible promissory note, net of original issue discount, deferred financing costs and debt discount at March 31, 2020 was $23,301.

On January 9, 2020, the Company entered into a securities purchase agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $110,000 (including a $5,000 original issue discount) to the Lender with a maturity date of January 9, 2021. On January 13, 2020, the Company received net proceeds in the amount of $100,000 as a result of $5,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory note. This convertible debenture converts at a price of $0.50 per share, however, in the event the closing bid price of the Company’s common stock is less than $0.70 per share on any day while this convertible promissory note is outstanding, this convertible debenture will convert at 60% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $107,338, original issue discount of $5,000, deferred financing costs of $5,000 and debt discount of $100,000. The original issue discount, deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $110,000 and $2,194, respectively, at March 31, 2020. The aggregate balance of the convertible promissory note, net of original issue discount, deferred financing costs and debt discount at March 31, 2020 was $24,712.

On January 21, 2020, the Company entered into approximately 59,744,681a securities purchase agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $68,000 to the Lender with a maturity date of January 21, 2021. On January 23, 2020, the Company received net proceeds in the amount of $65,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory note. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $60,735, deferred financing costs of $3,000 and debt discount of $65,000. The deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $68,000 and $1,058, respectively, at March 31, 2020. The aggregate balance of the convertible promissory note, net of deferred financing costs and debt discount at March 31, 2020 was $13,227.

F-54

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 8: Convertible Debt Arrangements (continued)

On February 24, 2020, the Company entered into a securities purchase agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $53,000 to the Lender with a maturity date of February 24, 2021. On February 26, 2020, the Company received net proceeds in the amount of $50,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory note. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $43,426, deferred financing costs of $3,000 and debt discount of $50,000. The deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $53,000 and $430, respectively, at March 31, 2020. The aggregate balance of the convertible promissory note, net of deferred financing costs and debt discount at March 31, 2020 was $5,373.

On March 3, 2020, the Company entered into a securities purchase agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $63,000 to the Lender with a maturity date of March 3, 2021. On March 5, 2020, the Company received net proceeds in the amount of $60,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this securities purchase agreement and convertible promissory note. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $51,269, deferred financing costs of $3,000 and debt discount of $60,000. The deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $63,000 and $400, respectively, at March 31, 2020. The aggregate balance of the convertible promissory note, net of deferred financing costs and debt discount at March 31, 2020 was $5,005.

At March 31, 2020 and June 30, 2019, there was $894,200 and $78,000 of convertible notes payable outstanding, net of discounts of $640,488 and $75,649, respectively.

During the nine months ended March 31, 2020 and 2019, amortization of original issue discount, deferred financing costs, and debt discount amounted to $453,361 and $7,976, respectively.

During the nine months ended March 31, 2020, $19,000 of convertible notes, including fees, were converted into 68,093 shares of the Company’s common stock. During the nine months ended March 31, 2019, there were no conversions of convertible notes into shares of the Company’s common stock.

At March 31, 2020, the Company was in compliance with the terms of the Accredited Investors convertible promissory notes.

NOTE 9: DERIVATIVE LIABILITY

The Convertible Note which originally scheduledCompany evaluates its convertible instruments, options, warrants or other contracts to mature March 4, 2011was extended untildetermine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under ASC Topic 815, Derivatives and Hedging. The result of this accounting treatment is that the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operation as other income (expense). Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under ASC Topic 815 are reclassified to liabilities at the fair value of the instrument on the reclassification date.

The following table presents a reconciliation of the derivative liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) from June 30, 20122018 to March 31, 2020:

  

Conversion

feature derivative liability

 
June 30, 2018 $- 
Initial fair value of derivative liability recorded as debt discount  75,000 
Initial fair value of derivative liability recorded as deferred financing costs  3,000 
Initial fair value of derivative liability charged to other expense  25,161 
Loss on change in fair value included in earnings  30,508 
June 30, 2019 $133,669 
Initial fair value of derivative liability recorded as debt discount  940,001 
Initial fair value of derivative liability charged to other expense  245,572 
Gain on change in fair value included in earnings  (976,049)
March 31, 2020 $343,193 

F-55

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 9: DERIVATIVE LIABILITY (continued)

Total derivative liability at March 31, 2020 and June 30, 2019 amounted to $343,193 and $133,669, respectively. The change in fair value included in earnings of $976,049 is due in part to the quoted market price of the Company’s common stock decreasing from $0.85 at June 30, 2019 to $0.55 at March 31, 2020, coupled with decreased conversion prices due to the effect of “ratchet” provisions incorporated within the convertible notes payable.

The Company used the following assumptions for determining the fair value of the convertible instruments granted under the binomial pricing model with binomial simulations at March 31, 2020:

Expected volatility141.9% - 233.2%
Expected term5.8 months – 11.1 months
Risk-free interest rate0.15% - 0.17%
Stock price$0.55

NOTE 10: STOCKHOLDERS’ EQUITY

The total number of shares of all classes of stock that the Company shall have the authority to issue is 100,001,000 shares consisting of 100,000,000 shares of common stock, $0.01 par value per share, of which 13,486,040 are issued, 13,312,314 are outstanding, and 173,726 are to be issued at March 31, 2020, and 1,000 shares of preferred stock, par value $0.01 per share of which 1,000 shares have been designated as Series A Super Voting Preferred of which 1,000 are issued and outstanding at March 31, 2020.

Common Stock

Private Placements

During the nine months ended March 31, 2020, the Company received $347,000 of net proceeds from the sale of 997,577 shares of common stock in private placements with accredited investors, incurring $11,250 in finder’s fees, which were paid by the issuance of 11,003 shares of common stock. During the nine months ended March 31, 2020, the Company issued 132,000 shares of common stock which was sold in private placements with accredited investors and presented as common stock to be issued at June 30, 2019 on the consolidated balance sheets.

During the nine months ended March 31, 2019, the Company received $110,000 of net proceeds from the issuance of 440,000 shares of common stock in private placements with accredited investors, incurring no finder’s fees.

Stock Award Payable

During the nine months ended March 31, 2020, the Company did not issue any shares of common stock to former officers, outside directors, or strategic consultants.

During the nine months ended March 31, 2019, three former officers of the Company, Mr. Biderman as an outside director, and certain strategic consultants, who provided services to the Company, received a total of 1,150,000 shares of common stock, which were valued at $0.50 or $575,000, based on the closing price of the Company’s common stock on September 24, 2018, and was included in accrued expenses at June 30, 2018.

Stock Based Compensation

During the nine months ended March 31, 2020, the Company issued 231,635 restricted shares of its common stock to Mr. Cutchens, the Company’s Chief Financial Officer, which were granted on June 1, 2019 (the “Grant Date”), pursuant to the Forbearance Agreement dated asterms of September 13, 2011. Increases inan employment agreement with the principal amountCompany. The restricted shares of common stock vest 25% on the six-month, 1 year, 2 year, and 3 year anniversaries of the Grant Date. During the nine months ended March 31, 2020, the Company recorded $113,815 of stock-based compensation expense related to the vested portion of this award.

During the nine months ended March 31, 2019, the Company issued 2,620,899 shares of its common stock to Mr. Bhatnagar, the Company’s President and Chief Executive Officer, which were granted on January 11, 2019 (the “Grant Date”), pursuant to the terms of an employment agreement and related transition agreement with the Company. The shares of common stock were immediately vested and the Company recorded $1,310,449 of stock-based compensation expense during the nine months ended March 31, 2020.

F-56

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 10: STOCKHOLDERS’ EQUITY (continued)

Conversion of Service Fees

During the nine months ended March 31, 2020, the Company issued 62,000 shares of common stock to a former officer who provided services to the Company.

During the nine months ended March 31, 2019, former officers converted $671,787 accrued wages into 1,609,594 shares and $702,105 of notes payable and accrued interest into 1,404,210 shares and a director converted $186,000 of accrued fees into 372,000 shares and $126,364 of a note and accrued interest into 252,728 shares, of the Company’s common stock. Also, accounts payable to strategic vendors totaling $114,800 were converted into 260,200 shares of common stock.

Reserved Shares

At March 31, 2020, the convertible note are alsopromissory notes entered into with the accredited investors require the Company to reserve 34,209,383 shares of its common stock for potential future conversions under such instruments.

At March 31, 2020, 7,202 shares of the Company’s common stock remain subject to be convertible intoreturned to the Company’s treasury for cancellation. Such shares were not sold as part of 8,000 shares of the Company’s common stock that was advanced during fiscal year 2014 under an Equity Line of Credit.

Common Stock Warrants

Warrant Agreement – Earned Warrants

Mr. Bhatnagar, the Company’s President and Chief Executive Officer, is entitled to receive warrants to acquire 4% of the outstanding fully diluted common stock of the Company at(the “Earned Warrants”) each time the optionCompany’s revenue increases by $1,000,000. The exercise price of the holder at a priceEarned Warrants is equal to $0.50 per share, and he may not receive Earned Warrants to the dollarextent that the number of Signing Shares (as defined in the Warrant Agreement) and Earned Warrants exceed 80% of the fully diluted common stock of the Company (“Warrant Cap”).

Warrant Agreement – Accelerated Warrants

Mr. Bhatnagar, the Company’s President and Chief Executive Officer, shall immediately receive the remaining amount of the note being converted divided by 75%warrants necessary to acquire up to 80% of the three lowest volume weighted average prices during the 20 day trading period immediately preceding the dateoutstanding fully diluted common stock of conversion.

On September 13, 2011, the Company issued a second Convertible Note to John Fife in a Private Placement pursuant to Section 4(2)(“Accelerated Warrants”) when either of the Securities Act of 1933. The initial principal amountfollowing occur:

a)the Company completes a stock or asset purchase of Scepter Commodities, LLC; or
b)the Company completes a stock or asset purchase of any other entity, either of which, in the aggregate, together with prior revenue increases achieved by the Company, results in the consolidated revenues of the Company being not less than $15,000,000; or
c)the Company grows a similar business organically within mPhase to include contracts generating revenues in excess of $15,000,000; or
d)the Company meets the listing requirements of either the NYSE or NASDAQ

For the first funded tranche ofnine months ended March 31, 2020, since the Convertible NoteCompany’s revenue was $357,500 and the Company received cash proceeds of $300,000. A second tranche of the Convertible Note in the amount of $200,000 cash is funded upon the filing by the Company of a Registration Statement on Form S-1 with the Securities and Exchange Commission providing for the registration of 185,400,000$22,688,086, Mr. Bhatnagar earned warrants to acquire 32,405,058 shares of common stock that may be converted into from time to time by the holder of the Convertible Note. The instrument is convertible into the Company’s common stock at 75%under the provisions of the volume weight average priceWarrant Agreement. At March 31, 2020, as Mr. Bhatnagar has earned the maximum number of warrants available under the provisions of the Warrant Agreement to acquire 37,390,452 shares of the Company’s common stock, there remains no additional shares of the Company’s common stock that Mr. Bhatnagar can earn.

F-57

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 10: STOCKHOLDERS’ EQUITY (continued)

For the nine months ended March 31, 2020, the Company recognized $16,202,529 of stock-based compensation expense related to the earned warrants, based upon a value of $0.50 per warrant. At March 31, 2020, there remains no additional stock-based compensation expense related to the averageWarrant Agreement that the Company expects to recognize over the next three months.

The Company estimates the fair value of the three lowest trading days in the 20 day trading period immediately preceding such conversion. Absent an effective Registration Statement, the holder of the Convertible Note may not sell any common stock prior to 6 months fromeach option award on the date of fundinggrant using a black-scholes option valuation model that uses the assumptions noted in the table below. Because black-scholes option valuation models incorporate ranges of eachassumptions for inputs, those ranges are disclosed. Expected volatilities are based on the historical volatility of the respective tranchesCompany’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model; separate groups of such instrument under Rule 144employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected term of options granted is derived from the output of the Securities Actoption valuation model and represents the period of 1933.time that options granted are expected to be outstanding; the range given below results from certain groups of employees exhibiting different behavior. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The following assumptions were utilized during the nine months ended March 31, 2020:

14. SUBSEQUENT EVENTS- (Unaudited)

Expected volatility21,779.77%
Weighted-average volatility21,779.77%
Expected dividends0%
Expected term (in years)5.0
Risk-free rate2.52%

From October 1, through November 4, 2011, theThe following table sets forth common stock purchase warrants outstanding at March 31, 2020:

  Warrants  Weighted
Average
Exercise Price
  Intrinsic
Value
 
Outstanding, June 30, 2019  4,985,394  $0.50  $- 
Warrants earned  32,405,058   0.50   - 
Warrants forfeited  -   -   - 
Outstanding, March 31, 2020  37,390,452  $0.50  $- 
             
Common stock issuable upon exercise of warrants  37,390,452  $0.50  $- 

   

Common Stock Issuable Upon Exercise of

Warrants Outstanding

  Common Stock Issuable Upon
Warrants Exercisable
 
Range of
Exercise
Prices
  Number
Outstanding at
March 31, 2020
  Weighted
Average
Remaining
Contractual
Life (Years)
  Weighted
Average
Exercise
Price
  Number
Exercisable at
March 31, 2020
  Weighted
Average
Exercise
Price
 
$0.50   37,390,452   4.55  $0.50   37,390,452  $0.50 
     37,390,452   4.55  $0.50   37,390,452  $0.50 

F-58

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 10: STOCKHOLDERS’ EQUITY (continued)

Settlement and New Funding Share Reserves

The Company issued 59,700,000agreed to reserve a total of 3,000,000 shares of its common stock of which 532,040 shares of common stock were reserved for and issued concurrently for the conversion of 75% of outstanding accounts payables to officers’ and a director (discussed below), 1,967,960 shares of common stock were reserved to reduce liabilities outstanding at December 31, 2018 (“Settlement Reserve”), and 500,000 shares of common stock were reserved to fund continuing operations (“Funding Reserve”). At March 31, 2020, 315,949 shares of common stock remained available from the initial Settlement Reserve to settle prior liabilities and 185,063, shares of common stock remained available from the Funding Reserve to fund continuing operations.

  Settlement Reserve  Funding Reserve 
Initial Shares of Common Stock to Establish Reserve  1,967,960   500,000 
Shares issued concurrently to transition agreement for the conversion of 75% strategic vendors, outstanding December 31, 2018  (61,200)  - 
Shares available upon execution of the Transition Agreement dated January 11, 2019  1,906,760   500,000 
Shares issued subsequent to a “Change in Control” to accredited investors in private placements through March 31, 2020  (1,590,811)  (314,937)
Shares of Common Stock available at March 31, 2020  315,949   185,063 

Prior Liabilities – Settlement Reserve

1,967,960 shares of the Company’s common stock have been reserved to settle the debts of the Company that were outstanding at December 31, 2018, in the following priority; the Judgement Settlement Agreement (formerly Fife forbearance Agreement), JMJ Financial, Inc., MH Investment Trust, Power Up Lending Ltd, as well as other liabilities satisfactory to the Chief Executive Officer of the Company and the Company (as per Section 2(a) of the Reserve Agreement concurrent with “Change in Control Agreements”, dated January 11, 2019). At March 31, 2020, 315,949 shares of common stock remain available under this reserve category.

Officer’s and Director’s – Conversion Share Reserve

532,040 shares of the Company’s common stock were reserved for the conversion of 75% of payables to officers’ and a director that were outstanding December 31, 2018, (as per Section 2(a) of the Reserve Agreement concurrent with “Change in Control Agreements”, dated January 11, 2019). All these shares were issued effective December 31, 2018 and no shares remain available under this reserve category.

Continuing Operations Share Reserve

500,000 shares of the Company’s common stock were reserved as per Section 2(c) to be sold at a price, not less than $0.25 per share in periodic Private Placements, (as per Section 2(a) of the Reserve Agreement concurrent with “Change in Control Agreements”, dated January 11, 2019). At March 31, 2020, 185,063 shares of common stock remain available under this reserve category.

Final Adjustment for Liabilities Eliminated by Settlement Reserve

On October 9, 2019, the Company and its Chief Executive Officer entered into Amendment No. 1 to the original Reserve Agreement dated January 11, 2019, to extend the date whereby the Company is able to eliminate the above-mentioned liabilities from July 11, 2019 to March 31, 2020. In the event the Company is not able to eliminate the above-mentioned liabilities, or the cost to do so requires more than the funding provided by the Warrant Cap pertaining to Warrants to be issued to Mr. Bhatnagar, the Settlement Reserve shares shall be increased by that number of shares at $0.25, which equals the amount of the remaining liabilities. Amendment No. 1 to the original Reserve Agreement expired with no further amendment.

Series A Preferred Stock

On January 11, 2019, the Company issued 1,000 shares of Series A Preferred Stock to Mr. Bhatnagar as the Company’s new President and Chief Executive Officer, to effectuate voting control of the Company pursuant to the terms of the Transition Agreement. The Series A Preferred shares were recorded at par value, are not tradeable, and have a nominal liquidation value.

F-59

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 11: RELATED PARTY TRANSACTIONS

Microphase Corporation

At March 31, 2020, the Company owed $32,545 to Microphase for previously leased office space at its Norwalk location and for certain research and development services and shared administrative personnel from time to time, all through December 31, 2015.

Former Director

During September 2018, a former outside director converted $130,733 of his note payable and accrued interest and $186,000 of accrued fees into an aggregate of 642,203 shares of common stock.

During the nine months ended March 31, 2020 and 2019, the Company recorded $0 and $1,931 of accrued interest.

Transactions With Officers

At various points during past fiscal years certain officers and former officers of the Company provided bridge loans to the Company evidenced by individual promissory notes and deferred compensation so as to provide working capital to the Company. All of these notes accrue interest at the rate of 6% per annum, and are payable on demand. During the nine months ended March 31, 2020 and 2019, the officers and former officers advanced $48,052 and $53,712 to provide working capital to the Company and $3,625 and $38,545 has been charged for interest on loans from officers and former officers.

At March 31, 2020 and June 30, 2019, these outstanding notes including accrued interest totaled $77,591 and $58,165, respectively. At March 31, 2020, these promissory notes are not convertible into shares of the Company’s common stock.

During the nine months ended March 31, 2019, three former officers of the Company, Mr. Biderman as a former outside director, and certain strategic consultants, who provided services to the Company, received a total of 1,150,000 shares of common stock, which were valued at $0.50 or $575,000, based on the closing price of the Company’s common stock on September 24, 2018, and was included in accrued expenses at June 30, 2018.

During the nine months ended March 31, 2020, the Company incurred $15,500 of expense related to legal and consulting services provided by Mr. Smiley, the Company’s former Chief Financial Officer and legal counsel. During October 2019, the entire balance of $15,500 was converted into 62,000 shares of common stock.

Office Lease

Effective May 1, 2019, the Company relocated its corporate office to 9841 Washingtonian Blvd., Suite 390, Gaithersburg, MD 20878, and incurs rent expense of $1,350 per month, which is payable to a related party. The lease term with the related party is a month-to-month arrangement.

F-60

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 12: COMMITMENTS AND CONTINGENCIES

Commitments

Office Lease

Effective May 1, 2019, the Company relocated its corporate office to 9841 Washingtonian Blvd., Suite 390, Gaithersburg, MD 20878, and incurs rent expense of $1,350 per month, which is payable to a related party. The lease term with the related party is a month-to-month arrangement.

Contracts and Commitments Executed Pursuant to the Transition Agreement

In the transaction whereby, Mr. Bhatnagar acquired control of the Company on January 11, 2019, the Company entered into material commitments including an employment agreement and a warrant agreement (see Note 10).

Contingencies

Judgment Settlement Agreement

Effective December 10, 2018, the Company entered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife that was previously in effect. As a result, under the Judgment Settlement Agreement, no shares of the Company’s common stock are issuable or eligible to be converted into. Under the terms of the Judgment Settlement Agreement, the Company is required to pay $15,000 per month from January 15, 2019 through and including February 15, 2020, with a final payment of $195,000 due and payable in March of 2020. The Company made all required payments with the exception of the final payment of $195,000 which was due and payable in March of 2020. The Company and Fife are negotiating a structure whereby the Company will be able to make the final payment of $195,000, which may include additional consideration depending upon the timing of when the final payment is made. The Company expects to repay Fife the agreed upon balance due as quickly as possible based upon its available capital. The ultimate final payment amount is expected to be less than the liability balance of $762,921 presented as liabilities in arrears – judgement settlement agreement on the consolidated balance sheets (see Note 7).

Amounts Contingent upon Certain Terms of Change in Control Agreements Effective January 11, 2019

To the extent Company does not eliminate the certain liabilities by March 31, 2020, the Warrant Cap pertaining to Warrants to be issued to Mr. Bhatnagar, the Settlement Reserve shares shall be increased by that number of shares at $0.25, which equals the amount of the remaining liabilities. Amendment No. 1 to the original Reserve Agreement expired with no further amendment.

The Change in Control Agreements, effective January 11, 2019, also have certain provisions that may accelerate the warrant “earn out” formula contained in the Transition Agreement. As of March 31, 2020, all available warrants to be earned by the Chief Executive Officer have been earned.

F-61

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 13: DISCONTINUED OPERATIONS

The Company has classified the operating results and associated assets and liabilities from its Jump line of products, which ceased generating material revenue during the first quarter of fiscal year 2017, as discontinued operations in the consolidated financial statements for the nine months ended March 31, 2020 and 2019.

The assets and liabilities associated with discontinued operations included in our consolidated balance sheets were as follows:

  March 31, 2020  June 30, 2019 
  Discontinued  Continuing  Total  Discontinued  Continuing  Total 
Assets                        
Current Assets                        
Cash $-  $8,054  $8,054  $-  $33,996  $33,996 
Accounts receivable, net  -   6,409,386   6,409,386   -   2,526,155   2,526,155 
Prepaid expenses  -   437   437   -   8,280   8,280 
Other assets  -   227,486   227,486   -   -   - 
Total Current Assets  -   6,645,363   6,645,363   -   2,568,971   2,568,971 
Property and equipment, net  -   10,678   10,678   -   11,048   11,048 
Goodwill  -   6,020   6,020   -   6,020   6,020 
Intangible asset - purchased software, net  -   2,117,009   2,117,009   -   3,025,801   3,025,801 
Other assets  -   12,792   12,792   -   3,058   3,058 
Total Assets $-  $8,791,862  $8,791,862  $-  $5,614,898  $5,614,898 
                         
Liabilities                        
Current Liabilities                        
Accounts payable $82,795  $3,560,910  $3,643,705  $82,795  $366,274  $449,069 
Accrued expenses  -   796,434   796,434   -   3,368,801   3,368,801 
Contract liabilities  -   170,449   170,449   -   -   - 
Due to related parties  -   88,907   88,907   -   65,459   65,459 
Notes payable to officers  -   26,420   26,420   -   25,251   25,251 
Convertible notes payable, net  -   253,712   253,712   -   2,351   2,351 
Liabilities in arrears with convertible features  -   109,000   109,000   -   109,000   109,000 
Liabilities in arrears - judgement settlement agreement (Note 7)  -   762,921   762,921   -   855,660   855,660 
Derivative liability  -   343,193   343,193   -   133,669   133,669 
Total Current Liabilities $82,795  $6,111,946  $6,194,741  $82,795  $4,926,465  $5,009,260 

F-62

mPHASE TECHNOLOGIES, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED MARCH 31, 2020 AND 2019

(UNAUDITED)

NOTE 13: DISCONTINUED OPERATIONS (continued)

For the three and nine months ended March 31, 2020, there were no revenue or expenses associated with discontinued operations included in our consolidated statements of operations. For the three and nine months ended March 31, 2019, the revenue and expenses associated with discontinued operations included in our consolidated statements of operations were as follows:

  For The Three Months Ended 
  March 31, 2019 
  Discontinued  Continuing  Total 
Revenue $-  $-  $- 
Cost of revenue  -   -   - 
Gross Profit  -   -   - 
Operating Expenses:            
Software development costs  -   -   - 
General and administrative  -   1,422,737   1,442,737 
Total Operating Expenses  -   1,422,737   1,442,737 
Operating loss  -   (1,422,737)  (1,422,737)
Other Income (Expense):            
Interest expense  (3,805)  (14,027)  (17,832)
Amortization of debt discount  -   (1,843)  (1,843)
Total Other Income (Expense)  (3,805)  (15,870)  (19,675)
Income (loss) before income taxes  (3,805)  (1,438,607)  (1,442,412)
Income taxes  -   -   - 
Net loss $(3,805) $(1,438,607) $(1,442,412)

  For The Nine Months Ended 
  March 31, 2019 
  Discontinued  Continuing  Total 
Revenue $-  $-  $- 
Cost of revenue  -   -   - 
Gross Profit  -   -   - 
Operating Expenses:            
Software development costs  -   -   - 
General and administrative  -   1,541,960   1,541,960 
Total Operating Expenses  -   1,541,960   1,541,960 
Operating loss  -   (1,541,960)  (1,541,960)
Other Income (Expense):            
Interest expense  (27,245)  (147,936)  (175,181)
Amortization of debt discount  -   (7,976)  (7,976)
Gain on extinguishment of debts  12,532   16,279   28,811 
Total Other Income (Expense)  (14,713)  (139,633)  (154,346)
Loss before income taxes  (14,713)  (1,681,593)  (1,696,306)
Income taxes  -   -   - 
Net loss $(14,713) $(1,681,593) $(1,696,306)

NOTE 14: SUBSEQUENT EVENTS

Subsequent to March 31, 2020, an aggregate of $114,428 of principal, accrued interest, and fees have been converted into 815,500 shares of the Company’s common stock.

Subsequent to March 31, 2020, the Company entered into an Asset Purchase Agreement (“APA”) to acquire CloseComms Limited (“CloseComms”), a United Kingdom based company with offices in Wales (U.K.) and California (U.S.), that has developed a patented, software application platform that can be integrated into a retail customer’s existing Wi-Fi infrastructure, giving the retailer important customer data and enabling AI-enhanced, targeted promotions to drive store traffic and sales. Pursuant to the terms of the APA, the Company acquired all of the assets owned, used, or held by CloseComms in connection with the conversion of $238,800Business (as defined within the APA), other than Excluded Assets (as defined within the APA), and assuming certain specified liabilities of the convertible debt arrangements and accrued interest thereon.

On July 28, 2011, the Company announced that it entered into a letter of intent (LOI) to acquire Energy Innovative Products, Inc. (EIP), a developer of proprietary technologiesBusiness, in exchange for reducing energy usage in refrigeration and cooling systems, as well as equipment utilizing AC induction motors. EIP, based in Fairfield, NJ, uses patented and patent pending solutions to offer a series of products that control voltage and current used by compressor systems, including those in refrigeration decks, HVAC wall units, commercial refrigeration systems, and consumer equipment. The Company has revised its estimate date to execute the terms2,666,666 restricted shares of the deal include the issuance ofCompany’s common shares and warrants for an 81% stake in EIP. The transaction is expected to become a Definitive Agreement by the end of January 15, 2012 and close by February 1, 2012.stock.

98


F-63

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 13. Other Expenses of Issuance

OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION

The following table sets forth the costs and Distribution

We will pay all expenses payable by the Company in connection with the registration and sale of the Common Stock by the selling shareholders. The estimated expenses of issuance and distribution of the securities being registered hereunder. All amounts are set forth below.

SEC filing fee$ 252
Legal expenses$ 0
Accounting expenses$ 5,000
Miscellaneous$ 350
Total$ 5,602

* Estimateestimates except the SEC registration fee.

Item 14. Indemnification of Directors and Officers

SEC registration fees $46 
Printing expenses $5,000 
Accounting fees and expenses $3,000 
Legal fees and expenses $5,000 
Blue sky fees $10,000 
Miscellaneous $954 
Total $24,000 

INDEMNIFICATION OF DIRECTORS AND OFFICERS

Our directors and officers are indemnified by our bylaws against amounts actually and necessarily incurred by them in connection with the defense of any action, suit or proceeding in which they are a party by reason of being or having been directors or officers of the Company. Our certificate of incorporation provides that none of our directors or officers shall be personally liable for damages for breach of any fiduciary duty as a director or officer involving any act or omission of any such director or officer. Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended, may be permitted to such directors, officers and controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

In the event that a claim for indemnification against such liabilities, other than the payment by us of expenses incurred or paid by such director, officer or controlling person in the successful defense of any action, suit or proceeding, is asserted by such director, officer or controlling person in connection with the securities being registered, we will, unless in the opinion of counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

Item 15. Recent Sales of Unregistered Securities

Private PlacementsRECENT SALES OF UNREGISTERED SECURITIES

During the fiscal years ended June 30, 2009, 2010 and 2011 the following transactions resulted in the issuances of the Company’s Common Stock:

Fiscal Year ended June 30, 2009

Private Placements

During the quarter ended September 30, 2008, the Company issued 4,000,000 shares of its common stock at $.05 per share in private placements, generating gross proceeds of $200,000 which after deducting finder fees of $20,000 to Eagle Advisors who acted as placement agent, generated net proceeds of $180,000. The proceeds were used as working capital by the Company. Related to this transaction was the issuance of 3,862,000 shares as reparations shares to effect re-pricing at a cost estimated to be $216,689.

No private placements occurred in the quarter ending December 31, 2008.

During the quarter ended March 31, 2009, the Company issued 35,000,000 shares of its common stock at $.01 per share in private placements, generating gross proceeds of $350,000 which after deducting finder fees of $35,000 to Eagle Advisors who acted as placement agent, generated net proceeds of $315,000. Related to these transactions was the issuance of 7,660,000 shares as reparations shares to effect re-pricing, costing an estimated $99,483.

During the quarter ended June 30, 2009, the Company issued 33,333,333 shares of its common stock at $.0075 per share in private placements, generating gross proceeds of $250,000 which after deducting finder fees of $25,000 to Eagle Advisors who acted as placement agent, generated gross proceeds of $225,000. Related to these transactions was the issuance of 2,000,000 shares as reparations shares to effect re-pricing, costing an estimated $64,000 and finder's fees of $25,000.

99


Also during the quarter ended June 30, 2009, the Company issued 20,775,000 shares in settlement of $169,875 of prior promissory notes payable plus accrued interest and incurred a beneficial conversion of $114,500.

In connection withUnless otherwise indicated, the foregoing the Company relied uponsecurities were offered, sold and issued in reliance on the exemption from securities registration requirements under the Securities Act afforded by Section 4(a)(2) thereof and/or Rule 506 of Regulation D as promulgated by the United States Securities and Exchange Commission underthereunder or Section 3(a)(9) of the Securities Act of 1933, as amended,Act. Purchasers were “accredited investors” and/or “sophisticated investors” pursuant to Section 4(2) of said Securities Act. No advertising or general solicitation was employed in offering the securities. The issuances were made to a limited number of persons, all of whom were accredited investors, and transfer of the securities was restricted in accordance with the requirements501(a)(b) of the Securities Act, of 1933.

All proceeds receivedwho provided the Company with representations, warranties and information concerning their respective qualifications as “sophisticated investors” and/or “accredited investors.” The Company provided and made available to purchasers full information regarding its business and operations. There was no general solicitation in connection with the above transactions were usedoffer or sale of the restricted securities. Purchasers acquired the restricted common stock for their own account, for investment purposes and not with a view to public resale or distribution thereof within the meaning of the Securities Act. The restricted shares cannot be sold unless pursuant to an effective registration statement by the Company, as working capital.

Stock Based Compensation

During the three months ended September 30, 2008, the Company issued 5 year options to purchase 104,675,000 sharesor by an exemption from registration requirements of common stock at $.05 per share. The value of such options was estimated to be $4,071,348 using the Black Scholes method, based on an assumed volatility of 78% and an interest rate of 1.5% . In addition, 61,750,000 shares of common stock valued at $3,525,615 were issued to employees and consultants.

No such transactions occurred in the quarters ended December 31, 2008, nor March 31, 2009.

During the quarter ended June 30, 2009, the Company granted 3 officers of the Company the right to convert an aggregate of $1,465,992 of loans and accrued and unpaid compensation and accrued interest into common stock of the Company at a price of $.0075 per share.

All of the above transactions are exempt from Section 5 of the Securities ActAct—the existence of 1933, as amended since no “sale” for additional consideration of a “security” took place.any such exemption subject to legal review and approval by the Company.

Conversion of debt securities

During the fiscal year endedFrom July 1, 2017 through June 30, 2009, $3,303,333 of debt was converted into 278,346,019 shares of common stock. Included in this amount is $112,500 of notes payable to a related party which were sold to an investor for $112,500 cash and reinvested in2018, the Company and the investor subsequently converted into 15,000,000 sharesissued an aggregate of the Company's common stock valued at $.0075 per share. Additionally $57,375 of prior notes plus accrued interest outstanding was settled by the issuance of 5,775,000 shares of common stock. All other debt converted involved long term convertible debentures as described below.

In connection with the foregoing, the Company relied upon the exemption from securities registration afforded by Rule 506 of Regulation D as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended, and/or Section 4(2) of said Securities Act. No advertising or general solicitation was employed in offering the securities. The issuances were made to a limited number of persons, all of whom were accredited investors, and transfer of the securities was restricted in accordance with the requirements of the Securities Act of 1933.

All proceeds received by the Company in connection with the above transactions was used as working capital.

Long Term Convertible Debentures / Note Receivable / Debt Discount and Related Interest

During the fiscal year ended June 30, 2009, the Company entered into convertible debt arrangements as follows:

(JMJ Financial, Inc.)

On December 31, 2008, the Company entered into a private placement pursuant to Section 4(2) of the Securities Act of 1933, as amended with JMJ Financial. This transaction involved 1) the issuance by the Company of a convertible note in the amount of $1.1 million, plus a one-time interest factor of 12% ($132,000) and a maturity date of December 31, 2011, and 2) a secured note receivable in the amount of $1.0 million, plus a one-time interest factor of 13.2 % ($132,000) and maturity date of December 31, 2012 due from the holder of the convertible note to pay periodic installments of the purchase price of the instrument. No cash was initially exchanged relative to this agreement.

100


Conversion of outstanding debentures into common shares is at the option of the holder. The number of shares into which this debenture can be converted is equal to the dollar amount of the debenture divided by 75% of the lowest trading price during the 20 day trading period prior to conversion. As of June 30, 2010, all installments in cash had been funded under the secured note and converted into shares of common stock no amounts remain outstanding under this agreement.

During the fiscal year ended June 30, 2010, the Company received $1,000,000 of cash advances and $132,000 of contract interest. During the year ended June 30, 2010, the holder converted $1,232,000 of principal and interest into 78,792,702360,000 shares of the Company’s common stock. Additionally,Common Stock under private placements.

From July 1, 2018 through June 30, 2019, the Company recorded $488,889 amortizationissued an aggregate of debt discount under this agreement.

All5,688,733 shares of the proceeds received byCompany’s Common Stock for the following; 640,000 shares under private placements, 1,150,000 shares for accrued services rendered, and 3,898,733 shares for the conversion of related party debts and strategic vendor payables.

On January 16, 2019, the Company in connection with the above transaction were used as working capital.

(LaJolla Cove Investors, Inc.)

On Sept 11, 2008, the Company received proceeds of $200,000 under a Securities Purchase Agreement in a Private Placement pursuant to Rule 506 of Regulation Dissued its Chief Executive Officer 2,620,899 shares of the Securities Act of 1933, as amended. This transaction involved three related agreements: 1) a Securities Purchase Agreement which may under certain circumstances permit the Company to draw up to $2,000,000 of funds, 2) the issuance by the Company of a convertible debenture totaling $2,000,000, with an interest rate of 7 1/4% and a maturity date of September 30, 2011, and 3) a secured note receivable in the amount of $1,800,000, with an interest rate of 8 1/4% and maturity dates of September 30, 2011 to fund periodic payments of the purchase price of the Convertible Debenture due from the holder of the instrument.

Conversion of outstanding debentures into common shares is similarCompany’s Common Stock pursuant to the terms of Arrangement were based upon a 20% discount from the price of the Company’s common stock based upon a formula look-back period from the date of the conversion. The transaction resulted in a note discount which is being amortized as expense over the life of the loan. During the twelve month period ended June 30, 2010, amortization of debt discount amounted to $71,646. However the transaction was terminated by mutual agreement by the Company and the holder and no further payments were received by the Company. The original $200,000 received was converted down to $10,000 of common stock and as part of the termination of the agreement the Company paid the holder $17,000 to assign the unconverted portion of the instrument to a third party investor as a Section 4(2) Private Placement. On September 22, 2011 said investor converted the remaining $10,000 into 2,560,976 shares of the Company’s common stock. Accordingly all amounts under this instrument have been fully converted into common stock and no amount of indebtedness remains outstanding.his employment agreement.

All proceeds received by the Company from the above-transactions was used as working capital.

Fiscal Year Ended June 30, 2010

Private Placements

During the quarter ended September 30, 2009, the Company received $200,000 of gross proceeds from the issuance of 26,666,667 shares of common stock in private placements with accredited investors, which after deducting finder fees of $20,000 generated net proceeds of $180,000.

No private placements occurred in the quarter ending December 31, 2009.

During the quarter ended March 31, 2010 the Company received $50,000 of gross proceeds from the issuance of 4,000,000 shares of common stock in private placements with accredited investors, which after deducting finder fees of $5,000 generated net proceeds of $45,000.

In connection with the foregoing, the Company relied upon the exemption from securities registration afforded by Rule 506 of Regulation D as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended, and/or Section 4(2) of said Securities Act. No advertising or general solicitation was employed in offering the securities. The issuances were made to a limited number of persons, all of whom were accredited investors, and transfer of the securities was restricted in accordance with the requirements of the Securities Act of 1933.

101


Stock Based Compensation

The Company did not issue any awards of common stock or options to Officers, Directors or Employees during the fiscal year ended June 30, 2010. The Company issued 1,575,000 shares of common stock to various vendors and consultants valued at a total of $34,313 based upon the market price of the common stock on various different dates to such persons during the period.

Conversion of debt securities

During the fiscal year ended June 30, 2010, $3,415,250 of debt was converted into 232,723,736 shares of common stock to holders of Convertible Notes. The Company did not receive any proceeds in connection with such conversions.

In addition the Company issued 26,666,667 shares of common stock to Microphase Corporation for the conversion of $200,000 of previously outstanding accounts payable at $.0075 per share in a Private Placement pursuant to Section 3(a)(9) and Section 4(2) of the Securities Act of 1933. The price was based upon the price offered to investors in concurrent private placements with accredited investors during this period. The Company recorded an addition to interest expense on this beneficial conversion feature.

Long Term Convertible Debentures / Note Receivable / Debt Discount and Related Interest

(JMJ Financial, Inc.)

On August 19, 2009 the Company issued a 12% convertible note maturing on August 10, 2012 in the principal amount of $1,870,000 to JMJ Financial for a purchase price of $1,700,000 in a private placement pursuant to Section 4(2) of the Securities Act of 1933. The Company initially received $250,000 in cash as partial payment of the purchase price for the convertible note plus a 13.2% secured promissory note maturing on August 10, 2012 in the amount of $1,450,000. The number of shares into which this convertible note can be converted is equal to the dollar amount of the debenture divided by 75% of the lowest trading price during the 20 day trading period prior to conversion.

The Company has receive all cash installments due by June 29, 2010 from the holder for the purchase price of the instrument in the amount of $1,924,400 and the full amount of the debenture debt has been converted into 176,092,858 shares of common stock by the holder by October 12, 2010.

All proceeds received by the Company were used as working capital.

(JMJ Financial, Inc.)

On September 30, 2009, the Company issued a 12% convertible note maturing on September 23, 2012 in the principal amount of $1,200,000 to JMJ Financial for a purchase price of $1,100,000 in a Private Placement pursuant to Section 4(2) of the Securities Act of 1933. The Company initially received $150,000 in cash as partial payment of the purchase price for the convertible note plus a 13.2% secured promissory note maturing on August 10, 2012 in the amount of $950,000. The number of shares into which this convertible note can be converted is equal to the dollar amount of the note divided by 75% of the lowest trading price during the 20 day trading period prior to conversion. To date the Company has received a total of $1,244,100 cash equal to the purchase price of the instrument plus accrued interest through June 18, 2011 and has issued 240,722,223 shares of common stock to the holder upon conversions of the entire indebtedness through June 30, 2011. Accordingly the instrument has been fully paid off through such conversions.

All funds received were used by the Company as working capital.

(JMJ Financial, Inc.)

On November 17, 2009, the Company received a total of $186,000 of proceeds in connection with a new Private Placement pursuant to Section 4(2) of the Securities Act of 1933 with JMJ Financial. This transaction consists of the following: 1)25, 2019, the Company issued a convertible note in the amount of $1,200,000 plus a one-time interest factor of 12% ($144,000) and a maturity date of September 23, 2012 and (2) a secured promissory note in the amount of $1,100,000 plus a one-time interest rate factor of 13.2% ($144,000 each) and a maturity date of September 23, 2012 due from the holder of the convertible note.

Periodic prepayments under the secured note plus the amount originally received by the Company equal $639,500 as of the date hereof. Conversions of $33,750 ,$22,500 and $31,956 have been made into 10,000,000 shares, 5,000,000 shares and 9,187,500 shares respectively of common stock of the Company have been made through September 30, 2011. Conversion of outstanding principal into shares of common stock is at the option of the holder. The number of shares into which this note can be converted is equal to the dollar amount of the note divided by 75% of the lowest trade price during the 20 day trading period prior to conversion. A remaining balance of $604,500 to be funded as payment in full under the instrument is not expected to be made by agreement of the parties.

All cash proceeds received by the Company were used as working capital.

102


(JMJ Financial, Inc.)

On December 15, 2009 the Company entered into a new Private Placement pursuant to Section 4(2) of the Securities Act of 1933 agreement with JMJ Financial that consists of the following: 1) a convertible note issued by the Company in the amount of $1,500,000 plus a one-time interest factor of 12% ($180,000) and a maturity date of December15, 2012 and (2) a secured promissory note in the amount of $1,400,000 plus a one-time interest rate factor of 13.2% ($180,000 ) and a maturity date of December 15, 2012 due from the holder of the convertible note. The number of shares into which this convertible note can be converted is equal to the dollar amount of the note divided by 75% of the lowest trade price during the 20 day trading period prior to conversion.

To date the Company has received a total of $300,000 cash and has issued no shares of common stock to the holder upon conversions. The remaining $1,280,000 of cash to be received from the holder plus accrued and unpaid interest is not expected to be received by the mutual agreement of the parties. Based upon the stock price on September 30, 2011of $.0047 per share the holder could convert the outstanding balance into approximately 85,714,286 shares of the Company’s common stock.

All proceeds received in connection with the above transaction have been used by the Company as working capital.

(JMJ Financial, Inc.)

On April 5, 2010, the Company entered into a new Private Placement pursuant to Section 4(2) of the Securities Act of 1933 with JMJ Financial that consists of the following: 1) the issuance by the Company of a convertible note in the principal amount of $1,200,000 plus a one- time interest factor of 12% ($144,000) and a maturity date of December 15, 2012, and (2) a secured promissory note from the holder of the convertible note in the amount of $1,100,000 plus a one-time interest rate factor of 13.2% ($144,000 each) and a maturity date of December 15, 2012.$78,000.

To date

-44-

From July 1, 2019 through September 30, 2019, the Company has received a totalissued an aggregate of $100,000 cash and has issued no674,654 shares of common stock to the holder upon conversions. The remaining portion of the purchase price to be received from the holder plus accrued and unpaid interest under the secured note is not expected to be received by mutual agreement of the parties. The number of shares into which this convertible note can be converted is equal to the dollar amount of the note divided by 75% of the lowest trade price during the 20 day trading period prior to conversion. Based upon the price of the Company’s common stock on September 30, 2011Common Stock for the following; 380,000 shares under private placements and 294,654 shares for the conversion of $.0047 per sharerelated party debts and strategic vendor payables.

On July 1, 2019, the holder could convert the funded amount of this convertible note into approximately 28,571,429Company issued its Chief Executive Officer warrants to purchase up to 4,985,394 shares of common stock.the Company’s Common Stock pursuant to the terms of his employment agreement.

All proceeds received by

On July 30, 2019, the Company were used as working capital.

(John Fife)

On March 3, 2010, the Company entered into a new Private Placement pursuant to Section 4(2) of the Securities Act of 1933 with John Fife that consists ofissued a convertible promissory note issued by the Company in the principal amount of $550,000 bearing interest at 7.5% per annum in which$53,000.

On September 5, 2019, the Company received $495,000 cash up front. Theissued a convertible note has a maturity date of 4 years from the date of issuance. In addition, the Company has committed to issue in the future 2 additional promissory notes eachnote in the principal amount of $275,000, each with an interest rate of 7.5% and each upon$53,000.

On September 24, 2019, the receipt of $250,000 of cash funding in exchange for such notes. Each of the instruments isCompany issued convertible into the Company’s common stock at 75% of the volume weight average price of the stock based upon the average of the three lowest trading dayspromissory notes in the 20 day trading period immediately preceding such conversion.

Fiscal Year ended June 30, 2011

During the twelve months ended June 30, 2011, the holder converted $398,245 of principal into 65,280,866 shares of common stock. All proceeds received by the Company were used as working capital.

103


Private Placements

During the fiscal year ended June 30, 2011, the Company received $265,500 of net proceeds from the issuance of 67,500,000 shares of common stock in private placements with accredited investors effected pursuant to Rule 506 of Regulation D under the Securities Act. The aggregate cost of these placements was $29,500, and Eagle Advisors acted as placement agent.

All proceeds received from the financings were used by the Company for working capital needs. The dates and amounts of each placement are as follows: 10,000,000 shares of common stock were issued on both November 18, 2010 and December 1, 2010 respectively, 5 million shares of common stock were issued on December 20, 2010 and 30 million shares of common stock were issued on June 30, 2011. Subsequently, 12,500,000 shares of common stock were issued on July 6, 2011.

Stock Based Compensation

The Company did not issue any awards of common stock or options to officers, directors or employees during the fiscal year ended June 30, 2011. The Company issued 15,075,000 shares of common stock to various vendors and consultants valued at a total of $126,945 based upon the market price of the common stock on various different dates to such persons during the period. Such shares were issued pursuant to Section 3(a)(9) and Section 4(2) of the Securities Act of 1933 as Private Placements.

Conversion of debt securities

During the fiscal year ended June 30, 2011, $2,346,896 of debt and interest thereon was converted into 382,175,312 shares of common stock to holders of Convertible Notes. No proceeds were received by the Company.

Long Term Convertible Debentures / Note Receivable / Debt Discount and Related Interest

On October 22, 2010 the Company entered into a Forbearance Agreement with John Fife in respect of the financing agreement entered into on March 3, 2010, in which the lender agreed not to convert any additional amounts under the convertible notes until January 15, 2011 in exchange for increasing the original principal amount of those notes by 10% from $550,000 to $605,000 resulting$124,200 (including an aggregate of $9,200 in a chargeoriginal issuance discounts).

From October 1, 2019 through December 31, 2019, the Company issued an aggregate of $55,000 for debt extension fees corresponding with the addition to the note principal.

During the current fiscal year ending June 30, 2012, the following transactions resulted in the issuances72,000 shares of the Company’s Common Stock:Stock for the following; 10,000 shares under private placements and 62,000 shares for the conversion of related party debts and strategic vendor payables.

Private Placements

During the Quarter ended September 30, 2011,On October 1, 2019, the Company issued 32,500,000 shares of common stock in private placements, generating gross proceeds of $130,000 and it paid finders’ fees in connection therewith of $13,000its Chief Executive Officer warrants to Eagle Advisors who acted as placement agent. The proceeds were used as working capital by the Company.

In connection with the foregoing, the Company relied upon the exemption from securities registration afforded by Rule 506 of Regulation D as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended, and/or Section 4(2) of said Securities Act. No advertising or general solicitation was employed in offering the securities. The issuances were madepurchase up to a limited number of persons, all of whom were accredited investors, and transfer of the securities was restricted in accordance with the requirements of the Securities Act of 1933.

Stock Based Compensation

During the Quarter ended September 30, 2011 the Company issued awards of common stock and/or options to officers, directors and employees as follows: On August 25, 2011, the Board of Directors awarded Messrs Ronald A. Durando, CEO, Gustave T. Dotoli, COO and Martin Smiley, EVP, 395,000,000, 295,000,000 and 295,000,000 restricted shares of common stock of the Company and awarded Messrs. Abraham Biderman and Victor Lawrence, as Directors 40,000,000 and 10,000,000 restricted shares of common stock of the Company.

In addition, previous 5 year option awards issued on September 18, 2008 to Messrs. Durando, Dotoli and Smiley were re-priced to $.0040 per share from $.05 per share covering 50,000,000 shares, 30,000,000 shares and 18,000,000 shares of common stock of the Company respectively. Additionally, the Board amended the conversion feature of officers loans discussed in Note 9, originally with a conversion price of $.0075 in April 2009, to a conversion price of $.0040.

104


Since the issuances were made as additional compensation awards, the Company received no cash proceeds and no “sale“ of a security took place.

Conversion of debt securities

During the Quarter ended September 30, 2011, $57,250 of debt and $500 interest thereon was converted into 26,748,476 shares of common stock to holders of Convertible Notes.

Long Term Convertible Debentures / Note Receivable / Debt Discount and Related Interest

On September 13, 2011 the Company entered into a second Forbearance Agreements with John Fife restructuring the investment. Under the terms of the Forbearance Agreement the agreed principal amount of the Convertible Note outstanding was $328,000 and the two additional promissory notes were cancelled. As of September 30, 2011, $47,200 of the outstanding balance has been converted into 10,000,000 shares of common stock leaving a remaining outstanding balance of $280,800. Based upon the price of the Company’s common stock price of $.0047 on September 30, 2011, the holder could convert into approximately 59,744,68119,941,574 shares of the Company’s common stock.

The Convertible Note which originally scheduled to mature March 4, 2011was extended until June 30, 2012Common Stock pursuant to the Forbearance Agreement dated asterms of September 13, 2011. Increaseshis employment agreement.

On December 1, 2019, 57,909 shares of Common Stock, vested and were issued to our Chief Financial Officer, which shares were subject to a vesting schedule, for services rendered.

On December 2, 2019, the Company issued convertible promissory notes in the aggregate principal amount of $413,000 (including an aggregate of $14,250 in original issuance discounts).

On December 17, 2019, the Company issued a convertible promissory note in the principal amount of $81,000 (including a $6,000 original issuance discount).

From January 1, 2020 through March 31, 2020, the convertible note are also be convertible into common stockCompany issued an aggregate of 818,673 shares of the Company’s Common Stock for the following; 739,577 shares under private placements, 11,003 shares for services related to private placements, and 68,093 shares for the conversion of outstanding convertible notes.

On January 1, 2020, the Company at the optionissued its Chief Executive Officer warrants to purchase up to 12,463,484 shares of the holder at a price equalCompany’s Common Stock pursuant to the dollar amountterms of the note being converted divided by 75% of the three lowest volume weighted average prices during the 20 day trading period immediately preceding the date of conversion.his employment agreement.

On September 13, 2011January 9, 2020, the Company issued a second Convertible Note to John Fife in a Private Placement pursuant to Section 4(2) of the Securities Act of 1933. The initial principal amount of the first funded tranche of the Convertible Note was $357,500 and the Company received cash proceeds of $300,000. A second tranche of the Convertible Note in the amount of $200,000 cash is funded upon the filing by the Company of a Registration Statement on Form S-1 with the Securities and Exchange Commission providing for the registration of 185,400,000 shares of common stock that may be converted into from time to time by the holder of the Convertible Note. The instrument is convertible into the Company’s common stock at 80% of the volume weight average price of the stock based upon the average of the three lowest trading days in the 20 day trading period immediately preceding such conversion. Absent an effective Registration Statement, the holder of the Convertible Note may not sell any common stock prior to 6 months from the date of funding of each of the respective tranches of such instrument under Rule 144 of the Securities Act of 1933.

All proceeds received in connection with the above financing have been used by the Company as working capital.

(Jay Wright)

On August 11, 2011 the Company issued to Jay Wright a Convertible Note plus a Warrant in a Private Placement pursuant to Section 4(2) of the Securities Act of 1933 and received $25,000 in gross proceeds. The instrument ispromissory note in the principal amount of $25,000 and matures on February 11, 2011. Interest only is payable at the rate of 1% per month by$110,000 (including a $5,000 original issuance discount).

On January 21, 2020, the Company toissued a convertible promissory note in the holder until maturity. The Convertible Note may be converted into common stockprincipal amount of $68,000.

On February 24, 2020, the Company at $.0068 per share, provided, however, such price may be adjusted downward ifissued a convertible promissory note in the principal amount of $53,000.

On March 3, 2020, the Company issues any common stock below such price. The Warrant givesissued a convertible promissory note in the holderprincipal amount of $63,000.

From April 1, 2020 through June 30, 2020, the right for a periodCompany issued an aggregate of 5 years to purchase up to 3,676,4715,804,269 shares of the Company’s common stock also at $.0068 per shareCommon Stock for the conversion of outstanding convertible notes.

On May 11, 2020, the Company entered into an Asset Purchase Agreement (“APA”) to acquire CloseComms Limited. Pursuant to the terms of the APA, the purchase price was 2,666,666 restricted shares of the Company’s Common Stock.

On June 1, 2020, 57,909 shares of Common Stock, vested and were issued to our Chief Financial Officer, which shares were subject also to a downward adjustment to provide anti-dilution protection.vesting schedule, for services rendered.

Dutchess Equity Line

On November 30, 2011,June 2, 2020, the Company issued 26,000,000a convertible promissory note in the principal amount of $78,000.

On June 12, 2020, the Company issued a convertible promissory note in the principal amount of $103,000.

From July 1, 2020 through August 13, 2020, the Company issued an aggregate of 16,531,766 shares of the Company’s Common Stock for the following; 200,000 shares for vendor services, and 16,331,766 shares for the conversion of outstanding convertible notes.

On July 15, 2020, the Company entered into an exchange agreement with its common stockChief Executive Officer whereby earned and issued warrants to Dutchess as a Commitment Fee for an equity line of credit pursuant to Section 4(2)purchase 37,390,452 shares of the Securities ActCompany’s Common Stock were forfeited and exchanged for 37,390,452 shares of 1933, as amended. the Company’s Common Stock. 

On July 24, 2020, the Company issued a convertible promissory note in the principal amount of $105,000 (including a $5,000 original issuance discount).

On July 31, 2020, the Company issued a convertible promissory note in the principal amount of $68,000.

-45-

EXHIBITS AND FINANCIAL STATEMENTS SCHEDULES

(a) Exhibits

The Company did not receive any proceeds in connection  with this private placement exhibit index attached hereto is incorporated herein by reference.

(b) Financial Statement Schedule

All proceeds received in connection with the above financingschedules have been used byomitted because the Company as working capital.information required to be set forth in the schedules is either not applicable or is shown in the financial statements or notes thereto.

Item 16. Exhibits and Financial Statement Schedules

2.1*

Exchange of Stock Agreement and Plan of Reorganization (incorporated by reference to Exhibit 2(a) to our registration statement on Form 10SB-12G filed on October 16, 1998 (file no. 000-24969)).

2.2*

Exchange of Stock Agreement and Plan of Reorganization dated June 25, 1998 (incorporated by reference to Exhibit 2(b) to our registration statement on Form 10SB-12G filed on May 6, 1999 (file no. 000-24969)).

3.1***

Certificate of Incorporation of the Company.

105



3.2***

Bylaws of the Company

4.1*

Minutes of Special Meeting of the Board of Directors held on April 27, 2009, authorizing convertibility of officers’ promissory notes. (Amendment No. 4 to Form 10-K for the period ended June 30, 2010, filed January 11, 2011 (file no. 000-30202))

5.1

Opinion of Martin Smiley, ESQ., General Counsel To The Company.

10.1*

License Agreement, dated March 26, 1998, between the Company and Georgia Tech Research Corporation (incorporated by reference to Exhibit 10(e) to our registration statement on Form 10SB-12G filed on October 16, 1998 (file no. 000- 24969)).

10.2*

First Amendment to the License Agreement dated January 8, 2001, between the Company and Georgia Tech Research Corporation (incorporated by reference to Exhibit 10.2 to our registration statement on Form S-1 filed on June 18, 2001 (file no. 33-63262)).

10.9*

Facilities/Services Agreement between the Company and Microphase Corporation, dated as of July 1, 1998 (incorporated by reference to Exhibit 10.9 to our registration statement on Form S- 1 filed on June 18, 2001 (file no. 33- 63262).

10.10*

Company’s 2001 Stock Incentive incorporated by reference to Exhibit C to Preliminary Proxy on Schedule 14A filed on March 21, 2001 (file no. 000- 30202).

10.18***

Development Agreement effective February 3, 2004 between Lucent Technologies, Inc. and mPhase Technologies, Inc for development of micro fuel cell Nano Technology.

10.21***

Development Agreement effective March 1, 2005 between Lucent Technologies Inc and mPhase Technologies relating to development of Magnetometers.

10.22***

Amendment No. 2 to Development Agreement executed as of March 9, 2005 amending Development Agreement effective as of February 5, 2004, as amended relating to Micro Power Source Cells between mPhase Technologies, Inc. and Lucent Technologies, Inc.

10.33***

Amendment No. 3 dated May 19, 2006 to Development Agreement between Lucent Technologies, Inc. and mPhase Technologies, Inc. effective February 3, 2004 for Development of micro fuel cell Nanotechnology.

10.34***

Amendment No. 4 dated February 3, 2007 to Development Agreement between Lucent Technologies, Inc. and mPhase Technologies, Inc. effective February 3, 2004 for Development of micro fuel cell Nanotechnology.

10.35***

Cooperative Research Agreement Rutgers University and mPhase Technologies, Inc. executed October 18, 2005.

10.36***

Modification No. 1 to Cooperative Research Agreement with Rutgers University dated February 22, 2006.

10.37***

Modification No. 2 to Cooperative Research Agreement with Rutgers University dated September 22, 2006.

10.38***

Modification No. 3 to Cooperative Research Agreement with Rutgers University dated February 7, 2007.

10.40***

CT NanoBusiness Alliance Consulting Agreement dated May 10, 2007.

10.41***

Amendment No.5 dated April 28, 2007 to Development Agreement between Lucent Technologies, Inc. and mPhase Technologies, Inc. effective February 3, 2004 for Development of micro fuel cell Nanotechnology.

10.43*

Cooperative Research and Development Agreement between US Army Picatinny Arsenal and mPhase Technologies, Inc. dated December 20, 2006. (Exhibit 43 to Form S-1 filed July 12, 2007, File No. 333-144527).

10.44***.

Small Business Technology Transfer Collaboration Agreement between Rutgers University and mPhase Technologies, Inc. dated June 25, 2007

10.46*

Phase I Army Grant dated July 7, 2007 (Form 10-K filed October 7, 2009, Commission File No. 000-24969)

10.47*

Securities Purchase Agreement dated December 11, 1007 between mPhase Technologies, Inc. and Golden Gate Investors and Related Documents in connection with $1,500,000 Convertible Debenture Financing (Form 10-K filed October 7, 2009, Commission File No. 000-24969)

10.48*

Securities Purchase Agreement dated February 29, 2008 between St. George Investments and mPhase Technologies, Inc and Related Documents in connection with $550,000 Convertible Debenture Financing. (Form 10-K filed October 7, 2009, Commission File No. 000-24969)

10.49*

Documentation including $350,000 Convertible Note and $1,000,000 Convertible Note and Secured Note for $1,000,000 Financing between mPhase Technologies, Inc. and JMJ Financial dated March 25, 2008 (Form 10-K filed October 7, 2009, Commission File No. 000-24969)

10.52*

Phase II Army Grant dated August 29, 2008 (Form 10-K filed October 7, 2009, Commission File No. 000-24969)

10.53*

Securities Purchase Agreement dated September 12, 2008 between mPhase Technologies, Inc. and La Jolla Cove Investors and Related Documents in connection with $2,000,000 Convertible Debenture Financing (Form 8K filing dated September 18, 2008)

10.54*

Design Development Agreement between mPhase Technologies, Inc. and Porsche Design Studio for Emergency Flashlight dated November 3, 2008. (Form 8K filed on March 12, 2009) **

10.55*

Documentation dated December 31, 2008 for $1,100,000 Convertible Note and Secured Note Financing between mPhase Technologies, Inc. and JMJ Financial and Amendment to $350,000 Convertible Note Financing (Form 8K Filing dated January 21, 2009, Commission File No. 000-24969)

106



10.56*

Eagle Picher Proposal for mPhase Technologies, Inc. dated January 26, 2009 for design and development of mechanically- activated Reserve Battery to be used in Emergency Flashlight. (Form 8-K filed January 30, 2009)**

10.57*

Termination Agreement with Golden Gate Investors dated March 17, 2009 with respect to Convertible Debenture Financing dated December 11, 2007 (Form 10-K filed October 7, 2009, Commission File No. 000-24969)

10.59*

Documentation including $1,870,000 Convertible Note and Secured Note for Financing with JMJ Financial dated August 21, 2009 (Form August 21, 2009, Commission File No. 000-24969)

10.60*

Documentation including two $1,200,00 Convertible Notes executed September 23, 2009 and November 17, 2009 and Secured Notes r connection with financing with JMJ Financial (Amendment No. 3 to Form 10Q for the period ended December 31, 2009 filed September 3,2010, Commission File No. 000-30202)

10.61*

Promissory Notes Payable to Mr. Durando (Amendment No. 4 to Form 10-K for the period ended June 30, 2010, filed January 11, 2011 (Commission File No. 000-30202))

10.62*

Promissory Notes Payable to Mr. Dotoli (Amendment No. 4 to Form 10-K for the period ended June 30, 2010, filed January 11, 2011 (Commission File No. 000-30202))

10.63*

Promissory Notes Payable to Mr. Smiley (Amendment No. 4 to Form 10-K for the period ended June 30, 2010, filed January 11, 2011 (Commission File No. 000-30202))

10.64*

Forbearance Agreement dated as of September 13, 2011 between mPhase Technologies, Inc. and John Fife ( Exhibit 99.1 to Form 8k filed September 16, 2011, (Commission file No. 000-24969))

10.65*

Securities Purchase Agreement, dated as of September 13, 2011 between mPhase Technologies, Inc and John Fife ( Exhibit 99.2 to Form 8k filed September 16, 2011, (Commission file No. 000-24969))

10.66*

Officer’s Certificate delivered pursuant to Securities Purchase Agreement, dated as of September 13, 2011 between mPhase Technologies, Inc. and John Fife (Exhibit 99.3 to Form 8k filed September 16, 2011, (Commission file No. 000- 24969))

10.67*

Confession of Judgment 1 delivered pursuant to Securities Purchase Agreement, dated as of September 13, 2011 between mPhase Technologies, Inc. and John Fife (Exhibit 99.4 to Form 8k filed September 16, 2011, (Commission file No. 000- 24969))

10.68*

Confession of Judgment 2 delivered pursuant to Securities Purchase Agreement, dated as of September 13, 2011 between mPhase Technologies, Inc. and John Fife (Exhibit 99.5 to Form 8k filed September 16, 2011, (Commission file No. 000- 24969))

10.69*

Registration Rights Agreement dated as of September 13, 2011 between mPhase Technologies, Inc. and John Fife (Exhibit 99.6 to Form 8k filed September 16, 2011, (Commission file No. 000-24969))

10.70*

Convertible Note dated September 13, 2011issued by mPhase Technologies, Inc. to John Fife (Exhibit 99.7 to Form 8k filed September 16, 2011, (Commission file No. 000-24969))

10.71

Convertible Note dated August 11, 2011 issued by mPhase Technologies to Jay Wright

10.72

Warrant dated August 11, 2011 issued by mPhase Technologies to Jay Wright

10.73Investment Agreement
10.74Registration Rights Agreement
21.1

Consent of Demetrius and Company

21.2

Consent of Rosenberg Rich Baker Berman & Company

21.3

Consent of Schuhalter, Coughlin & Suozzo, LLC (formerly Schuhalter, Coughlin & Suozzo, PC)


*

Incorporated by reference.

**

All or portions of such Agreements have been omitted and the Company has requested that the omitted sections be treated as “Confidential Information” pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended and has been filed with the Securities and Exchange Commission separately.

***

Incorporated by reference from Amendment No. 6 to Form 10K for the period ended June 30, 2009 file on August 13, 2009.

107


Item 17. UndertakingsUNDERTAKINGS

(a) The undersigned Registrantregistrant hereby undertakes:

1.

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:Registration Statement:

(a)

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

(b)

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in the volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

(c)

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.

Provided however, that:

(1)That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(2)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(4)That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

(i)If the registrant is relying on Rule 430B (§230.430B of this chapter):

               (i) Paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the registration statement is on Form S-8, and the information required to be included in a post-effective amendment by those paragraphs is contained in reports(A) Each prospectus filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d)Rule 424(b)(3) (§230.424(b)(3) of this chapter) shall be deemed to be part of the Securities Exchange Actregistration statement as of 1934 that are incorporated by referencethe date the filed prospectus was deemed part of and included in the registration statement; and

 (ii) Paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the registration statement is on Form S-3 or Form F-3 and the information

(B) Each prospectus required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is(2), (b)(5), or (b)(7) (§230.424(b)(2), (b)(5), or (b)(7) of this chapter) as part of thea registration statement.

2. That,statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) (§230.415(a)(1)(i), (vii), or (x) of this chapter) for the purpose of determining any liability underproviding the information required by section 10(a) of the Securities Act of 1933 eachshall be deemed to be part of and included in the registration statement as of the earlier of the date such post- effective amendmentform of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities offered herein,in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

3. To remove from Provided, however, that no statement made in a registration by means of a post-effective amendment anystatement or prospectus that is part of the securities being registered which remain unsold atregistration statement or made in a document incorporated or deemed incorporated by reference into the terminationregistration statement or prospectus that is part of the offering.

4. That, for determining liabilityregistration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the undersigned registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities;

               The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or soldmade in any such document immediately prior to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offereffective date; or sell such securities to such purchaser:

108


-46-

(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

SinceIf the registrant is subject to Rule 430,430C (§230.430C of this chapter), each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430(B)430B or other than prospectuses filed in reliance on Rule 430A (§230.430A of this chapter), shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness.Provided,;however,, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

Insofar as indemnification for liabilities arising

(5)That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities:

The undersigned registrant undertakes that in a primary offering of securities of the Securities Act of 1933 may be permitted to directors, officers and controlling persons of theundersigned registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinionthis registration statement, regardless of the Securities and Exchange Commissionunderwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the paymentpurchaser by the registrantmeans of expenses incurred or paid by a director, officer or controlling personany of the registrant infollowing communications, the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, theundersigned registrant will unless inbe a seller to the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Actpurchaser and will be governedconsidered to offer or sell such securities to such purchaser:

(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424 (§230.424 of this chapter);

(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the final adjudicationundersigned registrant;

(iii) The portion of such issue.any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

109


(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

(b)The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c)Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

-47-

SIGNATURES

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statementRegistration Statement on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Norwalk,Gaithersburg, State of Connecticut,Maryland, on January 17, 2012.August 14, 2020.

mPhase Technologies, Inc.

mPHASE TECHNOLOGIES, INC.
/s/ Anshu Bhatnagar
Anshu Bhatnagar
Chief Executive Officer (Principal Executive Officer)

By: /s/Ronald A. Durando
Ronald A. Durando
President and Chief Executive
Officer and Director (Principal Chief
Executive Officer)

By: /s/Martin S. Smiley
Martin S. Smiley
EVP and Chief Financial Officer
General Counsel and Director and
PRINCIPAL ACCOUNTING OFFICER

Each person whose signature appears below constitutes and appoints Ronald A. Durando his true and lawful attorney in fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any or all amendments (including post effective amendments) to the Registration Statement, and to sign any registration statement for the same offering covered by this Registration Statement that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and all post effective amendments thereto, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, each acting alone, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statementRegistration Statement has been signed below by the following persons in the capacities and on the dates indicated.

By:/s/Ronald A. DurandoNameJanuary 17, 2012TitleDate
Ronald A. Durando 
/s/ Anshu BhatnagarChief Executive Officer Directorand Chairman of the BoardAugust 14, 2020
Anshu Bhatnagar(Principal Executive Officer) 
By:/s/Gustave T. DotoliJanuary 17, 2012
Gustave T. Dotoli 
/s/ Christopher CutchensChief OperatingFinancial Officer DirectorAugust 14, 2020
Christopher Cutchens(Principal Financial and Accounting Officer) 

By:/s/Martin S. Smiley-48-

Exhibit NumberDescription
2.1Exchange of Stock Agreement and Plan of Reorganization (incorporated by reference to Exhibit 2(a) to our registration statement on Form 10SB-12G filed on October 16, 1998 (Commission File no. 000-24969)).
2.2Exchange of Stock Agreement and Plan of Reorganization dated June 25, 1998 (incorporated by reference to Exhibit 2(b) to our registration statement on Form 10SB-12G filed on May 6, 1999 (Commission File no. 000-24969)).
3.1Certificate of Incorporation of the Company. (Exhibit 3.1 to Form S-1 filed July 19, 2019 Registration No. 333-23273).
3.2Amendment to Certificate of Incorporation of the Company creating a new class of Series A Super voting - Preferred Stock of the Company and increase of authorized shares of common stock to 125 billion shares (Exhibit 10.1 to Form 8-K filed January 4, 2019, (Commission File No. 00024969)).
3.3By Laws of the Company (Exhibit 3.3 to Form S-1 filed July 19, 2019 Registration No. 333-23273).
3.4Amendment to Certificate of Incorporation of the Company increasing the authorized shares of common stock to 100 million shares from 25 million shares (Form 8-K filed September 9, 2019, (Commission File No. 00030202)).
3.5Amendment to Certificate of Incorporation of the Company increasing the authorized shares of common stock to 250 million shares from 100 million shares (Form 8-K filed July 17, 2020, (Commission File No. 00030202)).
3.6Amendment to Certificate of Incorporation of the Company increasing the authorized shares of common stock to 500 million shares from 250 million shares (Form 8-K filed August 6, 2020, (Commission File No. 00030202)).
4.1Definitive Schedule 14C Information Statement for a 5000/1 Reverse Split of the Company’s Common stock (filed April 22, 2019).
5.1*Opinion of Mailander Law Office, Inc., as to the legality of securities being registered
10.1Development Agreement effective February 3, 2004 between Lucent Technologies, Inc. and mPhase Technologies for development of micro fuel cell Nano Technology (Exhibit 10.18 to Amendment No. 6 to Form 10-K filed August 13, 2010, (Commission File No. 000-30202)).
10.2Amendment No.2 to Development Agreement executed as of March 9, 2005 amending Development Agreement effective as of February 3, 2004, as amended relating to Micro Power Source Cells between mPhase Technologies, Inc. and Lucent Technologies, Inc. (Exhibit 10.22 to Amendment No. 6 to Form 10-K filed August 13, 2010, (Commission File No. 000-30202)).
10.3Amendment No. 3 dated May 19, 2006 to Development Agreement between Lucent Technologies, Inc. and mPhase Technologies, Inc. effective February 3, 2004 for development of micro fuel cell nanotechnology (Exhibit 10.33 to Amendment No. 1 to Form 10-K filed August 13, 2010, (Commission File No. 000-30202)).
10.4Amendment No. 4 dated February 3, 2007 to Development Agreement effective February 3, 2004 for development of Micro Fuel Cell Nanotechnology (Exhibit 10.34 to Amendment No. 6 to Form 10-K filed August 13, 2010, (Commission File No. 000-30202)).
10.5Phase I U.S. Army Grant dated July 7, 2007 (Exhibit 10.46 to Form 10-K filed October 7, 2009, (Commission File No. 000-24969)).
10.6Documentation including $350,000 Note and $1,000,000 Secured Note for financing between the Company and JMJ Financial dated March 25, 2008 (Exhibit 10.49 to Form 10-K filed October 7, 2009, (Commission File No. 000-24969)).
10.7Phase II U.S. Army grant dated August 29, 2008 (Exhibit 10.52 to Form 10-K filed October 6, 2009, (Commission File No. 000-24969)).
10.8Forbearance Agreement dated as of September 13, 2011 between mPhase Technologies, Inc. and John Fife (Exhibit 99.1 to Form 8-K filed September 16, 2011, Commission file No. 000-24969).
10.9Securities Purchase Agreement, dated as of September 13, 2011 between mPhase Technologies, Inc and John Fife (Exhibit 99.2 to Form 8-K filed September 16, 2011, (Commission file No. 000-24969)).
10.10Officer’s Certificate delivered pursuant to Securities Purchase Agreement, dated as of September 13, 2011 between mPhase Technologies, Inc. and John Fife (Exhibit 99.3 to Form 8-K filed September 16, 2011, (Commission file No. 000- 24969)).
10.11Confession of Judgment 1 delivered pursuant to Securities Purchase Agreement, dated as of September 13, 2011 between mPhase Technologies, Inc. and John Fife (Exhibit 99.4 to Form 8-K filed September 16, 2011, (Commission file No. 000- 24969)).
10.12Confession of Judgment 2 delivered pursuant to Securities Purchase Agreement, dated as of September 13, 2011 between mPhase Technologies, Inc. and John Fife (Exhibit 99.5 to Form 8-K filed September 16, 2011, (Commission file No. 000- 24969)).
10.13Registration Rights Agreement dated as of September 13, 2011 between mPhase Technologies, Inc. and John Fife (Exhibit 99.6 to Form 8-K filed September 16, 2011, (Commission file No. 000-24969)).
10.14Convertible Note dated September 13, 2011issued by mPhase Technologies, Inc. to John Fife (Exhibit 99.7 to Form 8-K filed September 16, 2011, (Commission file No. 000-24969)).
10.15Stand Still and Restructuring Agreement entered into as of May 31,2012 with John Fife (Exhibit 99.1 to Form 8-K filed June 5, 2012 (Commission file No. 000-24969)).
10.16Stand Still and Restructuring Agreement entered into as of June 1,2012 with JMJ Financial (Exhibit 99.2 to Form 8-K filed June 5, 2012 (Commission file No. 000-24969)).
10.17Forbearance Agreement and Amendment thereto dated February 15, 2015 as amended on August 11, 2015 with John Fife (Exhibits 99.1 and 99.2 to form 8-K filed August 12, 2015, (Commission File No. 000-24969)).
10.18Second Modification to Forbearance Agreement with John Fife (Exhibit 99.1 to Form 8-K filed January 29, 2016, Commission File No. 000-30202)).

-49-

10.19Third Modification to Forbearance Agreement with John Fife (Exhibit 99.1 to Form 8-K filed May 23rd, 2016, (Commission File No. 000-24969)).
10.20Amendment to Judgment Settlement Agreement with John Fife (Exhibit 10.1 to Form 8-K filed February 23, 2018, (Commission File No. 000-24969)).
10.21Debt/Equity Conversion Agreements of Related Parties, dated as of January 1, 2018 (Exhibit 10.97 to Form 10-K filed October 15, 2018, (Commission File No. 000-30202)).
10.22Employment Agreement dated as of January 11, 2019 between Mr. Anshu Bhatnagar and mPhase Technologies, Inc. (Exhibit 10.1 to Form 8-K filed January 14, 2019, (Commission File No. 000-30202)).
10.23Transition Agreement dated as of January 11, 2019 (Exhibit 10.2 to Form 8-K filed January 14, 2019, (Commission File No. 000-30202)).
10.24Warrant granted to Mr. Anshu Bhatnagar (Exhibit 10.3 to Form 8-K filed January 14, 2019, (Commission File No. 000-30202)).
10.25Series A Super Voting Preferred Stock (Exhibit 10.4 to Form 8-K filed January 14, 2019, (Commission File No. 000-30202)).
10.26Reserve Agreement (Exhibit 10.5 to Form 8-K filed January 14, 2019, (Commission File No. 000-30202)).
10.27Debt Conversion Agreement (Exhibit 10.6 to Form 8-K filed January 14, 2019, (Commission File No. 000-30202)).
10.28Officers and Directors Resignation Letters (Exhibit 10.7 to Form 8-K filed January 14, 2019, (Commission File No. 000-30202)).
10.29Amendment to Judgment Settlement Agreement with John Fife (Exhibit 10.1 to Form 8-K filed February 11, 2019, (Commission File No. 000-24969)).
10.30Stock Purchase Agreement with AI Robotics (Exhibit 1 to Form 8-K filed April 25, 2019, (Commission File No. 000-30202)).
10.31Employment Agreement effective June 1, 2019 between Christopher Cutchens and the Company (Exhibit 10.1 to Form 8-K filed June 6, 2019, (Commission File No. 000-30202).
10.32Securities Purchase Agreement and Convertible Promissory Note each dated as of June 19, 2019 between the Company and Power Up Lending Group LTD (Form 8-K Exhibits 10.1 and 10.2, filed July 1, 2019, (Commission File No. 000-30202)).
10.33Securities Purchase Agreement and Convertible Promissory Note each dated as of July 30, 2019 between the Company and Power Up Lending Group LTD (Form 8-K Exhibits 10.1 and 10.2, filed August 1, 2019, (Commission File Number 000-30202)).
10.34Product License and Content Agreement (“Agreement”) between the Company and iLearningEngines, Inc., a Delaware corporation (“ILE”). (Exhibit 1 to Amendment No. 1 to Form 8-K, filed August 12, 2019, (Commission File No. 000-30202)).
10.35Securities Purchase Agreement and Convertible Promissory Note each dated as of September 5, 2019 between the Company and Power Up Lending Group LTD (Form 8-K Exhibits 10.1 and 10.2, filed September 12, 2019, (Commission file No. 000-30202)).
10.36Securities Purchase Agreement and Convertible Promissory Notes each dated as of September 24, 2019 between the Company and Accredited Investors (Form 8-K Exhibits 10.1 and 10.2, filed October 3, 2019, (Commission file No. 000-30202)).
10.37Amendment to Reserve Agreement dated October 9, 2019 (Form 10-K Exhibit 10.37, filed October 15, 2019, (Commission file No. 000-30202)).
10.38Securities Purchase Agreement and Convertible Promissory Note each dated as of December 2, 2019 between the Company and an Accredited Investor (Form 8-K Exhibits 10.1 and 10.2, filed December 6, 2019, (Commission file No. 000-30202)).
10.39Securities Purchase Agreements and Convertible Promissory Notes each dated as of December 2, 2019 between the Company and Accredited Investors (Form 8-K Exhibits 10.1, 10.2, 103, and 10.4, filed December 9, 2019, (Commission file No. 000-30202)).
10.40Securities Purchase Agreement and Convertible Promissory Note each dated as of December 17, 2019 between the Company and an Accredited Investor (Form 8-K Exhibits 10.1 and 10.2, filed December 23, 2019, (Commission file No. 000-30202)).

-50-

10.41Securities Purchase Agreement and Convertible Promissory Note each dated as of January 9, 2020 between the Company and an Accredited Investor (Form 8-K Exhibits 10.1 and 10.2, filed January 17, 20122020, (Commission file No. 000-30202)).
Martin Smiley10.42 Securities Purchase Agreement and Convertible Promissory Note each dated as of January 21, 2020 between the Company and an Accredited Investor (Form 8-K Exhibits 10.1 and 10.2, filed January 28, 2020, (Commission file No. 000-30202)).
Executive Vice President,10.43Securities Purchase Agreement and Convertible Promissory Note each dated as of February 24, 2020 between the Company and an Accredited Investor (Form 8-K Exhibits 10.1 and 10.2, filed February 28, 2020, (Commission file No. 000-30202)).
10.44Securities Purchase Agreement and Convertible Promissory Note each dated as of March 3, 2020 between the Company and an Accredited Investor (Form 8-K Exhibits 10.1 and 10.2, filed March 9, 2020, (Commission file No. 000-30202)).
10.45Asset Purchase Agreement dated as of May 11, 2020 between the Company and CloseComms Limited (Form 8-K Exhibit 10.1, filed May 15, 2020, (Commission file No. 000-30202)).
10.46Securities Purchase Agreement and Convertible Promissory Note each dated as of June 2, 2020 between the Company and an Accredited Investor (Form 8-K Exhibits 10.1 and 10.2, filed June 8, 2020, (Commission file No. 000-30202)).
10.47Convertible Promissory Note dated as of June 12, 2020 between the Company and an Accredited Investor (Form 8-K Exhibit 10.1, filed June 22, 2020, (Commission file No. 000-30202)).
10.48Common Stock Purchase Agreement and Registration Rights Agreement, by and among mPhase Technologies, Inc. and White Lion Capital, LLC, dated July 13, 2020 (Form 8-K Exhibits 10.1 and 10.2, filed July 17, 2020, (Commission file No. 000-30202)).
10.49Exchange Agreement dated as of July 15, 2020 between Mr. Anshu Bhatnagar and mPhase Technologies, Inc. (Form 8-K Exhibit 10.3, filed July 17, 2020, (Commission file No. 000-30202)).
10.50Securities Purchase Agreement and Convertible Promissory Note each dated as of July 24, 2020 between the Company and an Accredited Investor (Form 8-K Exhibits 10.1 and 10.2, filed July 30, 2020, (Commission file No. 000-30202)).
10.51Securities Purchase Agreement and Convertible Promissory Note each dated as of July 31, 2020 between the Company and an Accredited Investor (Form 8-K Exhibits 10.1 and 10.2, filed August 6, 2020, (Commission file No. 000-30202)).
20.1Financial Statements of Alpha Predictions (Exhibits 99.1 and 99.2 to Form 8-K/A Amendment No. 1 filed September 13, 2019, (Commission File No. 000-30202)).
21.1*List of subsidiaries
23.1*Consent of Assurance Dimensions
23.2*Consent of Mailander Law Office, Inc. (included as part of Exhibit 5.1)
99.1Minutes of Board of Directors meeting electing Anshu Bhatnagar to the Board of Directors of the Company (Exhibit 99,1 to Form S-1 filed July 19, 2019 (Commission Registration No. 333-23273)).
99.2Announcement of James Largotta declining to serve on Board of Directors of the Company (Form 8-K filed February 19, 2019, (Commission File No. 000-30202)).
99.3Minutes of Board of Directors Meeting electing Martin Smiley as Interim CFO of the Company (Exhibit 10.1 to Form 8-K filed February 1, 2019, (Commission File No. 000-30202)).
99.4Resignation of Ronald Durando as a member of the Board of Directors of the Company (Form 8-K filed March 20, 2019, (Commission File No. 000-30202)).
99.5Resignation Letter of Martin Smiley as Interim CFO of the Company (Exhibit 10.2 to Form 8-K filed June 6, 2019, (Commission File No. 000-30202)).
99.6Minutes of Board of Directors Meeting electing Christopher Cutchens as Chief Financial Officer and General Counsel, Director
By:/s/Anthony GuerinoJanuary 17, 2012
Anthony Guerino
Director
By:/s/Abraham BidermanJanuary 17, 2012
Abraham Biderman
Director
By:/s/Victor LawerenceJanuary 17, 2012
Victor Lawrence
Directorof the Company (Exhibit 10.3 to Form 8-K filed June 6, 2019. (Commission File No. 000-30202)).

110


* Filed herewith.

-51-